BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 562605 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(CC(F)(F)F)c2)n1 InChI=1S/C23H21F3N6O2S/c1-14-6-7-18(35(33,34)31-21-5-3-4-15(2)30-21)9-19(14)16-8-20(22(27)28-10-16)17-11-29-32(12-17)13-23(24,25)26/h3-12H,13H2,1-2H3,(H2,27,28)(H,30,31) NSTFOXCDXMJUGH-UHFFFAOYSA-N 295029 3-{6-Amino-5-[1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-4-yl]-pyridin-3-yl}-4-methyl-N-(6-methyl-pyridin-2-yl)-benzenesulfonamide::US10112926, Example 1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 190 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295029&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470282 381618124 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562606 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(CC(F)(F)F)c2)n1 InChI=1S/C23H21F3N6O2S/c1-14-6-7-18(35(33,34)31-21-5-3-4-15(2)30-21)9-19(14)16-8-20(22(27)28-10-16)17-11-29-32(12-17)13-23(24,25)26/h3-12H,13H2,1-2H3,(H2,27,28)(H,30,31) NSTFOXCDXMJUGH-UHFFFAOYSA-N 295029 3-{6-Amino-5-[1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-4-yl]-pyridin-3-yl}-4-methyl-N-(6-methyl-pyridin-2-yl)-benzenesulfonamide::US10112926, Example 1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4050 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295029&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470282 381618124 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562607 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(CC(F)(F)F)c2)n1 InChI=1S/C23H21F3N6O2S/c1-14-6-7-18(35(33,34)31-21-5-3-4-15(2)30-21)9-19(14)16-8-20(22(27)28-10-16)17-11-29-32(12-17)13-23(24,25)26/h3-12H,13H2,1-2H3,(H2,27,28)(H,30,31) NSTFOXCDXMJUGH-UHFFFAOYSA-N 295029 3-{6-Amino-5-[1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-4-yl]-pyridin-3-yl}-4-methyl-N-(6-methyl-pyridin-2-yl)-benzenesulfonamide::US10112926, Example 1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >9100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295029&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470282 381618124 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562608 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(CC(F)(F)F)c2)n1 InChI=1S/C23H21F3N6O2S/c1-14-6-7-18(35(33,34)31-21-5-3-4-15(2)30-21)9-19(14)16-8-20(22(27)28-10-16)17-11-29-32(12-17)13-23(24,25)26/h3-12H,13H2,1-2H3,(H2,27,28)(H,30,31) NSTFOXCDXMJUGH-UHFFFAOYSA-N 295029 3-{6-Amino-5-[1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-4-yl]-pyridin-3-yl}-4-methyl-N-(6-methyl-pyridin-2-yl)-benzenesulfonamide::US10112926, Example 1 Phosphatidylinositol 4-kinase beta Human 1950 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295029&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470282 381618124 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562609 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(CC(F)(F)F)c2)n1 InChI=1S/C23H21F3N6O2S/c1-14-6-7-18(35(33,34)31-21-5-3-4-15(2)30-21)9-19(14)16-8-20(22(27)28-10-16)17-11-29-32(12-17)13-23(24,25)26/h3-12H,13H2,1-2H3,(H2,27,28)(H,30,31) NSTFOXCDXMJUGH-UHFFFAOYSA-N 295029 3-{6-Amino-5-[1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-4-yl]-pyridin-3-yl}-4-methyl-N-(6-methyl-pyridin-2-yl)-benzenesulfonamide::US10112926, Example 1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 7.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295029&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470282 381618124 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562610 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(CC(F)(F)F)c2)n1 InChI=1S/C23H21F3N6O2S/c1-14-6-7-18(35(33,34)31-21-5-3-4-15(2)30-21)9-19(14)16-8-20(22(27)28-10-16)17-11-29-32(12-17)13-23(24,25)26/h3-12H,13H2,1-2H3,(H2,27,28)(H,30,31) NSTFOXCDXMJUGH-UHFFFAOYSA-N 295029 3-{6-Amino-5-[1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-4-yl]-pyridin-3-yl}-4-methyl-N-(6-methyl-pyridin-2-yl)-benzenesulfonamide::US10112926, Example 1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 170 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295029&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470282 381618124 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562611 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(CC(F)(F)F)c2)n1 InChI=1S/C23H21F3N6O2S/c1-14-6-7-18(35(33,34)31-21-5-3-4-15(2)30-21)9-19(14)16-8-20(22(27)28-10-16)17-11-29-32(12-17)13-23(24,25)26/h3-12H,13H2,1-2H3,(H2,27,28)(H,30,31) NSTFOXCDXMJUGH-UHFFFAOYSA-N 295029 3-{6-Amino-5-[1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-4-yl]-pyridin-3-yl}-4-methyl-N-(6-methyl-pyridin-2-yl)-benzenesulfonamide::US10112926, Example 1 Serine/threonine-protein kinase mTOR Human 2370 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295029&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470282 381618124 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562612 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H27N5O3S/c1-14-5-6-17(30(28,29)25-8-7-21(2,3)27)10-18(14)15-9-19(20(22)23-11-15)16-12-24-26(4)13-16/h5-6,9-13,25,27H,7-8H2,1-4H3,(H2,22,23) PVVPCKINUWBPAJ-UHFFFAOYSA-N 295030 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 2 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 530 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295030&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469996 381618125 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562613 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H27N5O3S/c1-14-5-6-17(30(28,29)25-8-7-21(2,3)27)10-18(14)15-9-19(20(22)23-11-15)16-12-24-26(4)13-16/h5-6,9-13,25,27H,7-8H2,1-4H3,(H2,22,23) PVVPCKINUWBPAJ-UHFFFAOYSA-N 295030 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3150 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295030&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469996 381618125 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562614 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H27N5O3S/c1-14-5-6-17(30(28,29)25-8-7-21(2,3)27)10-18(14)15-9-19(20(22)23-11-15)16-12-24-26(4)13-16/h5-6,9-13,25,27H,7-8H2,1-4H3,(H2,22,23) PVVPCKINUWBPAJ-UHFFFAOYSA-N 295030 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 2 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >9100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295030&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469996 381618125 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562615 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H27N5O3S/c1-14-5-6-17(30(28,29)25-8-7-21(2,3)27)10-18(14)15-9-19(20(22)23-11-15)16-12-24-26(4)13-16/h5-6,9-13,25,27H,7-8H2,1-4H3,(H2,22,23) PVVPCKINUWBPAJ-UHFFFAOYSA-N 295030 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 2 Phosphatidylinositol 4-kinase beta Human 5400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295030&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469996 381618125 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562616 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H27N5O3S/c1-14-5-6-17(30(28,29)25-8-7-21(2,3)27)10-18(14)15-9-19(20(22)23-11-15)16-12-24-26(4)13-16/h5-6,9-13,25,27H,7-8H2,1-4H3,(H2,22,23) PVVPCKINUWBPAJ-UHFFFAOYSA-N 295030 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 65.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295030&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469996 381618125 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562617 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H27N5O3S/c1-14-5-6-17(30(28,29)25-8-7-21(2,3)27)10-18(14)15-9-19(20(22)23-11-15)16-12-24-26(4)13-16/h5-6,9-13,25,27H,7-8H2,1-4H3,(H2,22,23) PVVPCKINUWBPAJ-UHFFFAOYSA-N 295030 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 460 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295030&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469996 381618125 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562618 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H27N5O3S/c1-14-5-6-17(30(28,29)25-8-7-21(2,3)27)10-18(14)15-9-19(20(22)23-11-15)16-12-24-26(4)13-16/h5-6,9-13,25,27H,7-8H2,1-4H3,(H2,22,23) PVVPCKINUWBPAJ-UHFFFAOYSA-N 295030 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 2 Serine/threonine-protein kinase mTOR Human >9100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295030&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469996 381618125 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562619 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26F3N5O3S/c1-14-4-5-17(34(32,33)29-7-6-21(2,3)31)9-18(14)15-8-19(20(26)27-10-15)16-11-28-30(12-16)13-22(23,24)25/h4-5,8-12,29,31H,6-7,13H2,1-3H3,(H2,26,27) ADFBGHLIVBZYKW-UHFFFAOYSA-N 295031 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 3 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 770 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295031&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470093 381618126 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562620 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26F3N5O3S/c1-14-4-5-17(34(32,33)29-7-6-21(2,3)31)9-18(14)15-8-19(20(26)27-10-15)16-11-28-30(12-16)13-22(23,24)25/h4-5,8-12,29,31H,6-7,13H2,1-3H3,(H2,26,27) ADFBGHLIVBZYKW-UHFFFAOYSA-N 295031 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2040 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295031&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470093 381618126 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562621 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26F3N5O3S/c1-14-4-5-17(34(32,33)29-7-6-21(2,3)31)9-18(14)15-8-19(20(26)27-10-15)16-11-28-30(12-16)13-22(23,24)25/h4-5,8-12,29,31H,6-7,13H2,1-3H3,(H2,26,27) ADFBGHLIVBZYKW-UHFFFAOYSA-N 295031 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 3 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >9100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295031&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470093 381618126 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562622 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26F3N5O3S/c1-14-4-5-17(34(32,33)29-7-6-21(2,3)31)9-18(14)15-8-19(20(26)27-10-15)16-11-28-30(12-16)13-22(23,24)25/h4-5,8-12,29,31H,6-7,13H2,1-3H3,(H2,26,27) ADFBGHLIVBZYKW-UHFFFAOYSA-N 295031 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 3 Phosphatidylinositol 4-kinase beta Human 1080 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295031&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470093 381618126 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562623 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26F3N5O3S/c1-14-4-5-17(34(32,33)29-7-6-21(2,3)31)9-18(14)15-8-19(20(26)27-10-15)16-11-28-30(12-16)13-22(23,24)25/h4-5,8-12,29,31H,6-7,13H2,1-3H3,(H2,26,27) ADFBGHLIVBZYKW-UHFFFAOYSA-N 295031 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 44.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295031&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470093 381618126 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562624 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26F3N5O3S/c1-14-4-5-17(34(32,33)29-7-6-21(2,3)31)9-18(14)15-8-19(20(26)27-10-15)16-11-28-30(12-16)13-22(23,24)25/h4-5,8-12,29,31H,6-7,13H2,1-3H3,(H2,26,27) ADFBGHLIVBZYKW-UHFFFAOYSA-N 295031 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 70.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295031&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470093 381618126 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562625 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26F3N5O3S/c1-14-4-5-17(34(32,33)29-7-6-21(2,3)31)9-18(14)15-8-19(20(26)27-10-15)16-11-28-30(12-16)13-22(23,24)25/h4-5,8-12,29,31H,6-7,13H2,1-3H3,(H2,26,27) ADFBGHLIVBZYKW-UHFFFAOYSA-N 295031 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 3 Serine/threonine-protein kinase mTOR Human 3110 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295031&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470093 381618126 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562626 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) AWKBWQVKZBUMPV-UHFFFAOYSA-N 295032 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 4 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 190 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295032&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470168 381618127 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562627 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) AWKBWQVKZBUMPV-UHFFFAOYSA-N 295032 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1870 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295032&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470168 381618127 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562628 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) AWKBWQVKZBUMPV-UHFFFAOYSA-N 295032 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 4 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1950 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295032&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470168 381618127 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562629 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) AWKBWQVKZBUMPV-UHFFFAOYSA-N 295032 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 4 Phosphatidylinositol 4-kinase beta Human 1440 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295032&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470168 381618127 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562630 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) AWKBWQVKZBUMPV-UHFFFAOYSA-N 295032 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 11.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295032&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470168 381618127 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562631 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) AWKBWQVKZBUMPV-UHFFFAOYSA-N 295032 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 80.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295032&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470168 381618127 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562632 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) AWKBWQVKZBUMPV-UHFFFAOYSA-N 295032 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 4 Serine/threonine-protein kinase mTOR Human 2630 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295032&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470168 381618127 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562633 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5.01,;.82,-5.78,;-1.85,-5.78,;-3.19,-5.01,)| InChI=1S/C22H27N5O3S/c1-14-3-8-19(31(29,30)26-17-4-6-18(28)7-5-17)10-20(14)15-9-21(22(23)24-11-15)16-12-25-27(2)13-16/h3,8-13,17-18,26,28H,4-7H2,1-2H3,(H2,23,24) SPXPFOZHHLWRME-UHFFFAOYSA-N 295033 trans 3-(6-Amino-5-(1- methyl-1H-pyrazol-4- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene- sulfonamide::US10112926, Example 4.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 280 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295033&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470255 381618128 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562634 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5.01,;.82,-5.78,;-1.85,-5.78,;-3.19,-5.01,)| InChI=1S/C22H27N5O3S/c1-14-3-8-19(31(29,30)26-17-4-6-18(28)7-5-17)10-20(14)15-9-21(22(23)24-11-15)16-12-25-27(2)13-16/h3,8-13,17-18,26,28H,4-7H2,1-2H3,(H2,23,24) SPXPFOZHHLWRME-UHFFFAOYSA-N 295033 trans 3-(6-Amino-5-(1- methyl-1H-pyrazol-4- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene- sulfonamide::US10112926, Example 4.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295033&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470255 381618128 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562635 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5.01,;.82,-5.78,;-1.85,-5.78,;-3.19,-5.01,)| InChI=1S/C22H27N5O3S/c1-14-3-8-19(31(29,30)26-17-4-6-18(28)7-5-17)10-20(14)15-9-21(22(23)24-11-15)16-12-25-27(2)13-16/h3,8-13,17-18,26,28H,4-7H2,1-2H3,(H2,23,24) SPXPFOZHHLWRME-UHFFFAOYSA-N 295033 trans 3-(6-Amino-5-(1- methyl-1H-pyrazol-4- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene- sulfonamide::US10112926, Example 4.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 6600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295033&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470255 381618128 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562636 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5.01,;.82,-5.78,;-1.85,-5.78,;-3.19,-5.01,)| InChI=1S/C22H27N5O3S/c1-14-3-8-19(31(29,30)26-17-4-6-18(28)7-5-17)10-20(14)15-9-21(22(23)24-11-15)16-12-25-27(2)13-16/h3,8-13,17-18,26,28H,4-7H2,1-2H3,(H2,23,24) SPXPFOZHHLWRME-UHFFFAOYSA-N 295033 trans 3-(6-Amino-5-(1- methyl-1H-pyrazol-4- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene- sulfonamide::US10112926, Example 4.1 Phosphatidylinositol 4-kinase beta Human 3900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295033&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470255 381618128 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562637 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5.01,;.82,-5.78,;-1.85,-5.78,;-3.19,-5.01,)| InChI=1S/C22H27N5O3S/c1-14-3-8-19(31(29,30)26-17-4-6-18(28)7-5-17)10-20(14)15-9-21(22(23)24-11-15)16-12-25-27(2)13-16/h3,8-13,17-18,26,28H,4-7H2,1-2H3,(H2,23,24) SPXPFOZHHLWRME-UHFFFAOYSA-N 295033 trans 3-(6-Amino-5-(1- methyl-1H-pyrazol-4- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene- sulfonamide::US10112926, Example 4.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 18.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295033&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470255 381618128 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562638 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5.01,;.82,-5.78,;-1.85,-5.78,;-3.19,-5.01,)| InChI=1S/C22H27N5O3S/c1-14-3-8-19(31(29,30)26-17-4-6-18(28)7-5-17)10-20(14)15-9-21(22(23)24-11-15)16-12-25-27(2)13-16/h3,8-13,17-18,26,28H,4-7H2,1-2H3,(H2,23,24) SPXPFOZHHLWRME-UHFFFAOYSA-N 295033 trans 3-(6-Amino-5-(1- methyl-1H-pyrazol-4- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene- sulfonamide::US10112926, Example 4.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 460 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295033&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470255 381618128 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562639 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5.01,;.82,-5.78,;-1.85,-5.78,;-3.19,-5.01,)| InChI=1S/C22H27N5O3S/c1-14-3-8-19(31(29,30)26-17-4-6-18(28)7-5-17)10-20(14)15-9-21(22(23)24-11-15)16-12-25-27(2)13-16/h3,8-13,17-18,26,28H,4-7H2,1-2H3,(H2,23,24) SPXPFOZHHLWRME-UHFFFAOYSA-N 295033 trans 3-(6-Amino-5-(1- methyl-1H-pyrazol-4- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene- sulfonamide::US10112926, Example 4.1 Serine/threonine-protein kinase mTOR Human 9500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295033&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470255 381618128 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562640 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-5.65,4.23,;-5.65,2.69,;-6.98,1.92,;-6.98,.38,;-5.65,-.39,;-4.31,.38,;-4.31,1.92,;-2.98,2.7,;-2.98,4.24,;-1.65,5,;-.31,4.24,;1.02,5.01,;-.31,2.7,;-1.65,1.93,;1.02,1.92,;1.02,.38,;2.49,-.09,;3.39,1.15,;4.93,1.15,;5.7,2.49,;4.93,3.82,;6.47,3.82,;7.19,2.09,;2.49,2.4,;-5.65,-1.93,;-7.19,-1.93,;-4.11,-1.93,;-5.65,-3.47,;-4.31,-4.24,;-2.98,-3.47,;-1.65,-4.24,;-1.65,-5.78,;-.31,-6.55,;-2.98,-6.55,;-4.31,-5.78,)| InChI=1S/C23H26F3N5O3S/c1-14-2-7-19(35(33,34)30-17-3-5-18(32)6-4-17)9-20(14)15-8-21(22(27)28-10-15)16-11-29-31(12-16)13-23(24,25)26/h2,7-12,17-18,30,32H,3-6,13H2,1H3,(H2,27,28) RCBNWWLBZCYILT-UHFFFAOYSA-N 295034 trans 3-(6-Amino-5-(1- (2,2,2-trifluoro ethyl)-1H- pyrazol-4-yl)pyridin-3- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.2 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 210 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295034&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470304 381618129 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562641 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-5.65,4.23,;-5.65,2.69,;-6.98,1.92,;-6.98,.38,;-5.65,-.39,;-4.31,.38,;-4.31,1.92,;-2.98,2.7,;-2.98,4.24,;-1.65,5,;-.31,4.24,;1.02,5.01,;-.31,2.7,;-1.65,1.93,;1.02,1.92,;1.02,.38,;2.49,-.09,;3.39,1.15,;4.93,1.15,;5.7,2.49,;4.93,3.82,;6.47,3.82,;7.19,2.09,;2.49,2.4,;-5.65,-1.93,;-7.19,-1.93,;-4.11,-1.93,;-5.65,-3.47,;-4.31,-4.24,;-2.98,-3.47,;-1.65,-4.24,;-1.65,-5.78,;-.31,-6.55,;-2.98,-6.55,;-4.31,-5.78,)| InChI=1S/C23H26F3N5O3S/c1-14-2-7-19(35(33,34)30-17-3-5-18(32)6-4-17)9-20(14)15-8-21(22(27)28-10-15)16-11-29-31(12-16)13-23(24,25)26/h2,7-12,17-18,30,32H,3-6,13H2,1H3,(H2,27,28) RCBNWWLBZCYILT-UHFFFAOYSA-N 295034 trans 3-(6-Amino-5-(1- (2,2,2-trifluoro ethyl)-1H- pyrazol-4-yl)pyridin-3- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295034&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470304 381618129 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562642 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-5.65,4.23,;-5.65,2.69,;-6.98,1.92,;-6.98,.38,;-5.65,-.39,;-4.31,.38,;-4.31,1.92,;-2.98,2.7,;-2.98,4.24,;-1.65,5,;-.31,4.24,;1.02,5.01,;-.31,2.7,;-1.65,1.93,;1.02,1.92,;1.02,.38,;2.49,-.09,;3.39,1.15,;4.93,1.15,;5.7,2.49,;4.93,3.82,;6.47,3.82,;7.19,2.09,;2.49,2.4,;-5.65,-1.93,;-7.19,-1.93,;-4.11,-1.93,;-5.65,-3.47,;-4.31,-4.24,;-2.98,-3.47,;-1.65,-4.24,;-1.65,-5.78,;-.31,-6.55,;-2.98,-6.55,;-4.31,-5.78,)| InChI=1S/C23H26F3N5O3S/c1-14-2-7-19(35(33,34)30-17-3-5-18(32)6-4-17)9-20(14)15-8-21(22(27)28-10-15)16-11-29-31(12-16)13-23(24,25)26/h2,7-12,17-18,30,32H,3-6,13H2,1H3,(H2,27,28) RCBNWWLBZCYILT-UHFFFAOYSA-N 295034 trans 3-(6-Amino-5-(1- (2,2,2-trifluoro ethyl)-1H- pyrazol-4-yl)pyridin-3- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.2 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295034&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470304 381618129 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562643 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-5.65,4.23,;-5.65,2.69,;-6.98,1.92,;-6.98,.38,;-5.65,-.39,;-4.31,.38,;-4.31,1.92,;-2.98,2.7,;-2.98,4.24,;-1.65,5,;-.31,4.24,;1.02,5.01,;-.31,2.7,;-1.65,1.93,;1.02,1.92,;1.02,.38,;2.49,-.09,;3.39,1.15,;4.93,1.15,;5.7,2.49,;4.93,3.82,;6.47,3.82,;7.19,2.09,;2.49,2.4,;-5.65,-1.93,;-7.19,-1.93,;-4.11,-1.93,;-5.65,-3.47,;-4.31,-4.24,;-2.98,-3.47,;-1.65,-4.24,;-1.65,-5.78,;-.31,-6.55,;-2.98,-6.55,;-4.31,-5.78,)| InChI=1S/C23H26F3N5O3S/c1-14-2-7-19(35(33,34)30-17-3-5-18(32)6-4-17)9-20(14)15-8-21(22(27)28-10-15)16-11-29-31(12-16)13-23(24,25)26/h2,7-12,17-18,30,32H,3-6,13H2,1H3,(H2,27,28) RCBNWWLBZCYILT-UHFFFAOYSA-N 295034 trans 3-(6-Amino-5-(1- (2,2,2-trifluoro ethyl)-1H- pyrazol-4-yl)pyridin-3- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.2 Phosphatidylinositol 4-kinase beta Human 650 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295034&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470304 381618129 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562644 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-5.65,4.23,;-5.65,2.69,;-6.98,1.92,;-6.98,.38,;-5.65,-.39,;-4.31,.38,;-4.31,1.92,;-2.98,2.7,;-2.98,4.24,;-1.65,5,;-.31,4.24,;1.02,5.01,;-.31,2.7,;-1.65,1.93,;1.02,1.92,;1.02,.38,;2.49,-.09,;3.39,1.15,;4.93,1.15,;5.7,2.49,;4.93,3.82,;6.47,3.82,;7.19,2.09,;2.49,2.4,;-5.65,-1.93,;-7.19,-1.93,;-4.11,-1.93,;-5.65,-3.47,;-4.31,-4.24,;-2.98,-3.47,;-1.65,-4.24,;-1.65,-5.78,;-.31,-6.55,;-2.98,-6.55,;-4.31,-5.78,)| InChI=1S/C23H26F3N5O3S/c1-14-2-7-19(35(33,34)30-17-3-5-18(32)6-4-17)9-20(14)15-8-21(22(27)28-10-15)16-11-29-31(12-16)13-23(24,25)26/h2,7-12,17-18,30,32H,3-6,13H2,1H3,(H2,27,28) RCBNWWLBZCYILT-UHFFFAOYSA-N 295034 trans 3-(6-Amino-5-(1- (2,2,2-trifluoro ethyl)-1H- pyrazol-4-yl)pyridin-3- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 8.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295034&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470304 381618129 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562645 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-5.65,4.23,;-5.65,2.69,;-6.98,1.92,;-6.98,.38,;-5.65,-.39,;-4.31,.38,;-4.31,1.92,;-2.98,2.7,;-2.98,4.24,;-1.65,5,;-.31,4.24,;1.02,5.01,;-.31,2.7,;-1.65,1.93,;1.02,1.92,;1.02,.38,;2.49,-.09,;3.39,1.15,;4.93,1.15,;5.7,2.49,;4.93,3.82,;6.47,3.82,;7.19,2.09,;2.49,2.4,;-5.65,-1.93,;-7.19,-1.93,;-4.11,-1.93,;-5.65,-3.47,;-4.31,-4.24,;-2.98,-3.47,;-1.65,-4.24,;-1.65,-5.78,;-.31,-6.55,;-2.98,-6.55,;-4.31,-5.78,)| InChI=1S/C23H26F3N5O3S/c1-14-2-7-19(35(33,34)30-17-3-5-18(32)6-4-17)9-20(14)15-8-21(22(27)28-10-15)16-11-29-31(12-16)13-23(24,25)26/h2,7-12,17-18,30,32H,3-6,13H2,1H3,(H2,27,28) RCBNWWLBZCYILT-UHFFFAOYSA-N 295034 trans 3-(6-Amino-5-(1- (2,2,2-trifluoro ethyl)-1H- pyrazol-4-yl)pyridin-3- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 380 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295034&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470304 381618129 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562646 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-5.65,4.23,;-5.65,2.69,;-6.98,1.92,;-6.98,.38,;-5.65,-.39,;-4.31,.38,;-4.31,1.92,;-2.98,2.7,;-2.98,4.24,;-1.65,5,;-.31,4.24,;1.02,5.01,;-.31,2.7,;-1.65,1.93,;1.02,1.92,;1.02,.38,;2.49,-.09,;3.39,1.15,;4.93,1.15,;5.7,2.49,;4.93,3.82,;6.47,3.82,;7.19,2.09,;2.49,2.4,;-5.65,-1.93,;-7.19,-1.93,;-4.11,-1.93,;-5.65,-3.47,;-4.31,-4.24,;-2.98,-3.47,;-1.65,-4.24,;-1.65,-5.78,;-.31,-6.55,;-2.98,-6.55,;-4.31,-5.78,)| InChI=1S/C23H26F3N5O3S/c1-14-2-7-19(35(33,34)30-17-3-5-18(32)6-4-17)9-20(14)15-8-21(22(27)28-10-15)16-11-29-31(12-16)13-23(24,25)26/h2,7-12,17-18,30,32H,3-6,13H2,1H3,(H2,27,28) RCBNWWLBZCYILT-UHFFFAOYSA-N 295034 trans 3-(6-Amino-5-(1- (2,2,2-trifluoro ethyl)-1H- pyrazol-4-yl)pyridin-3- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.2 Serine/threonine-protein kinase mTOR Human 1300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295034&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470304 381618129 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562647 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:25.27,wD:28.31,(6.1,2.69,;4.77,1.92,;3.44,2.7,;2.1,1.92,;2.1,.39,;3.44,-.39,;4.77,.39,;.77,2.7,;-.56,1.93,;-1.9,2.7,;-1.9,4.24,;-.56,5,;.77,4.24,;2.1,5.01,;-3.23,1.92,;-3.23,.38,;-4.56,-.39,;-5.9,.38,;-5.9,1.92,;-4.56,2.69,;-4.56,4.23,;-4.56,-1.93,;-6.1,-1.93,;-3.02,-1.93,;-4.56,-3.47,;-3.23,-4.24,;-1.9,-3.47,;-.56,-4.24,;-.56,-5.78,;.77,-6.55,;-1.9,-6.55,;-3.23,-5.78,)| InChI=1S/C24H28N4O3S/c1-15-3-8-21(32(30,31)28-19-4-6-20(29)7-5-19)13-22(15)18-12-23(24(25)27-14-18)17-9-10-26-16(2)11-17/h3,8-14,19-20,28-29H,4-7H2,1-2H3,(H2,25,27) RGCKLULZGWBAOV-UHFFFAOYSA-N 295035 trans 3-(2-Amino-2'- methyl-[3,4'-bi pyridin]-5- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.3 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 260 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295035&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470247 381618130 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562648 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:25.27,wD:28.31,(6.1,2.69,;4.77,1.92,;3.44,2.7,;2.1,1.92,;2.1,.39,;3.44,-.39,;4.77,.39,;.77,2.7,;-.56,1.93,;-1.9,2.7,;-1.9,4.24,;-.56,5,;.77,4.24,;2.1,5.01,;-3.23,1.92,;-3.23,.38,;-4.56,-.39,;-5.9,.38,;-5.9,1.92,;-4.56,2.69,;-4.56,4.23,;-4.56,-1.93,;-6.1,-1.93,;-3.02,-1.93,;-4.56,-3.47,;-3.23,-4.24,;-1.9,-3.47,;-.56,-4.24,;-.56,-5.78,;.77,-6.55,;-1.9,-6.55,;-3.23,-5.78,)| InChI=1S/C24H28N4O3S/c1-15-3-8-21(32(30,31)28-19-4-6-20(29)7-5-19)13-22(15)18-12-23(24(25)27-14-18)17-9-10-26-16(2)11-17/h3,8-14,19-20,28-29H,4-7H2,1-2H3,(H2,25,27) RGCKLULZGWBAOV-UHFFFAOYSA-N 295035 trans 3-(2-Amino-2'- methyl-[3,4'-bi pyridin]-5- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 7200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295035&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470247 381618130 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562649 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:25.27,wD:28.31,(6.1,2.69,;4.77,1.92,;3.44,2.7,;2.1,1.92,;2.1,.39,;3.44,-.39,;4.77,.39,;.77,2.7,;-.56,1.93,;-1.9,2.7,;-1.9,4.24,;-.56,5,;.77,4.24,;2.1,5.01,;-3.23,1.92,;-3.23,.38,;-4.56,-.39,;-5.9,.38,;-5.9,1.92,;-4.56,2.69,;-4.56,4.23,;-4.56,-1.93,;-6.1,-1.93,;-3.02,-1.93,;-4.56,-3.47,;-3.23,-4.24,;-1.9,-3.47,;-.56,-4.24,;-.56,-5.78,;.77,-6.55,;-1.9,-6.55,;-3.23,-5.78,)| InChI=1S/C24H28N4O3S/c1-15-3-8-21(32(30,31)28-19-4-6-20(29)7-5-19)13-22(15)18-12-23(24(25)27-14-18)17-9-10-26-16(2)11-17/h3,8-14,19-20,28-29H,4-7H2,1-2H3,(H2,25,27) RGCKLULZGWBAOV-UHFFFAOYSA-N 295035 trans 3-(2-Amino-2'- methyl-[3,4'-bi pyridin]-5- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.3 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295035&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470247 381618130 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562650 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:25.27,wD:28.31,(6.1,2.69,;4.77,1.92,;3.44,2.7,;2.1,1.92,;2.1,.39,;3.44,-.39,;4.77,.39,;.77,2.7,;-.56,1.93,;-1.9,2.7,;-1.9,4.24,;-.56,5,;.77,4.24,;2.1,5.01,;-3.23,1.92,;-3.23,.38,;-4.56,-.39,;-5.9,.38,;-5.9,1.92,;-4.56,2.69,;-4.56,4.23,;-4.56,-1.93,;-6.1,-1.93,;-3.02,-1.93,;-4.56,-3.47,;-3.23,-4.24,;-1.9,-3.47,;-.56,-4.24,;-.56,-5.78,;.77,-6.55,;-1.9,-6.55,;-3.23,-5.78,)| InChI=1S/C24H28N4O3S/c1-15-3-8-21(32(30,31)28-19-4-6-20(29)7-5-19)13-22(15)18-12-23(24(25)27-14-18)17-9-10-26-16(2)11-17/h3,8-14,19-20,28-29H,4-7H2,1-2H3,(H2,25,27) RGCKLULZGWBAOV-UHFFFAOYSA-N 295035 trans 3-(2-Amino-2'- methyl-[3,4'-bi pyridin]-5- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.3 Phosphatidylinositol 4-kinase beta Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295035&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470247 381618130 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562651 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:25.27,wD:28.31,(6.1,2.69,;4.77,1.92,;3.44,2.7,;2.1,1.92,;2.1,.39,;3.44,-.39,;4.77,.39,;.77,2.7,;-.56,1.93,;-1.9,2.7,;-1.9,4.24,;-.56,5,;.77,4.24,;2.1,5.01,;-3.23,1.92,;-3.23,.38,;-4.56,-.39,;-5.9,.38,;-5.9,1.92,;-4.56,2.69,;-4.56,4.23,;-4.56,-1.93,;-6.1,-1.93,;-3.02,-1.93,;-4.56,-3.47,;-3.23,-4.24,;-1.9,-3.47,;-.56,-4.24,;-.56,-5.78,;.77,-6.55,;-1.9,-6.55,;-3.23,-5.78,)| InChI=1S/C24H28N4O3S/c1-15-3-8-21(32(30,31)28-19-4-6-20(29)7-5-19)13-22(15)18-12-23(24(25)27-14-18)17-9-10-26-16(2)11-17/h3,8-14,19-20,28-29H,4-7H2,1-2H3,(H2,25,27) RGCKLULZGWBAOV-UHFFFAOYSA-N 295035 trans 3-(2-Amino-2'- methyl-[3,4'-bi pyridin]-5- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 21.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295035&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470247 381618130 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562652 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:25.27,wD:28.31,(6.1,2.69,;4.77,1.92,;3.44,2.7,;2.1,1.92,;2.1,.39,;3.44,-.39,;4.77,.39,;.77,2.7,;-.56,1.93,;-1.9,2.7,;-1.9,4.24,;-.56,5,;.77,4.24,;2.1,5.01,;-3.23,1.92,;-3.23,.38,;-4.56,-.39,;-5.9,.38,;-5.9,1.92,;-4.56,2.69,;-4.56,4.23,;-4.56,-1.93,;-6.1,-1.93,;-3.02,-1.93,;-4.56,-3.47,;-3.23,-4.24,;-1.9,-3.47,;-.56,-4.24,;-.56,-5.78,;.77,-6.55,;-1.9,-6.55,;-3.23,-5.78,)| InChI=1S/C24H28N4O3S/c1-15-3-8-21(32(30,31)28-19-4-6-20(29)7-5-19)13-22(15)18-12-23(24(25)27-14-18)17-9-10-26-16(2)11-17/h3,8-14,19-20,28-29H,4-7H2,1-2H3,(H2,25,27) RGCKLULZGWBAOV-UHFFFAOYSA-N 295035 trans 3-(2-Amino-2'- methyl-[3,4'-bi pyridin]-5- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295035&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470247 381618130 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562653 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:25.27,wD:28.31,(6.1,2.69,;4.77,1.92,;3.44,2.7,;2.1,1.92,;2.1,.39,;3.44,-.39,;4.77,.39,;.77,2.7,;-.56,1.93,;-1.9,2.7,;-1.9,4.24,;-.56,5,;.77,4.24,;2.1,5.01,;-3.23,1.92,;-3.23,.38,;-4.56,-.39,;-5.9,.38,;-5.9,1.92,;-4.56,2.69,;-4.56,4.23,;-4.56,-1.93,;-6.1,-1.93,;-3.02,-1.93,;-4.56,-3.47,;-3.23,-4.24,;-1.9,-3.47,;-.56,-4.24,;-.56,-5.78,;.77,-6.55,;-1.9,-6.55,;-3.23,-5.78,)| InChI=1S/C24H28N4O3S/c1-15-3-8-21(32(30,31)28-19-4-6-20(29)7-5-19)13-22(15)18-12-23(24(25)27-14-18)17-9-10-26-16(2)11-17/h3,8-14,19-20,28-29H,4-7H2,1-2H3,(H2,25,27) RGCKLULZGWBAOV-UHFFFAOYSA-N 295035 trans 3-(2-Amino-2'- methyl-[3,4'-bi pyridin]-5- yl)-N-(4-hydroxy cyclohexyl)-4-methyl- benzenesulfonamide::US10112926, Example 4.3 Serine/threonine-protein kinase mTOR Human 7300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295035&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470247 381618130 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562654 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)23-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-22-25(4)24-17/h5-10,23,26H,11H2,1-4H3,(H2,20,21) OUGWFIXWGKIEGR-UHFFFAOYSA-N 295036 3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 4.4 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 560 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295036&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470198 381618131 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562655 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)23-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-22-25(4)24-17/h5-10,23,26H,11H2,1-4H3,(H2,20,21) OUGWFIXWGKIEGR-UHFFFAOYSA-N 295036 3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 4.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2950 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295036&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470198 381618131 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562656 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)23-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-22-25(4)24-17/h5-10,23,26H,11H2,1-4H3,(H2,20,21) OUGWFIXWGKIEGR-UHFFFAOYSA-N 295036 3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 4.4 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295036&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470198 381618131 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562657 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)23-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-22-25(4)24-17/h5-10,23,26H,11H2,1-4H3,(H2,20,21) OUGWFIXWGKIEGR-UHFFFAOYSA-N 295036 3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 4.4 Phosphatidylinositol 4-kinase beta Human 8200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295036&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470198 381618131 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562658 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)23-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-22-25(4)24-17/h5-10,23,26H,11H2,1-4H3,(H2,20,21) OUGWFIXWGKIEGR-UHFFFAOYSA-N 295036 3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 4.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 212 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295036&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470198 381618131 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562659 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)23-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-22-25(4)24-17/h5-10,23,26H,11H2,1-4H3,(H2,20,21) OUGWFIXWGKIEGR-UHFFFAOYSA-N 295036 3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 4.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1850 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295036&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470198 381618131 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562660 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)23-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-22-25(4)24-17/h5-10,23,26H,11H2,1-4H3,(H2,20,21) OUGWFIXWGKIEGR-UHFFFAOYSA-N 295036 3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 4.4 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295036&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470198 381618131 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562661 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5,;.82,-5.78,;-1.85,-5.77,;-3.19,-5,)| InChI=1S/C21H26N6O3S/c1-13-3-8-17(31(29,30)26-15-4-6-16(28)7-5-15)10-18(13)14-9-19(21(22)23-11-14)20-12-24-27(2)25-20/h3,8-12,15-16,26,28H,4-7H2,1-2H3,(H2,22,23) MTNQTVCKFYRZKH-UHFFFAOYSA-N 295037 trans 3-(6-Amino-5-(2- methyl-2H-1,2,3-triazol- 4-yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 4.5 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 250 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295037&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470373 381618132 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562662 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5,;.82,-5.78,;-1.85,-5.77,;-3.19,-5,)| InChI=1S/C21H26N6O3S/c1-13-3-8-17(31(29,30)26-15-4-6-16(28)7-5-15)10-18(13)14-9-19(21(22)23-11-14)20-12-24-27(2)25-20/h3,8-12,15-16,26,28H,4-7H2,1-2H3,(H2,22,23) MTNQTVCKFYRZKH-UHFFFAOYSA-N 295037 trans 3-(6-Amino-5-(2- methyl-2H-1,2,3-triazol- 4-yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 4.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295037&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470373 381618132 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562663 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5,;.82,-5.78,;-1.85,-5.77,;-3.19,-5,)| InChI=1S/C21H26N6O3S/c1-13-3-8-17(31(29,30)26-15-4-6-16(28)7-5-15)10-18(13)14-9-19(21(22)23-11-14)20-12-24-27(2)25-20/h3,8-12,15-16,26,28H,4-7H2,1-2H3,(H2,22,23) MTNQTVCKFYRZKH-UHFFFAOYSA-N 295037 trans 3-(6-Amino-5-(2- methyl-2H-1,2,3-triazol- 4-yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 4.5 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295037&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470373 381618132 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562664 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5,;.82,-5.78,;-1.85,-5.77,;-3.19,-5,)| InChI=1S/C21H26N6O3S/c1-13-3-8-17(31(29,30)26-15-4-6-16(28)7-5-15)10-18(13)14-9-19(21(22)23-11-14)20-12-24-27(2)25-20/h3,8-12,15-16,26,28H,4-7H2,1-2H3,(H2,22,23) MTNQTVCKFYRZKH-UHFFFAOYSA-N 295037 trans 3-(6-Amino-5-(2- methyl-2H-1,2,3-triazol- 4-yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 4.5 Phosphatidylinositol 4-kinase beta Human 5250 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295037&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470373 381618132 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562665 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5,;.82,-5.78,;-1.85,-5.77,;-3.19,-5,)| InChI=1S/C21H26N6O3S/c1-13-3-8-17(31(29,30)26-15-4-6-16(28)7-5-15)10-18(13)14-9-19(21(22)23-11-14)20-12-24-27(2)25-20/h3,8-12,15-16,26,28H,4-7H2,1-2H3,(H2,22,23) MTNQTVCKFYRZKH-UHFFFAOYSA-N 295037 trans 3-(6-Amino-5-(2- methyl-2H-1,2,3-triazol- 4-yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 4.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 575 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295037&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470373 381618132 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562666 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5,;.82,-5.78,;-1.85,-5.77,;-3.19,-5,)| InChI=1S/C21H26N6O3S/c1-13-3-8-17(31(29,30)26-15-4-6-16(28)7-5-15)10-18(13)14-9-19(21(22)23-11-14)20-12-24-27(2)25-20/h3,8-12,15-16,26,28H,4-7H2,1-2H3,(H2,22,23) MTNQTVCKFYRZKH-UHFFFAOYSA-N 295037 trans 3-(6-Amino-5-(2- methyl-2H-1,2,3-triazol- 4-yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 4.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 480 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295037&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470373 381618132 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562667 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(-4.52,5,;-4.52,3.46,;-5.85,2.69,;-5.85,1.15,;-4.52,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5.01,;-.52,5.77,;.82,5.01,;2.15,5.78,;.82,3.47,;-.52,2.7,;2.15,2.69,;2.15,1.15,;3.61,.68,;4.52,1.92,;6.06,1.92,;3.61,3.17,;-4.52,-1.16,;-6.06,-1.16,;-2.98,-1.16,;-4.52,-2.7,;-3.19,-3.47,;-1.85,-2.7,;-.52,-3.47,;-.52,-5,;.82,-5.78,;-1.85,-5.77,;-3.19,-5,)| InChI=1S/C21H26N6O3S/c1-13-3-8-17(31(29,30)26-15-4-6-16(28)7-5-15)10-18(13)14-9-19(21(22)23-11-14)20-12-24-27(2)25-20/h3,8-12,15-16,26,28H,4-7H2,1-2H3,(H2,22,23) MTNQTVCKFYRZKH-UHFFFAOYSA-N 295037 trans 3-(6-Amino-5-(2- methyl-2H-1,2,3-triazol- 4-yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 4.5 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295037&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470373 381618132 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562668 CCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O4S/c1-5-15-9-19(29-25-15)18-8-14(11-23-20(18)22)17-10-16(7-6-13(17)2)30(27,28)24-12-21(3,4)26/h6-11,24,26H,5,12H2,1-4H3,(H2,22,23) DFTRUCNLZXQDKU-UHFFFAOYSA-N 295038 3-(6-Amino-5-(3- ethylisoxazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.6 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 520 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295038&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470408 381618133 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562669 CCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O4S/c1-5-15-9-19(29-25-15)18-8-14(11-23-20(18)22)17-10-16(7-6-13(17)2)30(27,28)24-12-21(3,4)26/h6-11,24,26H,5,12H2,1-4H3,(H2,22,23) DFTRUCNLZXQDKU-UHFFFAOYSA-N 295038 3-(6-Amino-5-(3- ethylisoxazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295038&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470408 381618133 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562670 CCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O4S/c1-5-15-9-19(29-25-15)18-8-14(11-23-20(18)22)17-10-16(7-6-13(17)2)30(27,28)24-12-21(3,4)26/h6-11,24,26H,5,12H2,1-4H3,(H2,22,23) DFTRUCNLZXQDKU-UHFFFAOYSA-N 295038 3-(6-Amino-5-(3- ethylisoxazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.6 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295038&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470408 381618133 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562671 CCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O4S/c1-5-15-9-19(29-25-15)18-8-14(11-23-20(18)22)17-10-16(7-6-13(17)2)30(27,28)24-12-21(3,4)26/h6-11,24,26H,5,12H2,1-4H3,(H2,22,23) DFTRUCNLZXQDKU-UHFFFAOYSA-N 295038 3-(6-Amino-5-(3- ethylisoxazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.6 Phosphatidylinositol 4-kinase beta Human 2700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295038&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470408 381618133 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562672 CCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O4S/c1-5-15-9-19(29-25-15)18-8-14(11-23-20(18)22)17-10-16(7-6-13(17)2)30(27,28)24-12-21(3,4)26/h6-11,24,26H,5,12H2,1-4H3,(H2,22,23) DFTRUCNLZXQDKU-UHFFFAOYSA-N 295038 3-(6-Amino-5-(3- ethylisoxazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 21.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295038&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470408 381618133 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562673 CCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O4S/c1-5-15-9-19(29-25-15)18-8-14(11-23-20(18)22)17-10-16(7-6-13(17)2)30(27,28)24-12-21(3,4)26/h6-11,24,26H,5,12H2,1-4H3,(H2,22,23) DFTRUCNLZXQDKU-UHFFFAOYSA-N 295038 3-(6-Amino-5-(3- ethylisoxazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1900 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295038&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470408 381618133 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562674 CCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O4S/c1-5-15-9-19(29-25-15)18-8-14(11-23-20(18)22)17-10-16(7-6-13(17)2)30(27,28)24-12-21(3,4)26/h6-11,24,26H,5,12H2,1-4H3,(H2,22,23) DFTRUCNLZXQDKU-UHFFFAOYSA-N 295038 3-(6-Amino-5-(3- ethylisoxazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.6 Serine/threonine-protein kinase mTOR Human 1400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295038&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470408 381618133 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562675 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295039 (R)-3-(6-Amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-((tetra hydrofuran-3- yl)methyl)benzene- sulfonamide hydrochloride::US10112926, Example 4.7 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295039&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470026 381618134 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562676 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295039 (R)-3-(6-Amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-((tetra hydrofuran-3- yl)methyl)benzene- sulfonamide hydrochloride::US10112926, Example 4.7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295039&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470026 381618134 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562677 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295039 (R)-3-(6-Amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-((tetra hydrofuran-3- yl)methyl)benzene- sulfonamide hydrochloride::US10112926, Example 4.7 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295039&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470026 381618134 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562678 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295039 (R)-3-(6-Amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-((tetra hydrofuran-3- yl)methyl)benzene- sulfonamide hydrochloride::US10112926, Example 4.7 Phosphatidylinositol 4-kinase beta Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295039&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470026 381618134 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562679 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295039 (R)-3-(6-Amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-((tetra hydrofuran-3- yl)methyl)benzene- sulfonamide hydrochloride::US10112926, Example 4.7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 850 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295039&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470026 381618134 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562680 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295039 (R)-3-(6-Amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-((tetra hydrofuran-3- yl)methyl)benzene- sulfonamide hydrochloride::US10112926, Example 4.7 Serine/threonine-protein kinase mTOR Human 7700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295039&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470026 381618134 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562681 Cc1cc(sn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) AZVJHJZDMFRHDB-UHFFFAOYSA-N 295040 3-(6-Amino-5-(3- methylisothiazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.8 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 570 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295040&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512219 381618135 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562682 Cc1cc(sn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) AZVJHJZDMFRHDB-UHFFFAOYSA-N 295040 3-(6-Amino-5-(3- methylisothiazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4650 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295040&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512219 381618135 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562683 Cc1cc(sn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) AZVJHJZDMFRHDB-UHFFFAOYSA-N 295040 3-(6-Amino-5-(3- methylisothiazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.8 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295040&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512219 381618135 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562684 Cc1cc(sn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) AZVJHJZDMFRHDB-UHFFFAOYSA-N 295040 3-(6-Amino-5-(3- methylisothiazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.8 Phosphatidylinositol 4-kinase beta Human 3150 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295040&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512219 381618135 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562685 Cc1cc(sn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) AZVJHJZDMFRHDB-UHFFFAOYSA-N 295040 3-(6-Amino-5-(3- methylisothiazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 150 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295040&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512219 381618135 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562686 Cc1cc(sn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) AZVJHJZDMFRHDB-UHFFFAOYSA-N 295040 3-(6-Amino-5-(3- methylisothiazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 210 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295040&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512219 381618135 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562687 Cc1cc(sn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) AZVJHJZDMFRHDB-UHFFFAOYSA-N 295040 3-(6-Amino-5-(3- methylisothiazol-5- yl)pyridin-3-yl)-N-(2- hydroxy-2- methylpropyl)-4-methyl- benzenesulfonamide hydrochloride::US10112926, Example 4.8 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295040&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 126512219 381618135 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562688 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(26,27)23-9-20(3)10-28-11-20)7-16(12)14-6-17(18(21)22-8-14)19-24-13(2)25-29-19/h4-8,23H,9-11H2,1-3H3,(H2,21,22) WUZRDHWCBDKJTL-UHFFFAOYSA-N 295041 3-(6-Amino-5-(3-methyl- 1,2,4-oxadiazol-5- yl)pyridin-3-yl)-4-methyl- N-((3-methyloxetan-3- yl)methyl)benzene- sulfonamide::US10112926, Example 4.9 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 620 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295041&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469969 381618136 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562689 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(26,27)23-9-20(3)10-28-11-20)7-16(12)14-6-17(18(21)22-8-14)19-24-13(2)25-29-19/h4-8,23H,9-11H2,1-3H3,(H2,21,22) WUZRDHWCBDKJTL-UHFFFAOYSA-N 295041 3-(6-Amino-5-(3-methyl- 1,2,4-oxadiazol-5- yl)pyridin-3-yl)-4-methyl- N-((3-methyloxetan-3- yl)methyl)benzene- sulfonamide::US10112926, Example 4.9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295041&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469969 381618136 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562690 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(26,27)23-9-20(3)10-28-11-20)7-16(12)14-6-17(18(21)22-8-14)19-24-13(2)25-29-19/h4-8,23H,9-11H2,1-3H3,(H2,21,22) WUZRDHWCBDKJTL-UHFFFAOYSA-N 295041 3-(6-Amino-5-(3-methyl- 1,2,4-oxadiazol-5- yl)pyridin-3-yl)-4-methyl- N-((3-methyloxetan-3- yl)methyl)benzene- sulfonamide::US10112926, Example 4.9 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295041&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469969 381618136 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562691 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(26,27)23-9-20(3)10-28-11-20)7-16(12)14-6-17(18(21)22-8-14)19-24-13(2)25-29-19/h4-8,23H,9-11H2,1-3H3,(H2,21,22) WUZRDHWCBDKJTL-UHFFFAOYSA-N 295041 3-(6-Amino-5-(3-methyl- 1,2,4-oxadiazol-5- yl)pyridin-3-yl)-4-methyl- N-((3-methyloxetan-3- yl)methyl)benzene- sulfonamide::US10112926, Example 4.9 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295041&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469969 381618136 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562692 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(26,27)23-9-20(3)10-28-11-20)7-16(12)14-6-17(18(21)22-8-14)19-24-13(2)25-29-19/h4-8,23H,9-11H2,1-3H3,(H2,21,22) WUZRDHWCBDKJTL-UHFFFAOYSA-N 295041 3-(6-Amino-5-(3-methyl- 1,2,4-oxadiazol-5- yl)pyridin-3-yl)-4-methyl- N-((3-methyloxetan-3- yl)methyl)benzene- sulfonamide::US10112926, Example 4.9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 46.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295041&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469969 381618136 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562693 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(26,27)23-9-20(3)10-28-11-20)7-16(12)14-6-17(18(21)22-8-14)19-24-13(2)25-29-19/h4-8,23H,9-11H2,1-3H3,(H2,21,22) WUZRDHWCBDKJTL-UHFFFAOYSA-N 295041 3-(6-Amino-5-(3-methyl- 1,2,4-oxadiazol-5- yl)pyridin-3-yl)-4-methyl- N-((3-methyloxetan-3- yl)methyl)benzene- sulfonamide::US10112926, Example 4.9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295041&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469969 381618136 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562694 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(26,27)23-9-20(3)10-28-11-20)7-16(12)14-6-17(18(21)22-8-14)19-24-13(2)25-29-19/h4-8,23H,9-11H2,1-3H3,(H2,21,22) WUZRDHWCBDKJTL-UHFFFAOYSA-N 295041 3-(6-Amino-5-(3-methyl- 1,2,4-oxadiazol-5- yl)pyridin-3-yl)-4-methyl- N-((3-methyloxetan-3- yl)methyl)benzene- sulfonamide::US10112926, Example 4.9 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295041&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469969 381618136 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562695 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-24-13(2)25-29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) BGNRHJBZCKJOLD-UHFFFAOYSA-N 295042 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 5 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 80.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295042&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470226 381618137 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562696 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-24-13(2)25-29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) BGNRHJBZCKJOLD-UHFFFAOYSA-N 295042 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1150 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295042&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470226 381618137 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562697 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-24-13(2)25-29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) BGNRHJBZCKJOLD-UHFFFAOYSA-N 295042 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 5 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >9550 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295042&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470226 381618137 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562698 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-24-13(2)25-29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) BGNRHJBZCKJOLD-UHFFFAOYSA-N 295042 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 5 Phosphatidylinositol 4-kinase beta Human 4900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295042&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470226 381618137 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562699 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-24-13(2)25-29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) BGNRHJBZCKJOLD-UHFFFAOYSA-N 295042 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 11.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295042&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470226 381618137 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562700 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-24-13(2)25-29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) BGNRHJBZCKJOLD-UHFFFAOYSA-N 295042 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 60.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295042&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470226 381618137 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562701 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-24-13(2)25-29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) BGNRHJBZCKJOLD-UHFFFAOYSA-N 295042 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 5 Serine/threonine-protein kinase mTOR Human 6500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295042&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470226 381618137 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562702 CC(C)c1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O4S/c1-12(2)19-25-20(30-26-19)17-8-14(10-23-18(17)22)16-9-15(7-6-13(16)3)31(28,29)24-11-21(4,5)27/h6-10,12,24,27H,11H2,1-5H3,(H2,22,23) ZEGPSHKDFGWMLD-UHFFFAOYSA-N 295043 3-(6-Amino-5-(3-isopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 5.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1250 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295043&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470178 381618138 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562703 CC(C)c1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O4S/c1-12(2)19-25-20(30-26-19)17-8-14(10-23-18(17)22)16-9-15(7-6-13(16)3)31(28,29)24-11-21(4,5)27/h6-10,12,24,27H,11H2,1-5H3,(H2,22,23) ZEGPSHKDFGWMLD-UHFFFAOYSA-N 295043 3-(6-Amino-5-(3-isopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 5.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6450 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295043&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470178 381618138 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562704 CC(C)c1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O4S/c1-12(2)19-25-20(30-26-19)17-8-14(10-23-18(17)22)16-9-15(7-6-13(16)3)31(28,29)24-11-21(4,5)27/h6-10,12,24,27H,11H2,1-5H3,(H2,22,23) ZEGPSHKDFGWMLD-UHFFFAOYSA-N 295043 3-(6-Amino-5-(3-isopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 5.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295043&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470178 381618138 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562705 CC(C)c1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O4S/c1-12(2)19-25-20(30-26-19)17-8-14(10-23-18(17)22)16-9-15(7-6-13(16)3)31(28,29)24-11-21(4,5)27/h6-10,12,24,27H,11H2,1-5H3,(H2,22,23) ZEGPSHKDFGWMLD-UHFFFAOYSA-N 295043 3-(6-Amino-5-(3-isopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 5.1 Phosphatidylinositol 4-kinase beta Human 4400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295043&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470178 381618138 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562706 CC(C)c1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O4S/c1-12(2)19-25-20(30-26-19)17-8-14(10-23-18(17)22)16-9-15(7-6-13(16)3)31(28,29)24-11-21(4,5)27/h6-10,12,24,27H,11H2,1-5H3,(H2,22,23) ZEGPSHKDFGWMLD-UHFFFAOYSA-N 295043 3-(6-Amino-5-(3-isopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 5.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 28.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295043&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470178 381618138 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562707 CC(C)c1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O4S/c1-12(2)19-25-20(30-26-19)17-8-14(10-23-18(17)22)16-9-15(7-6-13(16)3)31(28,29)24-11-21(4,5)27/h6-10,12,24,27H,11H2,1-5H3,(H2,22,23) ZEGPSHKDFGWMLD-UHFFFAOYSA-N 295043 3-(6-Amino-5-(3-isopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 5.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295043&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470178 381618138 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562708 CC(C)c1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O4S/c1-12(2)19-25-20(30-26-19)17-8-14(10-23-18(17)22)16-9-15(7-6-13(16)3)31(28,29)24-11-21(4,5)27/h6-10,12,24,27H,11H2,1-5H3,(H2,22,23) ZEGPSHKDFGWMLD-UHFFFAOYSA-N 295043 3-(6-Amino-5-(3-isopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 5.1 Serine/threonine-protein kinase mTOR Human 8200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295043&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470178 381618138 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562709 Cc1cnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.93,;6.42,1.93,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.69,;.05,3.47,;.05,5,;1.38,5.78,;2.71,5,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.47,;-2.62,5,;-2.62,-1.15,;-4.16,-1.15,;-1.08,-1.15,;-2.62,-2.69,;-3.96,-3.47,;-3.96,-5,;-5.29,-5.78,;-6.62,-5,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.69,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(21(23)24-12-15)22-25-11-14(2)30-22/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) GLWIEKCNAKUHPZ-UHFFFAOYSA-N 295044 trans 3-(6-Amino-5- (5-methyloxazol-2- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)- 4-methylbenzene sulfonamide hydrochloride::US10112926, Example 5.2 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 190 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295044&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470118 381618139 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562710 Cc1cnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.93,;6.42,1.93,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.69,;.05,3.47,;.05,5,;1.38,5.78,;2.71,5,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.47,;-2.62,5,;-2.62,-1.15,;-4.16,-1.15,;-1.08,-1.15,;-2.62,-2.69,;-3.96,-3.47,;-3.96,-5,;-5.29,-5.78,;-6.62,-5,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.69,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(21(23)24-12-15)22-25-11-14(2)30-22/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) GLWIEKCNAKUHPZ-UHFFFAOYSA-N 295044 trans 3-(6-Amino-5- (5-methyloxazol-2- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)- 4-methylbenzene sulfonamide hydrochloride::US10112926, Example 5.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295044&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470118 381618139 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562711 Cc1cnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.93,;6.42,1.93,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.69,;.05,3.47,;.05,5,;1.38,5.78,;2.71,5,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.47,;-2.62,5,;-2.62,-1.15,;-4.16,-1.15,;-1.08,-1.15,;-2.62,-2.69,;-3.96,-3.47,;-3.96,-5,;-5.29,-5.78,;-6.62,-5,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.69,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(21(23)24-12-15)22-25-11-14(2)30-22/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) GLWIEKCNAKUHPZ-UHFFFAOYSA-N 295044 trans 3-(6-Amino-5- (5-methyloxazol-2- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)- 4-methylbenzene sulfonamide hydrochloride::US10112926, Example 5.2 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295044&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470118 381618139 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562712 Cc1cnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.93,;6.42,1.93,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.69,;.05,3.47,;.05,5,;1.38,5.78,;2.71,5,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.47,;-2.62,5,;-2.62,-1.15,;-4.16,-1.15,;-1.08,-1.15,;-2.62,-2.69,;-3.96,-3.47,;-3.96,-5,;-5.29,-5.78,;-6.62,-5,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.69,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(21(23)24-12-15)22-25-11-14(2)30-22/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) GLWIEKCNAKUHPZ-UHFFFAOYSA-N 295044 trans 3-(6-Amino-5- (5-methyloxazol-2- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)- 4-methylbenzene sulfonamide hydrochloride::US10112926, Example 5.2 Phosphatidylinositol 4-kinase beta Human 900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295044&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470118 381618139 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562713 Cc1cnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.93,;6.42,1.93,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.69,;.05,3.47,;.05,5,;1.38,5.78,;2.71,5,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.47,;-2.62,5,;-2.62,-1.15,;-4.16,-1.15,;-1.08,-1.15,;-2.62,-2.69,;-3.96,-3.47,;-3.96,-5,;-5.29,-5.78,;-6.62,-5,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.69,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(21(23)24-12-15)22-25-11-14(2)30-22/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) GLWIEKCNAKUHPZ-UHFFFAOYSA-N 295044 trans 3-(6-Amino-5- (5-methyloxazol-2- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)- 4-methylbenzene sulfonamide hydrochloride::US10112926, Example 5.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 7.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295044&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470118 381618139 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562714 Cc1cnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.93,;6.42,1.93,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.69,;.05,3.47,;.05,5,;1.38,5.78,;2.71,5,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.47,;-2.62,5,;-2.62,-1.15,;-4.16,-1.15,;-1.08,-1.15,;-2.62,-2.69,;-3.96,-3.47,;-3.96,-5,;-5.29,-5.78,;-6.62,-5,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.69,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(21(23)24-12-15)22-25-11-14(2)30-22/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) GLWIEKCNAKUHPZ-UHFFFAOYSA-N 295044 trans 3-(6-Amino-5- (5-methyloxazol-2- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)- 4-methylbenzene sulfonamide hydrochloride::US10112926, Example 5.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 280 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295044&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470118 381618139 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562715 Cc1cnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.93,;6.42,1.93,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.69,;.05,3.47,;.05,5,;1.38,5.78,;2.71,5,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.47,;-2.62,5,;-2.62,-1.15,;-4.16,-1.15,;-1.08,-1.15,;-2.62,-2.69,;-3.96,-3.47,;-3.96,-5,;-5.29,-5.78,;-6.62,-5,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.69,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(21(23)24-12-15)22-25-11-14(2)30-22/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) GLWIEKCNAKUHPZ-UHFFFAOYSA-N 295044 trans 3-(6-Amino-5- (5-methyloxazol-2- yl)pyridin-3-yl)-N-(4- hydroxy cyclohexyl)- 4-methylbenzene sulfonamide hydrochloride::US10112926, Example 5.2 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295044&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470118 381618139 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562716 CCc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-5-17-24-19(29-25-17)16-8-13(10-22-18(16)21)15-9-14(7-6-12(15)2)30(27,28)23-11-20(3,4)26/h6-10,23,26H,5,11H2,1-4H3,(H2,21,22) ONTJFJBLGNRKST-UHFFFAOYSA-N 295045 3-(6-Amino-5-(3- ethyl-1,2,4-oxadiazol- 5-yl)pyridin-3-yl)-N- (2-hydroxy-2- methylpropyl)-4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.3 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295045&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470249 381618140 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562717 CCc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-5-17-24-19(29-25-17)16-8-13(10-22-18(16)21)15-9-14(7-6-12(15)2)30(27,28)23-11-20(3,4)26/h6-10,23,26H,5,11H2,1-4H3,(H2,21,22) ONTJFJBLGNRKST-UHFFFAOYSA-N 295045 3-(6-Amino-5-(3- ethyl-1,2,4-oxadiazol- 5-yl)pyridin-3-yl)-N- (2-hydroxy-2- methylpropyl)-4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295045&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470249 381618140 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562718 CCc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-5-17-24-19(29-25-17)16-8-13(10-22-18(16)21)15-9-14(7-6-12(15)2)30(27,28)23-11-20(3,4)26/h6-10,23,26H,5,11H2,1-4H3,(H2,21,22) ONTJFJBLGNRKST-UHFFFAOYSA-N 295045 3-(6-Amino-5-(3- ethyl-1,2,4-oxadiazol- 5-yl)pyridin-3-yl)-N- (2-hydroxy-2- methylpropyl)-4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.3 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295045&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470249 381618140 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562719 CCc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-5-17-24-19(29-25-17)16-8-13(10-22-18(16)21)15-9-14(7-6-12(15)2)30(27,28)23-11-20(3,4)26/h6-10,23,26H,5,11H2,1-4H3,(H2,21,22) ONTJFJBLGNRKST-UHFFFAOYSA-N 295045 3-(6-Amino-5-(3- ethyl-1,2,4-oxadiazol- 5-yl)pyridin-3-yl)-N- (2-hydroxy-2- methylpropyl)-4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.3 Phosphatidylinositol 4-kinase beta Human 7500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295045&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470249 381618140 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562720 CCc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-5-17-24-19(29-25-17)16-8-13(10-22-18(16)21)15-9-14(7-6-12(15)2)30(27,28)23-11-20(3,4)26/h6-10,23,26H,5,11H2,1-4H3,(H2,21,22) ONTJFJBLGNRKST-UHFFFAOYSA-N 295045 3-(6-Amino-5-(3- ethyl-1,2,4-oxadiazol- 5-yl)pyridin-3-yl)-N- (2-hydroxy-2- methylpropyl)-4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 26.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295045&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470249 381618140 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562721 CCc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-5-17-24-19(29-25-17)16-8-13(10-22-18(16)21)15-9-14(7-6-12(15)2)30(27,28)23-11-20(3,4)26/h6-10,23,26H,5,11H2,1-4H3,(H2,21,22) ONTJFJBLGNRKST-UHFFFAOYSA-N 295045 3-(6-Amino-5-(3- ethyl-1,2,4-oxadiazol- 5-yl)pyridin-3-yl)-N- (2-hydroxy-2- methylpropyl)-4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 420 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295045&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470249 381618140 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562722 CCc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-5-17-24-19(29-25-17)16-8-13(10-22-18(16)21)15-9-14(7-6-12(15)2)30(27,28)23-11-20(3,4)26/h6-10,23,26H,5,11H2,1-4H3,(H2,21,22) ONTJFJBLGNRKST-UHFFFAOYSA-N 295045 3-(6-Amino-5-(3- ethyl-1,2,4-oxadiazol- 5-yl)pyridin-3-yl)-N- (2-hydroxy-2- methylpropyl)-4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.3 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295045&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470249 381618140 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562723 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(5.15,-.65,;4.38,.68,;2.92,1.16,;2.92,2.7,;4.38,3.17,;5.29,1.93,;1.59,3.47,;.25,2.7,;-1.08,3.47,;-1.08,5.01,;.25,5.78,;1.59,5.01,;2.92,5.78,;-2.42,2.7,;-2.42,1.16,;-3.75,.39,;-5.08,1.16,;-5.08,2.7,;-3.75,3.47,;-3.75,5.01,;-3.75,-1.15,;-5.29,-1.15,;-2.21,-1.15,;-3.75,-2.69,;-2.42,-3.46,;-1.08,-2.69,;.25,-3.46,;.25,-5,;1.59,-5.77,;-1.08,-5.78,;-2.42,-5,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)11-19(13)15-10-20(22(23)24-12-15)21-9-14(2)25-30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) YGVFZWRVQCNDLQ-UHFFFAOYSA-N 295046 trans 3-(6-Amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-N-(-4- hydroxy cyclohexyl)- 4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.4 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 250 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295046&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469954 381618141 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562724 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(5.15,-.65,;4.38,.68,;2.92,1.16,;2.92,2.7,;4.38,3.17,;5.29,1.93,;1.59,3.47,;.25,2.7,;-1.08,3.47,;-1.08,5.01,;.25,5.78,;1.59,5.01,;2.92,5.78,;-2.42,2.7,;-2.42,1.16,;-3.75,.39,;-5.08,1.16,;-5.08,2.7,;-3.75,3.47,;-3.75,5.01,;-3.75,-1.15,;-5.29,-1.15,;-2.21,-1.15,;-3.75,-2.69,;-2.42,-3.46,;-1.08,-2.69,;.25,-3.46,;.25,-5,;1.59,-5.77,;-1.08,-5.78,;-2.42,-5,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)11-19(13)15-10-20(22(23)24-12-15)21-9-14(2)25-30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) YGVFZWRVQCNDLQ-UHFFFAOYSA-N 295046 trans 3-(6-Amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-N-(-4- hydroxy cyclohexyl)- 4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295046&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469954 381618141 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562725 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(5.15,-.65,;4.38,.68,;2.92,1.16,;2.92,2.7,;4.38,3.17,;5.29,1.93,;1.59,3.47,;.25,2.7,;-1.08,3.47,;-1.08,5.01,;.25,5.78,;1.59,5.01,;2.92,5.78,;-2.42,2.7,;-2.42,1.16,;-3.75,.39,;-5.08,1.16,;-5.08,2.7,;-3.75,3.47,;-3.75,5.01,;-3.75,-1.15,;-5.29,-1.15,;-2.21,-1.15,;-3.75,-2.69,;-2.42,-3.46,;-1.08,-2.69,;.25,-3.46,;.25,-5,;1.59,-5.77,;-1.08,-5.78,;-2.42,-5,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)11-19(13)15-10-20(22(23)24-12-15)21-9-14(2)25-30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) YGVFZWRVQCNDLQ-UHFFFAOYSA-N 295046 trans 3-(6-Amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-N-(-4- hydroxy cyclohexyl)- 4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.4 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295046&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469954 381618141 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562726 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(5.15,-.65,;4.38,.68,;2.92,1.16,;2.92,2.7,;4.38,3.17,;5.29,1.93,;1.59,3.47,;.25,2.7,;-1.08,3.47,;-1.08,5.01,;.25,5.78,;1.59,5.01,;2.92,5.78,;-2.42,2.7,;-2.42,1.16,;-3.75,.39,;-5.08,1.16,;-5.08,2.7,;-3.75,3.47,;-3.75,5.01,;-3.75,-1.15,;-5.29,-1.15,;-2.21,-1.15,;-3.75,-2.69,;-2.42,-3.46,;-1.08,-2.69,;.25,-3.46,;.25,-5,;1.59,-5.77,;-1.08,-5.78,;-2.42,-5,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)11-19(13)15-10-20(22(23)24-12-15)21-9-14(2)25-30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) YGVFZWRVQCNDLQ-UHFFFAOYSA-N 295046 trans 3-(6-Amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-N-(-4- hydroxy cyclohexyl)- 4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.4 Phosphatidylinositol 4-kinase beta Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295046&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469954 381618141 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562727 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(5.15,-.65,;4.38,.68,;2.92,1.16,;2.92,2.7,;4.38,3.17,;5.29,1.93,;1.59,3.47,;.25,2.7,;-1.08,3.47,;-1.08,5.01,;.25,5.78,;1.59,5.01,;2.92,5.78,;-2.42,2.7,;-2.42,1.16,;-3.75,.39,;-5.08,1.16,;-5.08,2.7,;-3.75,3.47,;-3.75,5.01,;-3.75,-1.15,;-5.29,-1.15,;-2.21,-1.15,;-3.75,-2.69,;-2.42,-3.46,;-1.08,-2.69,;.25,-3.46,;.25,-5,;1.59,-5.77,;-1.08,-5.78,;-2.42,-5,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)11-19(13)15-10-20(22(23)24-12-15)21-9-14(2)25-30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) YGVFZWRVQCNDLQ-UHFFFAOYSA-N 295046 trans 3-(6-Amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-N-(-4- hydroxy cyclohexyl)- 4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 22.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295046&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469954 381618141 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562728 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(5.15,-.65,;4.38,.68,;2.92,1.16,;2.92,2.7,;4.38,3.17,;5.29,1.93,;1.59,3.47,;.25,2.7,;-1.08,3.47,;-1.08,5.01,;.25,5.78,;1.59,5.01,;2.92,5.78,;-2.42,2.7,;-2.42,1.16,;-3.75,.39,;-5.08,1.16,;-5.08,2.7,;-3.75,3.47,;-3.75,5.01,;-3.75,-1.15,;-5.29,-1.15,;-2.21,-1.15,;-3.75,-2.69,;-2.42,-3.46,;-1.08,-2.69,;.25,-3.46,;.25,-5,;1.59,-5.77,;-1.08,-5.78,;-2.42,-5,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)11-19(13)15-10-20(22(23)24-12-15)21-9-14(2)25-30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) YGVFZWRVQCNDLQ-UHFFFAOYSA-N 295046 trans 3-(6-Amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-N-(-4- hydroxy cyclohexyl)- 4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 570 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295046&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469954 381618141 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562729 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(5.15,-.65,;4.38,.68,;2.92,1.16,;2.92,2.7,;4.38,3.17,;5.29,1.93,;1.59,3.47,;.25,2.7,;-1.08,3.47,;-1.08,5.01,;.25,5.78,;1.59,5.01,;2.92,5.78,;-2.42,2.7,;-2.42,1.16,;-3.75,.39,;-5.08,1.16,;-5.08,2.7,;-3.75,3.47,;-3.75,5.01,;-3.75,-1.15,;-5.29,-1.15,;-2.21,-1.15,;-3.75,-2.69,;-2.42,-3.46,;-1.08,-2.69,;.25,-3.46,;.25,-5,;1.59,-5.77,;-1.08,-5.78,;-2.42,-5,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)11-19(13)15-10-20(22(23)24-12-15)21-9-14(2)25-30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) YGVFZWRVQCNDLQ-UHFFFAOYSA-N 295046 trans 3-(6-Amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-N-(-4- hydroxy cyclohexyl)- 4- methylbenzenesulfon- amide hydrochloride::US10112926, Example 5.4 Serine/threonine-protein kinase mTOR Human 3000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295046&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469954 381618141 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562730 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(O)C1 |(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-3.78,-1.38,;-.7,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295047 Diastereomers of 3- (6-Amino-5-(3- methyl-1,2,4- oxadiazol-5- yl)pyridin-3-yl)-N-(3- hydroxy cyclobutyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 5.5 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 320 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295047&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618142 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562731 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(O)C1 |(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-3.78,-1.38,;-.7,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295047 Diastereomers of 3- (6-Amino-5-(3- methyl-1,2,4- oxadiazol-5- yl)pyridin-3-yl)-N-(3- hydroxy cyclobutyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 5.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295047&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618142 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562732 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(O)C1 |(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-3.78,-1.38,;-.7,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295047 Diastereomers of 3- (6-Amino-5-(3- methyl-1,2,4- oxadiazol-5- yl)pyridin-3-yl)-N-(3- hydroxy cyclobutyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 5.5 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295047&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618142 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562733 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(O)C1 |(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-3.78,-1.38,;-.7,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295047 Diastereomers of 3- (6-Amino-5-(3- methyl-1,2,4- oxadiazol-5- yl)pyridin-3-yl)-N-(3- hydroxy cyclobutyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 5.5 Phosphatidylinositol 4-kinase beta Human 4000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295047&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618142 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562734 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(O)C1 |(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-3.78,-1.38,;-.7,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295047 Diastereomers of 3- (6-Amino-5-(3- methyl-1,2,4- oxadiazol-5- yl)pyridin-3-yl)-N-(3- hydroxy cyclobutyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 5.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 21.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295047&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618142 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562735 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(O)C1 |(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-3.78,-1.38,;-.7,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295047 Diastereomers of 3- (6-Amino-5-(3- methyl-1,2,4- oxadiazol-5- yl)pyridin-3-yl)-N-(3- hydroxy cyclobutyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 5.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 390 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295047&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618142 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562736 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(O)C1 |(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-3.78,-1.38,;-.7,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295047 Diastereomers of 3- (6-Amino-5-(3- methyl-1,2,4- oxadiazol-5- yl)pyridin-3-yl)-N-(3- hydroxy cyclobutyl)-4- methylbenzene sulfonamide hydrochloride::US10112926, Example 5.5 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295047&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618142 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562737 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-.7,-1.38,;-3.78,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295048 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1s,3s)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 5.5a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 760 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295048&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618143 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562738 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-.7,-1.38,;-3.78,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295048 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1s,3s)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 5.5a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295048&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618143 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562739 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-.7,-1.38,;-3.78,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295048 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1s,3s)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 5.5a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295048&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618143 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562740 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-.7,-1.38,;-3.78,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295048 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1s,3s)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 5.5a Phosphatidylinositol 4-kinase beta Human 4600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295048&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618143 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562741 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-.7,-1.38,;-3.78,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295048 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1s,3s)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 5.5a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 110 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295048&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618143 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562742 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-.7,-1.38,;-3.78,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295048 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1s,3s)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 5.5a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 950 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295048&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618143 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562743 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.66,-.88,;5.89,.45,;6.8,1.7,;5.89,2.95,;4.43,2.47,;4.43,.93,;3.09,3.24,;1.76,2.47,;.43,3.24,;.43,4.78,;1.76,5.55,;3.09,4.78,;4.43,5.55,;-.91,2.47,;-.91,.93,;-2.24,.16,;-3.58,.93,;-3.58,2.47,;-2.24,3.24,;-2.24,4.78,;-2.24,-1.38,;-.7,-1.38,;-3.78,-1.38,;-2.24,-2.92,;-3.58,-3.69,;-5.06,-3.29,;-5.46,-4.78,;-6.8,-5.55,;-3.97,-5.18,)| InChI=1S/C19H21N5O4S/c1-10-3-4-15(29(26,27)24-13-6-14(25)7-13)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-28-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) ALYMJMACGKTBIZ-UHFFFAOYSA-N 295048 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1s,3s)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 5.5a Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295048&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470106 381618143 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562744 Cc1nnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) MWXOKLKTIOEEPK-UHFFFAOYSA-N 295049 3-(6-Amino-5-(5- methyl-1,3,4-oxa- diazol-2-yl)pyridin-3- yl)-N-(3-hydroxy-3- methylbutyl)-4- methylbenzenesulfon- amide::US10112926, Example 5.6 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295049&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470163 381618144 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562745 Cc1nnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) MWXOKLKTIOEEPK-UHFFFAOYSA-N 295049 3-(6-Amino-5-(5- methyl-1,3,4-oxa- diazol-2-yl)pyridin-3- yl)-N-(3-hydroxy-3- methylbutyl)-4- methylbenzenesulfon- amide::US10112926, Example 5.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295049&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470163 381618144 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562746 Cc1nnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) MWXOKLKTIOEEPK-UHFFFAOYSA-N 295049 3-(6-Amino-5-(5- methyl-1,3,4-oxa- diazol-2-yl)pyridin-3- yl)-N-(3-hydroxy-3- methylbutyl)-4- methylbenzenesulfon- amide::US10112926, Example 5.6 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295049&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470163 381618144 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562747 Cc1nnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) MWXOKLKTIOEEPK-UHFFFAOYSA-N 295049 3-(6-Amino-5-(5- methyl-1,3,4-oxa- diazol-2-yl)pyridin-3- yl)-N-(3-hydroxy-3- methylbutyl)-4- methylbenzenesulfon- amide::US10112926, Example 5.6 Phosphatidylinositol 4-kinase beta Human 7800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295049&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470163 381618144 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562748 Cc1nnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) MWXOKLKTIOEEPK-UHFFFAOYSA-N 295049 3-(6-Amino-5-(5- methyl-1,3,4-oxa- diazol-2-yl)pyridin-3- yl)-N-(3-hydroxy-3- methylbutyl)-4- methylbenzenesulfon- amide::US10112926, Example 5.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 11.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295049&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470163 381618144 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562749 Cc1nnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) MWXOKLKTIOEEPK-UHFFFAOYSA-N 295049 3-(6-Amino-5-(5- methyl-1,3,4-oxa- diazol-2-yl)pyridin-3- yl)-N-(3-hydroxy-3- methylbutyl)-4- methylbenzenesulfon- amide::US10112926, Example 5.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 350 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295049&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470163 381618144 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562750 Cc1nnc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) MWXOKLKTIOEEPK-UHFFFAOYSA-N 295049 3-(6-Amino-5-(5- methyl-1,3,4-oxa- diazol-2-yl)pyridin-3- yl)-N-(3-hydroxy-3- methylbutyl)-4- methylbenzenesulfon- amide::US10112926, Example 5.6 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295049&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470163 381618144 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562751 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) UQIUWUJYJBQZBY-UHFFFAOYSA-N 295050 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 6 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295050&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470069 381618145 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562752 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) UQIUWUJYJBQZBY-UHFFFAOYSA-N 295050 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295050&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470069 381618145 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562753 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) UQIUWUJYJBQZBY-UHFFFAOYSA-N 295050 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 6 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295050&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470069 381618145 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562754 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) UQIUWUJYJBQZBY-UHFFFAOYSA-N 295050 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 6 Phosphatidylinositol 4-kinase beta Human 2730 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295050&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470069 381618145 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562755 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) UQIUWUJYJBQZBY-UHFFFAOYSA-N 295050 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 36.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295050&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470069 381618145 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562756 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) UQIUWUJYJBQZBY-UHFFFAOYSA-N 295050 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 620 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295050&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470069 381618145 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562757 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) UQIUWUJYJBQZBY-UHFFFAOYSA-N 295050 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 6 Serine/threonine-protein kinase mTOR Human 6850 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295050&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470069 381618145 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562758 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) PJSOHQYOAVQLMP-UHFFFAOYSA-N 295051 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 7 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 950 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295051&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470204 381618146 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562759 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) PJSOHQYOAVQLMP-UHFFFAOYSA-N 295051 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295051&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470204 381618146 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562760 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) PJSOHQYOAVQLMP-UHFFFAOYSA-N 295051 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 7 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295051&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470204 381618146 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562761 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) PJSOHQYOAVQLMP-UHFFFAOYSA-N 295051 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 7 Phosphatidylinositol 4-kinase beta Human 3980 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295051&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470204 381618146 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562762 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) PJSOHQYOAVQLMP-UHFFFAOYSA-N 295051 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 24.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295051&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470204 381618146 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562763 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) PJSOHQYOAVQLMP-UHFFFAOYSA-N 295051 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 820 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295051&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470204 381618146 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562764 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) PJSOHQYOAVQLMP-UHFFFAOYSA-N 295051 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 7 Serine/threonine-protein kinase mTOR Human 8100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295051&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470204 381618146 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562765 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(5.15,-.34,;4.38,1,;5.29,2.24,;4.38,3.49,;2.92,3.01,;2.92,1.47,;1.59,3.78,;.25,3.01,;-1.08,3.78,;-1.08,5.32,;.25,6.09,;1.59,5.32,;2.92,6.09,;-2.42,3.01,;-2.42,1.47,;-3.75,.7,;-5.08,1.47,;-5.08,3.01,;-3.75,3.78,;-3.75,5.32,;-3.75,-.84,;-2.21,-.84,;-5.29,-.84,;-3.75,-2.38,;-2.42,-3.15,;-2.02,-4.63,;-.53,-4.23,;-.13,-5.72,;1.36,-5.32,;2.69,-6.09,;.96,-3.84,;-.93,-2.75,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295052 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(6-hydroxy-spiro[3.3]hept-2-yl)-4-methyl-benzenesulfonamide (racemate)::US10112926, Example 8 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 60.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295052&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618147 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562766 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(5.15,-.34,;4.38,1,;5.29,2.24,;4.38,3.49,;2.92,3.01,;2.92,1.47,;1.59,3.78,;.25,3.01,;-1.08,3.78,;-1.08,5.32,;.25,6.09,;1.59,5.32,;2.92,6.09,;-2.42,3.01,;-2.42,1.47,;-3.75,.7,;-5.08,1.47,;-5.08,3.01,;-3.75,3.78,;-3.75,5.32,;-3.75,-.84,;-2.21,-.84,;-5.29,-.84,;-3.75,-2.38,;-2.42,-3.15,;-2.02,-4.63,;-.53,-4.23,;-.13,-5.72,;1.36,-5.32,;2.69,-6.09,;.96,-3.84,;-.93,-2.75,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295052 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(6-hydroxy-spiro[3.3]hept-2-yl)-4-methyl-benzenesulfonamide (racemate)::US10112926, Example 8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 430 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295052&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618147 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562767 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(5.15,-.34,;4.38,1,;5.29,2.24,;4.38,3.49,;2.92,3.01,;2.92,1.47,;1.59,3.78,;.25,3.01,;-1.08,3.78,;-1.08,5.32,;.25,6.09,;1.59,5.32,;2.92,6.09,;-2.42,3.01,;-2.42,1.47,;-3.75,.7,;-5.08,1.47,;-5.08,3.01,;-3.75,3.78,;-3.75,5.32,;-3.75,-.84,;-2.21,-.84,;-5.29,-.84,;-3.75,-2.38,;-2.42,-3.15,;-2.02,-4.63,;-.53,-4.23,;-.13,-5.72,;1.36,-5.32,;2.69,-6.09,;.96,-3.84,;-.93,-2.75,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295052 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(6-hydroxy-spiro[3.3]hept-2-yl)-4-methyl-benzenesulfonamide (racemate)::US10112926, Example 8 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295052&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618147 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562768 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(5.15,-.34,;4.38,1,;5.29,2.24,;4.38,3.49,;2.92,3.01,;2.92,1.47,;1.59,3.78,;.25,3.01,;-1.08,3.78,;-1.08,5.32,;.25,6.09,;1.59,5.32,;2.92,6.09,;-2.42,3.01,;-2.42,1.47,;-3.75,.7,;-5.08,1.47,;-5.08,3.01,;-3.75,3.78,;-3.75,5.32,;-3.75,-.84,;-2.21,-.84,;-5.29,-.84,;-3.75,-2.38,;-2.42,-3.15,;-2.02,-4.63,;-.53,-4.23,;-.13,-5.72,;1.36,-5.32,;2.69,-6.09,;.96,-3.84,;-.93,-2.75,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295052 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(6-hydroxy-spiro[3.3]hept-2-yl)-4-methyl-benzenesulfonamide (racemate)::US10112926, Example 8 Phosphatidylinositol 4-kinase beta Human 6100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295052&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618147 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562769 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(5.15,-.34,;4.38,1,;5.29,2.24,;4.38,3.49,;2.92,3.01,;2.92,1.47,;1.59,3.78,;.25,3.01,;-1.08,3.78,;-1.08,5.32,;.25,6.09,;1.59,5.32,;2.92,6.09,;-2.42,3.01,;-2.42,1.47,;-3.75,.7,;-5.08,1.47,;-5.08,3.01,;-3.75,3.78,;-3.75,5.32,;-3.75,-.84,;-2.21,-.84,;-5.29,-.84,;-3.75,-2.38,;-2.42,-3.15,;-2.02,-4.63,;-.53,-4.23,;-.13,-5.72,;1.36,-5.32,;2.69,-6.09,;.96,-3.84,;-.93,-2.75,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295052 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(6-hydroxy-spiro[3.3]hept-2-yl)-4-methyl-benzenesulfonamide (racemate)::US10112926, Example 8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 4.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295052&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618147 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562770 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(5.15,-.34,;4.38,1,;5.29,2.24,;4.38,3.49,;2.92,3.01,;2.92,1.47,;1.59,3.78,;.25,3.01,;-1.08,3.78,;-1.08,5.32,;.25,6.09,;1.59,5.32,;2.92,6.09,;-2.42,3.01,;-2.42,1.47,;-3.75,.7,;-5.08,1.47,;-5.08,3.01,;-3.75,3.78,;-3.75,5.32,;-3.75,-.84,;-2.21,-.84,;-5.29,-.84,;-3.75,-2.38,;-2.42,-3.15,;-2.02,-4.63,;-.53,-4.23,;-.13,-5.72,;1.36,-5.32,;2.69,-6.09,;.96,-3.84,;-.93,-2.75,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295052 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(6-hydroxy-spiro[3.3]hept-2-yl)-4-methyl-benzenesulfonamide (racemate)::US10112926, Example 8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 80.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295052&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618147 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562771 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(5.15,-.34,;4.38,1,;5.29,2.24,;4.38,3.49,;2.92,3.01,;2.92,1.47,;1.59,3.78,;.25,3.01,;-1.08,3.78,;-1.08,5.32,;.25,6.09,;1.59,5.32,;2.92,6.09,;-2.42,3.01,;-2.42,1.47,;-3.75,.7,;-5.08,1.47,;-5.08,3.01,;-3.75,3.78,;-3.75,5.32,;-3.75,-.84,;-2.21,-.84,;-5.29,-.84,;-3.75,-2.38,;-2.42,-3.15,;-2.02,-4.63,;-.53,-4.23,;-.13,-5.72,;1.36,-5.32,;2.69,-6.09,;.96,-3.84,;-.93,-2.75,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295052 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(6-hydroxy-spiro[3.3]hept-2-yl)-4-methyl-benzenesulfonamide (racemate)::US10112926, Example 8 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295052&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618147 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562772 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 20.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562773 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 360 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562774 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562775 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 4-kinase beta Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562776 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 17.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562777 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 80.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562778 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Serine/threonine-protein kinase mTOR Human 980 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562779 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 40.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562780 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562781 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562782 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 4-kinase beta Human 5100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562783 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 5.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562784 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 80.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562785 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC2(C[C@H](O)C2)C1 |r,wU:24.26,28.31,(5.15,-7.55,;4.38,-6.22,;5.29,-4.97,;4.38,-3.73,;2.92,-4.2,;2.92,-5.74,;1.59,-3.43,;.25,-4.2,;-1.08,-3.43,;-1.08,-1.89,;.25,-1.12,;1.59,-1.89,;2.92,-1.12,;-2.42,-4.2,;-2.42,-5.74,;-3.75,-6.51,;-5.08,-5.74,;-5.08,-4.2,;-3.75,-3.43,;-3.75,-1.89,;-3.75,-8.05,;-2.21,-8.05,;-5.29,-8.05,;-3.75,-9.59,;-2.42,-10.36,;-.93,-9.97,;-.53,-11.45,;-.13,-12.94,;1.36,-12.54,;2.69,-13.31,;.96,-11.05,;-2.02,-11.85,)| InChI=1S/C22H25N5O4S/c1-12-3-4-17(32(29,30)27-15-7-22(8-15)9-16(28)10-22)6-18(12)14-5-19(20(23)24-11-14)21-25-13(2)26-31-21/h3-6,11,15-16,27-28H,7-10H2,1-2H3,(H2,23,24) ARQVUQLTJMJHQG-UHFFFAOYSA-N 295053 US10112926, Example 8.2::US10112926, Example 8.1 Serine/threonine-protein kinase mTOR Human 8200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295053&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470252 381618148 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562786 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O3S2/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) ZHHKIDAEQSNMOI-UHFFFAOYSA-N 295055 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 9 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295055&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470611 381618149 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562787 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O3S2/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) ZHHKIDAEQSNMOI-UHFFFAOYSA-N 295055 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >9100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295055&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470611 381618149 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562788 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O3S2/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) ZHHKIDAEQSNMOI-UHFFFAOYSA-N 295055 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 9 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 890 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295055&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470611 381618149 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562789 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O3S2/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) ZHHKIDAEQSNMOI-UHFFFAOYSA-N 295055 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 9 Phosphatidylinositol 4-kinase beta Human 1920 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295055&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470611 381618149 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562790 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O3S2/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) ZHHKIDAEQSNMOI-UHFFFAOYSA-N 295055 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 14.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295055&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470611 381618149 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562791 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O3S2/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) ZHHKIDAEQSNMOI-UHFFFAOYSA-N 295055 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 220 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295055&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470611 381618149 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562792 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O3S2/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) ZHHKIDAEQSNMOI-UHFFFAOYSA-N 295055 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 9 Serine/threonine-protein kinase mTOR Human 5900 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295055&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470611 381618149 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562793 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O4S/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) HAWIAVPLXUYCRU-UHFFFAOYSA-N 295056 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide, hydrochloride salt::US10112926, Example 10 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295056&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470054 381618150 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562794 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O4S/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) HAWIAVPLXUYCRU-UHFFFAOYSA-N 295056 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide, hydrochloride salt::US10112926, Example 10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295056&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470054 381618150 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562795 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O4S/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) HAWIAVPLXUYCRU-UHFFFAOYSA-N 295056 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide, hydrochloride salt::US10112926, Example 10 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >9800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295056&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470054 381618150 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562796 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O4S/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) HAWIAVPLXUYCRU-UHFFFAOYSA-N 295056 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide, hydrochloride salt::US10112926, Example 10 Phosphatidylinositol 4-kinase beta Human >9800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295056&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470054 381618150 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562797 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O4S/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) HAWIAVPLXUYCRU-UHFFFAOYSA-N 295056 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide, hydrochloride salt::US10112926, Example 10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 40.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295056&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470054 381618150 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562798 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O4S/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) HAWIAVPLXUYCRU-UHFFFAOYSA-N 295056 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide, hydrochloride salt::US10112926, Example 10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 550 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295056&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470054 381618150 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562799 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O4S/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) HAWIAVPLXUYCRU-UHFFFAOYSA-N 295056 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide, hydrochloride salt::US10112926, Example 10 Serine/threonine-protein kinase mTOR Human 4200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295056&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470054 381618150 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562800 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C19H23N5O5S/c1-11-5-6-14(30(26,27)24-28-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-22-12(2)23-29-18/h5-9,24-25H,10H2,1-4H3,(H2,20,21) XQDCEYRYQNFRMX-UHFFFAOYSA-N 295057 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propoxy)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 11 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 70.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295057&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469974 381618151 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562801 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C19H23N5O5S/c1-11-5-6-14(30(26,27)24-28-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-22-12(2)23-29-18/h5-9,24-25H,10H2,1-4H3,(H2,20,21) XQDCEYRYQNFRMX-UHFFFAOYSA-N 295057 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propoxy)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 11 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 290 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295057&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469974 381618151 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562802 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C19H23N5O5S/c1-11-5-6-14(30(26,27)24-28-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-22-12(2)23-29-18/h5-9,24-25H,10H2,1-4H3,(H2,20,21) XQDCEYRYQNFRMX-UHFFFAOYSA-N 295057 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propoxy)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 11 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295057&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469974 381618151 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562803 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C19H23N5O5S/c1-11-5-6-14(30(26,27)24-28-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-22-12(2)23-29-18/h5-9,24-25H,10H2,1-4H3,(H2,20,21) XQDCEYRYQNFRMX-UHFFFAOYSA-N 295057 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propoxy)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 11 Phosphatidylinositol 4-kinase beta Human 5100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295057&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469974 381618151 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562804 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C19H23N5O5S/c1-11-5-6-14(30(26,27)24-28-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-22-12(2)23-29-18/h5-9,24-25H,10H2,1-4H3,(H2,20,21) XQDCEYRYQNFRMX-UHFFFAOYSA-N 295057 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propoxy)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 11 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 12.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295057&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469974 381618151 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562805 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C19H23N5O5S/c1-11-5-6-14(30(26,27)24-28-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-22-12(2)23-29-18/h5-9,24-25H,10H2,1-4H3,(H2,20,21) XQDCEYRYQNFRMX-UHFFFAOYSA-N 295057 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propoxy)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 11 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 50.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295057&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469974 381618151 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562806 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C19H23N5O5S/c1-11-5-6-14(30(26,27)24-28-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-22-12(2)23-29-18/h5-9,24-25H,10H2,1-4H3,(H2,20,21) XQDCEYRYQNFRMX-UHFFFAOYSA-N 295057 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propoxy)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 11 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295057&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469974 381618151 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562807 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.05,-.65,;6.28,.68,;7.19,1.93,;6.28,3.17,;4.82,2.69,;4.82,1.15,;3.48,3.47,;2.15,2.69,;.82,3.47,;.82,5,;2.15,5.78,;3.48,5,;4.82,5.78,;-.52,2.69,;-.52,1.15,;-1.85,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5,;-1.85,-1.15,;-.31,-1.15,;-3.39,-1.15,;-1.85,-2.69,;-3.19,-3.47,;-3.19,-5,;-4.52,-5.78,;-5.85,-5,;-7.19,-5.78,;-5.85,-3.47,;-4.52,-2.69,)| InChI=1S/C21H25N5O4S/c1-12-3-8-17(31(28,29)26-15-4-6-16(27)7-5-15)10-18(12)14-9-19(20(22)23-11-14)21-24-13(2)25-30-21/h3,8-11,15-16,26-27H,4-7H2,1-2H3,(H2,22,23) XFGGNFBJRMXYAG-UHFFFAOYSA-N 295058 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxy-cyclohexyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 12 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 160 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295058&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470131 381618152 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562808 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.05,-.65,;6.28,.68,;7.19,1.93,;6.28,3.17,;4.82,2.69,;4.82,1.15,;3.48,3.47,;2.15,2.69,;.82,3.47,;.82,5,;2.15,5.78,;3.48,5,;4.82,5.78,;-.52,2.69,;-.52,1.15,;-1.85,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5,;-1.85,-1.15,;-.31,-1.15,;-3.39,-1.15,;-1.85,-2.69,;-3.19,-3.47,;-3.19,-5,;-4.52,-5.78,;-5.85,-5,;-7.19,-5.78,;-5.85,-3.47,;-4.52,-2.69,)| InChI=1S/C21H25N5O4S/c1-12-3-8-17(31(28,29)26-15-4-6-16(27)7-5-15)10-18(12)14-9-19(20(22)23-11-14)21-24-13(2)25-30-21/h3,8-11,15-16,26-27H,4-7H2,1-2H3,(H2,22,23) XFGGNFBJRMXYAG-UHFFFAOYSA-N 295058 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxy-cyclohexyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 230 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295058&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470131 381618152 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562809 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.05,-.65,;6.28,.68,;7.19,1.93,;6.28,3.17,;4.82,2.69,;4.82,1.15,;3.48,3.47,;2.15,2.69,;.82,3.47,;.82,5,;2.15,5.78,;3.48,5,;4.82,5.78,;-.52,2.69,;-.52,1.15,;-1.85,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5,;-1.85,-1.15,;-.31,-1.15,;-3.39,-1.15,;-1.85,-2.69,;-3.19,-3.47,;-3.19,-5,;-4.52,-5.78,;-5.85,-5,;-7.19,-5.78,;-5.85,-3.47,;-4.52,-2.69,)| InChI=1S/C21H25N5O4S/c1-12-3-8-17(31(28,29)26-15-4-6-16(27)7-5-15)10-18(12)14-9-19(20(22)23-11-14)21-24-13(2)25-30-21/h3,8-11,15-16,26-27H,4-7H2,1-2H3,(H2,22,23) XFGGNFBJRMXYAG-UHFFFAOYSA-N 295058 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxy-cyclohexyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 12 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295058&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470131 381618152 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562810 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.05,-.65,;6.28,.68,;7.19,1.93,;6.28,3.17,;4.82,2.69,;4.82,1.15,;3.48,3.47,;2.15,2.69,;.82,3.47,;.82,5,;2.15,5.78,;3.48,5,;4.82,5.78,;-.52,2.69,;-.52,1.15,;-1.85,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5,;-1.85,-1.15,;-.31,-1.15,;-3.39,-1.15,;-1.85,-2.69,;-3.19,-3.47,;-3.19,-5,;-4.52,-5.78,;-5.85,-5,;-7.19,-5.78,;-5.85,-3.47,;-4.52,-2.69,)| InChI=1S/C21H25N5O4S/c1-12-3-8-17(31(28,29)26-15-4-6-16(27)7-5-15)10-18(12)14-9-19(20(22)23-11-14)21-24-13(2)25-30-21/h3,8-11,15-16,26-27H,4-7H2,1-2H3,(H2,22,23) XFGGNFBJRMXYAG-UHFFFAOYSA-N 295058 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxy-cyclohexyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 12 Phosphatidylinositol 4-kinase beta Human 5300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295058&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470131 381618152 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562811 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.05,-.65,;6.28,.68,;7.19,1.93,;6.28,3.17,;4.82,2.69,;4.82,1.15,;3.48,3.47,;2.15,2.69,;.82,3.47,;.82,5,;2.15,5.78,;3.48,5,;4.82,5.78,;-.52,2.69,;-.52,1.15,;-1.85,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5,;-1.85,-1.15,;-.31,-1.15,;-3.39,-1.15,;-1.85,-2.69,;-3.19,-3.47,;-3.19,-5,;-4.52,-5.78,;-5.85,-5,;-7.19,-5.78,;-5.85,-3.47,;-4.52,-2.69,)| InChI=1S/C21H25N5O4S/c1-12-3-8-17(31(28,29)26-15-4-6-16(27)7-5-15)10-18(12)14-9-19(20(22)23-11-14)21-24-13(2)25-30-21/h3,8-11,15-16,26-27H,4-7H2,1-2H3,(H2,22,23) XFGGNFBJRMXYAG-UHFFFAOYSA-N 295058 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxy-cyclohexyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 8.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295058&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470131 381618152 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562812 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.05,-.65,;6.28,.68,;7.19,1.93,;6.28,3.17,;4.82,2.69,;4.82,1.15,;3.48,3.47,;2.15,2.69,;.82,3.47,;.82,5,;2.15,5.78,;3.48,5,;4.82,5.78,;-.52,2.69,;-.52,1.15,;-1.85,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5,;-1.85,-1.15,;-.31,-1.15,;-3.39,-1.15,;-1.85,-2.69,;-3.19,-3.47,;-3.19,-5,;-4.52,-5.78,;-5.85,-5,;-7.19,-5.78,;-5.85,-3.47,;-4.52,-2.69,)| InChI=1S/C21H25N5O4S/c1-12-3-8-17(31(28,29)26-15-4-6-16(27)7-5-15)10-18(12)14-9-19(20(22)23-11-14)21-24-13(2)25-30-21/h3,8-11,15-16,26-27H,4-7H2,1-2H3,(H2,22,23) XFGGNFBJRMXYAG-UHFFFAOYSA-N 295058 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxy-cyclohexyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 270 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295058&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470131 381618152 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562813 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.05,-.65,;6.28,.68,;7.19,1.93,;6.28,3.17,;4.82,2.69,;4.82,1.15,;3.48,3.47,;2.15,2.69,;.82,3.47,;.82,5,;2.15,5.78,;3.48,5,;4.82,5.78,;-.52,2.69,;-.52,1.15,;-1.85,.38,;-3.19,1.15,;-3.19,2.69,;-1.85,3.47,;-1.85,5,;-1.85,-1.15,;-.31,-1.15,;-3.39,-1.15,;-1.85,-2.69,;-3.19,-3.47,;-3.19,-5,;-4.52,-5.78,;-5.85,-5,;-7.19,-5.78,;-5.85,-3.47,;-4.52,-2.69,)| InChI=1S/C21H25N5O4S/c1-12-3-8-17(31(28,29)26-15-4-6-16(27)7-5-15)10-18(12)14-9-19(20(22)23-11-14)21-24-13(2)25-30-21/h3,8-11,15-16,26-27H,4-7H2,1-2H3,(H2,22,23) XFGGNFBJRMXYAG-UHFFFAOYSA-N 295058 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxy-cyclohexyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 12 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295058&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470131 381618152 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562814 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) HYYDYXKGKDQGAW-UHFFFAOYSA-N 295059 3-[6-Amino-5-(2-methyl-oxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 13 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 140 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295059&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470183 381618153 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562815 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) HYYDYXKGKDQGAW-UHFFFAOYSA-N 295059 3-[6-Amino-5-(2-methyl-oxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 850 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295059&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470183 381618153 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562816 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) HYYDYXKGKDQGAW-UHFFFAOYSA-N 295059 3-[6-Amino-5-(2-methyl-oxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 13 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295059&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470183 381618153 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562817 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) HYYDYXKGKDQGAW-UHFFFAOYSA-N 295059 3-[6-Amino-5-(2-methyl-oxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 13 Phosphatidylinositol 4-kinase beta Human 4400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295059&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470183 381618153 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562818 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) HYYDYXKGKDQGAW-UHFFFAOYSA-N 295059 3-[6-Amino-5-(2-methyl-oxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 16.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295059&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470183 381618153 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562819 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) HYYDYXKGKDQGAW-UHFFFAOYSA-N 295059 3-[6-Amino-5-(2-methyl-oxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 110 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295059&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470183 381618153 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562820 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(20(22)24-11-15)19-12-23-14(2)29-19/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,24) HYYDYXKGKDQGAW-UHFFFAOYSA-N 295059 3-[6-Amino-5-(2-methyl-oxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 13 Serine/threonine-protein kinase mTOR Human 1600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295059&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470183 381618153 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562821 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)11-17(13)15-10-18(20(22)23-12-15)19-9-14(2)25-29-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) JNDYHRYIYXJWHN-UHFFFAOYSA-N 295060 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 14 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 170 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295060&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469778 381618154 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562822 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)11-17(13)15-10-18(20(22)23-12-15)19-9-14(2)25-29-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) JNDYHRYIYXJWHN-UHFFFAOYSA-N 295060 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 14 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295060&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469778 381618154 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562823 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)11-17(13)15-10-18(20(22)23-12-15)19-9-14(2)25-29-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) JNDYHRYIYXJWHN-UHFFFAOYSA-N 295060 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 14 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295060&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469778 381618154 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562824 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)11-17(13)15-10-18(20(22)23-12-15)19-9-14(2)25-29-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) JNDYHRYIYXJWHN-UHFFFAOYSA-N 295060 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 14 Phosphatidylinositol 4-kinase beta Human 2600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295060&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469778 381618154 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562825 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)11-17(13)15-10-18(20(22)23-12-15)19-9-14(2)25-29-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) JNDYHRYIYXJWHN-UHFFFAOYSA-N 295060 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 14 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 13.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295060&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469778 381618154 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562826 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)11-17(13)15-10-18(20(22)23-12-15)19-9-14(2)25-29-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) JNDYHRYIYXJWHN-UHFFFAOYSA-N 295060 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 14 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 100.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295060&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469778 381618154 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562827 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)11-17(13)15-10-18(20(22)23-12-15)19-9-14(2)25-29-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) JNDYHRYIYXJWHN-UHFFFAOYSA-N 295060 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide, hydrochloride salt::US10112926, Example 14 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295060&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469778 381618154 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562828 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) MAXHGWQUDVMRJX-UHFFFAOYSA-N 295061 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 15 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 620 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295061&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470445 381618155 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562829 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) MAXHGWQUDVMRJX-UHFFFAOYSA-N 295061 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295061&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470445 381618155 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562830 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) MAXHGWQUDVMRJX-UHFFFAOYSA-N 295061 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 15 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1620 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295061&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470445 381618155 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562831 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) MAXHGWQUDVMRJX-UHFFFAOYSA-N 295061 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 15 Phosphatidylinositol 4-kinase beta Human 3390 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295061&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470445 381618155 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562832 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) MAXHGWQUDVMRJX-UHFFFAOYSA-N 295061 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 12.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295061&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470445 381618155 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562833 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) MAXHGWQUDVMRJX-UHFFFAOYSA-N 295061 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 240 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295061&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470445 381618155 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562834 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) MAXHGWQUDVMRJX-UHFFFAOYSA-N 295061 3-[6-Amino-5-(2-methyl-thiazol-5-yl)-pyridin-3-yl]-N-(2-hydroxy-2-methyl-propyl)-4-methyl-benzenesulfonamide::US10112926, Example 15 Serine/threonine-protein kinase mTOR Human 7900 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295061&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470445 381618155 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562835 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H28N4O3S/c1-15-5-6-19(31(29,30)27-10-8-23(3,4)28)13-20(15)18-12-21(22(24)26-14-18)17-7-9-25-16(2)11-17/h5-7,9,11-14,27-28H,8,10H2,1-4H3,(H2,24,26) WYFOXUQSJDNCQI-UHFFFAOYSA-N 295062 3-(2-Amino-2′-methyl-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 16 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 100.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295062&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470045 381618156 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562836 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H28N4O3S/c1-15-5-6-19(31(29,30)27-10-8-23(3,4)28)13-20(15)18-12-21(22(24)26-14-18)17-7-9-25-16(2)11-17/h5-7,9,11-14,27-28H,8,10H2,1-4H3,(H2,24,26) WYFOXUQSJDNCQI-UHFFFAOYSA-N 295062 3-(2-Amino-2′-methyl-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6360 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295062&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470045 381618156 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562837 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H28N4O3S/c1-15-5-6-19(31(29,30)27-10-8-23(3,4)28)13-20(15)18-12-21(22(24)26-14-18)17-7-9-25-16(2)11-17/h5-7,9,11-14,27-28H,8,10H2,1-4H3,(H2,24,26) WYFOXUQSJDNCQI-UHFFFAOYSA-N 295062 3-(2-Amino-2′-methyl-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 16 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >9100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295062&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470045 381618156 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562838 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H28N4O3S/c1-15-5-6-19(31(29,30)27-10-8-23(3,4)28)13-20(15)18-12-21(22(24)26-14-18)17-7-9-25-16(2)11-17/h5-7,9,11-14,27-28H,8,10H2,1-4H3,(H2,24,26) WYFOXUQSJDNCQI-UHFFFAOYSA-N 295062 3-(2-Amino-2′-methyl-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 16 Phosphatidylinositol 4-kinase beta Human 4660 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295062&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470045 381618156 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562839 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H28N4O3S/c1-15-5-6-19(31(29,30)27-10-8-23(3,4)28)13-20(15)18-12-21(22(24)26-14-18)17-7-9-25-16(2)11-17/h5-7,9,11-14,27-28H,8,10H2,1-4H3,(H2,24,26) WYFOXUQSJDNCQI-UHFFFAOYSA-N 295062 3-(2-Amino-2′-methyl-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 87.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295062&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470045 381618156 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562840 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H28N4O3S/c1-15-5-6-19(31(29,30)27-10-8-23(3,4)28)13-20(15)18-12-21(22(24)26-14-18)17-7-9-25-16(2)11-17/h5-7,9,11-14,27-28H,8,10H2,1-4H3,(H2,24,26) WYFOXUQSJDNCQI-UHFFFAOYSA-N 295062 3-(2-Amino-2′-methyl-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 260 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295062&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470045 381618156 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562841 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H28N4O3S/c1-15-5-6-19(31(29,30)27-10-8-23(3,4)28)13-20(15)18-12-21(22(24)26-14-18)17-7-9-25-16(2)11-17/h5-7,9,11-14,27-28H,8,10H2,1-4H3,(H2,24,26) WYFOXUQSJDNCQI-UHFFFAOYSA-N 295062 3-(2-Amino-2′-methyl-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 16 Serine/threonine-protein kinase mTOR Human >9100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295062&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470045 381618156 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562842 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)24-10-21(3)11-28-12-21)8-17(13)15-7-18(20(22)23-9-15)19-6-14(2)25-29-19/h4-9,24H,10-12H2,1-3H3,(H2,22,23) CVQRUKDDSJAEOB-UHFFFAOYSA-N 295063 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-4-methyl-N-(3-methyl-oxetan-3-ylmethyl)-benzenesulfonamide hydrochloride::US10112926, Example 17 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295063&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470005 381618157 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562843 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)24-10-21(3)11-28-12-21)8-17(13)15-7-18(20(22)23-9-15)19-6-14(2)25-29-19/h4-9,24H,10-12H2,1-3H3,(H2,22,23) CVQRUKDDSJAEOB-UHFFFAOYSA-N 295063 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-4-methyl-N-(3-methyl-oxetan-3-ylmethyl)-benzenesulfonamide hydrochloride::US10112926, Example 17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295063&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470005 381618157 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562844 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)24-10-21(3)11-28-12-21)8-17(13)15-7-18(20(22)23-9-15)19-6-14(2)25-29-19/h4-9,24H,10-12H2,1-3H3,(H2,22,23) CVQRUKDDSJAEOB-UHFFFAOYSA-N 295063 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-4-methyl-N-(3-methyl-oxetan-3-ylmethyl)-benzenesulfonamide hydrochloride::US10112926, Example 17 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 8100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295063&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470005 381618157 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562845 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)24-10-21(3)11-28-12-21)8-17(13)15-7-18(20(22)23-9-15)19-6-14(2)25-29-19/h4-9,24H,10-12H2,1-3H3,(H2,22,23) CVQRUKDDSJAEOB-UHFFFAOYSA-N 295063 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-4-methyl-N-(3-methyl-oxetan-3-ylmethyl)-benzenesulfonamide hydrochloride::US10112926, Example 17 Phosphatidylinositol 4-kinase beta Human 1500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295063&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470005 381618157 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562846 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)24-10-21(3)11-28-12-21)8-17(13)15-7-18(20(22)23-9-15)19-6-14(2)25-29-19/h4-9,24H,10-12H2,1-3H3,(H2,22,23) CVQRUKDDSJAEOB-UHFFFAOYSA-N 295063 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-4-methyl-N-(3-methyl-oxetan-3-ylmethyl)-benzenesulfonamide hydrochloride::US10112926, Example 17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 10.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295063&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470005 381618157 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562847 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)24-10-21(3)11-28-12-21)8-17(13)15-7-18(20(22)23-9-15)19-6-14(2)25-29-19/h4-9,24H,10-12H2,1-3H3,(H2,22,23) CVQRUKDDSJAEOB-UHFFFAOYSA-N 295063 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-4-methyl-N-(3-methyl-oxetan-3-ylmethyl)-benzenesulfonamide hydrochloride::US10112926, Example 17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 170 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295063&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470005 381618157 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562848 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)24-10-21(3)11-28-12-21)8-17(13)15-7-18(20(22)23-9-15)19-6-14(2)25-29-19/h4-9,24H,10-12H2,1-3H3,(H2,22,23) CVQRUKDDSJAEOB-UHFFFAOYSA-N 295063 3-[6-Amino-5-(3-methyl-isoxazol-5-yl)-pyridin-3-yl]-4-methyl-N-(3-methyl-oxetan-3-ylmethyl)-benzenesulfonamide hydrochloride::US10112926, Example 17 Serine/threonine-protein kinase mTOR Human 8500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295063&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470005 381618157 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562849 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccncc1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26N4O3S/c1-15-4-5-18(30(28,29)26-11-8-22(2,3)27)13-19(15)17-12-20(21(23)25-14-17)16-6-9-24-10-7-16/h4-7,9-10,12-14,26-27H,8,11H2,1-3H3,(H2,23,25) OYSGGHUEDHJEQN-UHFFFAOYSA-N 295064 3-(2-Amino-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 18 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 90.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295064&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470164 381618158 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562850 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccncc1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26N4O3S/c1-15-4-5-18(30(28,29)26-11-8-22(2,3)27)13-19(15)17-12-20(21(23)25-14-17)16-6-9-24-10-7-16/h4-7,9-10,12-14,26-27H,8,11H2,1-3H3,(H2,23,25) OYSGGHUEDHJEQN-UHFFFAOYSA-N 295064 3-(2-Amino-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3840 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295064&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470164 381618158 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562851 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccncc1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26N4O3S/c1-15-4-5-18(30(28,29)26-11-8-22(2,3)27)13-19(15)17-12-20(21(23)25-14-17)16-6-9-24-10-7-16/h4-7,9-10,12-14,26-27H,8,11H2,1-3H3,(H2,23,25) OYSGGHUEDHJEQN-UHFFFAOYSA-N 295064 3-(2-Amino-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 18 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >9100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295064&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470164 381618158 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562852 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccncc1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26N4O3S/c1-15-4-5-18(30(28,29)26-11-8-22(2,3)27)13-19(15)17-12-20(21(23)25-14-17)16-6-9-24-10-7-16/h4-7,9-10,12-14,26-27H,8,11H2,1-3H3,(H2,23,25) OYSGGHUEDHJEQN-UHFFFAOYSA-N 295064 3-(2-Amino-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 18 Phosphatidylinositol 4-kinase beta Human >9100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295064&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470164 381618158 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562853 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccncc1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26N4O3S/c1-15-4-5-18(30(28,29)26-11-8-22(2,3)27)13-19(15)17-12-20(21(23)25-14-17)16-6-9-24-10-7-16/h4-7,9-10,12-14,26-27H,8,11H2,1-3H3,(H2,23,25) OYSGGHUEDHJEQN-UHFFFAOYSA-N 295064 3-(2-Amino-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 58.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295064&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470164 381618158 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562854 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccncc1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26N4O3S/c1-15-4-5-18(30(28,29)26-11-8-22(2,3)27)13-19(15)17-12-20(21(23)25-14-17)16-6-9-24-10-7-16/h4-7,9-10,12-14,26-27H,8,11H2,1-3H3,(H2,23,25) OYSGGHUEDHJEQN-UHFFFAOYSA-N 295064 3-(2-Amino-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 470 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295064&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470164 381618158 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562855 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccncc1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C22H26N4O3S/c1-15-4-5-18(30(28,29)26-11-8-22(2,3)27)13-19(15)17-12-20(21(23)25-14-17)16-6-9-24-10-7-16/h4-7,9-10,12-14,26-27H,8,11H2,1-3H3,(H2,23,25) OYSGGHUEDHJEQN-UHFFFAOYSA-N 295064 3-(2-Amino-[3,4′]bipyridinyl-5-yl)-N-(3-hydroxy-3-methyl-butyl)-4-methyl-benzenesulfonamide::US10112926, Example 18 Serine/threonine-protein kinase mTOR Human >9100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295064&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470164 381618158 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562856 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:24.26,wD:27.30,(5.5,-.1,;4.73,1.23,;5.2,2.69,;3.96,3.6,;2.71,2.69,;3.19,1.23,;1.38,3.47,;.04,2.69,;-1.29,3.47,;-1.29,5,;.04,5.78,;1.38,5,;2.71,5.78,;-2.62,2.69,;-2.62,1.15,;-3.96,.38,;-5.29,1.15,;-5.29,2.69,;-3.96,3.47,;-3.96,5,;-3.96,-1.15,;-2.42,-1.15,;-5.5,-1.15,;-3.96,-2.69,;-2.62,-3.47,;-1.29,-2.69,;.04,-3.47,;.04,-5,;1.38,-5.78,;2.71,-5,;-1.29,-5.78,;-2.62,-5,)| InChI=1S/C22H27N5O4S/c1-13-3-8-18(32(29,30)27-17-6-4-15(12-28)5-7-17)10-19(13)16-9-20(21(23)24-11-16)22-25-14(2)26-31-22/h3,8-11,15,17,27-28H,4-7,12H2,1-2H3,(H2,23,24) NBCXNVNZDMPXJF-UHFFFAOYSA-N 295065 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxymethyl-cyclohexyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 19 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 40.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295065&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 92042839 381618159 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562857 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:24.26,wD:27.30,(5.5,-.1,;4.73,1.23,;5.2,2.69,;3.96,3.6,;2.71,2.69,;3.19,1.23,;1.38,3.47,;.04,2.69,;-1.29,3.47,;-1.29,5,;.04,5.78,;1.38,5,;2.71,5.78,;-2.62,2.69,;-2.62,1.15,;-3.96,.38,;-5.29,1.15,;-5.29,2.69,;-3.96,3.47,;-3.96,5,;-3.96,-1.15,;-2.42,-1.15,;-5.5,-1.15,;-3.96,-2.69,;-2.62,-3.47,;-1.29,-2.69,;.04,-3.47,;.04,-5,;1.38,-5.78,;2.71,-5,;-1.29,-5.78,;-2.62,-5,)| InChI=1S/C22H27N5O4S/c1-13-3-8-18(32(29,30)27-17-6-4-15(12-28)5-7-17)10-19(13)16-9-20(21(23)24-11-16)22-25-14(2)26-31-22/h3,8-11,15,17,27-28H,4-7,12H2,1-2H3,(H2,23,24) NBCXNVNZDMPXJF-UHFFFAOYSA-N 295065 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxymethyl-cyclohexyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 100.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295065&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 92042839 381618159 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562858 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:24.26,wD:27.30,(5.5,-.1,;4.73,1.23,;5.2,2.69,;3.96,3.6,;2.71,2.69,;3.19,1.23,;1.38,3.47,;.04,2.69,;-1.29,3.47,;-1.29,5,;.04,5.78,;1.38,5,;2.71,5.78,;-2.62,2.69,;-2.62,1.15,;-3.96,.38,;-5.29,1.15,;-5.29,2.69,;-3.96,3.47,;-3.96,5,;-3.96,-1.15,;-2.42,-1.15,;-5.5,-1.15,;-3.96,-2.69,;-2.62,-3.47,;-1.29,-2.69,;.04,-3.47,;.04,-5,;1.38,-5.78,;2.71,-5,;-1.29,-5.78,;-2.62,-5,)| InChI=1S/C22H27N5O4S/c1-13-3-8-18(32(29,30)27-17-6-4-15(12-28)5-7-17)10-19(13)16-9-20(21(23)24-11-16)22-25-14(2)26-31-22/h3,8-11,15,17,27-28H,4-7,12H2,1-2H3,(H2,23,24) NBCXNVNZDMPXJF-UHFFFAOYSA-N 295065 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxymethyl-cyclohexyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 19 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295065&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 92042839 381618159 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562859 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:24.26,wD:27.30,(5.5,-.1,;4.73,1.23,;5.2,2.69,;3.96,3.6,;2.71,2.69,;3.19,1.23,;1.38,3.47,;.04,2.69,;-1.29,3.47,;-1.29,5,;.04,5.78,;1.38,5,;2.71,5.78,;-2.62,2.69,;-2.62,1.15,;-3.96,.38,;-5.29,1.15,;-5.29,2.69,;-3.96,3.47,;-3.96,5,;-3.96,-1.15,;-2.42,-1.15,;-5.5,-1.15,;-3.96,-2.69,;-2.62,-3.47,;-1.29,-2.69,;.04,-3.47,;.04,-5,;1.38,-5.78,;2.71,-5,;-1.29,-5.78,;-2.62,-5,)| InChI=1S/C22H27N5O4S/c1-13-3-8-18(32(29,30)27-17-6-4-15(12-28)5-7-17)10-19(13)16-9-20(21(23)24-11-16)22-25-14(2)26-31-22/h3,8-11,15,17,27-28H,4-7,12H2,1-2H3,(H2,23,24) NBCXNVNZDMPXJF-UHFFFAOYSA-N 295065 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxymethyl-cyclohexyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 19 Phosphatidylinositol 4-kinase beta Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295065&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 92042839 381618159 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562860 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:24.26,wD:27.30,(5.5,-.1,;4.73,1.23,;5.2,2.69,;3.96,3.6,;2.71,2.69,;3.19,1.23,;1.38,3.47,;.04,2.69,;-1.29,3.47,;-1.29,5,;.04,5.78,;1.38,5,;2.71,5.78,;-2.62,2.69,;-2.62,1.15,;-3.96,.38,;-5.29,1.15,;-5.29,2.69,;-3.96,3.47,;-3.96,5,;-3.96,-1.15,;-2.42,-1.15,;-5.5,-1.15,;-3.96,-2.69,;-2.62,-3.47,;-1.29,-2.69,;.04,-3.47,;.04,-5,;1.38,-5.78,;2.71,-5,;-1.29,-5.78,;-2.62,-5,)| InChI=1S/C22H27N5O4S/c1-13-3-8-18(32(29,30)27-17-6-4-15(12-28)5-7-17)10-19(13)16-9-20(21(23)24-11-16)22-25-14(2)26-31-22/h3,8-11,15,17,27-28H,4-7,12H2,1-2H3,(H2,23,24) NBCXNVNZDMPXJF-UHFFFAOYSA-N 295065 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxymethyl-cyclohexyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human <3.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295065&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 92042839 381618159 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562861 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:24.26,wD:27.30,(5.5,-.1,;4.73,1.23,;5.2,2.69,;3.96,3.6,;2.71,2.69,;3.19,1.23,;1.38,3.47,;.04,2.69,;-1.29,3.47,;-1.29,5,;.04,5.78,;1.38,5,;2.71,5.78,;-2.62,2.69,;-2.62,1.15,;-3.96,.38,;-5.29,1.15,;-5.29,2.69,;-3.96,3.47,;-3.96,5,;-3.96,-1.15,;-2.42,-1.15,;-5.5,-1.15,;-3.96,-2.69,;-2.62,-3.47,;-1.29,-2.69,;.04,-3.47,;.04,-5,;1.38,-5.78,;2.71,-5,;-1.29,-5.78,;-2.62,-5,)| InChI=1S/C22H27N5O4S/c1-13-3-8-18(32(29,30)27-17-6-4-15(12-28)5-7-17)10-19(13)16-9-20(21(23)24-11-16)22-25-14(2)26-31-22/h3,8-11,15,17,27-28H,4-7,12H2,1-2H3,(H2,23,24) NBCXNVNZDMPXJF-UHFFFAOYSA-N 295065 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxymethyl-cyclohexyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 110 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295065&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 92042839 381618159 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562862 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:24.26,wD:27.30,(5.5,-.1,;4.73,1.23,;5.2,2.69,;3.96,3.6,;2.71,2.69,;3.19,1.23,;1.38,3.47,;.04,2.69,;-1.29,3.47,;-1.29,5,;.04,5.78,;1.38,5,;2.71,5.78,;-2.62,2.69,;-2.62,1.15,;-3.96,.38,;-5.29,1.15,;-5.29,2.69,;-3.96,3.47,;-3.96,5,;-3.96,-1.15,;-2.42,-1.15,;-5.5,-1.15,;-3.96,-2.69,;-2.62,-3.47,;-1.29,-2.69,;.04,-3.47,;.04,-5,;1.38,-5.78,;2.71,-5,;-1.29,-5.78,;-2.62,-5,)| InChI=1S/C22H27N5O4S/c1-13-3-8-18(32(29,30)27-17-6-4-15(12-28)5-7-17)10-19(13)16-9-20(21(23)24-11-16)22-25-14(2)26-31-22/h3,8-11,15,17,27-28H,4-7,12H2,1-2H3,(H2,23,24) NBCXNVNZDMPXJF-UHFFFAOYSA-N 295065 trans 3-[6-Amino-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-N-(4-hydroxymethyl-cyclohexyl)-4-methyl-benzenesulfonamide hydrochloride::US10112926, Example 19 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295065&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 92042839 381618159 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562863 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC2(C1)CCOC2 InChI=1S/C22H24N4O4S/c1-14-3-4-17(31(27,28)26-11-22(12-26)5-6-29-13-22)9-18(14)16-8-19(21(23)24-10-16)20-7-15(2)25-30-20/h3-4,7-10H,5-6,11-13H2,1-2H3,(H2,23,24) DYFDEJHJNPVHKG-UHFFFAOYSA-N 295066 5-(5-(6-oxa-2- azaspiro[3.4]octan-2- ylsulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 550 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295066&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470173 381618160 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562864 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC2(C1)CCOC2 InChI=1S/C22H24N4O4S/c1-14-3-4-17(31(27,28)26-11-22(12-26)5-6-29-13-22)9-18(14)16-8-19(21(23)24-10-16)20-7-15(2)25-30-20/h3-4,7-10H,5-6,11-13H2,1-2H3,(H2,23,24) DYFDEJHJNPVHKG-UHFFFAOYSA-N 295066 5-(5-(6-oxa-2- azaspiro[3.4]octan-2- ylsulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295066&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470173 381618160 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562865 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC2(C1)CCOC2 InChI=1S/C22H24N4O4S/c1-14-3-4-17(31(27,28)26-11-22(12-26)5-6-29-13-22)9-18(14)16-8-19(21(23)24-10-16)20-7-15(2)25-30-20/h3-4,7-10H,5-6,11-13H2,1-2H3,(H2,23,24) DYFDEJHJNPVHKG-UHFFFAOYSA-N 295066 5-(5-(6-oxa-2- azaspiro[3.4]octan-2- ylsulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295066&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470173 381618160 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562866 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC2(C1)CCOC2 InChI=1S/C22H24N4O4S/c1-14-3-4-17(31(27,28)26-11-22(12-26)5-6-29-13-22)9-18(14)16-8-19(21(23)24-10-16)20-7-15(2)25-30-20/h3-4,7-10H,5-6,11-13H2,1-2H3,(H2,23,24) DYFDEJHJNPVHKG-UHFFFAOYSA-N 295066 5-(5-(6-oxa-2- azaspiro[3.4]octan-2- ylsulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.1 Phosphatidylinositol 4-kinase beta Human 4000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295066&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470173 381618160 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562867 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC2(C1)CCOC2 InChI=1S/C22H24N4O4S/c1-14-3-4-17(31(27,28)26-11-22(12-26)5-6-29-13-22)9-18(14)16-8-19(21(23)24-10-16)20-7-15(2)25-30-20/h3-4,7-10H,5-6,11-13H2,1-2H3,(H2,23,24) DYFDEJHJNPVHKG-UHFFFAOYSA-N 295066 5-(5-(6-oxa-2- azaspiro[3.4]octan-2- ylsulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 140 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295066&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470173 381618160 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562868 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC2(C1)CCOC2 InChI=1S/C22H24N4O4S/c1-14-3-4-17(31(27,28)26-11-22(12-26)5-6-29-13-22)9-18(14)16-8-19(21(23)24-10-16)20-7-15(2)25-30-20/h3-4,7-10H,5-6,11-13H2,1-2H3,(H2,23,24) DYFDEJHJNPVHKG-UHFFFAOYSA-N 295066 5-(5-(6-oxa-2- azaspiro[3.4]octan-2- ylsulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1800 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295066&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470173 381618160 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562869 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOC1=O InChI=1S/C20H20N4O5S/c1-11-3-4-14(30(26,27)24-17-5-6-28-20(17)25)9-15(11)13-8-16(19(21)22-10-13)18-7-12(2)23-29-18/h3-4,7-10,17,24H,5-6H2,1-2H3,(H2,21,22) YHKJMQFPJKYQOU-UHFFFAOYSA-N 295067 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2- oxotetrahydrofuran-3- yl)benzene sulfonamide trifluoroacetic acid salt::US10112926, Example 19.2 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 680 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295067&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512230 381618161 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562870 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOC1=O InChI=1S/C20H20N4O5S/c1-11-3-4-14(30(26,27)24-17-5-6-28-20(17)25)9-15(11)13-8-16(19(21)22-10-13)18-7-12(2)23-29-18/h3-4,7-10,17,24H,5-6H2,1-2H3,(H2,21,22) YHKJMQFPJKYQOU-UHFFFAOYSA-N 295067 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2- oxotetrahydrofuran-3- yl)benzene sulfonamide trifluoroacetic acid salt::US10112926, Example 19.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295067&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512230 381618161 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562871 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOC1=O InChI=1S/C20H20N4O5S/c1-11-3-4-14(30(26,27)24-17-5-6-28-20(17)25)9-15(11)13-8-16(19(21)22-10-13)18-7-12(2)23-29-18/h3-4,7-10,17,24H,5-6H2,1-2H3,(H2,21,22) YHKJMQFPJKYQOU-UHFFFAOYSA-N 295067 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2- oxotetrahydrofuran-3- yl)benzene sulfonamide trifluoroacetic acid salt::US10112926, Example 19.2 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295067&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512230 381618161 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562872 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOC1=O InChI=1S/C20H20N4O5S/c1-11-3-4-14(30(26,27)24-17-5-6-28-20(17)25)9-15(11)13-8-16(19(21)22-10-13)18-7-12(2)23-29-18/h3-4,7-10,17,24H,5-6H2,1-2H3,(H2,21,22) YHKJMQFPJKYQOU-UHFFFAOYSA-N 295067 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2- oxotetrahydrofuran-3- yl)benzene sulfonamide trifluoroacetic acid salt::US10112926, Example 19.2 Phosphatidylinositol 4-kinase beta Human 3700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295067&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512230 381618161 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562873 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOC1=O InChI=1S/C20H20N4O5S/c1-11-3-4-14(30(26,27)24-17-5-6-28-20(17)25)9-15(11)13-8-16(19(21)22-10-13)18-7-12(2)23-29-18/h3-4,7-10,17,24H,5-6H2,1-2H3,(H2,21,22) YHKJMQFPJKYQOU-UHFFFAOYSA-N 295067 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2- oxotetrahydrofuran-3- yl)benzene sulfonamide trifluoroacetic acid salt::US10112926, Example 19.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 44.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295067&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512230 381618161 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562874 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOC1=O InChI=1S/C20H20N4O5S/c1-11-3-4-14(30(26,27)24-17-5-6-28-20(17)25)9-15(11)13-8-16(19(21)22-10-13)18-7-12(2)23-29-18/h3-4,7-10,17,24H,5-6H2,1-2H3,(H2,21,22) YHKJMQFPJKYQOU-UHFFFAOYSA-N 295067 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2- oxotetrahydrofuran-3- yl)benzene sulfonamide trifluoroacetic acid salt::US10112926, Example 19.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 290 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295067&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512230 381618161 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562875 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](N)CC1 |r,wU:27.30,wD:24.26,(7.39,-.1,;6.62,1.23,;5.08,1.23,;4.61,2.69,;5.85,3.6,;7.1,2.69,;3.27,3.47,;1.94,2.69,;.61,3.47,;.61,5,;1.94,5.78,;3.27,5,;4.61,5.78,;-.73,2.69,;-.73,1.15,;-2.06,.38,;-3.39,1.15,;-3.39,2.69,;-2.06,3.47,;-2.06,5,;-2.06,-1.15,;-3.6,-1.15,;-.52,-1.15,;-2.06,-2.69,;-3.39,-3.47,;-4.73,-2.69,;-6.06,-3.47,;-6.06,-5,;-7.39,-5.78,;-4.73,-5.78,;-3.39,-5,)| InChI=1S/C22H27N5O3S/c1-13-3-8-18(31(28,29)27-17-6-4-16(23)5-7-17)11-19(13)15-10-20(22(24)25-12-15)21-9-14(2)26-30-21/h3,8-12,16-17,27H,4-7,23H2,1-2H3,(H2,24,25) ZBJQUHYYXNXALJ-UHFFFAOYSA-N 295068 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-aminocyclohexyl)-4- methylbenzenesulfon- amide acetic acid salt::US10112926, Example 19.3 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295068&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472655 381618162 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562876 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](N)CC1 |r,wU:27.30,wD:24.26,(7.39,-.1,;6.62,1.23,;5.08,1.23,;4.61,2.69,;5.85,3.6,;7.1,2.69,;3.27,3.47,;1.94,2.69,;.61,3.47,;.61,5,;1.94,5.78,;3.27,5,;4.61,5.78,;-.73,2.69,;-.73,1.15,;-2.06,.38,;-3.39,1.15,;-3.39,2.69,;-2.06,3.47,;-2.06,5,;-2.06,-1.15,;-3.6,-1.15,;-.52,-1.15,;-2.06,-2.69,;-3.39,-3.47,;-4.73,-2.69,;-6.06,-3.47,;-6.06,-5,;-7.39,-5.78,;-4.73,-5.78,;-3.39,-5,)| InChI=1S/C22H27N5O3S/c1-13-3-8-18(31(28,29)27-17-6-4-16(23)5-7-17)11-19(13)15-10-20(22(24)25-12-15)21-9-14(2)26-30-21/h3,8-12,16-17,27H,4-7,23H2,1-2H3,(H2,24,25) ZBJQUHYYXNXALJ-UHFFFAOYSA-N 295068 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-aminocyclohexyl)-4- methylbenzenesulfon- amide acetic acid salt::US10112926, Example 19.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 680 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295068&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472655 381618162 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562877 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](N)CC1 |r,wU:27.30,wD:24.26,(7.39,-.1,;6.62,1.23,;5.08,1.23,;4.61,2.69,;5.85,3.6,;7.1,2.69,;3.27,3.47,;1.94,2.69,;.61,3.47,;.61,5,;1.94,5.78,;3.27,5,;4.61,5.78,;-.73,2.69,;-.73,1.15,;-2.06,.38,;-3.39,1.15,;-3.39,2.69,;-2.06,3.47,;-2.06,5,;-2.06,-1.15,;-3.6,-1.15,;-.52,-1.15,;-2.06,-2.69,;-3.39,-3.47,;-4.73,-2.69,;-6.06,-3.47,;-6.06,-5,;-7.39,-5.78,;-4.73,-5.78,;-3.39,-5,)| InChI=1S/C22H27N5O3S/c1-13-3-8-18(31(28,29)27-17-6-4-16(23)5-7-17)11-19(13)15-10-20(22(24)25-12-15)21-9-14(2)26-30-21/h3,8-12,16-17,27H,4-7,23H2,1-2H3,(H2,24,25) ZBJQUHYYXNXALJ-UHFFFAOYSA-N 295068 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-aminocyclohexyl)-4- methylbenzenesulfon- amide acetic acid salt::US10112926, Example 19.3 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295068&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472655 381618162 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562878 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](N)CC1 |r,wU:27.30,wD:24.26,(7.39,-.1,;6.62,1.23,;5.08,1.23,;4.61,2.69,;5.85,3.6,;7.1,2.69,;3.27,3.47,;1.94,2.69,;.61,3.47,;.61,5,;1.94,5.78,;3.27,5,;4.61,5.78,;-.73,2.69,;-.73,1.15,;-2.06,.38,;-3.39,1.15,;-3.39,2.69,;-2.06,3.47,;-2.06,5,;-2.06,-1.15,;-3.6,-1.15,;-.52,-1.15,;-2.06,-2.69,;-3.39,-3.47,;-4.73,-2.69,;-6.06,-3.47,;-6.06,-5,;-7.39,-5.78,;-4.73,-5.78,;-3.39,-5,)| InChI=1S/C22H27N5O3S/c1-13-3-8-18(31(28,29)27-17-6-4-16(23)5-7-17)11-19(13)15-10-20(22(24)25-12-15)21-9-14(2)26-30-21/h3,8-12,16-17,27H,4-7,23H2,1-2H3,(H2,24,25) ZBJQUHYYXNXALJ-UHFFFAOYSA-N 295068 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-aminocyclohexyl)-4- methylbenzenesulfon- amide acetic acid salt::US10112926, Example 19.3 Phosphatidylinositol 4-kinase beta Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295068&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472655 381618162 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562879 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](N)CC1 |r,wU:27.30,wD:24.26,(7.39,-.1,;6.62,1.23,;5.08,1.23,;4.61,2.69,;5.85,3.6,;7.1,2.69,;3.27,3.47,;1.94,2.69,;.61,3.47,;.61,5,;1.94,5.78,;3.27,5,;4.61,5.78,;-.73,2.69,;-.73,1.15,;-2.06,.38,;-3.39,1.15,;-3.39,2.69,;-2.06,3.47,;-2.06,5,;-2.06,-1.15,;-3.6,-1.15,;-.52,-1.15,;-2.06,-2.69,;-3.39,-3.47,;-4.73,-2.69,;-6.06,-3.47,;-6.06,-5,;-7.39,-5.78,;-4.73,-5.78,;-3.39,-5,)| InChI=1S/C22H27N5O3S/c1-13-3-8-18(31(28,29)27-17-6-4-16(23)5-7-17)11-19(13)15-10-20(22(24)25-12-15)21-9-14(2)26-30-21/h3,8-12,16-17,27H,4-7,23H2,1-2H3,(H2,24,25) ZBJQUHYYXNXALJ-UHFFFAOYSA-N 295068 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-aminocyclohexyl)-4- methylbenzenesulfon- amide acetic acid salt::US10112926, Example 19.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 39.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295068&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472655 381618162 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562880 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](N)CC1 |r,wU:27.30,wD:24.26,(7.39,-.1,;6.62,1.23,;5.08,1.23,;4.61,2.69,;5.85,3.6,;7.1,2.69,;3.27,3.47,;1.94,2.69,;.61,3.47,;.61,5,;1.94,5.78,;3.27,5,;4.61,5.78,;-.73,2.69,;-.73,1.15,;-2.06,.38,;-3.39,1.15,;-3.39,2.69,;-2.06,3.47,;-2.06,5,;-2.06,-1.15,;-3.6,-1.15,;-.52,-1.15,;-2.06,-2.69,;-3.39,-3.47,;-4.73,-2.69,;-6.06,-3.47,;-6.06,-5,;-7.39,-5.78,;-4.73,-5.78,;-3.39,-5,)| InChI=1S/C22H27N5O3S/c1-13-3-8-18(31(28,29)27-17-6-4-16(23)5-7-17)11-19(13)15-10-20(22(24)25-12-15)21-9-14(2)26-30-21/h3,8-12,16-17,27H,4-7,23H2,1-2H3,(H2,24,25) ZBJQUHYYXNXALJ-UHFFFAOYSA-N 295068 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-aminocyclohexyl)-4- methylbenzenesulfon- amide acetic acid salt::US10112926, Example 19.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 140 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295068&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472655 381618162 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562881 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CNC[C@H]1O |r| InChI=1S/C20H23N5O4S/c1-11-3-4-14(30(27,28)25-17-9-22-10-18(17)26)7-15(11)13-6-16(20(21)23-8-13)19-5-12(2)24-29-19/h3-8,17-18,22,25-26H,9-10H2,1-2H3,(H2,21,23) PSLWWVGCOITTSU-UHFFFAOYSA-N 295069 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-hydroxypyrrolidin-3- yl)-4- methylbenzenesulfon- amide acetic acid salt (::US10112926, Example 19.4 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 460 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295069&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512330 381618163 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562882 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CNC[C@H]1O |r| InChI=1S/C20H23N5O4S/c1-11-3-4-14(30(27,28)25-17-9-22-10-18(17)26)7-15(11)13-6-16(20(21)23-8-13)19-5-12(2)24-29-19/h3-8,17-18,22,25-26H,9-10H2,1-2H3,(H2,21,23) PSLWWVGCOITTSU-UHFFFAOYSA-N 295069 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-hydroxypyrrolidin-3- yl)-4- methylbenzenesulfon- amide acetic acid salt (::US10112926, Example 19.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295069&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512330 381618163 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562883 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CNC[C@H]1O |r| InChI=1S/C20H23N5O4S/c1-11-3-4-14(30(27,28)25-17-9-22-10-18(17)26)7-15(11)13-6-16(20(21)23-8-13)19-5-12(2)24-29-19/h3-8,17-18,22,25-26H,9-10H2,1-2H3,(H2,21,23) PSLWWVGCOITTSU-UHFFFAOYSA-N 295069 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-hydroxypyrrolidin-3- yl)-4- methylbenzenesulfon- amide acetic acid salt (::US10112926, Example 19.4 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295069&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512330 381618163 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562884 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CNC[C@H]1O |r| InChI=1S/C20H23N5O4S/c1-11-3-4-14(30(27,28)25-17-9-22-10-18(17)26)7-15(11)13-6-16(20(21)23-8-13)19-5-12(2)24-29-19/h3-8,17-18,22,25-26H,9-10H2,1-2H3,(H2,21,23) PSLWWVGCOITTSU-UHFFFAOYSA-N 295069 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-hydroxypyrrolidin-3- yl)-4- methylbenzenesulfon- amide acetic acid salt (::US10112926, Example 19.4 Phosphatidylinositol 4-kinase beta Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295069&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512330 381618163 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562885 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CNC[C@H]1O |r| InChI=1S/C20H23N5O4S/c1-11-3-4-14(30(27,28)25-17-9-22-10-18(17)26)7-15(11)13-6-16(20(21)23-8-13)19-5-12(2)24-29-19/h3-8,17-18,22,25-26H,9-10H2,1-2H3,(H2,21,23) PSLWWVGCOITTSU-UHFFFAOYSA-N 295069 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-hydroxypyrrolidin-3- yl)-4- methylbenzenesulfon- amide acetic acid salt (::US10112926, Example 19.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 51.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295069&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512330 381618163 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562886 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CNC[C@H]1O |r| InChI=1S/C20H23N5O4S/c1-11-3-4-14(30(27,28)25-17-9-22-10-18(17)26)7-15(11)13-6-16(20(21)23-8-13)19-5-12(2)24-29-19/h3-8,17-18,22,25-26H,9-10H2,1-2H3,(H2,21,23) PSLWWVGCOITTSU-UHFFFAOYSA-N 295069 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(trans- 4-hydroxypyrrolidin-3- yl)-4- methylbenzenesulfon- amide acetic acid salt (::US10112926, Example 19.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 510 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295069&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512330 381618163 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562887 C[C@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295070 (S)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.5 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295070&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470501 381618164 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562888 C[C@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295070 (S)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 9200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295070&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470501 381618164 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562889 C[C@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295070 (S)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.5 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295070&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470501 381618164 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562890 C[C@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295070 (S)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.5 Phosphatidylinositol 4-kinase beta Human 2300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295070&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470501 381618164 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562891 C[C@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295070 (S)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 190 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295070&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470501 381618164 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562892 C[C@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295070 (S)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295070&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470501 381618164 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562893 C[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295071 (R)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.6 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295071&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470090 381618165 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562894 C[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295071 (R)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295071&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470090 381618165 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562895 C[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295071 (R)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.6 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295071&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470090 381618165 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562896 C[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295071 (R)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.6 Phosphatidylinositol 4-kinase beta Human 1500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295071&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470090 381618165 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562897 C[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295071 (R)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 150 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295071&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470090 381618165 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562898 C[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-13-4-5-17(30(26,27)25-6-7-28-12-15(25)3)10-18(13)16-9-19(21(22)23-11-16)20-8-14(2)24-29-20/h4-5,8-11,15H,6-7,12H2,1-3H3,(H2,22,23) WERKQLPDYHXUHN-UHFFFAOYSA-N 295071 (R)-5-(2-methyl-5-((3- methylmorpholino)sulfon- yl)phenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295071&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470090 381618165 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562899 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)C InChI=1S/C21H26N4O3S/c1-13-6-7-16(29(26,27)24-12-21(3,4)5)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-28-19/h6-11,24H,12H2,1-5H3,(H2,22,23) GLJGECLJJJLXHJ-UHFFFAOYSA-N 295072 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N- neopentylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.7 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 410 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295072&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512157 381618166 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562900 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)C InChI=1S/C21H26N4O3S/c1-13-6-7-16(29(26,27)24-12-21(3,4)5)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-28-19/h6-11,24H,12H2,1-5H3,(H2,22,23) GLJGECLJJJLXHJ-UHFFFAOYSA-N 295072 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N- neopentylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295072&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512157 381618166 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562901 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)C InChI=1S/C21H26N4O3S/c1-13-6-7-16(29(26,27)24-12-21(3,4)5)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-28-19/h6-11,24H,12H2,1-5H3,(H2,22,23) GLJGECLJJJLXHJ-UHFFFAOYSA-N 295072 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N- neopentylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.7 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295072&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512157 381618166 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562902 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)C InChI=1S/C21H26N4O3S/c1-13-6-7-16(29(26,27)24-12-21(3,4)5)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-28-19/h6-11,24H,12H2,1-5H3,(H2,22,23) GLJGECLJJJLXHJ-UHFFFAOYSA-N 295072 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N- neopentylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.7 Phosphatidylinositol 4-kinase beta Human 3200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295072&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512157 381618166 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562903 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)C InChI=1S/C21H26N4O3S/c1-13-6-7-16(29(26,27)24-12-21(3,4)5)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-28-19/h6-11,24H,12H2,1-5H3,(H2,22,23) GLJGECLJJJLXHJ-UHFFFAOYSA-N 295072 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N- neopentylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 78.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295072&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512157 381618166 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562904 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)C InChI=1S/C21H26N4O3S/c1-13-6-7-16(29(26,27)24-12-21(3,4)5)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-28-19/h6-11,24H,12H2,1-5H3,(H2,22,23) GLJGECLJJJLXHJ-UHFFFAOYSA-N 295072 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N- neopentylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 530 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295072&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512157 381618166 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562905 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(C)(C)C InChI=1S/C20H24N4O3S/c1-12-6-7-15(28(25,26)24-20(3,4)5)10-16(12)14-9-17(19(21)22-11-14)18-8-13(2)23-27-18/h6-11,24H,1-5H3,(H2,21,22) JVBBAZKFBQMHIM-UHFFFAOYSA-N 295073 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(tert- butyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.8 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 3000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295073&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472770 381618167 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562906 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(C)(C)C InChI=1S/C20H24N4O3S/c1-12-6-7-15(28(25,26)24-20(3,4)5)10-16(12)14-9-17(19(21)22-11-14)18-8-13(2)23-27-18/h6-11,24H,1-5H3,(H2,21,22) JVBBAZKFBQMHIM-UHFFFAOYSA-N 295073 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(tert- butyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295073&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472770 381618167 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562907 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(C)(C)C InChI=1S/C20H24N4O3S/c1-12-6-7-15(28(25,26)24-20(3,4)5)10-16(12)14-9-17(19(21)22-11-14)18-8-13(2)23-27-18/h6-11,24H,1-5H3,(H2,21,22) JVBBAZKFBQMHIM-UHFFFAOYSA-N 295073 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(tert- butyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.8 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295073&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472770 381618167 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562908 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(C)(C)C InChI=1S/C20H24N4O3S/c1-12-6-7-15(28(25,26)24-20(3,4)5)10-16(12)14-9-17(19(21)22-11-14)18-8-13(2)23-27-18/h6-11,24H,1-5H3,(H2,21,22) JVBBAZKFBQMHIM-UHFFFAOYSA-N 295073 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(tert- butyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.8 Phosphatidylinositol 4-kinase beta Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295073&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472770 381618167 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562909 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(C)(C)C InChI=1S/C20H24N4O3S/c1-12-6-7-15(28(25,26)24-20(3,4)5)10-16(12)14-9-17(19(21)22-11-14)18-8-13(2)23-27-18/h6-11,24H,1-5H3,(H2,21,22) JVBBAZKFBQMHIM-UHFFFAOYSA-N 295073 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(tert- butyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 230 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295073&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472770 381618167 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562910 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(C)(C)C InChI=1S/C20H24N4O3S/c1-12-6-7-15(28(25,26)24-20(3,4)5)10-16(12)14-9-17(19(21)22-11-14)18-8-13(2)23-27-18/h6-11,24H,1-5H3,(H2,21,22) JVBBAZKFBQMHIM-UHFFFAOYSA-N 295073 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(tert- butyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295073&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472770 381618167 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562911 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC1(C)C InChI=1S/C22H26N4O3S/c1-14-6-7-17(30(27,28)26-9-5-8-22(26,3)4)12-18(14)16-11-19(21(23)24-13-16)20-10-15(2)25-29-20/h6-7,10-13H,5,8-9H2,1-4H3,(H2,23,24) AWWYEVODAMLABW-UHFFFAOYSA-N 295074 5-(5-((2,2- dimethylpyrrolidin-1- yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.9 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295074&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470123 381618168 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562912 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC1(C)C InChI=1S/C22H26N4O3S/c1-14-6-7-17(30(27,28)26-9-5-8-22(26,3)4)12-18(14)16-11-19(21(23)24-13-16)20-10-15(2)25-29-20/h6-7,10-13H,5,8-9H2,1-4H3,(H2,23,24) AWWYEVODAMLABW-UHFFFAOYSA-N 295074 5-(5-((2,2- dimethylpyrrolidin-1- yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 9500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295074&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470123 381618168 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562913 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC1(C)C InChI=1S/C22H26N4O3S/c1-14-6-7-17(30(27,28)26-9-5-8-22(26,3)4)12-18(14)16-11-19(21(23)24-13-16)20-10-15(2)25-29-20/h6-7,10-13H,5,8-9H2,1-4H3,(H2,23,24) AWWYEVODAMLABW-UHFFFAOYSA-N 295074 5-(5-((2,2- dimethylpyrrolidin-1- yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.9 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295074&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470123 381618168 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562914 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC1(C)C InChI=1S/C22H26N4O3S/c1-14-6-7-17(30(27,28)26-9-5-8-22(26,3)4)12-18(14)16-11-19(21(23)24-13-16)20-10-15(2)25-29-20/h6-7,10-13H,5,8-9H2,1-4H3,(H2,23,24) AWWYEVODAMLABW-UHFFFAOYSA-N 295074 5-(5-((2,2- dimethylpyrrolidin-1- yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.9 Phosphatidylinositol 4-kinase beta Human 1900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295074&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470123 381618168 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562915 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC1(C)C InChI=1S/C22H26N4O3S/c1-14-6-7-17(30(27,28)26-9-5-8-22(26,3)4)12-18(14)16-11-19(21(23)24-13-16)20-10-15(2)25-29-20/h6-7,10-13H,5,8-9H2,1-4H3,(H2,23,24) AWWYEVODAMLABW-UHFFFAOYSA-N 295074 5-(5-((2,2- dimethylpyrrolidin-1- yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295074&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470123 381618168 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562916 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC1(C)C InChI=1S/C22H26N4O3S/c1-14-6-7-17(30(27,28)26-9-5-8-22(26,3)4)12-18(14)16-11-19(21(23)24-13-16)20-10-15(2)25-29-20/h6-7,10-13H,5,8-9H2,1-4H3,(H2,23,24) AWWYEVODAMLABW-UHFFFAOYSA-N 295074 5-(5-((2,2- dimethylpyrrolidin-1- yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295074&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470123 381618168 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562917 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)23-11-20(25)5-6-20)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h3-4,7-10,23,25H,5-6,11H2,1-2H3,(H2,21,22) PDXZRWGUWIWZGB-UHFFFAOYSA-N 295075 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.10 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 420 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295075&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470231 381618169 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562918 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)23-11-20(25)5-6-20)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h3-4,7-10,23,25H,5-6,11H2,1-2H3,(H2,21,22) PDXZRWGUWIWZGB-UHFFFAOYSA-N 295075 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295075&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470231 381618169 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562919 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)23-11-20(25)5-6-20)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h3-4,7-10,23,25H,5-6,11H2,1-2H3,(H2,21,22) PDXZRWGUWIWZGB-UHFFFAOYSA-N 295075 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.10 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295075&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470231 381618169 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562920 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)23-11-20(25)5-6-20)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h3-4,7-10,23,25H,5-6,11H2,1-2H3,(H2,21,22) PDXZRWGUWIWZGB-UHFFFAOYSA-N 295075 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.10 Phosphatidylinositol 4-kinase beta Human 3700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295075&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470231 381618169 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562921 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)23-11-20(25)5-6-20)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h3-4,7-10,23,25H,5-6,11H2,1-2H3,(H2,21,22) PDXZRWGUWIWZGB-UHFFFAOYSA-N 295075 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 28.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295075&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470231 381618169 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562922 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)23-11-20(25)5-6-20)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)24-28-18/h3-4,7-10,23,25H,5-6,11H2,1-2H3,(H2,21,22) PDXZRWGUWIWZGB-UHFFFAOYSA-N 295075 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 570 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295075&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470231 381618169 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562923 COCC(NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C(C)C InChI=1S/C22H28N4O4S/c1-13(2)20(12-29-5)26-31(27,28)17-7-6-14(3)18(10-17)16-9-19(22(23)24-11-16)21-8-15(4)25-30-21/h6-11,13,20,26H,12H2,1-5H3,(H2,23,24) OLGSBNCYXOWJTG-UHFFFAOYSA-N 295076 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- methoxy-3-methylbutan- 2-yl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.11 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 320 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295076 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295076&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512348 381618170 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562924 COCC(NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C(C)C InChI=1S/C22H28N4O4S/c1-13(2)20(12-29-5)26-31(27,28)17-7-6-14(3)18(10-17)16-9-19(22(23)24-11-16)21-8-15(4)25-30-21/h6-11,13,20,26H,12H2,1-5H3,(H2,23,24) OLGSBNCYXOWJTG-UHFFFAOYSA-N 295076 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- methoxy-3-methylbutan- 2-yl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.11 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295076 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295076&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512348 381618170 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562925 COCC(NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C(C)C InChI=1S/C22H28N4O4S/c1-13(2)20(12-29-5)26-31(27,28)17-7-6-14(3)18(10-17)16-9-19(22(23)24-11-16)21-8-15(4)25-30-21/h6-11,13,20,26H,12H2,1-5H3,(H2,23,24) OLGSBNCYXOWJTG-UHFFFAOYSA-N 295076 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- methoxy-3-methylbutan- 2-yl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.11 Phosphatidylinositol 4-kinase beta Human 5100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295076 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295076&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512348 381618170 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562926 COCC(NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C(C)C InChI=1S/C22H28N4O4S/c1-13(2)20(12-29-5)26-31(27,28)17-7-6-14(3)18(10-17)16-9-19(22(23)24-11-16)21-8-15(4)25-30-21/h6-11,13,20,26H,12H2,1-5H3,(H2,23,24) OLGSBNCYXOWJTG-UHFFFAOYSA-N 295076 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- methoxy-3-methylbutan- 2-yl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.11 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 56.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295076 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295076&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512348 381618170 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562927 COCC(NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C(C)C InChI=1S/C22H28N4O4S/c1-13(2)20(12-29-5)26-31(27,28)17-7-6-14(3)18(10-17)16-9-19(22(23)24-11-16)21-8-15(4)25-30-21/h6-11,13,20,26H,12H2,1-5H3,(H2,23,24) OLGSBNCYXOWJTG-UHFFFAOYSA-N 295076 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- methoxy-3-methylbutan- 2-yl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.11 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 420 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295076 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295076&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512348 381618170 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562928 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1CCOCC1 InChI=1S/C23H28N4O4S/c1-15-3-4-19(32(28,29)26-8-5-17-6-9-30-10-7-17)13-20(15)18-12-21(23(24)25-14-18)22-11-16(2)27-31-22/h3-4,11-14,17,26H,5-10H2,1-2H3,(H2,24,25) DNCJCVADVSHMIZ-UHFFFAOYSA-N 295077 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2-(tetrahydro-2H- pyran-4- yl)ethyl)benzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.12 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 240 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295077&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512423 381618171 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562929 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1CCOCC1 InChI=1S/C23H28N4O4S/c1-15-3-4-19(32(28,29)26-8-5-17-6-9-30-10-7-17)13-20(15)18-12-21(23(24)25-14-18)22-11-16(2)27-31-22/h3-4,11-14,17,26H,5-10H2,1-2H3,(H2,24,25) DNCJCVADVSHMIZ-UHFFFAOYSA-N 295077 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2-(tetrahydro-2H- pyran-4- yl)ethyl)benzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295077&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512423 381618171 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562930 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1CCOCC1 InChI=1S/C23H28N4O4S/c1-15-3-4-19(32(28,29)26-8-5-17-6-9-30-10-7-17)13-20(15)18-12-21(23(24)25-14-18)22-11-16(2)27-31-22/h3-4,11-14,17,26H,5-10H2,1-2H3,(H2,24,25) DNCJCVADVSHMIZ-UHFFFAOYSA-N 295077 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2-(tetrahydro-2H- pyran-4- yl)ethyl)benzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.12 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295077&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512423 381618171 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562931 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1CCOCC1 InChI=1S/C23H28N4O4S/c1-15-3-4-19(32(28,29)26-8-5-17-6-9-30-10-7-17)13-20(15)18-12-21(23(24)25-14-18)22-11-16(2)27-31-22/h3-4,11-14,17,26H,5-10H2,1-2H3,(H2,24,25) DNCJCVADVSHMIZ-UHFFFAOYSA-N 295077 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2-(tetrahydro-2H- pyran-4- yl)ethyl)benzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.12 Phosphatidylinositol 4-kinase beta Human 4300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295077&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512423 381618171 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562932 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1CCOCC1 InChI=1S/C23H28N4O4S/c1-15-3-4-19(32(28,29)26-8-5-17-6-9-30-10-7-17)13-20(15)18-12-21(23(24)25-14-18)22-11-16(2)27-31-22/h3-4,11-14,17,26H,5-10H2,1-2H3,(H2,24,25) DNCJCVADVSHMIZ-UHFFFAOYSA-N 295077 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2-(tetrahydro-2H- pyran-4- yl)ethyl)benzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 27.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295077&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512423 381618171 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562933 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1CCOCC1 InChI=1S/C23H28N4O4S/c1-15-3-4-19(32(28,29)26-8-5-17-6-9-30-10-7-17)13-20(15)18-12-21(23(24)25-14-18)22-11-16(2)27-31-22/h3-4,11-14,17,26H,5-10H2,1-2H3,(H2,24,25) DNCJCVADVSHMIZ-UHFFFAOYSA-N 295077 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4-methyl- N-(2-(tetrahydro-2H- pyran-4- yl)ethyl)benzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 620 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295077&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512423 381618171 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562934 C[C@H](NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C1CC1 |r| InChI=1S/C21H24N4O3S/c1-12-4-7-17(29(26,27)25-14(3)15-5-6-15)10-18(12)16-9-19(21(22)23-11-16)20-8-13(2)24-28-20/h4,7-11,14-15,25H,5-6H2,1-3H3,(H2,22,23) UATSBNOGNFUSGY-UHFFFAOYSA-N 295078 (S)-3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- cyclopropylethyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.13 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 610 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295078&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512371 381618172 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562935 C[C@H](NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C1CC1 |r| InChI=1S/C21H24N4O3S/c1-12-4-7-17(29(26,27)25-14(3)15-5-6-15)10-18(12)16-9-19(21(22)23-11-16)20-8-13(2)24-28-20/h4,7-11,14-15,25H,5-6H2,1-3H3,(H2,22,23) UATSBNOGNFUSGY-UHFFFAOYSA-N 295078 (S)-3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- cyclopropylethyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295078&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512371 381618172 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562936 C[C@H](NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C1CC1 |r| InChI=1S/C21H24N4O3S/c1-12-4-7-17(29(26,27)25-14(3)15-5-6-15)10-18(12)16-9-19(21(22)23-11-16)20-8-13(2)24-28-20/h4,7-11,14-15,25H,5-6H2,1-3H3,(H2,22,23) UATSBNOGNFUSGY-UHFFFAOYSA-N 295078 (S)-3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- cyclopropylethyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.13 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295078&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512371 381618172 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562937 C[C@H](NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C1CC1 |r| InChI=1S/C21H24N4O3S/c1-12-4-7-17(29(26,27)25-14(3)15-5-6-15)10-18(12)16-9-19(21(22)23-11-16)20-8-13(2)24-28-20/h4,7-11,14-15,25H,5-6H2,1-3H3,(H2,22,23) UATSBNOGNFUSGY-UHFFFAOYSA-N 295078 (S)-3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- cyclopropylethyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.13 Phosphatidylinositol 4-kinase beta Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295078&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512371 381618172 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562938 C[C@H](NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C1CC1 |r| InChI=1S/C21H24N4O3S/c1-12-4-7-17(29(26,27)25-14(3)15-5-6-15)10-18(12)16-9-19(21(22)23-11-16)20-8-13(2)24-28-20/h4,7-11,14-15,25H,5-6H2,1-3H3,(H2,22,23) UATSBNOGNFUSGY-UHFFFAOYSA-N 295078 (S)-3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- cyclopropylethyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 48.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295078&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512371 381618172 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562939 C[C@H](NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1)C1CC1 |r| InChI=1S/C21H24N4O3S/c1-12-4-7-17(29(26,27)25-14(3)15-5-6-15)10-18(12)16-9-19(21(22)23-11-16)20-8-13(2)24-28-20/h4,7-11,14-15,25H,5-6H2,1-3H3,(H2,22,23) UATSBNOGNFUSGY-UHFFFAOYSA-N 295078 (S)-3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N-(1- cyclopropylethyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 820 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295078&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512371 381618172 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562940 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCC[C@H]1CO |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(27,28)25-7-3-4-16(25)12-26)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)24-29-20/h5-6,8-11,16,26H,3-4,7,12H2,1-2H3,(H2,22,23) PJPYMAJZJCYLKR-UHFFFAOYSA-N 295079 (S)-(1-((3-(6-amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) pyrrolidin-2-yl)methanol trifluoroacetic acid salt::US10112926, Example 19.15 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 790 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295079&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469981 381618173 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562941 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCC[C@H]1CO |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(27,28)25-7-3-4-16(25)12-26)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)24-29-20/h5-6,8-11,16,26H,3-4,7,12H2,1-2H3,(H2,22,23) PJPYMAJZJCYLKR-UHFFFAOYSA-N 295079 (S)-(1-((3-(6-amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) pyrrolidin-2-yl)methanol trifluoroacetic acid salt::US10112926, Example 19.15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295079&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469981 381618173 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562942 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCC[C@H]1CO |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(27,28)25-7-3-4-16(25)12-26)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)24-29-20/h5-6,8-11,16,26H,3-4,7,12H2,1-2H3,(H2,22,23) PJPYMAJZJCYLKR-UHFFFAOYSA-N 295079 (S)-(1-((3-(6-amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) pyrrolidin-2-yl)methanol trifluoroacetic acid salt::US10112926, Example 19.15 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295079&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469981 381618173 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562943 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCC[C@H]1CO |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(27,28)25-7-3-4-16(25)12-26)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)24-29-20/h5-6,8-11,16,26H,3-4,7,12H2,1-2H3,(H2,22,23) PJPYMAJZJCYLKR-UHFFFAOYSA-N 295079 (S)-(1-((3-(6-amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) pyrrolidin-2-yl)methanol trifluoroacetic acid salt::US10112926, Example 19.15 Phosphatidylinositol 4-kinase beta Human 900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295079&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469981 381618173 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562944 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCC[C@H]1CO |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(27,28)25-7-3-4-16(25)12-26)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)24-29-20/h5-6,8-11,16,26H,3-4,7,12H2,1-2H3,(H2,22,23) PJPYMAJZJCYLKR-UHFFFAOYSA-N 295079 (S)-(1-((3-(6-amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) pyrrolidin-2-yl)methanol trifluoroacetic acid salt::US10112926, Example 19.15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 50.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295079&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469981 381618173 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562945 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCC[C@H]1CO |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(27,28)25-7-3-4-16(25)12-26)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)24-29-20/h5-6,8-11,16,26H,3-4,7,12H2,1-2H3,(H2,22,23) PJPYMAJZJCYLKR-UHFFFAOYSA-N 295079 (S)-(1-((3-(6-amino-5- (3-methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) pyrrolidin-2-yl)methanol trifluoroacetic acid salt::US10112926, Example 19.15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295079&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469981 381618173 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562946 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)10-16)11-19(13)15-9-20(22(23)24-12-15)21-8-14(2)25-30-21/h6-9,11-12,16-17,26-27H,3-5,10H2,1-2H3,(H2,23,24) JLLNJCLPXQOWFX-UHFFFAOYSA-N 295080 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N- ((1S,3S)-3- hydroxycyclohexyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.16 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295080&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470479 381618174 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562947 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)10-16)11-19(13)15-9-20(22(23)24-12-15)21-8-14(2)25-30-21/h6-9,11-12,16-17,26-27H,3-5,10H2,1-2H3,(H2,23,24) JLLNJCLPXQOWFX-UHFFFAOYSA-N 295080 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N- ((1S,3S)-3- hydroxycyclohexyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 980 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295080&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470479 381618174 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562948 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)10-16)11-19(13)15-9-20(22(23)24-12-15)21-8-14(2)25-30-21/h6-9,11-12,16-17,26-27H,3-5,10H2,1-2H3,(H2,23,24) JLLNJCLPXQOWFX-UHFFFAOYSA-N 295080 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N- ((1S,3S)-3- hydroxycyclohexyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.16 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295080&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470479 381618174 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562949 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)10-16)11-19(13)15-9-20(22(23)24-12-15)21-8-14(2)25-30-21/h6-9,11-12,16-17,26-27H,3-5,10H2,1-2H3,(H2,23,24) JLLNJCLPXQOWFX-UHFFFAOYSA-N 295080 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N- ((1S,3S)-3- hydroxycyclohexyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.16 Phosphatidylinositol 4-kinase beta Human 1500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295080&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470479 381618174 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562950 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)10-16)11-19(13)15-9-20(22(23)24-12-15)21-8-14(2)25-30-21/h6-9,11-12,16-17,26-27H,3-5,10H2,1-2H3,(H2,23,24) JLLNJCLPXQOWFX-UHFFFAOYSA-N 295080 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N- ((1S,3S)-3- hydroxycyclohexyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 14.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295080&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470479 381618174 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562951 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)10-16)11-19(13)15-9-20(22(23)24-12-15)21-8-14(2)25-30-21/h6-9,11-12,16-17,26-27H,3-5,10H2,1-2H3,(H2,23,24) JLLNJCLPXQOWFX-UHFFFAOYSA-N 295080 3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-N- ((1S,3S)-3- hydroxycyclohexyl)-4- methylbenzenesulfon- amide trifluoroacetic acid salt::US10112926, Example 19.16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 280 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295080&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470479 381618174 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562952 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCNC(=O)C1 InChI=1S/C20H21N5O4S/c1-12-3-4-15(30(27,28)25-6-5-22-19(26)11-25)9-16(12)14-8-17(20(21)23-10-14)18-7-13(2)24-29-18/h3-4,7-10H,5-6,11H2,1-2H3,(H2,21,23)(H,22,26) AURBRVARCDSJFG-UHFFFAOYSA-N 295081 4-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) piperazin-2-one trifluoroacetic acid salt::US10112926, Example 19.17 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295081&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469825 381618175 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562953 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCNC(=O)C1 InChI=1S/C20H21N5O4S/c1-12-3-4-15(30(27,28)25-6-5-22-19(26)11-25)9-16(12)14-8-17(20(21)23-10-14)18-7-13(2)24-29-18/h3-4,7-10H,5-6,11H2,1-2H3,(H2,21,23)(H,22,26) AURBRVARCDSJFG-UHFFFAOYSA-N 295081 4-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) piperazin-2-one trifluoroacetic acid salt::US10112926, Example 19.17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295081&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469825 381618175 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562954 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCNC(=O)C1 InChI=1S/C20H21N5O4S/c1-12-3-4-15(30(27,28)25-6-5-22-19(26)11-25)9-16(12)14-8-17(20(21)23-10-14)18-7-13(2)24-29-18/h3-4,7-10H,5-6,11H2,1-2H3,(H2,21,23)(H,22,26) AURBRVARCDSJFG-UHFFFAOYSA-N 295081 4-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) piperazin-2-one trifluoroacetic acid salt::US10112926, Example 19.17 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295081&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469825 381618175 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562955 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCNC(=O)C1 InChI=1S/C20H21N5O4S/c1-12-3-4-15(30(27,28)25-6-5-22-19(26)11-25)9-16(12)14-8-17(20(21)23-10-14)18-7-13(2)24-29-18/h3-4,7-10H,5-6,11H2,1-2H3,(H2,21,23)(H,22,26) AURBRVARCDSJFG-UHFFFAOYSA-N 295081 4-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) piperazin-2-one trifluoroacetic acid salt::US10112926, Example 19.17 Phosphatidylinositol 4-kinase beta Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295081&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469825 381618175 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562956 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCNC(=O)C1 InChI=1S/C20H21N5O4S/c1-12-3-4-15(30(27,28)25-6-5-22-19(26)11-25)9-16(12)14-8-17(20(21)23-10-14)18-7-13(2)24-29-18/h3-4,7-10H,5-6,11H2,1-2H3,(H2,21,23)(H,22,26) AURBRVARCDSJFG-UHFFFAOYSA-N 295081 4-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) piperazin-2-one trifluoroacetic acid salt::US10112926, Example 19.17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 130 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295081&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469825 381618175 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562957 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCNC(=O)C1 InChI=1S/C20H21N5O4S/c1-12-3-4-15(30(27,28)25-6-5-22-19(26)11-25)9-16(12)14-8-17(20(21)23-10-14)18-7-13(2)24-29-18/h3-4,7-10H,5-6,11H2,1-2H3,(H2,21,23)(H,22,26) AURBRVARCDSJFG-UHFFFAOYSA-N 295081 4-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl) piperazin-2-one trifluoroacetic acid salt::US10112926, Example 19.17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2800 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295081&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469825 381618175 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562958 COCC1CCN(CC1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H28N4O4S/c1-15-4-5-19(32(28,29)27-8-6-17(7-9-27)14-30-3)12-20(15)18-11-21(23(24)25-13-18)22-10-16(2)26-31-22/h4-5,10-13,17H,6-9,14H2,1-3H3,(H2,24,25) UBYSVCFUXBGISH-UHFFFAOYSA-N 295082 5-(5-((4- (methoxymethyl)piperidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.18 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 760 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295082&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470015 381618176 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562959 COCC1CCN(CC1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H28N4O4S/c1-15-4-5-19(32(28,29)27-8-6-17(7-9-27)14-30-3)12-20(15)18-11-21(23(24)25-13-18)22-10-16(2)26-31-22/h4-5,10-13,17H,6-9,14H2,1-3H3,(H2,24,25) UBYSVCFUXBGISH-UHFFFAOYSA-N 295082 5-(5-((4- (methoxymethyl)piperidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295082&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470015 381618176 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562960 COCC1CCN(CC1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H28N4O4S/c1-15-4-5-19(32(28,29)27-8-6-17(7-9-27)14-30-3)12-20(15)18-11-21(23(24)25-13-18)22-10-16(2)26-31-22/h4-5,10-13,17H,6-9,14H2,1-3H3,(H2,24,25) UBYSVCFUXBGISH-UHFFFAOYSA-N 295082 5-(5-((4- (methoxymethyl)piperidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.18 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295082&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470015 381618176 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562961 COCC1CCN(CC1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H28N4O4S/c1-15-4-5-19(32(28,29)27-8-6-17(7-9-27)14-30-3)12-20(15)18-11-21(23(24)25-13-18)22-10-16(2)26-31-22/h4-5,10-13,17H,6-9,14H2,1-3H3,(H2,24,25) UBYSVCFUXBGISH-UHFFFAOYSA-N 295082 5-(5-((4- (methoxymethyl)piperidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.18 Phosphatidylinositol 4-kinase beta Human 3800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295082&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470015 381618176 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562962 COCC1CCN(CC1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H28N4O4S/c1-15-4-5-19(32(28,29)27-8-6-17(7-9-27)14-30-3)12-20(15)18-11-21(23(24)25-13-18)22-10-16(2)26-31-22/h4-5,10-13,17H,6-9,14H2,1-3H3,(H2,24,25) UBYSVCFUXBGISH-UHFFFAOYSA-N 295082 5-(5-((4- (methoxymethyl)piperidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 180 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295082&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470015 381618176 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562963 COCC1CCN(CC1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H28N4O4S/c1-15-4-5-19(32(28,29)27-8-6-17(7-9-27)14-30-3)12-20(15)18-11-21(23(24)25-13-18)22-10-16(2)26-31-22/h4-5,10-13,17H,6-9,14H2,1-3H3,(H2,24,25) UBYSVCFUXBGISH-UHFFFAOYSA-N 295082 5-(5-((4- (methoxymethyl)piperidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295082&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470015 381618176 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562964 CN(C)C1CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H25N5O3S/c1-13-5-6-17(30(27,28)26-11-16(12-26)25(3)4)9-18(13)15-8-19(21(22)23-10-15)20-7-14(2)24-29-20/h5-10,16H,11-12H2,1-4H3,(H2,22,23) ONQGGZVSCZOWMX-UHFFFAOYSA-N 295083 5-(5-((3- (dimethylamino)azetidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.19 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 3100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295083&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470108 381618177 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562965 CN(C)C1CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H25N5O3S/c1-13-5-6-17(30(27,28)26-11-16(12-26)25(3)4)9-18(13)15-8-19(21(22)23-10-15)20-7-14(2)24-29-20/h5-10,16H,11-12H2,1-4H3,(H2,22,23) ONQGGZVSCZOWMX-UHFFFAOYSA-N 295083 5-(5-((3- (dimethylamino)azetidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295083&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470108 381618177 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562966 CN(C)C1CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H25N5O3S/c1-13-5-6-17(30(27,28)26-11-16(12-26)25(3)4)9-18(13)15-8-19(21(22)23-10-15)20-7-14(2)24-29-20/h5-10,16H,11-12H2,1-4H3,(H2,22,23) ONQGGZVSCZOWMX-UHFFFAOYSA-N 295083 5-(5-((3- (dimethylamino)azetidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.19 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295083&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470108 381618177 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562967 CN(C)C1CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H25N5O3S/c1-13-5-6-17(30(27,28)26-11-16(12-26)25(3)4)9-18(13)15-8-19(21(22)23-10-15)20-7-14(2)24-29-20/h5-10,16H,11-12H2,1-4H3,(H2,22,23) ONQGGZVSCZOWMX-UHFFFAOYSA-N 295083 5-(5-((3- (dimethylamino)azetidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.19 Phosphatidylinositol 4-kinase beta Human 8500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295083&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470108 381618177 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562968 CN(C)C1CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H25N5O3S/c1-13-5-6-17(30(27,28)26-11-16(12-26)25(3)4)9-18(13)15-8-19(21(22)23-10-15)20-7-14(2)24-29-20/h5-10,16H,11-12H2,1-4H3,(H2,22,23) ONQGGZVSCZOWMX-UHFFFAOYSA-N 295083 5-(5-((3- (dimethylamino)azetidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 380 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295083&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470108 381618177 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562969 CN(C)C1CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H25N5O3S/c1-13-5-6-17(30(27,28)26-11-16(12-26)25(3)4)9-18(13)15-8-19(21(22)23-10-15)20-7-14(2)24-29-20/h5-10,16H,11-12H2,1-4H3,(H2,22,23) ONQGGZVSCZOWMX-UHFFFAOYSA-N 295083 5-(5-((3- (dimethylamino)azetidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 3600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295083&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470108 381618177 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562970 COC[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H26N4O5S/c1-14-4-5-18(32(27,28)26-6-7-30-13-17(26)12-29-3)10-19(14)16-9-20(22(23)24-11-16)21-8-15(2)25-31-21/h4-5,8-11,17H,6-7,12-13H2,1-3H3,(H2,23,24) QEYGJSGEGSCDSB-UHFFFAOYSA-N 295084 (R)-5-(5-((3- (methoxymethyl)morpho- lino)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.20 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295084&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470290 381618178 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562971 COC[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H26N4O5S/c1-14-4-5-18(32(27,28)26-6-7-30-13-17(26)12-29-3)10-19(14)16-9-20(22(23)24-11-16)21-8-15(2)25-31-21/h4-5,8-11,17H,6-7,12-13H2,1-3H3,(H2,23,24) QEYGJSGEGSCDSB-UHFFFAOYSA-N 295084 (R)-5-(5-((3- (methoxymethyl)morpho- lino)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295084&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470290 381618178 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562972 COC[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H26N4O5S/c1-14-4-5-18(32(27,28)26-6-7-30-13-17(26)12-29-3)10-19(14)16-9-20(22(23)24-11-16)21-8-15(2)25-31-21/h4-5,8-11,17H,6-7,12-13H2,1-3H3,(H2,23,24) QEYGJSGEGSCDSB-UHFFFAOYSA-N 295084 (R)-5-(5-((3- (methoxymethyl)morpho- lino)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.20 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295084&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470290 381618178 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562973 COC[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H26N4O5S/c1-14-4-5-18(32(27,28)26-6-7-30-13-17(26)12-29-3)10-19(14)16-9-20(22(23)24-11-16)21-8-15(2)25-31-21/h4-5,8-11,17H,6-7,12-13H2,1-3H3,(H2,23,24) QEYGJSGEGSCDSB-UHFFFAOYSA-N 295084 (R)-5-(5-((3- (methoxymethyl)morpho- lino)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.20 Phosphatidylinositol 4-kinase beta Human 4200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295084&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470290 381618178 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562974 COC[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H26N4O5S/c1-14-4-5-18(32(27,28)26-6-7-30-13-17(26)12-29-3)10-19(14)16-9-20(22(23)24-11-16)21-8-15(2)25-31-21/h4-5,8-11,17H,6-7,12-13H2,1-3H3,(H2,23,24) QEYGJSGEGSCDSB-UHFFFAOYSA-N 295084 (R)-5-(5-((3- (methoxymethyl)morpho- lino)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295084&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470290 381618178 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562975 COC[C@@H]1COCCN1S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H26N4O5S/c1-14-4-5-18(32(27,28)26-6-7-30-13-17(26)12-29-3)10-19(14)16-9-20(22(23)24-11-16)21-8-15(2)25-31-21/h4-5,8-11,17H,6-7,12-13H2,1-3H3,(H2,23,24) QEYGJSGEGSCDSB-UHFFFAOYSA-N 295084 (R)-5-(5-((3- (methoxymethyl)morpho- lino)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine trifluoroacetic acid salt::US10112926, Example 19.20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2900 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295084&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470290 381618178 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562976 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC(C)(O)CC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)27-9-4-7-23(3,28)8-10-27)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)26-31-21/h5-6,11-14,28H,4,7-10H2,1-3H3,(H2,24,25) LILFWBUEZGJHFN-UHFFFAOYSA-N 295085 1-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl)- 4-methylazepan-4-ol trifluoroacetic acid salt::US10112926, Example 19.21 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 660 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295085&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512203 381618179 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562977 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC(C)(O)CC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)27-9-4-7-23(3,28)8-10-27)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)26-31-21/h5-6,11-14,28H,4,7-10H2,1-3H3,(H2,24,25) LILFWBUEZGJHFN-UHFFFAOYSA-N 295085 1-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl)- 4-methylazepan-4-ol trifluoroacetic acid salt::US10112926, Example 19.21 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295085&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512203 381618179 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562978 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC(C)(O)CC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)27-9-4-7-23(3,28)8-10-27)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)26-31-21/h5-6,11-14,28H,4,7-10H2,1-3H3,(H2,24,25) LILFWBUEZGJHFN-UHFFFAOYSA-N 295085 1-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl)- 4-methylazepan-4-ol trifluoroacetic acid salt::US10112926, Example 19.21 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295085&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512203 381618179 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562979 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC(C)(O)CC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)27-9-4-7-23(3,28)8-10-27)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)26-31-21/h5-6,11-14,28H,4,7-10H2,1-3H3,(H2,24,25) LILFWBUEZGJHFN-UHFFFAOYSA-N 295085 1-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl)- 4-methylazepan-4-ol trifluoroacetic acid salt::US10112926, Example 19.21 Phosphatidylinositol 4-kinase beta Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295085&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512203 381618179 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562980 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC(C)(O)CC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)27-9-4-7-23(3,28)8-10-27)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)26-31-21/h5-6,11-14,28H,4,7-10H2,1-3H3,(H2,24,25) LILFWBUEZGJHFN-UHFFFAOYSA-N 295085 1-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl)- 4-methylazepan-4-ol trifluoroacetic acid salt::US10112926, Example 19.21 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 16.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295085&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512203 381618179 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562981 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CCCC(C)(O)CC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)27-9-4-7-23(3,28)8-10-27)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)26-31-21/h5-6,11-14,28H,4,7-10H2,1-3H3,(H2,24,25) LILFWBUEZGJHFN-UHFFFAOYSA-N 295085 1-((3-(6-amino-5-(3- methylisoxazol-5- yl)pyridin-3-yl)-4- methylphenyl)sulfonyl)- 4-methylazepan-4-ol trifluoroacetic acid salt::US10112926, Example 19.21 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 540 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295085&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512203 381618179 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562982 CN(C)[C@H]1CCN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H27N5O3S/c1-14-5-6-18(31(28,29)27-8-7-17(13-27)26(3)4)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)25-30-21/h5-6,9-12,17H,7-8,13H2,1-4H3,(H2,23,24) VLIFRAXBRLFKDB-UHFFFAOYSA-N 295086 (S)-5-(5-((3- (dimethylamino)pyrrolidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.22 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 2000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295086&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512285 381618180 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562983 CN(C)[C@H]1CCN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H27N5O3S/c1-14-5-6-18(31(28,29)27-8-7-17(13-27)26(3)4)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)25-30-21/h5-6,9-12,17H,7-8,13H2,1-4H3,(H2,23,24) VLIFRAXBRLFKDB-UHFFFAOYSA-N 295086 (S)-5-(5-((3- (dimethylamino)pyrrolidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295086&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512285 381618180 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562984 CN(C)[C@H]1CCN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H27N5O3S/c1-14-5-6-18(31(28,29)27-8-7-17(13-27)26(3)4)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)25-30-21/h5-6,9-12,17H,7-8,13H2,1-4H3,(H2,23,24) VLIFRAXBRLFKDB-UHFFFAOYSA-N 295086 (S)-5-(5-((3- (dimethylamino)pyrrolidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.22 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295086&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512285 381618180 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562985 CN(C)[C@H]1CCN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H27N5O3S/c1-14-5-6-18(31(28,29)27-8-7-17(13-27)26(3)4)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)25-30-21/h5-6,9-12,17H,7-8,13H2,1-4H3,(H2,23,24) VLIFRAXBRLFKDB-UHFFFAOYSA-N 295086 (S)-5-(5-((3- (dimethylamino)pyrrolidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.22 Phosphatidylinositol 4-kinase beta Human 8600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295086&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512285 381618180 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562986 CN(C)[C@H]1CCN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H27N5O3S/c1-14-5-6-18(31(28,29)27-8-7-17(13-27)26(3)4)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)25-30-21/h5-6,9-12,17H,7-8,13H2,1-4H3,(H2,23,24) VLIFRAXBRLFKDB-UHFFFAOYSA-N 295086 (S)-5-(5-((3- (dimethylamino)pyrrolidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 510 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295086&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512285 381618180 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562987 CN(C)[C@H]1CCN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C22H27N5O3S/c1-14-5-6-18(31(28,29)27-8-7-17(13-27)26(3)4)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)25-30-21/h5-6,9-12,17H,7-8,13H2,1-4H3,(H2,23,24) VLIFRAXBRLFKDB-UHFFFAOYSA-N 295086 (S)-5-(5-((3- (dimethylamino)pyrrolidin- 1-yl)sulfonyl)-2- methylphenyl)-3-(3- methylisoxazol-5- yl)pyridin-2-amine acetic acid salt::US10112926, Example 19.22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295086&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512285 381618180 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562988 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)23-29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,22) ZUMGFOKBPTVVKE-UHFFFAOYSA-N 295087 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 20 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 80.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295087&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469940 381618181 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562989 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)23-29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,22) ZUMGFOKBPTVVKE-UHFFFAOYSA-N 295087 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295087&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469940 381618181 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562990 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)23-29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,22) ZUMGFOKBPTVVKE-UHFFFAOYSA-N 295087 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 20 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295087&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469940 381618181 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562991 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)23-29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,22) ZUMGFOKBPTVVKE-UHFFFAOYSA-N 295087 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 20 Phosphatidylinositol 4-kinase beta Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295087&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469940 381618181 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562992 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)23-29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,22) ZUMGFOKBPTVVKE-UHFFFAOYSA-N 295087 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 16.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295087&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469940 381618181 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 562993 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)23-29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,22) ZUMGFOKBPTVVKE-UHFFFAOYSA-N 295087 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 390 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295087&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469940 381618181 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 562994 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)9-16(12)14-8-17(19(21)22-10-14)18-7-13(2)23-29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,22) ZUMGFOKBPTVVKE-UHFFFAOYSA-N 295087 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 20 Serine/threonine-protein kinase mTOR Human 4050 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295087&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469940 381618181 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 562995 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295088 US10112926, Example 21a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 130 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295088&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470048 381618182 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 562996 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295088 US10112926, Example 21a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 680 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295088&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470048 381618182 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 562997 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295088 US10112926, Example 21a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295088&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470048 381618182 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 562998 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295088 US10112926, Example 21a Phosphatidylinositol 4-kinase beta Human 980 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295088&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470048 381618182 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 562999 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295088 US10112926, Example 21a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 13.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295088&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470048 381618182 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563000 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295088 US10112926, Example 21a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 40.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295088&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470048 381618182 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563001 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295089 US10112926, Example 21b Phosphatidylinositol 3-kinase regulatory subunit alpha Human 70.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295089&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469864 381618183 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563002 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295089 US10112926, Example 21b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 880 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295089&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469864 381618183 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563003 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295089 US10112926, Example 21b Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295089&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469864 381618183 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563004 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295089 US10112926, Example 21b Phosphatidylinositol 4-kinase beta Human 1710 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295089&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469864 381618183 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563005 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295089 US10112926, Example 21b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 5.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295089&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469864 381618183 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563006 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@@H]1CCOC1 |r| InChI=1S/C20H22N4O5S/c1-12-3-4-16(30(25,26)24-28-15-5-6-27-11-15)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-29-19/h3-4,7-10,15,24H,5-6,11H2,1-2H3,(H2,21,22) MABMRCWHKCPRMW-UHFFFAOYSA-N 295089 US10112926, Example 21b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 90.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295089&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469864 381618183 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563007 CCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-4-25-22-27(23,24)14-6-5-11(2)15(9-14)13-8-16(18(19)20-10-13)17-7-12(3)21-26-17/h5-10,22H,4H2,1-3H3,(H2,19,20) VYXZSLJQQXROKX-UHFFFAOYSA-N 295090 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-ethoxy-4-methylbenzenesulfonamide::US10112926, Example 22 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 210 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295090&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470382 381618184 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563008 CCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-4-25-22-27(23,24)14-6-5-11(2)15(9-14)13-8-16(18(19)20-10-13)17-7-12(3)21-26-17/h5-10,22H,4H2,1-3H3,(H2,19,20) VYXZSLJQQXROKX-UHFFFAOYSA-N 295090 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-ethoxy-4-methylbenzenesulfonamide::US10112926, Example 22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295090&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470382 381618184 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563009 CCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-4-25-22-27(23,24)14-6-5-11(2)15(9-14)13-8-16(18(19)20-10-13)17-7-12(3)21-26-17/h5-10,22H,4H2,1-3H3,(H2,19,20) VYXZSLJQQXROKX-UHFFFAOYSA-N 295090 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-ethoxy-4-methylbenzenesulfonamide::US10112926, Example 22 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295090&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470382 381618184 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563010 CCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-4-25-22-27(23,24)14-6-5-11(2)15(9-14)13-8-16(18(19)20-10-13)17-7-12(3)21-26-17/h5-10,22H,4H2,1-3H3,(H2,19,20) VYXZSLJQQXROKX-UHFFFAOYSA-N 295090 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-ethoxy-4-methylbenzenesulfonamide::US10112926, Example 22 Phosphatidylinositol 4-kinase beta Human 940 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295090&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470382 381618184 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563011 CCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-4-25-22-27(23,24)14-6-5-11(2)15(9-14)13-8-16(18(19)20-10-13)17-7-12(3)21-26-17/h5-10,22H,4H2,1-3H3,(H2,19,20) VYXZSLJQQXROKX-UHFFFAOYSA-N 295090 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-ethoxy-4-methylbenzenesulfonamide::US10112926, Example 22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 32.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295090&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470382 381618184 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563012 CCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-4-25-22-27(23,24)14-6-5-11(2)15(9-14)13-8-16(18(19)20-10-13)17-7-12(3)21-26-17/h5-10,22H,4H2,1-3H3,(H2,19,20) VYXZSLJQQXROKX-UHFFFAOYSA-N 295090 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-ethoxy-4-methylbenzenesulfonamide::US10112926, Example 22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295090&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470382 381618184 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563013 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295091 US10112926, Example 23a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 260 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295091&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472695 381618185 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563014 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295091 US10112926, Example 23a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2550 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295091&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472695 381618185 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563015 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295091 US10112926, Example 23a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295091&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472695 381618185 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563016 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295091 US10112926, Example 23a Phosphatidylinositol 4-kinase beta Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295091&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472695 381618185 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563017 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295091 US10112926, Example 23a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 27.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295091&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472695 381618185 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563018 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295091 US10112926, Example 23a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 120 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295091&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472695 381618185 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563019 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295092 US10112926, Example 23b Phosphatidylinositol 3-kinase regulatory subunit alpha Human 260 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295092&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512394 381618186 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563020 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295092 US10112926, Example 23b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295092&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512394 381618186 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563021 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295092 US10112926, Example 23b Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295092&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512394 381618186 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563022 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295092 US10112926, Example 23b Phosphatidylinositol 4-kinase beta Human 3000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295092&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512394 381618186 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563023 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295092 US10112926, Example 23b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 47.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295092&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512394 381618186 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563024 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCOC1 |r| InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)25-11-16-4-3-7-29-13-16)10-19(14)17-9-20(22(23)24-12-17)21-8-15(2)26-30-21/h5-6,8-10,12,16,25H,3-4,7,11,13H2,1-2H3,(H2,23,24) AQPXZIOUXMMPJH-UHFFFAOYSA-N 295092 US10112926, Example 23b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 130 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295092&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512394 381618186 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563025 C[C@@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295093 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 24 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 280 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295093&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469963 381618187 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563026 C[C@@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295093 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 24 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295093&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469963 381618187 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563027 C[C@@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295093 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 24 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295093&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469963 381618187 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563028 C[C@@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295093 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 24 Phosphatidylinositol 4-kinase beta Human 2400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295093&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469963 381618187 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563029 C[C@@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295093 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 24 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 41.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295093&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469963 381618187 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563030 C[C@@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295093 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 24 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 280 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295093&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469963 381618187 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563031 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)23-8-14-10-27-11-14)7-17(12)15-6-18(20(21)22-9-15)19-5-13(2)24-28-19/h3-7,9,14,23H,8,10-11H2,1-2H3,(H2,21,22) RFWIWJIKKWYZIY-UHFFFAOYSA-N 295094 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 25 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295094&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470111 381618188 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563032 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)23-8-14-10-27-11-14)7-17(12)15-6-18(20(21)22-9-15)19-5-13(2)24-28-19/h3-7,9,14,23H,8,10-11H2,1-2H3,(H2,21,22) RFWIWJIKKWYZIY-UHFFFAOYSA-N 295094 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 25 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295094&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470111 381618188 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563033 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)23-8-14-10-27-11-14)7-17(12)15-6-18(20(21)22-9-15)19-5-13(2)24-28-19/h3-7,9,14,23H,8,10-11H2,1-2H3,(H2,21,22) RFWIWJIKKWYZIY-UHFFFAOYSA-N 295094 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 25 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295094&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470111 381618188 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563034 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)23-8-14-10-27-11-14)7-17(12)15-6-18(20(21)22-9-15)19-5-13(2)24-28-19/h3-7,9,14,23H,8,10-11H2,1-2H3,(H2,21,22) RFWIWJIKKWYZIY-UHFFFAOYSA-N 295094 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 25 Phosphatidylinositol 4-kinase beta Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295094&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470111 381618188 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563035 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)23-8-14-10-27-11-14)7-17(12)15-6-18(20(21)22-9-15)19-5-13(2)24-28-19/h3-7,9,14,23H,8,10-11H2,1-2H3,(H2,21,22) RFWIWJIKKWYZIY-UHFFFAOYSA-N 295094 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 25 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 43.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295094&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470111 381618188 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563036 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)23-8-14-10-27-11-14)7-17(12)15-6-18(20(21)22-9-15)19-5-13(2)24-28-19/h3-7,9,14,23H,8,10-11H2,1-2H3,(H2,21,22) RFWIWJIKKWYZIY-UHFFFAOYSA-N 295094 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 25 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 430 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295094&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470111 381618188 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563037 Cc1nn(C)cc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(3.91,-5.14,;5.24,-4.37,;6.7,-4.85,;7.61,-3.6,;9.15,-3.6,;6.7,-2.36,;5.24,-2.83,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C24H29N5O3S/c1-14-4-5-19(33(31,32)28-17-8-24(9-17)10-18(30)11-24)7-20(14)16-6-21(23(25)26-12-16)22-13-29(3)27-15(22)2/h4-7,12-13,17-18,28,30H,8-11H2,1-3H3,(H2,25,26) NVFKNXAVJJJREP-UHFFFAOYSA-N 295095 3-(6-Amino-5-(1,3-di methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 26 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 220 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295095&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470064 381618189 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563038 Cc1nn(C)cc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(3.91,-5.14,;5.24,-4.37,;6.7,-4.85,;7.61,-3.6,;9.15,-3.6,;6.7,-2.36,;5.24,-2.83,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C24H29N5O3S/c1-14-4-5-19(33(31,32)28-17-8-24(9-17)10-18(30)11-24)7-20(14)16-6-21(23(25)26-12-16)22-13-29(3)27-15(22)2/h4-7,12-13,17-18,28,30H,8-11H2,1-3H3,(H2,25,26) NVFKNXAVJJJREP-UHFFFAOYSA-N 295095 3-(6-Amino-5-(1,3-di methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 26 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295095&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470064 381618189 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563039 Cc1nn(C)cc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(3.91,-5.14,;5.24,-4.37,;6.7,-4.85,;7.61,-3.6,;9.15,-3.6,;6.7,-2.36,;5.24,-2.83,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C24H29N5O3S/c1-14-4-5-19(33(31,32)28-17-8-24(9-17)10-18(30)11-24)7-20(14)16-6-21(23(25)26-12-16)22-13-29(3)27-15(22)2/h4-7,12-13,17-18,28,30H,8-11H2,1-3H3,(H2,25,26) NVFKNXAVJJJREP-UHFFFAOYSA-N 295095 3-(6-Amino-5-(1,3-di methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 26 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295095&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470064 381618189 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563040 Cc1nn(C)cc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(3.91,-5.14,;5.24,-4.37,;6.7,-4.85,;7.61,-3.6,;9.15,-3.6,;6.7,-2.36,;5.24,-2.83,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C24H29N5O3S/c1-14-4-5-19(33(31,32)28-17-8-24(9-17)10-18(30)11-24)7-20(14)16-6-21(23(25)26-12-16)22-13-29(3)27-15(22)2/h4-7,12-13,17-18,28,30H,8-11H2,1-3H3,(H2,25,26) NVFKNXAVJJJREP-UHFFFAOYSA-N 295095 3-(6-Amino-5-(1,3-di methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 26 Phosphatidylinositol 4-kinase beta Human 3400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295095&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470064 381618189 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563041 Cc1nn(C)cc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(3.91,-5.14,;5.24,-4.37,;6.7,-4.85,;7.61,-3.6,;9.15,-3.6,;6.7,-2.36,;5.24,-2.83,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C24H29N5O3S/c1-14-4-5-19(33(31,32)28-17-8-24(9-17)10-18(30)11-24)7-20(14)16-6-21(23(25)26-12-16)22-13-29(3)27-15(22)2/h4-7,12-13,17-18,28,30H,8-11H2,1-3H3,(H2,25,26) NVFKNXAVJJJREP-UHFFFAOYSA-N 295095 3-(6-Amino-5-(1,3-di methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 26 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 67.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295095&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470064 381618189 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563042 Cc1nn(C)cc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(3.91,-5.14,;5.24,-4.37,;6.7,-4.85,;7.61,-3.6,;9.15,-3.6,;6.7,-2.36,;5.24,-2.83,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C24H29N5O3S/c1-14-4-5-19(33(31,32)28-17-8-24(9-17)10-18(30)11-24)7-20(14)16-6-21(23(25)26-12-16)22-13-29(3)27-15(22)2/h4-7,12-13,17-18,28,30H,8-11H2,1-3H3,(H2,25,26) NVFKNXAVJJJREP-UHFFFAOYSA-N 295095 3-(6-Amino-5-(1,3-di methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 26 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295095&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470064 381618189 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563043 Cc1nn(C)cc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(3.91,-5.14,;5.24,-4.37,;6.7,-4.85,;7.61,-3.6,;9.15,-3.6,;6.7,-2.36,;5.24,-2.83,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C24H29N5O3S/c1-14-4-5-19(33(31,32)28-17-8-24(9-17)10-18(30)11-24)7-20(14)16-6-21(23(25)26-12-16)22-13-29(3)27-15(22)2/h4-7,12-13,17-18,28,30H,8-11H2,1-3H3,(H2,25,26) NVFKNXAVJJJREP-UHFFFAOYSA-N 295095 3-(6-Amino-5-(1,3-di methyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 26 Serine/threonine-protein kinase mTOR Human 320 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295095&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470064 381618189 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563044 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)23-9-17(19)20)7-14(10)12-6-15(18(21)22-8-12)16-5-11(2)24-27-16/h3-8,17,23H,9H2,1-2H3,(H2,21,22) HMEBOKIRXYGIPL-UHFFFAOYSA-N 295096 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2,2-difluoroethyl)-4-methylbenzenesulfonamide::US10112926, Example 27 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 660 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295096&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469814 381618190 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563045 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)23-9-17(19)20)7-14(10)12-6-15(18(21)22-8-12)16-5-11(2)24-27-16/h3-8,17,23H,9H2,1-2H3,(H2,21,22) HMEBOKIRXYGIPL-UHFFFAOYSA-N 295096 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2,2-difluoroethyl)-4-methylbenzenesulfonamide::US10112926, Example 27 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295096&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469814 381618190 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563046 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)23-9-17(19)20)7-14(10)12-6-15(18(21)22-8-12)16-5-11(2)24-27-16/h3-8,17,23H,9H2,1-2H3,(H2,21,22) HMEBOKIRXYGIPL-UHFFFAOYSA-N 295096 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2,2-difluoroethyl)-4-methylbenzenesulfonamide::US10112926, Example 27 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295096&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469814 381618190 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563047 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)23-9-17(19)20)7-14(10)12-6-15(18(21)22-8-12)16-5-11(2)24-27-16/h3-8,17,23H,9H2,1-2H3,(H2,21,22) HMEBOKIRXYGIPL-UHFFFAOYSA-N 295096 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2,2-difluoroethyl)-4-methylbenzenesulfonamide::US10112926, Example 27 Phosphatidylinositol 4-kinase beta Human 2400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295096&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469814 381618190 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563048 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)23-9-17(19)20)7-14(10)12-6-15(18(21)22-8-12)16-5-11(2)24-27-16/h3-8,17,23H,9H2,1-2H3,(H2,21,22) HMEBOKIRXYGIPL-UHFFFAOYSA-N 295096 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2,2-difluoroethyl)-4-methylbenzenesulfonamide::US10112926, Example 27 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 70.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295096&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469814 381618190 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563049 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)23-9-17(19)20)7-14(10)12-6-15(18(21)22-8-12)16-5-11(2)24-27-16/h3-8,17,23H,9H2,1-2H3,(H2,21,22) HMEBOKIRXYGIPL-UHFFFAOYSA-N 295096 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2,2-difluoroethyl)-4-methylbenzenesulfonamide::US10112926, Example 27 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 860 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295096&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469814 381618190 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563050 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(9.15,-3.6,;7.61,-3.6,;6.7,-4.85,;5.24,-4.37,;5.24,-2.83,;6.7,-2.36,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C23H26N4O3S2/c1-13-3-4-18(32(29,30)27-16-7-23(8-16)9-17(28)10-23)6-19(13)15-5-20(22(24)26-11-15)21-12-25-14(2)31-21/h3-6,11-12,16-17,27-28H,7-10H2,1-2H3,(H2,24,26) LODPWNVFWVRUDN-UHFFFAOYSA-N 295097 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 28 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 50.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295097&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470208 381618191 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563051 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(9.15,-3.6,;7.61,-3.6,;6.7,-4.85,;5.24,-4.37,;5.24,-2.83,;6.7,-2.36,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C23H26N4O3S2/c1-13-3-4-18(32(29,30)27-16-7-23(8-16)9-17(28)10-23)6-19(13)15-5-20(22(24)26-11-15)21-12-25-14(2)31-21/h3-6,11-12,16-17,27-28H,7-10H2,1-2H3,(H2,24,26) LODPWNVFWVRUDN-UHFFFAOYSA-N 295097 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 28 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 450 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295097&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470208 381618191 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563052 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(9.15,-3.6,;7.61,-3.6,;6.7,-4.85,;5.24,-4.37,;5.24,-2.83,;6.7,-2.36,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C23H26N4O3S2/c1-13-3-4-18(32(29,30)27-16-7-23(8-16)9-17(28)10-23)6-19(13)15-5-20(22(24)26-11-15)21-12-25-14(2)31-21/h3-6,11-12,16-17,27-28H,7-10H2,1-2H3,(H2,24,26) LODPWNVFWVRUDN-UHFFFAOYSA-N 295097 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 28 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 2000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295097&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470208 381618191 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563053 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(9.15,-3.6,;7.61,-3.6,;6.7,-4.85,;5.24,-4.37,;5.24,-2.83,;6.7,-2.36,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C23H26N4O3S2/c1-13-3-4-18(32(29,30)27-16-7-23(8-16)9-17(28)10-23)6-19(13)15-5-20(22(24)26-11-15)21-12-25-14(2)31-21/h3-6,11-12,16-17,27-28H,7-10H2,1-2H3,(H2,24,26) LODPWNVFWVRUDN-UHFFFAOYSA-N 295097 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 28 Phosphatidylinositol 4-kinase beta Human 680 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295097&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470208 381618191 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563054 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(9.15,-3.6,;7.61,-3.6,;6.7,-4.85,;5.24,-4.37,;5.24,-2.83,;6.7,-2.36,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C23H26N4O3S2/c1-13-3-4-18(32(29,30)27-16-7-23(8-16)9-17(28)10-23)6-19(13)15-5-20(22(24)26-11-15)21-12-25-14(2)31-21/h3-6,11-12,16-17,27-28H,7-10H2,1-2H3,(H2,24,26) LODPWNVFWVRUDN-UHFFFAOYSA-N 295097 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 28 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 130 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295097&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470208 381618191 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563055 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(9.15,-3.6,;7.61,-3.6,;6.7,-4.85,;5.24,-4.37,;5.24,-2.83,;6.7,-2.36,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C23H26N4O3S2/c1-13-3-4-18(32(29,30)27-16-7-23(8-16)9-17(28)10-23)6-19(13)15-5-20(22(24)26-11-15)21-12-25-14(2)31-21/h3-6,11-12,16-17,27-28H,7-10H2,1-2H3,(H2,24,26) LODPWNVFWVRUDN-UHFFFAOYSA-N 295097 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 28 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295097&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470208 381618191 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563056 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC2(CC(O)C2)C1 |(9.15,-3.6,;7.61,-3.6,;6.7,-4.85,;5.24,-4.37,;5.24,-2.83,;6.7,-2.36,;3.91,-2.06,;2.57,-2.83,;1.24,-2.06,;1.24,-.52,;2.57,.25,;3.91,-.52,;5.24,.25,;-.1,-2.83,;-1.43,-2.06,;-2.76,-2.83,;-2.76,-4.37,;-1.43,-5.14,;-.1,-4.37,;1.24,-5.14,;-4.1,-2.06,;-4.1,-.52,;-4.87,-3.4,;-5.43,-1.29,;-6.2,.04,;-7.69,.44,;-7.29,1.92,;-6.89,3.41,;-8.38,3.81,;-9.15,5.14,;-8.78,2.32,;-5.8,1.53,)| InChI=1S/C23H26N4O3S2/c1-13-3-4-18(32(29,30)27-16-7-23(8-16)9-17(28)10-23)6-19(13)15-5-20(22(24)26-11-15)21-12-25-14(2)31-21/h3-6,11-12,16-17,27-28H,7-10H2,1-2H3,(H2,24,26) LODPWNVFWVRUDN-UHFFFAOYSA-N 295097 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(6-hydroxyspiro[3.3]heptan-2-yl)-4-methylbenzenesulfonamide::US10112926, Example 28 Serine/threonine-protein kinase mTOR Human 130 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295097&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470208 381618191 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563057 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCOC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295098 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 29 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 420 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295098&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470137 381618192 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563058 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCOC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295098 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 29 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295098&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470137 381618192 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563059 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCOC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295098 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 29 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295098&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470137 381618192 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563060 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCOC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295098 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 29 Phosphatidylinositol 4-kinase beta Human 9900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295098&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470137 381618192 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563061 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCOC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295098 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 29 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 140 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295098&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470137 381618192 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563062 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCOC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295098 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 29 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295098&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470137 381618192 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563063 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCOC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295098 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 29 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295098&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470137 381618192 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563064 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(C)c2)n1 InChI=1S/C22H22N6O2S/c1-14-7-8-18(31(29,30)27-21-6-4-5-15(2)26-21)10-19(14)16-9-20(22(23)24-11-16)17-12-25-28(3)13-17/h4-13H,1-3H3,(H2,23,24)(H,26,27) AFBWDMCJTDLZBM-UHFFFAOYSA-N 295099 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 30 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 330 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295099&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470588 381618193 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563065 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(C)c2)n1 InChI=1S/C22H22N6O2S/c1-14-7-8-18(31(29,30)27-21-6-4-5-15(2)26-21)10-19(14)16-9-20(22(23)24-11-16)17-12-25-28(3)13-17/h4-13H,1-3H3,(H2,23,24)(H,26,27) AFBWDMCJTDLZBM-UHFFFAOYSA-N 295099 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 30 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295099&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470588 381618193 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563066 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(C)c2)n1 InChI=1S/C22H22N6O2S/c1-14-7-8-18(31(29,30)27-21-6-4-5-15(2)26-21)10-19(14)16-9-20(22(23)24-11-16)17-12-25-28(3)13-17/h4-13H,1-3H3,(H2,23,24)(H,26,27) AFBWDMCJTDLZBM-UHFFFAOYSA-N 295099 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 30 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295099&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470588 381618193 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563067 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(C)c2)n1 InChI=1S/C22H22N6O2S/c1-14-7-8-18(31(29,30)27-21-6-4-5-15(2)26-21)10-19(14)16-9-20(22(23)24-11-16)17-12-25-28(3)13-17/h4-13H,1-3H3,(H2,23,24)(H,26,27) AFBWDMCJTDLZBM-UHFFFAOYSA-N 295099 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 30 Phosphatidylinositol 4-kinase beta Human 3100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295099&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470588 381618193 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563068 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(C)c2)n1 InChI=1S/C22H22N6O2S/c1-14-7-8-18(31(29,30)27-21-6-4-5-15(2)26-21)10-19(14)16-9-20(22(23)24-11-16)17-12-25-28(3)13-17/h4-13H,1-3H3,(H2,23,24)(H,26,27) AFBWDMCJTDLZBM-UHFFFAOYSA-N 295099 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 30 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 10.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295099&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470588 381618193 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563069 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(C)c2)n1 InChI=1S/C22H22N6O2S/c1-14-7-8-18(31(29,30)27-21-6-4-5-15(2)26-21)10-19(14)16-9-20(22(23)24-11-16)17-12-25-28(3)13-17/h4-13H,1-3H3,(H2,23,24)(H,26,27) AFBWDMCJTDLZBM-UHFFFAOYSA-N 295099 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 30 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 990 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295099&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470588 381618193 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563070 Cc1cccc(NS(=O)(=O)c2ccc(C)c(c2)-c2cnc(N)c(c2)-c2cnn(C)c2)n1 InChI=1S/C22H22N6O2S/c1-14-7-8-18(31(29,30)27-21-6-4-5-15(2)26-21)10-19(14)16-9-20(22(23)24-11-16)17-12-25-28(3)13-17/h4-13H,1-3H3,(H2,23,24)(H,26,27) AFBWDMCJTDLZBM-UHFFFAOYSA-N 295099 3-(6-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 30 Serine/threonine-protein kinase mTOR Human 4700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295099&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470588 381618193 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563071 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)9-16(11)13-8-17(19(20)21-10-13)18-7-12(2)22-26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,21) GJLUGKQXXSECIU-UHFFFAOYSA-N 295100 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-cyclopropyl-4-methylbenzenesulfonamide::US10112926, Example 31 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 530 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295100&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470277 381618194 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563072 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)9-16(11)13-8-17(19(20)21-10-13)18-7-12(2)22-26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,21) GJLUGKQXXSECIU-UHFFFAOYSA-N 295100 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-cyclopropyl-4-methylbenzenesulfonamide::US10112926, Example 31 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3630 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295100&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470277 381618194 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563073 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)9-16(11)13-8-17(19(20)21-10-13)18-7-12(2)22-26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,21) GJLUGKQXXSECIU-UHFFFAOYSA-N 295100 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-cyclopropyl-4-methylbenzenesulfonamide::US10112926, Example 31 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295100&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470277 381618194 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563074 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)9-16(11)13-8-17(19(20)21-10-13)18-7-12(2)22-26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,21) GJLUGKQXXSECIU-UHFFFAOYSA-N 295100 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-cyclopropyl-4-methylbenzenesulfonamide::US10112926, Example 31 Phosphatidylinositol 4-kinase beta Human 1260 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295100&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470277 381618194 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563075 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)9-16(11)13-8-17(19(20)21-10-13)18-7-12(2)22-26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,21) GJLUGKQXXSECIU-UHFFFAOYSA-N 295100 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-cyclopropyl-4-methylbenzenesulfonamide::US10112926, Example 31 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 33.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295100&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470277 381618194 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563076 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)9-16(11)13-8-17(19(20)21-10-13)18-7-12(2)22-26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,21) GJLUGKQXXSECIU-UHFFFAOYSA-N 295100 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-cyclopropyl-4-methylbenzenesulfonamide::US10112926, Example 31 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 740 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295100&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470277 381618194 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563077 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)7-13(9)11-6-14(16(17)19-8-11)15-5-10(2)20-23-15/h3-8H,1-2H3,(H2,17,19)(H2,18,21,22) ROFBFSLYZQMAAZ-UHFFFAOYSA-N 295101 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 32 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1060 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295101&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470193 381618195 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563078 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)7-13(9)11-6-14(16(17)19-8-11)15-5-10(2)20-23-15/h3-8H,1-2H3,(H2,17,19)(H2,18,21,22) ROFBFSLYZQMAAZ-UHFFFAOYSA-N 295101 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 32 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 7050 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295101&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470193 381618195 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563079 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)7-13(9)11-6-14(16(17)19-8-11)15-5-10(2)20-23-15/h3-8H,1-2H3,(H2,17,19)(H2,18,21,22) ROFBFSLYZQMAAZ-UHFFFAOYSA-N 295101 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 32 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295101&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470193 381618195 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563080 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)7-13(9)11-6-14(16(17)19-8-11)15-5-10(2)20-23-15/h3-8H,1-2H3,(H2,17,19)(H2,18,21,22) ROFBFSLYZQMAAZ-UHFFFAOYSA-N 295101 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 32 Phosphatidylinositol 4-kinase beta Human 5750 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295101&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470193 381618195 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563081 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)7-13(9)11-6-14(16(17)19-8-11)15-5-10(2)20-23-15/h3-8H,1-2H3,(H2,17,19)(H2,18,21,22) ROFBFSLYZQMAAZ-UHFFFAOYSA-N 295101 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 32 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 62.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295101&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470193 381618195 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563082 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)7-13(9)11-6-14(16(17)19-8-11)15-5-10(2)20-23-15/h3-8H,1-2H3,(H2,17,19)(H2,18,21,22) ROFBFSLYZQMAAZ-UHFFFAOYSA-N 295101 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 32 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1150 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295101&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470193 381618195 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563083 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)7-13(9)11-6-14(16(17)19-8-11)15-5-10(2)20-23-15/h3-8H,1-2H3,(H2,17,19)(H2,18,21,22) ROFBFSLYZQMAAZ-UHFFFAOYSA-N 295101 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 32 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295101&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470193 381618195 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563084 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) RMIZOWRUIUEBDB-UHFFFAOYSA-N 295102 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 33 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 130 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295102&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470141 381618196 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563085 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) RMIZOWRUIUEBDB-UHFFFAOYSA-N 295102 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 33 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295102&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470141 381618196 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563086 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) RMIZOWRUIUEBDB-UHFFFAOYSA-N 295102 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 33 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 3900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295102&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470141 381618196 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563087 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) RMIZOWRUIUEBDB-UHFFFAOYSA-N 295102 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 33 Phosphatidylinositol 4-kinase beta Human 4450 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295102&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470141 381618196 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563088 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) RMIZOWRUIUEBDB-UHFFFAOYSA-N 295102 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 33 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 96.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295102&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470141 381618196 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563089 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O3S/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) RMIZOWRUIUEBDB-UHFFFAOYSA-N 295102 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 33 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 680 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295102&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470141 381618196 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563090 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NOCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-13-4-5-16(34(31,32)28-33-12-20(2,3)30)7-17(13)14-6-18(19(25)26-8-14)15-9-27-29(10-15)11-21(22,23)24/h4-10,28,30H,11-12H2,1-3H3,(H2,25,26) CREIFIKGPUXHPD-UHFFFAOYSA-N 295103 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 34 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 70.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295103&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470187 381618197 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563091 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NOCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-13-4-5-16(34(31,32)28-33-12-20(2,3)30)7-17(13)14-6-18(19(25)26-8-14)15-9-27-29(10-15)11-21(22,23)24/h4-10,28,30H,11-12H2,1-3H3,(H2,25,26) CREIFIKGPUXHPD-UHFFFAOYSA-N 295103 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 34 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 850 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295103&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470187 381618197 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563092 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NOCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-13-4-5-16(34(31,32)28-33-12-20(2,3)30)7-17(13)14-6-18(19(25)26-8-14)15-9-27-29(10-15)11-21(22,23)24/h4-10,28,30H,11-12H2,1-3H3,(H2,25,26) CREIFIKGPUXHPD-UHFFFAOYSA-N 295103 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 34 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295103&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470187 381618197 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563093 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NOCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-13-4-5-16(34(31,32)28-33-12-20(2,3)30)7-17(13)14-6-18(19(25)26-8-14)15-9-27-29(10-15)11-21(22,23)24/h4-10,28,30H,11-12H2,1-3H3,(H2,25,26) CREIFIKGPUXHPD-UHFFFAOYSA-N 295103 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 34 Phosphatidylinositol 4-kinase beta Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295103&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470187 381618197 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563094 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NOCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-13-4-5-16(34(31,32)28-33-12-20(2,3)30)7-17(13)14-6-18(19(25)26-8-14)15-9-27-29(10-15)11-21(22,23)24/h4-10,28,30H,11-12H2,1-3H3,(H2,25,26) CREIFIKGPUXHPD-UHFFFAOYSA-N 295103 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 34 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 59.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295103&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470187 381618197 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563095 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(CC(F)(F)F)c1)S(=O)(=O)NOCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-13-4-5-16(34(31,32)28-33-12-20(2,3)30)7-17(13)14-6-18(19(25)26-8-14)15-9-27-29(10-15)11-21(22,23)24/h4-10,28,30H,11-12H2,1-3H3,(H2,25,26) CREIFIKGPUXHPD-UHFFFAOYSA-N 295103 3-(6-Amino-5-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 34 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 40.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295103&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470187 381618197 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563096 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CC(F)(F)F)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H23F3N4O4S/c1-12-4-5-15(33(30,31)27-11-20(2,3)29)8-16(12)13-6-17(19(25)26-10-13)18-7-14(28-32-18)9-21(22,23)24/h4-8,10,27,29H,9,11H2,1-3H3,(H2,25,26) PVYZELXSBIFXIA-UHFFFAOYSA-N 295104 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 710 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295104&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470230 381618198 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563097 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CC(F)(F)F)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H23F3N4O4S/c1-12-4-5-15(33(30,31)27-11-20(2,3)29)8-16(12)13-6-17(19(25)26-10-13)18-7-14(28-32-18)9-21(22,23)24/h4-8,10,27,29H,9,11H2,1-3H3,(H2,25,26) PVYZELXSBIFXIA-UHFFFAOYSA-N 295104 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295104&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470230 381618198 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563098 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CC(F)(F)F)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H23F3N4O4S/c1-12-4-5-15(33(30,31)27-11-20(2,3)29)8-16(12)13-6-17(19(25)26-10-13)18-7-14(28-32-18)9-21(22,23)24/h4-8,10,27,29H,9,11H2,1-3H3,(H2,25,26) PVYZELXSBIFXIA-UHFFFAOYSA-N 295104 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295104&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470230 381618198 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563099 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CC(F)(F)F)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H23F3N4O4S/c1-12-4-5-15(33(30,31)27-11-20(2,3)29)8-16(12)13-6-17(19(25)26-10-13)18-7-14(28-32-18)9-21(22,23)24/h4-8,10,27,29H,9,11H2,1-3H3,(H2,25,26) PVYZELXSBIFXIA-UHFFFAOYSA-N 295104 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35 Phosphatidylinositol 4-kinase beta Human 820 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295104&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470230 381618198 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563100 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CC(F)(F)F)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H23F3N4O4S/c1-12-4-5-15(33(30,31)27-11-20(2,3)29)8-16(12)13-6-17(19(25)26-10-13)18-7-14(28-32-18)9-21(22,23)24/h4-8,10,27,29H,9,11H2,1-3H3,(H2,25,26) PVYZELXSBIFXIA-UHFFFAOYSA-N 295104 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 16.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295104&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470230 381618198 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563101 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CC(F)(F)F)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H23F3N4O4S/c1-12-4-5-15(33(30,31)27-11-20(2,3)29)8-16(12)13-6-17(19(25)26-10-13)18-7-14(28-32-18)9-21(22,23)24/h4-8,10,27,29H,9,11H2,1-3H3,(H2,25,26) PVYZELXSBIFXIA-UHFFFAOYSA-N 295104 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295104&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470230 381618198 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563102 CCCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-5-6-16-10-20(30-26-16)19-9-15(12-24-21(19)23)18-11-17(8-7-14(18)2)31(28,29)25-13-22(3,4)27/h7-12,25,27H,5-6,13H2,1-4H3,(H2,23,24) XESSMGMYMDVIMA-UHFFFAOYSA-N 295105 3-(6-Amino-5-(3-propyl isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 410 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295105&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470153 381618199 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563103 CCCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-5-6-16-10-20(30-26-16)19-9-15(12-24-21(19)23)18-11-17(8-7-14(18)2)31(28,29)25-13-22(3,4)27/h7-12,25,27H,5-6,13H2,1-4H3,(H2,23,24) XESSMGMYMDVIMA-UHFFFAOYSA-N 295105 3-(6-Amino-5-(3-propyl isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295105&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470153 381618199 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563104 CCCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-5-6-16-10-20(30-26-16)19-9-15(12-24-21(19)23)18-11-17(8-7-14(18)2)31(28,29)25-13-22(3,4)27/h7-12,25,27H,5-6,13H2,1-4H3,(H2,23,24) XESSMGMYMDVIMA-UHFFFAOYSA-N 295105 3-(6-Amino-5-(3-propyl isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295105&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470153 381618199 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563105 CCCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-5-6-16-10-20(30-26-16)19-9-15(12-24-21(19)23)18-11-17(8-7-14(18)2)31(28,29)25-13-22(3,4)27/h7-12,25,27H,5-6,13H2,1-4H3,(H2,23,24) XESSMGMYMDVIMA-UHFFFAOYSA-N 295105 3-(6-Amino-5-(3-propyl isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.1 Phosphatidylinositol 4-kinase beta Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295105&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470153 381618199 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563106 CCCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-5-6-16-10-20(30-26-16)19-9-15(12-24-21(19)23)18-11-17(8-7-14(18)2)31(28,29)25-13-22(3,4)27/h7-12,25,27H,5-6,13H2,1-4H3,(H2,23,24) XESSMGMYMDVIMA-UHFFFAOYSA-N 295105 3-(6-Amino-5-(3-propyl isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 8.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295105&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470153 381618199 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563107 CCCc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-5-6-16-10-20(30-26-16)19-9-15(12-24-21(19)23)18-11-17(8-7-14(18)2)31(28,29)25-13-22(3,4)27/h7-12,25,27H,5-6,13H2,1-4H3,(H2,23,24) XESSMGMYMDVIMA-UHFFFAOYSA-N 295105 3-(6-Amino-5-(3-propyl isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 470 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295105&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470153 381618199 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563108 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.29,wD:30.33,(-4.24,5,;-4.24,3.46,;-5.57,2.69,;-5.57,1.15,;-4.24,.38,;-2.91,1.15,;-2.91,2.69,;-1.57,3.46,;-1.57,5,;-.24,5.77,;1.1,5,;2.43,5.77,;1.1,3.46,;-.24,2.69,;2.43,2.69,;2.43,1.15,;3.89,.68,;4.8,1.92,;3.89,3.17,;4.29,-.81,;5.78,-1.21,;3.2,-1.9,;4.69,-2.3,;-4.24,-1.15,;-2.7,-1.16,;-5.78,-1.15,;-4.24,-2.69,;-2.91,-3.46,;-1.57,-2.69,;-.24,-3.46,;-.24,-5,;1.1,-5.77,;-1.57,-5.77,;-2.91,-5,)| InChI=1S/C25H32N4O4S/c1-15-5-10-19(34(31,32)29-17-6-8-18(30)9-7-17)12-20(15)16-11-21(24(26)27-14-16)22-13-23(28-33-22)25(2,3)4/h5,10-14,17-18,29-30H,6-9H2,1-4H3,(H2,26,27) GLWWXTJSWUKLBH-UHFFFAOYSA-N 295106 trans-3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(−4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.2 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 270 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295106&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472286 381618200 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563109 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.29,wD:30.33,(-4.24,5,;-4.24,3.46,;-5.57,2.69,;-5.57,1.15,;-4.24,.38,;-2.91,1.15,;-2.91,2.69,;-1.57,3.46,;-1.57,5,;-.24,5.77,;1.1,5,;2.43,5.77,;1.1,3.46,;-.24,2.69,;2.43,2.69,;2.43,1.15,;3.89,.68,;4.8,1.92,;3.89,3.17,;4.29,-.81,;5.78,-1.21,;3.2,-1.9,;4.69,-2.3,;-4.24,-1.15,;-2.7,-1.16,;-5.78,-1.15,;-4.24,-2.69,;-2.91,-3.46,;-1.57,-2.69,;-.24,-3.46,;-.24,-5,;1.1,-5.77,;-1.57,-5.77,;-2.91,-5,)| InChI=1S/C25H32N4O4S/c1-15-5-10-19(34(31,32)29-17-6-8-18(30)9-7-17)12-20(15)16-11-21(24(26)27-14-16)22-13-23(28-33-22)25(2,3)4/h5,10-14,17-18,29-30H,6-9H2,1-4H3,(H2,26,27) GLWWXTJSWUKLBH-UHFFFAOYSA-N 295106 trans-3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(−4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295106&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472286 381618200 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563110 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.29,wD:30.33,(-4.24,5,;-4.24,3.46,;-5.57,2.69,;-5.57,1.15,;-4.24,.38,;-2.91,1.15,;-2.91,2.69,;-1.57,3.46,;-1.57,5,;-.24,5.77,;1.1,5,;2.43,5.77,;1.1,3.46,;-.24,2.69,;2.43,2.69,;2.43,1.15,;3.89,.68,;4.8,1.92,;3.89,3.17,;4.29,-.81,;5.78,-1.21,;3.2,-1.9,;4.69,-2.3,;-4.24,-1.15,;-2.7,-1.16,;-5.78,-1.15,;-4.24,-2.69,;-2.91,-3.46,;-1.57,-2.69,;-.24,-3.46,;-.24,-5,;1.1,-5.77,;-1.57,-5.77,;-2.91,-5,)| InChI=1S/C25H32N4O4S/c1-15-5-10-19(34(31,32)29-17-6-8-18(30)9-7-17)12-20(15)16-11-21(24(26)27-14-16)22-13-23(28-33-22)25(2,3)4/h5,10-14,17-18,29-30H,6-9H2,1-4H3,(H2,26,27) GLWWXTJSWUKLBH-UHFFFAOYSA-N 295106 trans-3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(−4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.2 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295106&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472286 381618200 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563111 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.29,wD:30.33,(-4.24,5,;-4.24,3.46,;-5.57,2.69,;-5.57,1.15,;-4.24,.38,;-2.91,1.15,;-2.91,2.69,;-1.57,3.46,;-1.57,5,;-.24,5.77,;1.1,5,;2.43,5.77,;1.1,3.46,;-.24,2.69,;2.43,2.69,;2.43,1.15,;3.89,.68,;4.8,1.92,;3.89,3.17,;4.29,-.81,;5.78,-1.21,;3.2,-1.9,;4.69,-2.3,;-4.24,-1.15,;-2.7,-1.16,;-5.78,-1.15,;-4.24,-2.69,;-2.91,-3.46,;-1.57,-2.69,;-.24,-3.46,;-.24,-5,;1.1,-5.77,;-1.57,-5.77,;-2.91,-5,)| InChI=1S/C25H32N4O4S/c1-15-5-10-19(34(31,32)29-17-6-8-18(30)9-7-17)12-20(15)16-11-21(24(26)27-14-16)22-13-23(28-33-22)25(2,3)4/h5,10-14,17-18,29-30H,6-9H2,1-4H3,(H2,26,27) GLWWXTJSWUKLBH-UHFFFAOYSA-N 295106 trans-3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(−4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.2 Phosphatidylinositol 4-kinase beta Human 630 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295106&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472286 381618200 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563112 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.29,wD:30.33,(-4.24,5,;-4.24,3.46,;-5.57,2.69,;-5.57,1.15,;-4.24,.38,;-2.91,1.15,;-2.91,2.69,;-1.57,3.46,;-1.57,5,;-.24,5.77,;1.1,5,;2.43,5.77,;1.1,3.46,;-.24,2.69,;2.43,2.69,;2.43,1.15,;3.89,.68,;4.8,1.92,;3.89,3.17,;4.29,-.81,;5.78,-1.21,;3.2,-1.9,;4.69,-2.3,;-4.24,-1.15,;-2.7,-1.16,;-5.78,-1.15,;-4.24,-2.69,;-2.91,-3.46,;-1.57,-2.69,;-.24,-3.46,;-.24,-5,;1.1,-5.77,;-1.57,-5.77,;-2.91,-5,)| InChI=1S/C25H32N4O4S/c1-15-5-10-19(34(31,32)29-17-6-8-18(30)9-7-17)12-20(15)16-11-21(24(26)27-14-16)22-13-23(28-33-22)25(2,3)4/h5,10-14,17-18,29-30H,6-9H2,1-4H3,(H2,26,27) GLWWXTJSWUKLBH-UHFFFAOYSA-N 295106 trans-3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(−4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 9.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295106&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472286 381618200 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563113 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.29,wD:30.33,(-4.24,5,;-4.24,3.46,;-5.57,2.69,;-5.57,1.15,;-4.24,.38,;-2.91,1.15,;-2.91,2.69,;-1.57,3.46,;-1.57,5,;-.24,5.77,;1.1,5,;2.43,5.77,;1.1,3.46,;-.24,2.69,;2.43,2.69,;2.43,1.15,;3.89,.68,;4.8,1.92,;3.89,3.17,;4.29,-.81,;5.78,-1.21,;3.2,-1.9,;4.69,-2.3,;-4.24,-1.15,;-2.7,-1.16,;-5.78,-1.15,;-4.24,-2.69,;-2.91,-3.46,;-1.57,-2.69,;-.24,-3.46,;-.24,-5,;1.1,-5.77,;-1.57,-5.77,;-2.91,-5,)| InChI=1S/C25H32N4O4S/c1-15-5-10-19(34(31,32)29-17-6-8-18(30)9-7-17)12-20(15)16-11-21(24(26)27-14-16)22-13-23(28-33-22)25(2,3)4/h5,10-14,17-18,29-30H,6-9H2,1-4H3,(H2,26,27) GLWWXTJSWUKLBH-UHFFFAOYSA-N 295106 trans-3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(−4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 90.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295106&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472286 381618200 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563114 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)25-12-22(2,3)27)9-17(13)15-8-18(21(23)24-11-15)20-10-19(26-30-20)14-5-6-14/h4,7-11,14,25,27H,5-6,12H2,1-3H3,(H2,23,24) JEJWVLIMIXHYDW-UHFFFAOYSA-N 295107 3-(6-Amino-5-(3-cyclopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.3 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 390 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295107&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470207 381618201 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563115 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)25-12-22(2,3)27)9-17(13)15-8-18(21(23)24-11-15)20-10-19(26-30-20)14-5-6-14/h4,7-11,14,25,27H,5-6,12H2,1-3H3,(H2,23,24) JEJWVLIMIXHYDW-UHFFFAOYSA-N 295107 3-(6-Amino-5-(3-cyclopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295107&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470207 381618201 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563116 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)25-12-22(2,3)27)9-17(13)15-8-18(21(23)24-11-15)20-10-19(26-30-20)14-5-6-14/h4,7-11,14,25,27H,5-6,12H2,1-3H3,(H2,23,24) JEJWVLIMIXHYDW-UHFFFAOYSA-N 295107 3-(6-Amino-5-(3-cyclopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.3 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295107&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470207 381618201 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563117 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)25-12-22(2,3)27)9-17(13)15-8-18(21(23)24-11-15)20-10-19(26-30-20)14-5-6-14/h4,7-11,14,25,27H,5-6,12H2,1-3H3,(H2,23,24) JEJWVLIMIXHYDW-UHFFFAOYSA-N 295107 3-(6-Amino-5-(3-cyclopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.3 Phosphatidylinositol 4-kinase beta Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295107&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470207 381618201 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563118 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)25-12-22(2,3)27)9-17(13)15-8-18(21(23)24-11-15)20-10-19(26-30-20)14-5-6-14/h4,7-11,14,25,27H,5-6,12H2,1-3H3,(H2,23,24) JEJWVLIMIXHYDW-UHFFFAOYSA-N 295107 3-(6-Amino-5-(3-cyclopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 33.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295107&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470207 381618201 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563119 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)25-12-22(2,3)27)9-17(13)15-8-18(21(23)24-11-15)20-10-19(26-30-20)14-5-6-14/h4,7-11,14,25,27H,5-6,12H2,1-3H3,(H2,23,24) JEJWVLIMIXHYDW-UHFFFAOYSA-N 295107 3-(6-Amino-5-(3-cyclopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 590 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295107&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470207 381618201 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563120 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14(2)20-12-21(31-27-20)19-10-16(13-25-22(19)24)18-11-17(7-6-15(18)3)32(29,30)26-9-8-23(4,5)28/h6-7,10-14,26,28H,8-9H2,1-5H3,(H2,24,25) OPVRUFKBBKOABM-UHFFFAOYSA-N 295108 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide::US10112926, Example 35.4 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 180 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295108&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469972 381618202 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563121 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14(2)20-12-21(31-27-20)19-10-16(13-25-22(19)24)18-11-17(7-6-15(18)3)32(29,30)26-9-8-23(4,5)28/h6-7,10-14,26,28H,8-9H2,1-5H3,(H2,24,25) OPVRUFKBBKOABM-UHFFFAOYSA-N 295108 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide::US10112926, Example 35.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295108&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469972 381618202 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563122 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14(2)20-12-21(31-27-20)19-10-16(13-25-22(19)24)18-11-17(7-6-15(18)3)32(29,30)26-9-8-23(4,5)28/h6-7,10-14,26,28H,8-9H2,1-5H3,(H2,24,25) OPVRUFKBBKOABM-UHFFFAOYSA-N 295108 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide::US10112926, Example 35.4 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295108&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469972 381618202 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563123 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14(2)20-12-21(31-27-20)19-10-16(13-25-22(19)24)18-11-17(7-6-15(18)3)32(29,30)26-9-8-23(4,5)28/h6-7,10-14,26,28H,8-9H2,1-5H3,(H2,24,25) OPVRUFKBBKOABM-UHFFFAOYSA-N 295108 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide::US10112926, Example 35.4 Phosphatidylinositol 4-kinase beta Human 1000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295108&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469972 381618202 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563124 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14(2)20-12-21(31-27-20)19-10-16(13-25-22(19)24)18-11-17(7-6-15(18)3)32(29,30)26-9-8-23(4,5)28/h6-7,10-14,26,28H,8-9H2,1-5H3,(H2,24,25) OPVRUFKBBKOABM-UHFFFAOYSA-N 295108 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide::US10112926, Example 35.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 33.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295108&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469972 381618202 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563125 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14(2)20-12-21(31-27-20)19-10-16(13-25-22(19)24)18-11-17(7-6-15(18)3)32(29,30)26-9-8-23(4,5)28/h6-7,10-14,26,28H,8-9H2,1-5H3,(H2,24,25) OPVRUFKBBKOABM-UHFFFAOYSA-N 295108 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide::US10112926, Example 35.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 510 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295108&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469972 381618202 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563126 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14(2)20-12-21(31-27-20)19-10-16(13-25-22(19)24)18-11-17(7-6-15(18)3)32(29,30)26-9-8-23(4,5)28/h6-7,10-14,26,28H,8-9H2,1-5H3,(H2,24,25) OPVRUFKBBKOABM-UHFFFAOYSA-N 295108 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide::US10112926, Example 35.4 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295108&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469972 381618202 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563127 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)NCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14-7-8-16(32(29,30)26-13-23(5,6)28)10-17(14)15-9-18(21(24)25-12-15)19-11-20(27-31-19)22(2,3)4/h7-12,26,28H,13H2,1-6H3,(H2,24,25) SOYILWAGZJGZIJ-UHFFFAOYSA-N 295109 3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.5 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295109&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470340 381618203 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563128 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)NCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14-7-8-16(32(29,30)26-13-23(5,6)28)10-17(14)15-9-18(21(24)25-12-15)19-11-20(27-31-19)22(2,3)4/h7-12,26,28H,13H2,1-6H3,(H2,24,25) SOYILWAGZJGZIJ-UHFFFAOYSA-N 295109 3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 8800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295109&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470340 381618203 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563129 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)NCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14-7-8-16(32(29,30)26-13-23(5,6)28)10-17(14)15-9-18(21(24)25-12-15)19-11-20(27-31-19)22(2,3)4/h7-12,26,28H,13H2,1-6H3,(H2,24,25) SOYILWAGZJGZIJ-UHFFFAOYSA-N 295109 3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.5 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295109&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470340 381618203 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563130 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)NCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14-7-8-16(32(29,30)26-13-23(5,6)28)10-17(14)15-9-18(21(24)25-12-15)19-11-20(27-31-19)22(2,3)4/h7-12,26,28H,13H2,1-6H3,(H2,24,25) SOYILWAGZJGZIJ-UHFFFAOYSA-N 295109 3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.5 Phosphatidylinositol 4-kinase beta Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295109&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470340 381618203 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563131 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)NCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14-7-8-16(32(29,30)26-13-23(5,6)28)10-17(14)15-9-18(21(24)25-12-15)19-11-20(27-31-19)22(2,3)4/h7-12,26,28H,13H2,1-6H3,(H2,24,25) SOYILWAGZJGZIJ-UHFFFAOYSA-N 295109 3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 71.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295109&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470340 381618203 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563132 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(C)(C)C)S(=O)(=O)NCC(C)(C)O InChI=1S/C23H30N4O4S/c1-14-7-8-16(32(29,30)26-13-23(5,6)28)10-17(14)15-9-18(21(24)25-12-15)19-11-20(27-31-19)22(2,3)4/h7-12,26,28H,13H2,1-6H3,(H2,24,25) SOYILWAGZJGZIJ-UHFFFAOYSA-N 295109 3-(6-Amino-5-(3-(tert-butyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 35.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 280 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295109&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470340 381618203 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563133 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-13(2)19-10-20(30-26-19)18-8-15(11-24-21(18)23)17-9-16(7-6-14(17)3)31(28,29)25-12-22(4,5)27/h6-11,13,25,27H,12H2,1-5H3,(H2,23,24) VOZATGBILRZYMT-UHFFFAOYSA-N 295110 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 35.6 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295110&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470549 381618204 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563134 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-13(2)19-10-20(30-26-19)18-8-15(11-24-21(18)23)17-9-16(7-6-14(17)3)31(28,29)25-12-22(4,5)27/h6-11,13,25,27H,12H2,1-5H3,(H2,23,24) VOZATGBILRZYMT-UHFFFAOYSA-N 295110 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 35.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 8000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295110&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470549 381618204 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563135 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-13(2)19-10-20(30-26-19)18-8-15(11-24-21(18)23)17-9-16(7-6-14(17)3)31(28,29)25-12-22(4,5)27/h6-11,13,25,27H,12H2,1-5H3,(H2,23,24) VOZATGBILRZYMT-UHFFFAOYSA-N 295110 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 35.6 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295110&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470549 381618204 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563136 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-13(2)19-10-20(30-26-19)18-8-15(11-24-21(18)23)17-9-16(7-6-14(17)3)31(28,29)25-12-22(4,5)27/h6-11,13,25,27H,12H2,1-5H3,(H2,23,24) VOZATGBILRZYMT-UHFFFAOYSA-N 295110 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 35.6 Phosphatidylinositol 4-kinase beta Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295110&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470549 381618204 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563137 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-13(2)19-10-20(30-26-19)18-8-15(11-24-21(18)23)17-9-16(7-6-14(17)3)31(28,29)25-12-22(4,5)27/h6-11,13,25,27H,12H2,1-5H3,(H2,23,24) VOZATGBILRZYMT-UHFFFAOYSA-N 295110 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 35.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 41.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295110&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470549 381618204 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563138 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-13(2)19-10-20(30-26-19)18-8-15(11-24-21(18)23)17-9-16(7-6-14(17)3)31(28,29)25-12-22(4,5)27/h6-11,13,25,27H,12H2,1-5H3,(H2,23,24) VOZATGBILRZYMT-UHFFFAOYSA-N 295110 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 35.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 540 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295110&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470549 381618204 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563139 CC(C)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H28N4O4S/c1-13(2)19-10-20(30-26-19)18-8-15(11-24-21(18)23)17-9-16(7-6-14(17)3)31(28,29)25-12-22(4,5)27/h6-11,13,25,27H,12H2,1-5H3,(H2,23,24) VOZATGBILRZYMT-UHFFFAOYSA-N 295110 3-(6-Amino-5-(3-isopropylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 35.6 Serine/threonine-protein kinase mTOR Human 6300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295110&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470549 381618204 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563140 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-2.22,-12.05,;-.74,-11.66,;.6,-12.43,;-1.14,-10.17,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295111 cis-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 390 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295111&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618205 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563141 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-2.22,-12.05,;-.74,-11.66,;.6,-12.43,;-1.14,-10.17,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295111 cis-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295111&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618205 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563142 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-2.22,-12.05,;-.74,-11.66,;.6,-12.43,;-1.14,-10.17,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295111 cis-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295111&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618205 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563143 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-2.22,-12.05,;-.74,-11.66,;.6,-12.43,;-1.14,-10.17,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295111 cis-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36a Phosphatidylinositol 4-kinase beta Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295111&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618205 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563144 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-2.22,-12.05,;-.74,-11.66,;.6,-12.43,;-1.14,-10.17,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295111 cis-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 21.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295111&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618205 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563145 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-2.22,-12.05,;-.74,-11.66,;.6,-12.43,;-1.14,-10.17,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295111 cis-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 750 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295111&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618205 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563146 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-1.14,-10.17,;-.74,-11.66,;.6,-12.43,;-2.22,-12.05,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295112 trans-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36b Phosphatidylinositol 3-kinase regulatory subunit alpha Human 260 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295112&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618206 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563147 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-1.14,-10.17,;-.74,-11.66,;.6,-12.43,;-2.22,-12.05,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295112 trans-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295112&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618206 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563148 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-1.14,-10.17,;-.74,-11.66,;.6,-12.43,;-2.22,-12.05,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295112 trans-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36b Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295112&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618206 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563149 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-1.14,-10.17,;-.74,-11.66,;.6,-12.43,;-2.22,-12.05,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295112 trans-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36b Phosphatidylinositol 4-kinase beta Human 960 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295112&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618206 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563150 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-1.14,-10.17,;-.74,-11.66,;.6,-12.43,;-2.22,-12.05,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295112 trans-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 21.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295112&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618206 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563151 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(5.5,-7.2,;4.73,-5.87,;3.19,-5.87,;2.71,-4.41,;3.96,-3.5,;5.2,-4.41,;1.38,-3.64,;.04,-4.41,;-1.29,-3.64,;-1.29,-2.1,;.04,-1.33,;1.38,-2.1,;2.71,-1.33,;-2.62,-4.41,;-2.62,-5.95,;-3.96,-6.72,;-5.29,-5.95,;-5.29,-4.41,;-3.96,-3.64,;-3.96,-2.1,;-3.96,-8.26,;-2.42,-8.26,;-5.5,-8.26,;-3.96,-9.8,;-2.62,-10.57,;-1.14,-10.17,;-.74,-11.66,;.6,-12.43,;-2.22,-12.05,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-7-15(25)8-14)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-28-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) RERZXCUAKWVHPD-UHFFFAOYSA-N 295112 trans-3-(6-aminoamino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 36b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 450 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295112&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470186 381618206 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563152 C[C@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295113 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 37 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 890 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295113&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469855 381618207 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563153 C[C@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295113 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 37 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295113&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469855 381618207 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563154 C[C@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295113 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 37 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295113&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469855 381618207 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563155 C[C@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295113 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 37 Phosphatidylinositol 4-kinase beta Human 3400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295113&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469855 381618207 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563156 C[C@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295113 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 37 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 35.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295113&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469855 381618207 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563157 C[C@H](O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)22-9-13(3)24)8-16(11)14-7-17(19(20)21-10-14)18-6-12(2)23-27-18/h4-8,10,13,22,24H,9H2,1-3H3,(H2,20,21) HFXBHLPRJMROSI-UHFFFAOYSA-N 295113 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide::US10112926, Example 37 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 550 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295113&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469855 381618207 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563158 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)26-13-23(14-28)5-7-31-8-6-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-32-21/h3-4,9-12,26,28H,5-8,13-14H2,1-2H3,(H2,24,25) JNLDJIWAENALOH-UHFFFAOYSA-N 295114 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 340 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295114&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470166 381618208 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563159 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)26-13-23(14-28)5-7-31-8-6-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-32-21/h3-4,9-12,26,28H,5-8,13-14H2,1-2H3,(H2,24,25) JNLDJIWAENALOH-UHFFFAOYSA-N 295114 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295114&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470166 381618208 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563160 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)26-13-23(14-28)5-7-31-8-6-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-32-21/h3-4,9-12,26,28H,5-8,13-14H2,1-2H3,(H2,24,25) JNLDJIWAENALOH-UHFFFAOYSA-N 295114 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295114&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470166 381618208 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563161 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)26-13-23(14-28)5-7-31-8-6-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-32-21/h3-4,9-12,26,28H,5-8,13-14H2,1-2H3,(H2,24,25) JNLDJIWAENALOH-UHFFFAOYSA-N 295114 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.1 Phosphatidylinositol 4-kinase beta Human 3500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295114&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470166 381618208 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563162 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)26-13-23(14-28)5-7-31-8-6-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-32-21/h3-4,9-12,26,28H,5-8,13-14H2,1-2H3,(H2,24,25) JNLDJIWAENALOH-UHFFFAOYSA-N 295114 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human <3.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295114&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470166 381618208 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563163 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)26-13-23(14-28)5-7-31-8-6-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-32-21/h3-4,9-12,26,28H,5-8,13-14H2,1-2H3,(H2,24,25) JNLDJIWAENALOH-UHFFFAOYSA-N 295114 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295114&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470166 381618208 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563164 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)26-13-23(14-28)5-7-31-8-6-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-32-21/h3-4,9-12,26,28H,5-8,13-14H2,1-2H3,(H2,24,25) JNLDJIWAENALOH-UHFFFAOYSA-N 295114 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.1 Serine/threonine-protein kinase mTOR Human 8800 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295114&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470166 381618208 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563165 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C20H23N5O4S/c1-12-5-6-15(30(26,27)25-10-20(3,11-25)28-4)8-16(12)14-7-17(18(21)22-9-14)19-23-13(2)24-29-19/h5-9H,10-11H2,1-4H3,(H2,21,22) BIOXPRCKGAVLPC-UHFFFAOYSA-N 295115 5-(5-((3-Methoxy-3-methylazetidin-1-yl)sulfonyl)-2-methylphenyl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-amine::US10112926, Example 37.2 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295115&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470263 381618209 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563166 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C20H23N5O4S/c1-12-5-6-15(30(26,27)25-10-20(3,11-25)28-4)8-16(12)14-7-17(18(21)22-9-14)19-23-13(2)24-29-19/h5-9H,10-11H2,1-4H3,(H2,21,22) BIOXPRCKGAVLPC-UHFFFAOYSA-N 295115 5-(5-((3-Methoxy-3-methylazetidin-1-yl)sulfonyl)-2-methylphenyl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-amine::US10112926, Example 37.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295115&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470263 381618209 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563167 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C20H23N5O4S/c1-12-5-6-15(30(26,27)25-10-20(3,11-25)28-4)8-16(12)14-7-17(18(21)22-9-14)19-23-13(2)24-29-19/h5-9H,10-11H2,1-4H3,(H2,21,22) BIOXPRCKGAVLPC-UHFFFAOYSA-N 295115 5-(5-((3-Methoxy-3-methylazetidin-1-yl)sulfonyl)-2-methylphenyl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-amine::US10112926, Example 37.2 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295115&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470263 381618209 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563168 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C20H23N5O4S/c1-12-5-6-15(30(26,27)25-10-20(3,11-25)28-4)8-16(12)14-7-17(18(21)22-9-14)19-23-13(2)24-29-19/h5-9H,10-11H2,1-4H3,(H2,21,22) BIOXPRCKGAVLPC-UHFFFAOYSA-N 295115 5-(5-((3-Methoxy-3-methylazetidin-1-yl)sulfonyl)-2-methylphenyl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-amine::US10112926, Example 37.2 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295115&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470263 381618209 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563169 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C20H23N5O4S/c1-12-5-6-15(30(26,27)25-10-20(3,11-25)28-4)8-16(12)14-7-17(18(21)22-9-14)19-23-13(2)24-29-19/h5-9H,10-11H2,1-4H3,(H2,21,22) BIOXPRCKGAVLPC-UHFFFAOYSA-N 295115 5-(5-((3-Methoxy-3-methylazetidin-1-yl)sulfonyl)-2-methylphenyl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-amine::US10112926, Example 37.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human <3.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295115&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470263 381618209 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563170 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C20H23N5O4S/c1-12-5-6-15(30(26,27)25-10-20(3,11-25)28-4)8-16(12)14-7-17(18(21)22-9-14)19-23-13(2)24-29-19/h5-9H,10-11H2,1-4H3,(H2,21,22) BIOXPRCKGAVLPC-UHFFFAOYSA-N 295115 5-(5-((3-Methoxy-3-methylazetidin-1-yl)sulfonyl)-2-methylphenyl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-amine::US10112926, Example 37.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 490 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295115&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470263 381618209 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563171 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C20H23N5O4S/c1-12-5-6-15(30(26,27)25-10-20(3,11-25)28-4)8-16(12)14-7-17(18(21)22-9-14)19-23-13(2)24-29-19/h5-9H,10-11H2,1-4H3,(H2,21,22) BIOXPRCKGAVLPC-UHFFFAOYSA-N 295115 5-(5-((3-Methoxy-3-methylazetidin-1-yl)sulfonyl)-2-methylphenyl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-amine::US10112926, Example 37.2 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295115&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470263 381618209 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563172 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-14-24(15-29)8-4-3-5-9-24)12-20(16)18-11-21(23(25)26-13-18)22-10-17(2)28-32-22/h6-7,10-13,27,29H,3-5,8-9,14-15H2,1-2H3,(H2,25,26) KHCOZIWAEDPGQT-UHFFFAOYSA-N 295116 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclohexyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.3 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 140 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295116&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470519 381618210 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563173 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-14-24(15-29)8-4-3-5-9-24)12-20(16)18-11-21(23(25)26-13-18)22-10-17(2)28-32-22/h6-7,10-13,27,29H,3-5,8-9,14-15H2,1-2H3,(H2,25,26) KHCOZIWAEDPGQT-UHFFFAOYSA-N 295116 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclohexyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295116&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470519 381618210 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563174 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-14-24(15-29)8-4-3-5-9-24)12-20(16)18-11-21(23(25)26-13-18)22-10-17(2)28-32-22/h6-7,10-13,27,29H,3-5,8-9,14-15H2,1-2H3,(H2,25,26) KHCOZIWAEDPGQT-UHFFFAOYSA-N 295116 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclohexyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.3 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295116&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470519 381618210 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563175 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-14-24(15-29)8-4-3-5-9-24)12-20(16)18-11-21(23(25)26-13-18)22-10-17(2)28-32-22/h6-7,10-13,27,29H,3-5,8-9,14-15H2,1-2H3,(H2,25,26) KHCOZIWAEDPGQT-UHFFFAOYSA-N 295116 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclohexyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.3 Phosphatidylinositol 4-kinase beta Human 1800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295116&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470519 381618210 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563176 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-14-24(15-29)8-4-3-5-9-24)12-20(16)18-11-21(23(25)26-13-18)22-10-17(2)28-32-22/h6-7,10-13,27,29H,3-5,8-9,14-15H2,1-2H3,(H2,25,26) KHCOZIWAEDPGQT-UHFFFAOYSA-N 295116 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclohexyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 4.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295116&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470519 381618210 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563177 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-14-24(15-29)8-4-3-5-9-24)12-20(16)18-11-21(23(25)26-13-18)22-10-17(2)28-32-22/h6-7,10-13,27,29H,3-5,8-9,14-15H2,1-2H3,(H2,25,26) KHCOZIWAEDPGQT-UHFFFAOYSA-N 295116 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclohexyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.3 Serine/threonine-protein kinase mTOR Human 3000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295116&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470519 381618210 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563178 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C21H23N5O4S/c1-12-3-4-16(31(28,29)26-15-5-6-23-20(27)9-15)10-17(12)14-8-18(21(22)24-11-14)19-7-13(2)25-30-19/h3-4,7-8,10-11,15,26H,5-6,9H2,1-2H3,(H2,22,24)(H,23,27) PGUDWAVWKFMVMF-UHFFFAOYSA-N 295117 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.4 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 570 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295117&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470065 381618211 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563179 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C21H23N5O4S/c1-12-3-4-16(31(28,29)26-15-5-6-23-20(27)9-15)10-17(12)14-8-18(21(22)24-11-14)19-7-13(2)25-30-19/h3-4,7-8,10-11,15,26H,5-6,9H2,1-2H3,(H2,22,24)(H,23,27) PGUDWAVWKFMVMF-UHFFFAOYSA-N 295117 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295117&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470065 381618211 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563180 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C21H23N5O4S/c1-12-3-4-16(31(28,29)26-15-5-6-23-20(27)9-15)10-17(12)14-8-18(21(22)24-11-14)19-7-13(2)25-30-19/h3-4,7-8,10-11,15,26H,5-6,9H2,1-2H3,(H2,22,24)(H,23,27) PGUDWAVWKFMVMF-UHFFFAOYSA-N 295117 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.4 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295117&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470065 381618211 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563181 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C21H23N5O4S/c1-12-3-4-16(31(28,29)26-15-5-6-23-20(27)9-15)10-17(12)14-8-18(21(22)24-11-14)19-7-13(2)25-30-19/h3-4,7-8,10-11,15,26H,5-6,9H2,1-2H3,(H2,22,24)(H,23,27) PGUDWAVWKFMVMF-UHFFFAOYSA-N 295117 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.4 Phosphatidylinositol 4-kinase beta Human 2400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295117&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470065 381618211 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563182 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C21H23N5O4S/c1-12-3-4-16(31(28,29)26-15-5-6-23-20(27)9-15)10-17(12)14-8-18(21(22)24-11-14)19-7-13(2)25-30-19/h3-4,7-8,10-11,15,26H,5-6,9H2,1-2H3,(H2,22,24)(H,23,27) PGUDWAVWKFMVMF-UHFFFAOYSA-N 295117 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 13.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295117&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470065 381618211 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563183 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C21H23N5O4S/c1-12-3-4-16(31(28,29)26-15-5-6-23-20(27)9-15)10-17(12)14-8-18(21(22)24-11-14)19-7-13(2)25-30-19/h3-4,7-8,10-11,15,26H,5-6,9H2,1-2H3,(H2,22,24)(H,23,27) PGUDWAVWKFMVMF-UHFFFAOYSA-N 295117 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295117&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470065 381618211 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563184 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCO1 |r| InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295118 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.5 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 160 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295118&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469819 381618212 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563185 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCO1 |r| InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295118 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295118&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469819 381618212 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563186 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCO1 |r| InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295118 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.5 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295118&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469819 381618212 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563187 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCO1 |r| InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295118 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.5 Phosphatidylinositol 4-kinase beta Human 8000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295118&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469819 381618212 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563188 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCO1 |r| InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295118 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 18.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295118&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469819 381618212 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563189 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCCO1 |r| InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295118 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 270 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295118&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469819 381618212 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563190 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C22H26N4O4S/c1-14-4-5-17(31(28,29)25-12-22(13-27)6-3-7-22)10-18(14)16-9-19(21(23)24-11-16)20-8-15(2)26-30-20/h4-5,8-11,25,27H,3,6-7,12-13H2,1-2H3,(H2,23,24) FZJSJVSWAKSDTQ-UHFFFAOYSA-N 295119 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.6 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 250 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295119&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512409 381618213 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563191 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C22H26N4O4S/c1-14-4-5-17(31(28,29)25-12-22(13-27)6-3-7-22)10-18(14)16-9-19(21(23)24-11-16)20-8-15(2)26-30-20/h4-5,8-11,25,27H,3,6-7,12-13H2,1-2H3,(H2,23,24) FZJSJVSWAKSDTQ-UHFFFAOYSA-N 295119 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295119&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512409 381618213 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563192 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C22H26N4O4S/c1-14-4-5-17(31(28,29)25-12-22(13-27)6-3-7-22)10-18(14)16-9-19(21(23)24-11-16)20-8-15(2)26-30-20/h4-5,8-11,25,27H,3,6-7,12-13H2,1-2H3,(H2,23,24) FZJSJVSWAKSDTQ-UHFFFAOYSA-N 295119 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.6 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295119&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512409 381618213 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563193 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C22H26N4O4S/c1-14-4-5-17(31(28,29)25-12-22(13-27)6-3-7-22)10-18(14)16-9-19(21(23)24-11-16)20-8-15(2)26-30-20/h4-5,8-11,25,27H,3,6-7,12-13H2,1-2H3,(H2,23,24) FZJSJVSWAKSDTQ-UHFFFAOYSA-N 295119 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.6 Phosphatidylinositol 4-kinase beta Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295119&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512409 381618213 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563194 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C22H26N4O4S/c1-14-4-5-17(31(28,29)25-12-22(13-27)6-3-7-22)10-18(14)16-9-19(21(23)24-11-16)20-8-15(2)26-30-20/h4-5,8-11,25,27H,3,6-7,12-13H2,1-2H3,(H2,23,24) FZJSJVSWAKSDTQ-UHFFFAOYSA-N 295119 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 27.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295119&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512409 381618213 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563195 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C22H26N4O4S/c1-14-4-5-17(31(28,29)25-12-22(13-27)6-3-7-22)10-18(14)16-9-19(21(23)24-11-16)20-8-15(2)26-30-20/h4-5,8-11,25,27H,3,6-7,12-13H2,1-2H3,(H2,23,24) FZJSJVSWAKSDTQ-UHFFFAOYSA-N 295119 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 380 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295119&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512409 381618213 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563196 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-11-21(3,4)12-26)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)25-29-19/h5-10,24,26H,11-12H2,1-4H3,(H2,22,23) XNXYCERJHJYNDT-UHFFFAOYSA-N 295120 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.7 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 470 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295120&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470428 381618214 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563197 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-11-21(3,4)12-26)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)25-29-19/h5-10,24,26H,11-12H2,1-4H3,(H2,22,23) XNXYCERJHJYNDT-UHFFFAOYSA-N 295120 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295120&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470428 381618214 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563198 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-11-21(3,4)12-26)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)25-29-19/h5-10,24,26H,11-12H2,1-4H3,(H2,22,23) XNXYCERJHJYNDT-UHFFFAOYSA-N 295120 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.7 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295120&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470428 381618214 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563199 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-11-21(3,4)12-26)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)25-29-19/h5-10,24,26H,11-12H2,1-4H3,(H2,22,23) XNXYCERJHJYNDT-UHFFFAOYSA-N 295120 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.7 Phosphatidylinositol 4-kinase beta Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295120&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470428 381618214 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563200 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-11-21(3,4)12-26)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)25-29-19/h5-10,24,26H,11-12H2,1-4H3,(H2,22,23) XNXYCERJHJYNDT-UHFFFAOYSA-N 295120 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 32.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295120&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470428 381618214 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563201 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)24-11-21(3,4)12-26)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)25-29-19/h5-10,24,26H,11-12H2,1-4H3,(H2,22,23) XNXYCERJHJYNDT-UHFFFAOYSA-N 295120 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295120&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470428 381618214 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563202 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)25-16-5-7-28-8-6-16)11-18(13)15-10-19(21(22)23-12-15)20-9-14(2)24-29-20/h3-4,9-12,16,25H,5-8H2,1-2H3,(H2,22,23) GIJQCKAFIZEMCM-UHFFFAOYSA-N 295121 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 37.8 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295121&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470447 381618215 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563203 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)25-16-5-7-28-8-6-16)11-18(13)15-10-19(21(22)23-12-15)20-9-14(2)24-29-20/h3-4,9-12,16,25H,5-8H2,1-2H3,(H2,22,23) GIJQCKAFIZEMCM-UHFFFAOYSA-N 295121 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 37.8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295121&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470447 381618215 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563204 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)25-16-5-7-28-8-6-16)11-18(13)15-10-19(21(22)23-12-15)20-9-14(2)24-29-20/h3-4,9-12,16,25H,5-8H2,1-2H3,(H2,22,23) GIJQCKAFIZEMCM-UHFFFAOYSA-N 295121 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 37.8 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295121&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470447 381618215 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563205 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)25-16-5-7-28-8-6-16)11-18(13)15-10-19(21(22)23-12-15)20-9-14(2)24-29-20/h3-4,9-12,16,25H,5-8H2,1-2H3,(H2,22,23) GIJQCKAFIZEMCM-UHFFFAOYSA-N 295121 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 37.8 Phosphatidylinositol 4-kinase beta Human 5700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295121&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470447 381618215 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563206 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)25-16-5-7-28-8-6-16)11-18(13)15-10-19(21(22)23-12-15)20-9-14(2)24-29-20/h3-4,9-12,16,25H,5-8H2,1-2H3,(H2,22,23) GIJQCKAFIZEMCM-UHFFFAOYSA-N 295121 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 37.8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 33.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295121&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470447 381618215 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563207 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)25-16-5-7-28-8-6-16)11-18(13)15-10-19(21(22)23-12-15)20-9-14(2)24-29-20/h3-4,9-12,16,25H,5-8H2,1-2H3,(H2,22,23) GIJQCKAFIZEMCM-UHFFFAOYSA-N 295121 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 37.8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 450 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295121&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470447 381618215 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563208 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)25-16-5-7-28-8-6-16)11-18(13)15-10-19(21(22)23-12-15)20-9-14(2)24-29-20/h3-4,9-12,16,25H,5-8H2,1-2H3,(H2,22,23) GIJQCKAFIZEMCM-UHFFFAOYSA-N 295121 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 37.8 Serine/threonine-protein kinase mTOR Human 6400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295121&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470447 381618215 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563209 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCCC1 InChI=1S/C23H28N4O4S/c1-15-6-7-18(32(29,30)26-14-23(28)8-4-3-5-9-23)12-19(15)17-11-20(22(24)25-13-17)21-10-16(2)27-31-21/h6-7,10-13,26,28H,3-5,8-9,14H2,1-2H3,(H2,24,25) JOWHQAYXFVOIIS-UHFFFAOYSA-N 295122 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclohexyl)methyl)-4-methylbenzenesulfonamide: diethyl ether (1:1::US10112926, Example 37.9 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 150 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295122&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470293 381618216 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563210 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCCC1 InChI=1S/C23H28N4O4S/c1-15-6-7-18(32(29,30)26-14-23(28)8-4-3-5-9-23)12-19(15)17-11-20(22(24)25-13-17)21-10-16(2)27-31-21/h6-7,10-13,26,28H,3-5,8-9,14H2,1-2H3,(H2,24,25) JOWHQAYXFVOIIS-UHFFFAOYSA-N 295122 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclohexyl)methyl)-4-methylbenzenesulfonamide: diethyl ether (1:1::US10112926, Example 37.9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 470 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295122&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470293 381618216 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563211 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCCC1 InChI=1S/C23H28N4O4S/c1-15-6-7-18(32(29,30)26-14-23(28)8-4-3-5-9-23)12-19(15)17-11-20(22(24)25-13-17)21-10-16(2)27-31-21/h6-7,10-13,26,28H,3-5,8-9,14H2,1-2H3,(H2,24,25) JOWHQAYXFVOIIS-UHFFFAOYSA-N 295122 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclohexyl)methyl)-4-methylbenzenesulfonamide: diethyl ether (1:1::US10112926, Example 37.9 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295122&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470293 381618216 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563212 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCCC1 InChI=1S/C23H28N4O4S/c1-15-6-7-18(32(29,30)26-14-23(28)8-4-3-5-9-23)12-19(15)17-11-20(22(24)25-13-17)21-10-16(2)27-31-21/h6-7,10-13,26,28H,3-5,8-9,14H2,1-2H3,(H2,24,25) JOWHQAYXFVOIIS-UHFFFAOYSA-N 295122 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclohexyl)methyl)-4-methylbenzenesulfonamide: diethyl ether (1:1::US10112926, Example 37.9 Phosphatidylinositol 4-kinase beta Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295122&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470293 381618216 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563213 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCCC1 InChI=1S/C23H28N4O4S/c1-15-6-7-18(32(29,30)26-14-23(28)8-4-3-5-9-23)12-19(15)17-11-20(22(24)25-13-17)21-10-16(2)27-31-21/h6-7,10-13,26,28H,3-5,8-9,14H2,1-2H3,(H2,24,25) JOWHQAYXFVOIIS-UHFFFAOYSA-N 295122 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclohexyl)methyl)-4-methylbenzenesulfonamide: diethyl ether (1:1::US10112926, Example 37.9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 43.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295122&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470293 381618216 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563214 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCCC1 InChI=1S/C23H28N4O4S/c1-15-6-7-18(32(29,30)26-14-23(28)8-4-3-5-9-23)12-19(15)17-11-20(22(24)25-13-17)21-10-16(2)27-31-21/h6-7,10-13,26,28H,3-5,8-9,14H2,1-2H3,(H2,24,25) JOWHQAYXFVOIIS-UHFFFAOYSA-N 295122 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclohexyl)methyl)-4-methylbenzenesulfonamide: diethyl ether (1:1::US10112926, Example 37.9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 180 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295122&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470293 381618216 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563215 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C22H27N5O5S/c1-14-3-4-17(33(29,30)25-12-22(13-28)5-7-31-8-6-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-32-21/h3-4,9-11,25,28H,5-8,12-13H2,1-2H3,(H2,23,24) YPEHJQSANCKVPH-UHFFFAOYSA-N 295123 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.10 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 560 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295123&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470498 381618217 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563216 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C22H27N5O5S/c1-14-3-4-17(33(29,30)25-12-22(13-28)5-7-31-8-6-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-32-21/h3-4,9-11,25,28H,5-8,12-13H2,1-2H3,(H2,23,24) YPEHJQSANCKVPH-UHFFFAOYSA-N 295123 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 9100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295123&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470498 381618217 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563217 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C22H27N5O5S/c1-14-3-4-17(33(29,30)25-12-22(13-28)5-7-31-8-6-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-32-21/h3-4,9-11,25,28H,5-8,12-13H2,1-2H3,(H2,23,24) YPEHJQSANCKVPH-UHFFFAOYSA-N 295123 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.10 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295123&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470498 381618217 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563218 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C22H27N5O5S/c1-14-3-4-17(33(29,30)25-12-22(13-28)5-7-31-8-6-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-32-21/h3-4,9-11,25,28H,5-8,12-13H2,1-2H3,(H2,23,24) YPEHJQSANCKVPH-UHFFFAOYSA-N 295123 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.10 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295123&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470498 381618217 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563219 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C22H27N5O5S/c1-14-3-4-17(33(29,30)25-12-22(13-28)5-7-31-8-6-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-32-21/h3-4,9-11,25,28H,5-8,12-13H2,1-2H3,(H2,23,24) YPEHJQSANCKVPH-UHFFFAOYSA-N 295123 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 43.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295123&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470498 381618217 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563220 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C22H27N5O5S/c1-14-3-4-17(33(29,30)25-12-22(13-28)5-7-31-8-6-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-32-21/h3-4,9-11,25,28H,5-8,12-13H2,1-2H3,(H2,23,24) YPEHJQSANCKVPH-UHFFFAOYSA-N 295123 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295123&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470498 381618217 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563221 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-10-9-22(28)7-3-4-8-22)12-18(14)16-11-19(20(23)24-13-16)21-26-15(2)27-31-21/h5-6,11-13,25,28H,3-4,7-10H2,1-2H3,(H2,23,24) FGCNFUVIPKIWLZ-UHFFFAOYSA-N 295124 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.11 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 190 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295124&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470095 381618218 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563222 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-10-9-22(28)7-3-4-8-22)12-18(14)16-11-19(20(23)24-13-16)21-26-15(2)27-31-21/h5-6,11-13,25,28H,3-4,7-10H2,1-2H3,(H2,23,24) FGCNFUVIPKIWLZ-UHFFFAOYSA-N 295124 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.11 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295124&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470095 381618218 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563223 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-10-9-22(28)7-3-4-8-22)12-18(14)16-11-19(20(23)24-13-16)21-26-15(2)27-31-21/h5-6,11-13,25,28H,3-4,7-10H2,1-2H3,(H2,23,24) FGCNFUVIPKIWLZ-UHFFFAOYSA-N 295124 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.11 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295124&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470095 381618218 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563224 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-10-9-22(28)7-3-4-8-22)12-18(14)16-11-19(20(23)24-13-16)21-26-15(2)27-31-21/h5-6,11-13,25,28H,3-4,7-10H2,1-2H3,(H2,23,24) FGCNFUVIPKIWLZ-UHFFFAOYSA-N 295124 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.11 Phosphatidylinositol 4-kinase beta Human 8100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295124&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470095 381618218 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563225 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-10-9-22(28)7-3-4-8-22)12-18(14)16-11-19(20(23)24-13-16)21-26-15(2)27-31-21/h5-6,11-13,25,28H,3-4,7-10H2,1-2H3,(H2,23,24) FGCNFUVIPKIWLZ-UHFFFAOYSA-N 295124 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.11 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 46.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295124&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470095 381618218 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563226 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-10-9-22(28)7-3-4-8-22)12-18(14)16-11-19(20(23)24-13-16)21-26-15(2)27-31-21/h5-6,11-13,25,28H,3-4,7-10H2,1-2H3,(H2,23,24) FGCNFUVIPKIWLZ-UHFFFAOYSA-N 295124 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.11 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295124&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470095 381618218 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563227 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-10-9-22(28)7-3-4-8-22)12-18(14)16-11-19(20(23)24-13-16)21-26-15(2)27-31-21/h5-6,11-13,25,28H,3-4,7-10H2,1-2H3,(H2,23,24) FGCNFUVIPKIWLZ-UHFFFAOYSA-N 295124 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.11 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295124&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470095 381618218 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563228 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-9-14(10-24)11-25)7-17(12)15-6-18(20(21)22-8-15)19-5-13(2)23-28-19/h3-8,14,25H,9-11H2,1-2H3,(H2,21,22) PZCVZMZNFNNIED-UHFFFAOYSA-N 295125 (1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.12 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 810 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295125&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470006 381618219 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563229 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-9-14(10-24)11-25)7-17(12)15-6-18(20(21)22-8-15)19-5-13(2)23-28-19/h3-8,14,25H,9-11H2,1-2H3,(H2,21,22) PZCVZMZNFNNIED-UHFFFAOYSA-N 295125 (1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295125&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470006 381618219 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563230 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-9-14(10-24)11-25)7-17(12)15-6-18(20(21)22-8-15)19-5-13(2)23-28-19/h3-8,14,25H,9-11H2,1-2H3,(H2,21,22) PZCVZMZNFNNIED-UHFFFAOYSA-N 295125 (1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.12 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295125&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470006 381618219 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563231 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-9-14(10-24)11-25)7-17(12)15-6-18(20(21)22-8-15)19-5-13(2)23-28-19/h3-8,14,25H,9-11H2,1-2H3,(H2,21,22) PZCVZMZNFNNIED-UHFFFAOYSA-N 295125 (1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.12 Phosphatidylinositol 4-kinase beta Human 3400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295125&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470006 381618219 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563232 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-9-14(10-24)11-25)7-17(12)15-6-18(20(21)22-8-15)19-5-13(2)23-28-19/h3-8,14,25H,9-11H2,1-2H3,(H2,21,22) PZCVZMZNFNNIED-UHFFFAOYSA-N 295125 (1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 60.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295125&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470006 381618219 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563233 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-9-14(10-24)11-25)7-17(12)15-6-18(20(21)22-8-15)19-5-13(2)23-28-19/h3-8,14,25H,9-11H2,1-2H3,(H2,21,22) PZCVZMZNFNNIED-UHFFFAOYSA-N 295125 (1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295125&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470006 381618219 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563234 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-12-22(13-28)7-3-4-8-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-31-21/h5-6,9-11,25,28H,3-4,7-8,12-13H2,1-2H3,(H2,23,24) ZHCDLCRIENFSJA-UHFFFAOYSA-N 295126 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.13 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 350 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295126&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470244 381618220 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563235 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-12-22(13-28)7-3-4-8-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-31-21/h5-6,9-11,25,28H,3-4,7-8,12-13H2,1-2H3,(H2,23,24) ZHCDLCRIENFSJA-UHFFFAOYSA-N 295126 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295126&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470244 381618220 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563236 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-12-22(13-28)7-3-4-8-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-31-21/h5-6,9-11,25,28H,3-4,7-8,12-13H2,1-2H3,(H2,23,24) ZHCDLCRIENFSJA-UHFFFAOYSA-N 295126 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.13 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295126&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470244 381618220 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563237 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-12-22(13-28)7-3-4-8-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-31-21/h5-6,9-11,25,28H,3-4,7-8,12-13H2,1-2H3,(H2,23,24) ZHCDLCRIENFSJA-UHFFFAOYSA-N 295126 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.13 Phosphatidylinositol 4-kinase beta Human 5000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295126&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470244 381618220 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563238 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-12-22(13-28)7-3-4-8-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-31-21/h5-6,9-11,25,28H,3-4,7-8,12-13H2,1-2H3,(H2,23,24) ZHCDLCRIENFSJA-UHFFFAOYSA-N 295126 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 63.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295126&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470244 381618220 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563239 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-12-22(13-28)7-3-4-8-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-31-21/h5-6,9-11,25,28H,3-4,7-8,12-13H2,1-2H3,(H2,23,24) ZHCDLCRIENFSJA-UHFFFAOYSA-N 295126 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295126&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470244 381618220 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563240 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C22H27N5O4S/c1-14-5-6-17(32(29,30)25-12-22(13-28)7-3-4-8-22)10-18(14)16-9-19(20(23)24-11-16)21-26-15(2)27-31-21/h5-6,9-11,25,28H,3-4,7-8,12-13H2,1-2H3,(H2,23,24) ZHCDLCRIENFSJA-UHFFFAOYSA-N 295126 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.13 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295126&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470244 381618220 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563241 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C19H19F3N4O3S/c1-11-3-4-14(30(27,28)25-6-5-19(20,21)22)9-15(11)13-8-16(18(23)24-10-13)17-7-12(2)26-29-17/h3-4,7-10,25H,5-6H2,1-2H3,(H2,23,24) CSEABPPVRHZLAB-UHFFFAOYSA-N 295127 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 37.14 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 360 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295127&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470120 381618221 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563242 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C19H19F3N4O3S/c1-11-3-4-14(30(27,28)25-6-5-19(20,21)22)9-15(11)13-8-16(18(23)24-10-13)17-7-12(2)26-29-17/h3-4,7-10,25H,5-6H2,1-2H3,(H2,23,24) CSEABPPVRHZLAB-UHFFFAOYSA-N 295127 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 37.14 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295127&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470120 381618221 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563243 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C19H19F3N4O3S/c1-11-3-4-14(30(27,28)25-6-5-19(20,21)22)9-15(11)13-8-16(18(23)24-10-13)17-7-12(2)26-29-17/h3-4,7-10,25H,5-6H2,1-2H3,(H2,23,24) CSEABPPVRHZLAB-UHFFFAOYSA-N 295127 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 37.14 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295127&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470120 381618221 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563244 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C19H19F3N4O3S/c1-11-3-4-14(30(27,28)25-6-5-19(20,21)22)9-15(11)13-8-16(18(23)24-10-13)17-7-12(2)26-29-17/h3-4,7-10,25H,5-6H2,1-2H3,(H2,23,24) CSEABPPVRHZLAB-UHFFFAOYSA-N 295127 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 37.14 Phosphatidylinositol 4-kinase beta Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295127&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470120 381618221 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563245 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C19H19F3N4O3S/c1-11-3-4-14(30(27,28)25-6-5-19(20,21)22)9-15(11)13-8-16(18(23)24-10-13)17-7-12(2)26-29-17/h3-4,7-10,25H,5-6H2,1-2H3,(H2,23,24) CSEABPPVRHZLAB-UHFFFAOYSA-N 295127 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 37.14 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 71.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295127&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470120 381618221 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563246 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C19H19F3N4O3S/c1-11-3-4-14(30(27,28)25-6-5-19(20,21)22)9-15(11)13-8-16(18(23)24-10-13)17-7-12(2)26-29-17/h3-4,7-10,25H,5-6H2,1-2H3,(H2,23,24) CSEABPPVRHZLAB-UHFFFAOYSA-N 295127 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 37.14 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 40.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295127&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470120 381618221 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563247 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(27,28)23-11-20(26)6-3-7-20)9-16(12)14-8-17(18(21)22-10-14)19-24-13(2)25-29-19/h4-5,8-10,23,26H,3,6-7,11H2,1-2H3,(H2,21,22) QVDJLTAGQFKKBG-UHFFFAOYSA-N 295128 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.15 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 290 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295128&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470516 381618222 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563248 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(27,28)23-11-20(26)6-3-7-20)9-16(12)14-8-17(18(21)22-10-14)19-24-13(2)25-29-19/h4-5,8-10,23,26H,3,6-7,11H2,1-2H3,(H2,21,22) QVDJLTAGQFKKBG-UHFFFAOYSA-N 295128 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295128&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470516 381618222 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563249 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(27,28)23-11-20(26)6-3-7-20)9-16(12)14-8-17(18(21)22-10-14)19-24-13(2)25-29-19/h4-5,8-10,23,26H,3,6-7,11H2,1-2H3,(H2,21,22) QVDJLTAGQFKKBG-UHFFFAOYSA-N 295128 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.15 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295128&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470516 381618222 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563250 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(27,28)23-11-20(26)6-3-7-20)9-16(12)14-8-17(18(21)22-10-14)19-24-13(2)25-29-19/h4-5,8-10,23,26H,3,6-7,11H2,1-2H3,(H2,21,22) QVDJLTAGQFKKBG-UHFFFAOYSA-N 295128 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.15 Phosphatidylinositol 4-kinase beta Human 5400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295128&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470516 381618222 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563251 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(27,28)23-11-20(26)6-3-7-20)9-16(12)14-8-17(18(21)22-10-14)19-24-13(2)25-29-19/h4-5,8-10,23,26H,3,6-7,11H2,1-2H3,(H2,21,22) QVDJLTAGQFKKBG-UHFFFAOYSA-N 295128 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 78.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295128&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470516 381618222 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563252 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(27,28)23-11-20(26)6-3-7-20)9-16(12)14-8-17(18(21)22-10-14)19-24-13(2)25-29-19/h4-5,8-10,23,26H,3,6-7,11H2,1-2H3,(H2,21,22) QVDJLTAGQFKKBG-UHFFFAOYSA-N 295128 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 160 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295128&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470516 381618222 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563253 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C20H23N5O4S/c1-12-4-5-15(30(27,28)23-11-20(26)6-3-7-20)9-16(12)14-8-17(18(21)22-10-14)19-24-13(2)25-29-19/h4-5,8-10,23,26H,3,6-7,11H2,1-2H3,(H2,21,22) QVDJLTAGQFKKBG-UHFFFAOYSA-N 295128 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.15 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295128&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470516 381618222 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563254 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-10-9-23(28)7-3-4-8-23)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)27-31-21/h5-6,11-14,26,28H,3-4,7-10H2,1-2H3,(H2,24,25) NOCNKNHXOANVQW-UHFFFAOYSA-N 295129 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.16 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 70.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295129&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469872 381618223 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563255 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-10-9-23(28)7-3-4-8-23)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)27-31-21/h5-6,11-14,26,28H,3-4,7-10H2,1-2H3,(H2,24,25) NOCNKNHXOANVQW-UHFFFAOYSA-N 295129 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295129&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469872 381618223 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563256 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-10-9-23(28)7-3-4-8-23)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)27-31-21/h5-6,11-14,26,28H,3-4,7-10H2,1-2H3,(H2,24,25) NOCNKNHXOANVQW-UHFFFAOYSA-N 295129 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.16 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295129&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469872 381618223 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563257 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-10-9-23(28)7-3-4-8-23)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)27-31-21/h5-6,11-14,26,28H,3-4,7-10H2,1-2H3,(H2,24,25) NOCNKNHXOANVQW-UHFFFAOYSA-N 295129 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.16 Phosphatidylinositol 4-kinase beta Human 900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295129&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469872 381618223 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563258 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-10-9-23(28)7-3-4-8-23)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)27-31-21/h5-6,11-14,26,28H,3-4,7-10H2,1-2H3,(H2,24,25) NOCNKNHXOANVQW-UHFFFAOYSA-N 295129 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 86.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295129&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469872 381618223 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563259 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-10-9-23(28)7-3-4-8-23)13-19(15)17-12-20(22(24)25-14-17)21-11-16(2)27-31-21/h5-6,11-14,26,28H,3-4,7-10H2,1-2H3,(H2,24,25) NOCNKNHXOANVQW-UHFFFAOYSA-N 295129 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclopentyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 40.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295129&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469872 381618223 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563260 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(F)(F)C1 InChI=1S/C19H19F2N5O3S/c1-10-3-4-14(30(27,28)26-13-7-19(20,21)8-13)6-15(10)12-5-16(17(22)23-9-12)18-24-11(2)25-29-18/h3-6,9,13,26H,7-8H2,1-2H3,(H2,22,23) QYTCVRUYMRUORC-UHFFFAOYSA-N 295130 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3,3-difluorocyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 37.17 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 470 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295130&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470328 381618224 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563261 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(F)(F)C1 InChI=1S/C19H19F2N5O3S/c1-10-3-4-14(30(27,28)26-13-7-19(20,21)8-13)6-15(10)12-5-16(17(22)23-9-12)18-24-11(2)25-29-18/h3-6,9,13,26H,7-8H2,1-2H3,(H2,22,23) QYTCVRUYMRUORC-UHFFFAOYSA-N 295130 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3,3-difluorocyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 37.17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295130&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470328 381618224 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563262 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(F)(F)C1 InChI=1S/C19H19F2N5O3S/c1-10-3-4-14(30(27,28)26-13-7-19(20,21)8-13)6-15(10)12-5-16(17(22)23-9-12)18-24-11(2)25-29-18/h3-6,9,13,26H,7-8H2,1-2H3,(H2,22,23) QYTCVRUYMRUORC-UHFFFAOYSA-N 295130 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3,3-difluorocyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 37.17 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295130&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470328 381618224 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563263 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(F)(F)C1 InChI=1S/C19H19F2N5O3S/c1-10-3-4-14(30(27,28)26-13-7-19(20,21)8-13)6-15(10)12-5-16(17(22)23-9-12)18-24-11(2)25-29-18/h3-6,9,13,26H,7-8H2,1-2H3,(H2,22,23) QYTCVRUYMRUORC-UHFFFAOYSA-N 295130 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3,3-difluorocyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 37.17 Phosphatidylinositol 4-kinase beta Human 8600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295130&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470328 381618224 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563264 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(F)(F)C1 InChI=1S/C19H19F2N5O3S/c1-10-3-4-14(30(27,28)26-13-7-19(20,21)8-13)6-15(10)12-5-16(17(22)23-9-12)18-24-11(2)25-29-18/h3-6,9,13,26H,7-8H2,1-2H3,(H2,22,23) QYTCVRUYMRUORC-UHFFFAOYSA-N 295130 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3,3-difluorocyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 37.17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 100.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295130&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470328 381618224 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563265 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(F)(F)C1 InChI=1S/C19H19F2N5O3S/c1-10-3-4-14(30(27,28)26-13-7-19(20,21)8-13)6-15(10)12-5-16(17(22)23-9-12)18-24-11(2)25-29-18/h3-6,9,13,26H,7-8H2,1-2H3,(H2,22,23) QYTCVRUYMRUORC-UHFFFAOYSA-N 295130 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3,3-difluorocyclobutyl)-4-methylbenzenesulfonamide::US10112926, Example 37.17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 450 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295130&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470328 381618224 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563266 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-10-20(3,4)11-26)8-16(12)14-7-17(18(21)22-9-14)19-24-13(2)25-29-19/h5-9,23,26H,10-11H2,1-4H3,(H2,21,22) UZMJFTQPNNCVLQ-UHFFFAOYSA-N 295131 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 37.18 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 470 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295131&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470172 381618225 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563267 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-10-20(3,4)11-26)8-16(12)14-7-17(18(21)22-9-14)19-24-13(2)25-29-19/h5-9,23,26H,10-11H2,1-4H3,(H2,21,22) UZMJFTQPNNCVLQ-UHFFFAOYSA-N 295131 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 37.18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 220 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295131&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470172 381618225 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563268 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-10-20(3,4)11-26)8-16(12)14-7-17(18(21)22-9-14)19-24-13(2)25-29-19/h5-9,23,26H,10-11H2,1-4H3,(H2,21,22) UZMJFTQPNNCVLQ-UHFFFAOYSA-N 295131 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 37.18 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295131&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470172 381618225 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563269 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-10-20(3,4)11-26)8-16(12)14-7-17(18(21)22-9-14)19-24-13(2)25-29-19/h5-9,23,26H,10-11H2,1-4H3,(H2,21,22) UZMJFTQPNNCVLQ-UHFFFAOYSA-N 295131 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 37.18 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295131&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470172 381618225 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563270 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-10-20(3,4)11-26)8-16(12)14-7-17(18(21)22-9-14)19-24-13(2)25-29-19/h5-9,23,26H,10-11H2,1-4H3,(H2,21,22) UZMJFTQPNNCVLQ-UHFFFAOYSA-N 295131 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 37.18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 110 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295131&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470172 381618225 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563271 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-10-20(3,4)11-26)8-16(12)14-7-17(18(21)22-9-14)19-24-13(2)25-29-19/h5-9,23,26H,10-11H2,1-4H3,(H2,21,22) UZMJFTQPNNCVLQ-UHFFFAOYSA-N 295131 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 37.18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 410 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295131&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470172 381618225 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563272 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C20H25N5O4S/c1-12-5-6-15(30(27,28)23-10-20(3,4)11-26)8-16(12)14-7-17(18(21)22-9-14)19-24-13(2)25-29-19/h5-9,23,26H,10-11H2,1-4H3,(H2,21,22) UZMJFTQPNNCVLQ-UHFFFAOYSA-N 295131 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 37.18 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295131&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470172 381618225 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563273 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C19H21N5O4S/c1-11-3-4-14(29(26,27)22-10-19(25)5-6-19)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h3-4,7-9,22,25H,5-6,10H2,1-2H3,(H2,20,21) QJTXTYURFBJYHR-UHFFFAOYSA-N 295132 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopropyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.19 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 540 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295132&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470107 381618226 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563274 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C19H21N5O4S/c1-11-3-4-14(29(26,27)22-10-19(25)5-6-19)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h3-4,7-9,22,25H,5-6,10H2,1-2H3,(H2,20,21) QJTXTYURFBJYHR-UHFFFAOYSA-N 295132 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopropyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295132&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470107 381618226 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563275 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C19H21N5O4S/c1-11-3-4-14(29(26,27)22-10-19(25)5-6-19)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h3-4,7-9,22,25H,5-6,10H2,1-2H3,(H2,20,21) QJTXTYURFBJYHR-UHFFFAOYSA-N 295132 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopropyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.19 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295132&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470107 381618226 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563276 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C19H21N5O4S/c1-11-3-4-14(29(26,27)22-10-19(25)5-6-19)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h3-4,7-9,22,25H,5-6,10H2,1-2H3,(H2,20,21) QJTXTYURFBJYHR-UHFFFAOYSA-N 295132 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopropyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.19 Phosphatidylinositol 4-kinase beta Human 8600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295132&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470107 381618226 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563277 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C19H21N5O4S/c1-11-3-4-14(29(26,27)22-10-19(25)5-6-19)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h3-4,7-9,22,25H,5-6,10H2,1-2H3,(H2,20,21) QJTXTYURFBJYHR-UHFFFAOYSA-N 295132 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopropyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 120 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295132&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470107 381618226 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563278 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C19H21N5O4S/c1-11-3-4-14(29(26,27)22-10-19(25)5-6-19)8-15(11)13-7-16(17(20)21-9-13)18-23-12(2)24-28-18/h3-4,7-9,22,25H,5-6,10H2,1-2H3,(H2,20,21) QJTXTYURFBJYHR-UHFFFAOYSA-N 295132 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopropyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 460 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295132&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470107 381618226 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563279 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H24N4O4S/c1-13-5-6-16(30(26,27)25-11-21(3,12-25)28-4)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)24-29-19/h5-10H,11-12H2,1-4H3,(H2,22,23) JMQJBDQCZXNOKS-UHFFFAOYSA-N 295133 5-(5-((3-Methoxy-3-methylazetidin-yl)sulfonyl)-2-methylphenyl)-3-(3-methylisoxazol-5-yl)pyridin-2-amine::US10112926, Example 37.20 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295133&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470461 381618227 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563280 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H24N4O4S/c1-13-5-6-16(30(26,27)25-11-21(3,12-25)28-4)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)24-29-19/h5-10H,11-12H2,1-4H3,(H2,22,23) JMQJBDQCZXNOKS-UHFFFAOYSA-N 295133 5-(5-((3-Methoxy-3-methylazetidin-yl)sulfonyl)-2-methylphenyl)-3-(3-methylisoxazol-5-yl)pyridin-2-amine::US10112926, Example 37.20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 9000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295133&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470461 381618227 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563281 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H24N4O4S/c1-13-5-6-16(30(26,27)25-11-21(3,12-25)28-4)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)24-29-19/h5-10H,11-12H2,1-4H3,(H2,22,23) JMQJBDQCZXNOKS-UHFFFAOYSA-N 295133 5-(5-((3-Methoxy-3-methylazetidin-yl)sulfonyl)-2-methylphenyl)-3-(3-methylisoxazol-5-yl)pyridin-2-amine::US10112926, Example 37.20 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295133&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470461 381618227 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563282 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H24N4O4S/c1-13-5-6-16(30(26,27)25-11-21(3,12-25)28-4)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)24-29-19/h5-10H,11-12H2,1-4H3,(H2,22,23) JMQJBDQCZXNOKS-UHFFFAOYSA-N 295133 5-(5-((3-Methoxy-3-methylazetidin-yl)sulfonyl)-2-methylphenyl)-3-(3-methylisoxazol-5-yl)pyridin-2-amine::US10112926, Example 37.20 Phosphatidylinositol 4-kinase beta Human 5100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295133&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470461 381618227 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563283 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H24N4O4S/c1-13-5-6-16(30(26,27)25-11-21(3,12-25)28-4)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)24-29-19/h5-10H,11-12H2,1-4H3,(H2,22,23) JMQJBDQCZXNOKS-UHFFFAOYSA-N 295133 5-(5-((3-Methoxy-3-methylazetidin-yl)sulfonyl)-2-methylphenyl)-3-(3-methylisoxazol-5-yl)pyridin-2-amine::US10112926, Example 37.20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 130 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295133&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470461 381618227 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563284 COC1(C)CN(C1)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C21H24N4O4S/c1-13-5-6-16(30(26,27)25-11-21(3,12-25)28-4)9-17(13)15-8-18(20(22)23-10-15)19-7-14(2)24-29-19/h5-10H,11-12H2,1-4H3,(H2,22,23) JMQJBDQCZXNOKS-UHFFFAOYSA-N 295133 5-(5-((3-Methoxy-3-methylazetidin-yl)sulfonyl)-2-methylphenyl)-3-(3-methylisoxazol-5-yl)pyridin-2-amine::US10112926, Example 37.20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295133&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470461 381618227 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563285 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C1CCOC1 InChI=1S/C21H25N5O5S/c1-12-3-4-16(32(28,29)26-19(10-27)14-5-6-30-11-14)8-17(12)15-7-18(20(22)23-9-15)21-24-13(2)25-31-21/h3-4,7-9,14,19,26-27H,5-6,10-11H2,1-2H3,(H2,22,23) ROXJBMKRTXMVDP-UHFFFAOYSA-N 295134 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-1-(tetrahydrofuran-3-yl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.21 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295134&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470456 381618228 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563286 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C1CCOC1 InChI=1S/C21H25N5O5S/c1-12-3-4-16(32(28,29)26-19(10-27)14-5-6-30-11-14)8-17(12)15-7-18(20(22)23-9-15)21-24-13(2)25-31-21/h3-4,7-9,14,19,26-27H,5-6,10-11H2,1-2H3,(H2,22,23) ROXJBMKRTXMVDP-UHFFFAOYSA-N 295134 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-1-(tetrahydrofuran-3-yl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.21 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295134&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470456 381618228 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563287 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C1CCOC1 InChI=1S/C21H25N5O5S/c1-12-3-4-16(32(28,29)26-19(10-27)14-5-6-30-11-14)8-17(12)15-7-18(20(22)23-9-15)21-24-13(2)25-31-21/h3-4,7-9,14,19,26-27H,5-6,10-11H2,1-2H3,(H2,22,23) ROXJBMKRTXMVDP-UHFFFAOYSA-N 295134 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-1-(tetrahydrofuran-3-yl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.21 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295134&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470456 381618228 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563288 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C1CCOC1 InChI=1S/C21H25N5O5S/c1-12-3-4-16(32(28,29)26-19(10-27)14-5-6-30-11-14)8-17(12)15-7-18(20(22)23-9-15)21-24-13(2)25-31-21/h3-4,7-9,14,19,26-27H,5-6,10-11H2,1-2H3,(H2,22,23) ROXJBMKRTXMVDP-UHFFFAOYSA-N 295134 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-1-(tetrahydrofuran-3-yl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.21 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295134&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470456 381618228 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563289 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C1CCOC1 InChI=1S/C21H25N5O5S/c1-12-3-4-16(32(28,29)26-19(10-27)14-5-6-30-11-14)8-17(12)15-7-18(20(22)23-9-15)21-24-13(2)25-31-21/h3-4,7-9,14,19,26-27H,5-6,10-11H2,1-2H3,(H2,22,23) ROXJBMKRTXMVDP-UHFFFAOYSA-N 295134 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-1-(tetrahydrofuran-3-yl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.21 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 120 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295134&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470456 381618228 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563290 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C1CCOC1 InChI=1S/C21H25N5O5S/c1-12-3-4-16(32(28,29)26-19(10-27)14-5-6-30-11-14)8-17(12)15-7-18(20(22)23-9-15)21-24-13(2)25-31-21/h3-4,7-9,14,19,26-27H,5-6,10-11H2,1-2H3,(H2,22,23) ROXJBMKRTXMVDP-UHFFFAOYSA-N 295134 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-1-(tetrahydrofuran-3-yl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.21 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 990 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295134&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470456 381618228 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563291 CON(C)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-11-5-6-14(27(23,24)22(3)25-4)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)21-26-17/h5-10H,1-4H3,(H2,19,20) HNIRNZFINBZQJF-UHFFFAOYSA-N 295135 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-methoxy-N,4-dimethylbenzenesulfonamide::US10112926, Example 37.22 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 620 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295135&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469971 381618229 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563292 CON(C)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-11-5-6-14(27(23,24)22(3)25-4)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)21-26-17/h5-10H,1-4H3,(H2,19,20) HNIRNZFINBZQJF-UHFFFAOYSA-N 295135 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-methoxy-N,4-dimethylbenzenesulfonamide::US10112926, Example 37.22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295135&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469971 381618229 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563293 CON(C)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-11-5-6-14(27(23,24)22(3)25-4)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)21-26-17/h5-10H,1-4H3,(H2,19,20) HNIRNZFINBZQJF-UHFFFAOYSA-N 295135 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-methoxy-N,4-dimethylbenzenesulfonamide::US10112926, Example 37.22 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295135&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469971 381618229 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563294 CON(C)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-11-5-6-14(27(23,24)22(3)25-4)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)21-26-17/h5-10H,1-4H3,(H2,19,20) HNIRNZFINBZQJF-UHFFFAOYSA-N 295135 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-methoxy-N,4-dimethylbenzenesulfonamide::US10112926, Example 37.22 Phosphatidylinositol 4-kinase beta Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295135&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469971 381618229 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563295 CON(C)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-11-5-6-14(27(23,24)22(3)25-4)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)21-26-17/h5-10H,1-4H3,(H2,19,20) HNIRNZFINBZQJF-UHFFFAOYSA-N 295135 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-methoxy-N,4-dimethylbenzenesulfonamide::US10112926, Example 37.22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 150 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295135&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469971 381618229 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563296 CON(C)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C18H20N4O4S/c1-11-5-6-14(27(23,24)22(3)25-4)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)21-26-17/h5-10H,1-4H3,(H2,19,20) HNIRNZFINBZQJF-UHFFFAOYSA-N 295135 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-methoxy-N,4-dimethylbenzenesulfonamide::US10112926, Example 37.22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 460 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295135&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469971 381618229 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563297 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-13-23(14-28)7-3-4-8-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-31-21/h5-6,9-12,26,28H,3-4,7-8,13-14H2,1-2H3,(H2,24,25) LNSXRVPUHIMMHI-UHFFFAOYSA-N 295136 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl) methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.23 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 130 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295136&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470224 381618230 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563298 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-13-23(14-28)7-3-4-8-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-31-21/h5-6,9-12,26,28H,3-4,7-8,13-14H2,1-2H3,(H2,24,25) LNSXRVPUHIMMHI-UHFFFAOYSA-N 295136 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl) methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.23 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295136&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470224 381618230 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563299 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-13-23(14-28)7-3-4-8-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-31-21/h5-6,9-12,26,28H,3-4,7-8,13-14H2,1-2H3,(H2,24,25) LNSXRVPUHIMMHI-UHFFFAOYSA-N 295136 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl) methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.23 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295136&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470224 381618230 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563300 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-13-23(14-28)7-3-4-8-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-31-21/h5-6,9-12,26,28H,3-4,7-8,13-14H2,1-2H3,(H2,24,25) LNSXRVPUHIMMHI-UHFFFAOYSA-N 295136 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl) methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.23 Phosphatidylinositol 4-kinase beta Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295136&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470224 381618230 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563301 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-13-23(14-28)7-3-4-8-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-31-21/h5-6,9-12,26,28H,3-4,7-8,13-14H2,1-2H3,(H2,24,25) LNSXRVPUHIMMHI-UHFFFAOYSA-N 295136 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl) methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.23 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 160 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295136&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470224 381618230 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563302 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCCC1 InChI=1S/C23H28N4O4S/c1-15-5-6-18(32(29,30)26-13-23(14-28)7-3-4-8-23)11-19(15)17-10-20(22(24)25-12-17)21-9-16(2)27-31-21/h5-6,9-12,26,28H,3-4,7-8,13-14H2,1-2H3,(H2,24,25) LNSXRVPUHIMMHI-UHFFFAOYSA-N 295136 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclopentyl) methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.23 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 360 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295136&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470224 381618230 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563303 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@@H](O)C1 |r| InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-6-5-15(25)11-24)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-28-19/h3-4,7-10,15,25H,5-6,11H2,1-2H3,(H2,21,22) UYUQXTRYWZDXQI-UHFFFAOYSA-N 295137 (R)-1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol::US10112926, Example 37.24 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295137&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470046 381618231 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563304 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@@H](O)C1 |r| InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-6-5-15(25)11-24)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-28-19/h3-4,7-10,15,25H,5-6,11H2,1-2H3,(H2,21,22) UYUQXTRYWZDXQI-UHFFFAOYSA-N 295137 (R)-1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol::US10112926, Example 37.24 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295137&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470046 381618231 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563305 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@@H](O)C1 |r| InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-6-5-15(25)11-24)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-28-19/h3-4,7-10,15,25H,5-6,11H2,1-2H3,(H2,21,22) UYUQXTRYWZDXQI-UHFFFAOYSA-N 295137 (R)-1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol::US10112926, Example 37.24 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295137&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470046 381618231 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563306 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@@H](O)C1 |r| InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-6-5-15(25)11-24)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-28-19/h3-4,7-10,15,25H,5-6,11H2,1-2H3,(H2,21,22) UYUQXTRYWZDXQI-UHFFFAOYSA-N 295137 (R)-1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol::US10112926, Example 37.24 Phosphatidylinositol 4-kinase beta Human 2900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295137&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470046 381618231 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563307 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@@H](O)C1 |r| InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-6-5-15(25)11-24)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-28-19/h3-4,7-10,15,25H,5-6,11H2,1-2H3,(H2,21,22) UYUQXTRYWZDXQI-UHFFFAOYSA-N 295137 (R)-1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol::US10112926, Example 37.24 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295137&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470046 381618231 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563308 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@@H](O)C1 |r| InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(26,27)24-6-5-15(25)11-24)9-17(12)14-8-18(20(21)22-10-14)19-7-13(2)23-28-19/h3-4,7-10,15,25H,5-6,11H2,1-2H3,(H2,21,22) UYUQXTRYWZDXQI-UHFFFAOYSA-N 295137 (R)-1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol::US10112926, Example 37.24 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 510 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295137&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470046 381618231 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563309 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C20H22N6O4S/c1-11-3-4-15(31(28,29)26-14-5-6-22-18(27)8-14)9-16(11)13-7-17(19(21)23-10-13)20-24-12(2)25-30-20/h3-4,7,9-10,14,26H,5-6,8H2,1-2H3,(H2,21,23)(H,22,27) LCCAWGQTDWUOCE-UHFFFAOYSA-N 295138 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.25 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 3800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295138&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470393 381618232 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563310 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C20H22N6O4S/c1-11-3-4-15(31(28,29)26-14-5-6-22-18(27)8-14)9-16(11)13-7-17(19(21)23-10-13)20-24-12(2)25-30-20/h3-4,7,9-10,14,26H,5-6,8H2,1-2H3,(H2,21,23)(H,22,27) LCCAWGQTDWUOCE-UHFFFAOYSA-N 295138 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.25 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295138&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470393 381618232 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563311 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C20H22N6O4S/c1-11-3-4-15(31(28,29)26-14-5-6-22-18(27)8-14)9-16(11)13-7-17(19(21)23-10-13)20-24-12(2)25-30-20/h3-4,7,9-10,14,26H,5-6,8H2,1-2H3,(H2,21,23)(H,22,27) LCCAWGQTDWUOCE-UHFFFAOYSA-N 295138 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.25 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295138&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470393 381618232 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563312 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C20H22N6O4S/c1-11-3-4-15(31(28,29)26-14-5-6-22-18(27)8-14)9-16(11)13-7-17(19(21)23-10-13)20-24-12(2)25-30-20/h3-4,7,9-10,14,26H,5-6,8H2,1-2H3,(H2,21,23)(H,22,27) LCCAWGQTDWUOCE-UHFFFAOYSA-N 295138 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.25 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295138&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470393 381618232 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563313 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C20H22N6O4S/c1-11-3-4-15(31(28,29)26-14-5-6-22-18(27)8-14)9-16(11)13-7-17(19(21)23-10-13)20-24-12(2)25-30-20/h3-4,7,9-10,14,26H,5-6,8H2,1-2H3,(H2,21,23)(H,22,27) LCCAWGQTDWUOCE-UHFFFAOYSA-N 295138 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.25 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 220 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295138&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470393 381618232 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563314 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C20H22N6O4S/c1-11-3-4-15(31(28,29)26-14-5-6-22-18(27)8-14)9-16(11)13-7-17(19(21)23-10-13)20-24-12(2)25-30-20/h3-4,7,9-10,14,26H,5-6,8H2,1-2H3,(H2,21,23)(H,22,27) LCCAWGQTDWUOCE-UHFFFAOYSA-N 295138 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.25 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1800 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295138&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470393 381618232 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563315 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1CCNC(=O)C1 |r| InChI=1S/C20H22N6O4S/c1-11-3-4-15(31(28,29)26-14-5-6-22-18(27)8-14)9-16(11)13-7-17(19(21)23-10-13)20-24-12(2)25-30-20/h3-4,7,9-10,14,26H,5-6,8H2,1-2H3,(H2,21,23)(H,22,27) LCCAWGQTDWUOCE-UHFFFAOYSA-N 295138 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(2-oxopiperidin-4-yl)benzenesulfonamide::US10112926, Example 37.25 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295138&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470393 381618232 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563316 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C21H25N5O4S/c1-13-4-5-16(31(28,29)24-11-21(12-27)6-3-7-21)9-17(13)15-8-18(19(22)23-10-15)20-25-14(2)26-30-20/h4-5,8-10,24,27H,3,6-7,11-12H2,1-2H3,(H2,22,23) SZFASTIWCGYNMP-UHFFFAOYSA-N 295139 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.26 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 720 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295139&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470455 381618233 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563317 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C21H25N5O4S/c1-13-4-5-16(31(28,29)24-11-21(12-27)6-3-7-21)9-17(13)15-8-18(19(22)23-10-15)20-25-14(2)26-30-20/h4-5,8-10,24,27H,3,6-7,11-12H2,1-2H3,(H2,22,23) SZFASTIWCGYNMP-UHFFFAOYSA-N 295139 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.26 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295139&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470455 381618233 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563318 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C21H25N5O4S/c1-13-4-5-16(31(28,29)24-11-21(12-27)6-3-7-21)9-17(13)15-8-18(19(22)23-10-15)20-25-14(2)26-30-20/h4-5,8-10,24,27H,3,6-7,11-12H2,1-2H3,(H2,22,23) SZFASTIWCGYNMP-UHFFFAOYSA-N 295139 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.26 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295139&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470455 381618233 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563319 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C21H25N5O4S/c1-13-4-5-16(31(28,29)24-11-21(12-27)6-3-7-21)9-17(13)15-8-18(19(22)23-10-15)20-25-14(2)26-30-20/h4-5,8-10,24,27H,3,6-7,11-12H2,1-2H3,(H2,22,23) SZFASTIWCGYNMP-UHFFFAOYSA-N 295139 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.26 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295139&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470455 381618233 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563320 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C21H25N5O4S/c1-13-4-5-16(31(28,29)24-11-21(12-27)6-3-7-21)9-17(13)15-8-18(19(22)23-10-15)20-25-14(2)26-30-20/h4-5,8-10,24,27H,3,6-7,11-12H2,1-2H3,(H2,22,23) SZFASTIWCGYNMP-UHFFFAOYSA-N 295139 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.26 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 280 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295139&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470455 381618233 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563321 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C21H25N5O4S/c1-13-4-5-16(31(28,29)24-11-21(12-27)6-3-7-21)9-17(13)15-8-18(19(22)23-10-15)20-25-14(2)26-30-20/h4-5,8-10,24,27H,3,6-7,11-12H2,1-2H3,(H2,22,23) SZFASTIWCGYNMP-UHFFFAOYSA-N 295139 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.26 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295139&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470455 381618233 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563322 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCC1 InChI=1S/C21H25N5O4S/c1-13-4-5-16(31(28,29)24-11-21(12-27)6-3-7-21)9-17(13)15-8-18(19(22)23-10-15)20-25-14(2)26-30-20/h4-5,8-10,24,27H,3,6-7,11-12H2,1-2H3,(H2,22,23) SZFASTIWCGYNMP-UHFFFAOYSA-N 295139 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1-(hydroxymethyl)cyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.26 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295139&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470455 381618233 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563323 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563324 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563325 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563326 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human 4800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563327 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 290 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563328 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 120 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563329 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(C)(O)C1 InChI=1S/C20H22N4O4S/c1-12-4-5-15(29(26,27)24-10-20(3,25)11-24)8-16(12)14-7-17(19(21)22-9-14)18-6-13(2)23-28-18/h4-9,25H,10-11H2,1-3H3,(H2,21,22) MLVFRXVGQAOUEK-UHFFFAOYSA-N 295141 1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-3-methylazetidin-3-ol::US10112926, Example 37.28 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 580 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295141&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470330 381618235 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563330 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(C)(O)C1 InChI=1S/C20H22N4O4S/c1-12-4-5-15(29(26,27)24-10-20(3,25)11-24)8-16(12)14-7-17(19(21)22-9-14)18-6-13(2)23-28-18/h4-9,25H,10-11H2,1-3H3,(H2,21,22) MLVFRXVGQAOUEK-UHFFFAOYSA-N 295141 1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-3-methylazetidin-3-ol::US10112926, Example 37.28 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295141&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470330 381618235 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563331 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(C)(O)C1 InChI=1S/C20H22N4O4S/c1-12-4-5-15(29(26,27)24-10-20(3,25)11-24)8-16(12)14-7-17(19(21)22-9-14)18-6-13(2)23-28-18/h4-9,25H,10-11H2,1-3H3,(H2,21,22) MLVFRXVGQAOUEK-UHFFFAOYSA-N 295141 1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-3-methylazetidin-3-ol::US10112926, Example 37.28 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295141&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470330 381618235 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563332 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(C)(O)C1 InChI=1S/C20H22N4O4S/c1-12-4-5-15(29(26,27)24-10-20(3,25)11-24)8-16(12)14-7-17(19(21)22-9-14)18-6-13(2)23-28-18/h4-9,25H,10-11H2,1-3H3,(H2,21,22) MLVFRXVGQAOUEK-UHFFFAOYSA-N 295141 1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-3-methylazetidin-3-ol::US10112926, Example 37.28 Phosphatidylinositol 4-kinase beta Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295141&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470330 381618235 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563333 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(C)(O)C1 InChI=1S/C20H22N4O4S/c1-12-4-5-15(29(26,27)24-10-20(3,25)11-24)8-16(12)14-7-17(19(21)22-9-14)18-6-13(2)23-28-18/h4-9,25H,10-11H2,1-3H3,(H2,21,22) MLVFRXVGQAOUEK-UHFFFAOYSA-N 295141 1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-3-methylazetidin-3-ol::US10112926, Example 37.28 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 310 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295141&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470330 381618235 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563334 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(C)(O)C1 InChI=1S/C20H22N4O4S/c1-12-4-5-15(29(26,27)24-10-20(3,25)11-24)8-16(12)14-7-17(19(21)22-9-14)18-6-13(2)23-28-18/h4-9,25H,10-11H2,1-3H3,(H2,21,22) MLVFRXVGQAOUEK-UHFFFAOYSA-N 295141 1-((3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-3-methylazetidin-3-ol::US10112926, Example 37.28 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 640 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295141&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470330 381618235 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563335 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCN InChI=1S/C17H20N6O3S/c1-10-3-4-13(27(24,25)21-6-5-18)8-14(10)12-7-15(16(19)20-9-12)17-22-11(2)23-26-17/h3-4,7-9,21H,5-6,18H2,1-2H3,(H2,19,20) MERXYOJXPZEPTO-UHFFFAOYSA-N 295142 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-aminoethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.29 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 910 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295142&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470073 381618236 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563336 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCN InChI=1S/C17H20N6O3S/c1-10-3-4-13(27(24,25)21-6-5-18)8-14(10)12-7-15(16(19)20-9-12)17-22-11(2)23-26-17/h3-4,7-9,21H,5-6,18H2,1-2H3,(H2,19,20) MERXYOJXPZEPTO-UHFFFAOYSA-N 295142 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-aminoethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.29 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 910 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295142&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470073 381618236 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563337 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCN InChI=1S/C17H20N6O3S/c1-10-3-4-13(27(24,25)21-6-5-18)8-14(10)12-7-15(16(19)20-9-12)17-22-11(2)23-26-17/h3-4,7-9,21H,5-6,18H2,1-2H3,(H2,19,20) MERXYOJXPZEPTO-UHFFFAOYSA-N 295142 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-aminoethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.29 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295142&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470073 381618236 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563338 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCN InChI=1S/C17H20N6O3S/c1-10-3-4-13(27(24,25)21-6-5-18)8-14(10)12-7-15(16(19)20-9-12)17-22-11(2)23-26-17/h3-4,7-9,21H,5-6,18H2,1-2H3,(H2,19,20) MERXYOJXPZEPTO-UHFFFAOYSA-N 295142 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-aminoethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.29 Phosphatidylinositol 4-kinase beta Human 7100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295142&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470073 381618236 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563339 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCN InChI=1S/C17H20N6O3S/c1-10-3-4-13(27(24,25)21-6-5-18)8-14(10)12-7-15(16(19)20-9-12)17-22-11(2)23-26-17/h3-4,7-9,21H,5-6,18H2,1-2H3,(H2,19,20) MERXYOJXPZEPTO-UHFFFAOYSA-N 295142 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-aminoethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.29 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 350 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295142&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470073 381618236 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563340 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCN InChI=1S/C17H20N6O3S/c1-10-3-4-13(27(24,25)21-6-5-18)8-14(10)12-7-15(16(19)20-9-12)17-22-11(2)23-26-17/h3-4,7-9,21H,5-6,18H2,1-2H3,(H2,19,20) MERXYOJXPZEPTO-UHFFFAOYSA-N 295142 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-aminoethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.29 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 610 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295142&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470073 381618236 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563341 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCN InChI=1S/C17H20N6O3S/c1-10-3-4-13(27(24,25)21-6-5-18)8-14(10)12-7-15(16(19)20-9-12)17-22-11(2)23-26-17/h3-4,7-9,21H,5-6,18H2,1-2H3,(H2,19,20) MERXYOJXPZEPTO-UHFFFAOYSA-N 295142 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-aminoethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.29 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295142&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470073 381618236 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563342 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-11-10-24(29)8-4-3-5-9-24)14-20(16)18-13-21(23(25)26-15-18)22-12-17(2)28-32-22/h6-7,12-15,27,29H,3-5,8-11H2,1-2H3,(H2,25,26) GIIGINYWJBYLIW-UHFFFAOYSA-N 295143 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.30 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 100.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295143&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470028 381618237 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563343 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-11-10-24(29)8-4-3-5-9-24)14-20(16)18-13-21(23(25)26-15-18)22-12-17(2)28-32-22/h6-7,12-15,27,29H,3-5,8-11H2,1-2H3,(H2,25,26) GIIGINYWJBYLIW-UHFFFAOYSA-N 295143 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.30 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295143&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470028 381618237 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563344 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-11-10-24(29)8-4-3-5-9-24)14-20(16)18-13-21(23(25)26-15-18)22-12-17(2)28-32-22/h6-7,12-15,27,29H,3-5,8-11H2,1-2H3,(H2,25,26) GIIGINYWJBYLIW-UHFFFAOYSA-N 295143 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.30 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295143&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470028 381618237 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563345 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-11-10-24(29)8-4-3-5-9-24)14-20(16)18-13-21(23(25)26-15-18)22-12-17(2)28-32-22/h6-7,12-15,27,29H,3-5,8-11H2,1-2H3,(H2,25,26) GIIGINYWJBYLIW-UHFFFAOYSA-N 295143 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.30 Phosphatidylinositol 4-kinase beta Human 1900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295143&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470028 381618237 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563346 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-11-10-24(29)8-4-3-5-9-24)14-20(16)18-13-21(23(25)26-15-18)22-12-17(2)28-32-22/h6-7,12-15,27,29H,3-5,8-11H2,1-2H3,(H2,25,26) GIIGINYWJBYLIW-UHFFFAOYSA-N 295143 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.30 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 620 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295143&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470028 381618237 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563347 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C24H30N4O4S/c1-16-6-7-19(33(30,31)27-11-10-24(29)8-4-3-5-9-24)14-20(16)18-13-21(23(25)26-15-18)22-12-17(2)28-32-22/h6-7,12-15,27,29H,3-5,8-11H2,1-2H3,(H2,25,26) GIIGINYWJBYLIW-UHFFFAOYSA-N 295143 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.30 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 110 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295143&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470028 381618237 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563348 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C23H29N5O4S/c1-15-6-7-18(33(30,31)26-11-10-23(29)8-4-3-5-9-23)13-19(15)17-12-20(21(24)25-14-17)22-27-16(2)28-32-22/h6-7,12-14,26,29H,3-5,8-11H2,1-2H3,(H2,24,25) LPMJWZMKALMHML-UHFFFAOYSA-N 295144 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.31 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 50.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295144&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470119 381618238 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563349 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C23H29N5O4S/c1-15-6-7-18(33(30,31)26-11-10-23(29)8-4-3-5-9-23)13-19(15)17-12-20(21(24)25-14-17)22-27-16(2)28-32-22/h6-7,12-14,26,29H,3-5,8-11H2,1-2H3,(H2,24,25) LPMJWZMKALMHML-UHFFFAOYSA-N 295144 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.31 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295144&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470119 381618238 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563350 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C23H29N5O4S/c1-15-6-7-18(33(30,31)26-11-10-23(29)8-4-3-5-9-23)13-19(15)17-12-20(21(24)25-14-17)22-27-16(2)28-32-22/h6-7,12-14,26,29H,3-5,8-11H2,1-2H3,(H2,24,25) LPMJWZMKALMHML-UHFFFAOYSA-N 295144 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.31 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295144&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470119 381618238 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563351 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C23H29N5O4S/c1-15-6-7-18(33(30,31)26-11-10-23(29)8-4-3-5-9-23)13-19(15)17-12-20(21(24)25-14-17)22-27-16(2)28-32-22/h6-7,12-14,26,29H,3-5,8-11H2,1-2H3,(H2,24,25) LPMJWZMKALMHML-UHFFFAOYSA-N 295144 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.31 Phosphatidylinositol 4-kinase beta Human 6200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295144&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470119 381618238 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563352 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C23H29N5O4S/c1-15-6-7-18(33(30,31)26-11-10-23(29)8-4-3-5-9-23)13-19(15)17-12-20(21(24)25-14-17)22-27-16(2)28-32-22/h6-7,12-14,26,29H,3-5,8-11H2,1-2H3,(H2,24,25) LPMJWZMKALMHML-UHFFFAOYSA-N 295144 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.31 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 690 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295144&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470119 381618238 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563353 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC1(O)CCCCC1 InChI=1S/C23H29N5O4S/c1-15-6-7-18(33(30,31)26-11-10-23(29)8-4-3-5-9-23)13-19(15)17-12-20(21(24)25-14-17)22-27-16(2)28-32-22/h6-7,12-14,26,29H,3-5,8-11H2,1-2H3,(H2,24,25) LPMJWZMKALMHML-UHFFFAOYSA-N 295144 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-(1-hydroxycyclohexyl)ethyl)-4-methylbenzenesulfonamide::US10112926, Example 37.31 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 260 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295144&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470119 381618238 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563354 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@H](O)C1 |r| InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-6-5-14(25)10-24)8-16(11)13-7-17(18(20)21-9-13)19-22-12(2)23-28-19/h3-4,7-9,14,25H,5-6,10H2,1-2H3,(H2,20,21) COTMEPWWKIZGOS-UHFFFAOYSA-N 295145 (S)-1-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol hydrochloride::US10112926, Example 37.32 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295145&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469844 381618239 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563355 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@H](O)C1 |r| InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-6-5-14(25)10-24)8-16(11)13-7-17(18(20)21-9-13)19-22-12(2)23-28-19/h3-4,7-9,14,25H,5-6,10H2,1-2H3,(H2,20,21) COTMEPWWKIZGOS-UHFFFAOYSA-N 295145 (S)-1-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol hydrochloride::US10112926, Example 37.32 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295145&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469844 381618239 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563356 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@H](O)C1 |r| InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-6-5-14(25)10-24)8-16(11)13-7-17(18(20)21-9-13)19-22-12(2)23-28-19/h3-4,7-9,14,25H,5-6,10H2,1-2H3,(H2,20,21) COTMEPWWKIZGOS-UHFFFAOYSA-N 295145 (S)-1-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol hydrochloride::US10112926, Example 37.32 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295145&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469844 381618239 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563357 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@H](O)C1 |r| InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-6-5-14(25)10-24)8-16(11)13-7-17(18(20)21-9-13)19-22-12(2)23-28-19/h3-4,7-9,14,25H,5-6,10H2,1-2H3,(H2,20,21) COTMEPWWKIZGOS-UHFFFAOYSA-N 295145 (S)-1-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol hydrochloride::US10112926, Example 37.32 Phosphatidylinositol 4-kinase beta Human 8500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295145&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469844 381618239 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563358 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@H](O)C1 |r| InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-6-5-14(25)10-24)8-16(11)13-7-17(18(20)21-9-13)19-22-12(2)23-28-19/h3-4,7-9,14,25H,5-6,10H2,1-2H3,(H2,20,21) COTMEPWWKIZGOS-UHFFFAOYSA-N 295145 (S)-1-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol hydrochloride::US10112926, Example 37.32 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295145&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469844 381618239 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563359 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC[C@H](O)C1 |r| InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-6-5-14(25)10-24)8-16(11)13-7-17(18(20)21-9-13)19-22-12(2)23-28-19/h3-4,7-9,14,25H,5-6,10H2,1-2H3,(H2,20,21) COTMEPWWKIZGOS-UHFFFAOYSA-N 295145 (S)-1-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)pyrrolidin-3-ol hydrochloride::US10112926, Example 37.32 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295145&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469844 381618239 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563360 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 2500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563361 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563362 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563363 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563364 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 770 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563365 CCN1CCCC1CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 InChI=1S/C23H29N5O3S/c1-4-28-9-5-6-18(28)14-26-32(29,30)19-8-7-15(2)20(12-19)17-11-21(23(24)25-13-17)22-10-16(3)27-31-22/h7-8,10-13,18,26H,4-6,9,14H2,1-3H3,(H2,24,25) AHSKYQFCDLZLFK-UHFFFAOYSA-N 295140 US10112926, Example 37.27::US10112926, Example 37.33::(R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-ethyl pyrrolidin-2-yl)methyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 180 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295140&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470042 381618234 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563366 CC(C)N1CCC(CC1)NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C23H30N6O3S/c1-14(2)29-9-7-18(8-10-29)28-33(30,31)19-6-5-15(3)20(12-19)17-11-21(22(24)25-13-17)23-26-16(4)27-32-23/h5-6,11-14,18,28H,7-10H2,1-4H3,(H2,24,25) SAFGWNVSWGGPGM-UHFFFAOYSA-N 295147 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(1-isopropylpiperidin-4-yl)-4-methylbenzenesulfonamide::US10112926, Example 37.34 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295147&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470216 381618240 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563367 CC(C)N1CCC(CC1)NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C23H30N6O3S/c1-14(2)29-9-7-18(8-10-29)28-33(30,31)19-6-5-15(3)20(12-19)17-11-21(22(24)25-13-17)23-26-16(4)27-32-23/h5-6,11-14,18,28H,7-10H2,1-4H3,(H2,24,25) SAFGWNVSWGGPGM-UHFFFAOYSA-N 295147 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(1-isopropylpiperidin-4-yl)-4-methylbenzenesulfonamide::US10112926, Example 37.34 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295147&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470216 381618240 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563368 CC(C)N1CCC(CC1)NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C23H30N6O3S/c1-14(2)29-9-7-18(8-10-29)28-33(30,31)19-6-5-15(3)20(12-19)17-11-21(22(24)25-13-17)23-26-16(4)27-32-23/h5-6,11-14,18,28H,7-10H2,1-4H3,(H2,24,25) SAFGWNVSWGGPGM-UHFFFAOYSA-N 295147 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(1-isopropylpiperidin-4-yl)-4-methylbenzenesulfonamide::US10112926, Example 37.34 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295147&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470216 381618240 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563369 CC(C)N1CCC(CC1)NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C23H30N6O3S/c1-14(2)29-9-7-18(8-10-29)28-33(30,31)19-6-5-15(3)20(12-19)17-11-21(22(24)25-13-17)23-26-16(4)27-32-23/h5-6,11-14,18,28H,7-10H2,1-4H3,(H2,24,25) SAFGWNVSWGGPGM-UHFFFAOYSA-N 295147 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(1-isopropylpiperidin-4-yl)-4-methylbenzenesulfonamide::US10112926, Example 37.34 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295147&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470216 381618240 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563370 CC(C)N1CCC(CC1)NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C23H30N6O3S/c1-14(2)29-9-7-18(8-10-29)28-33(30,31)19-6-5-15(3)20(12-19)17-11-21(22(24)25-13-17)23-26-16(4)27-32-23/h5-6,11-14,18,28H,7-10H2,1-4H3,(H2,24,25) SAFGWNVSWGGPGM-UHFFFAOYSA-N 295147 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(1-isopropylpiperidin-4-yl)-4-methylbenzenesulfonamide::US10112926, Example 37.34 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 5500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295147&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470216 381618240 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563371 CC(C)N1CCC(CC1)NS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C23H30N6O3S/c1-14(2)29-9-7-18(8-10-29)28-33(30,31)19-6-5-15(3)20(12-19)17-11-21(22(24)25-13-17)23-26-16(4)27-32-23/h5-6,11-14,18,28H,7-10H2,1-4H3,(H2,24,25) SAFGWNVSWGGPGM-UHFFFAOYSA-N 295147 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(1-isopropylpiperidin-4-yl)-4-methylbenzenesulfonamide::US10112926, Example 37.34 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 420 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295147&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470216 381618240 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563372 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(27,28)24-12-21(26)6-3-7-21)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-29-19/h4-5,8-11,24,26H,3,6-7,12H2,1-2H3,(H2,22,23) QANARCOXRLFBHU-UHFFFAOYSA-N 295148 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.35 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 590 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295148&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470194 381618241 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563373 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(27,28)24-12-21(26)6-3-7-21)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-29-19/h4-5,8-11,24,26H,3,6-7,12H2,1-2H3,(H2,22,23) QANARCOXRLFBHU-UHFFFAOYSA-N 295148 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.35 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295148&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470194 381618241 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563374 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(27,28)24-12-21(26)6-3-7-21)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-29-19/h4-5,8-11,24,26H,3,6-7,12H2,1-2H3,(H2,22,23) QANARCOXRLFBHU-UHFFFAOYSA-N 295148 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.35 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295148&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470194 381618241 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563375 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(27,28)24-12-21(26)6-3-7-21)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-29-19/h4-5,8-11,24,26H,3,6-7,12H2,1-2H3,(H2,22,23) QANARCOXRLFBHU-UHFFFAOYSA-N 295148 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.35 Phosphatidylinositol 4-kinase beta Human 3200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295148&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470194 381618241 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563376 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(27,28)24-12-21(26)6-3-7-21)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-29-19/h4-5,8-11,24,26H,3,6-7,12H2,1-2H3,(H2,22,23) QANARCOXRLFBHU-UHFFFAOYSA-N 295148 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.35 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295148&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470194 381618241 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563377 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(27,28)24-12-21(26)6-3-7-21)10-17(13)15-9-18(20(22)23-11-15)19-8-14(2)25-29-19/h4-5,8-11,24,26H,3,6-7,12H2,1-2H3,(H2,22,23) QANARCOXRLFBHU-UHFFFAOYSA-N 295148 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 37.35 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295148&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470194 381618241 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563378 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 390 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563379 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563380 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563381 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 4-kinase beta Human 3800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563382 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 46.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563383 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 490 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563384 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 420 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563385 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563386 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563387 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 4-kinase beta Human 3200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563388 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 17.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563389 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCCO1 |r| InChI=1S/C22H26N4O4S/c1-14-6-7-18(31(27,28)25-13-17-5-3-4-8-29-17)11-19(14)16-10-20(22(23)24-12-16)21-9-15(2)26-30-21/h6-7,9-12,17,25H,3-5,8,13H2,1-2H3,(H2,23,24) BUCWDQXJJGZECG-UHFFFAOYSA-N 295149 (R)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide and (S)-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydro-2H-pyran-2-yl)methyl)benzenesulfonamide::US10112926, Example 37.37b::US10112926, Example 37.37a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 800 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295149&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512424 381618242 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563390 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(F)F InChI=1S/C18H19F2N5O3S/c1-10-4-5-13(29(26,27)23-9-18(3,19)20)7-14(10)12-6-15(16(21)22-8-12)17-24-11(2)25-28-17/h4-8,23H,9H2,1-3H3,(H2,21,22) WECRALQRFCXKOL-UHFFFAOYSA-N 295151 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2,2-difluoropropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.38 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 550 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295151&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470053 381618243 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563391 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(F)F InChI=1S/C18H19F2N5O3S/c1-10-4-5-13(29(26,27)23-9-18(3,19)20)7-14(10)12-6-15(16(21)22-8-12)17-24-11(2)25-28-17/h4-8,23H,9H2,1-3H3,(H2,21,22) WECRALQRFCXKOL-UHFFFAOYSA-N 295151 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2,2-difluoropropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.38 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295151&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470053 381618243 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563392 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(F)F InChI=1S/C18H19F2N5O3S/c1-10-4-5-13(29(26,27)23-9-18(3,19)20)7-14(10)12-6-15(16(21)22-8-12)17-24-11(2)25-28-17/h4-8,23H,9H2,1-3H3,(H2,21,22) WECRALQRFCXKOL-UHFFFAOYSA-N 295151 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2,2-difluoropropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.38 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295151&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470053 381618243 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563393 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(F)F InChI=1S/C18H19F2N5O3S/c1-10-4-5-13(29(26,27)23-9-18(3,19)20)7-14(10)12-6-15(16(21)22-8-12)17-24-11(2)25-28-17/h4-8,23H,9H2,1-3H3,(H2,21,22) WECRALQRFCXKOL-UHFFFAOYSA-N 295151 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2,2-difluoropropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.38 Phosphatidylinositol 4-kinase beta Human 7500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295151&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470053 381618243 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563394 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(F)F InChI=1S/C18H19F2N5O3S/c1-10-4-5-13(29(26,27)23-9-18(3,19)20)7-14(10)12-6-15(16(21)22-8-12)17-24-11(2)25-28-17/h4-8,23H,9H2,1-3H3,(H2,21,22) WECRALQRFCXKOL-UHFFFAOYSA-N 295151 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2,2-difluoropropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.38 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 250 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295151&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470053 381618243 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563395 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(F)F InChI=1S/C18H19F2N5O3S/c1-10-4-5-13(29(26,27)23-9-18(3,19)20)7-14(10)12-6-15(16(21)22-8-12)17-24-11(2)25-28-17/h4-8,23H,9H2,1-3H3,(H2,21,22) WECRALQRFCXKOL-UHFFFAOYSA-N 295151 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2,2-difluoropropyl)-4-methylbenzenesulfonamide::US10112926, Example 37.38 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 370 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295151&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470053 381618243 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563396 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-8-13(9-24)10-25)6-16(11)14-5-17(18(20)21-7-14)19-22-12(2)23-28-19/h3-7,13,25H,8-10H2,1-2H3,(H2,20,21) WRNCEWZJPITBMV-UHFFFAOYSA-N 295152 (S)-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.39 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295152&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469823 381618244 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563397 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-8-13(9-24)10-25)6-16(11)14-5-17(18(20)21-7-14)19-22-12(2)23-28-19/h3-7,13,25H,8-10H2,1-2H3,(H2,20,21) WRNCEWZJPITBMV-UHFFFAOYSA-N 295152 (S)-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.39 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295152&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469823 381618244 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563398 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-8-13(9-24)10-25)6-16(11)14-5-17(18(20)21-7-14)19-22-12(2)23-28-19/h3-7,13,25H,8-10H2,1-2H3,(H2,20,21) WRNCEWZJPITBMV-UHFFFAOYSA-N 295152 (S)-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.39 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295152&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469823 381618244 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563399 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-8-13(9-24)10-25)6-16(11)14-5-17(18(20)21-7-14)19-22-12(2)23-28-19/h3-7,13,25H,8-10H2,1-2H3,(H2,20,21) WRNCEWZJPITBMV-UHFFFAOYSA-N 295152 (S)-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.39 Phosphatidylinositol 4-kinase beta Human 4800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295152&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469823 381618244 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563400 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-8-13(9-24)10-25)6-16(11)14-5-17(18(20)21-7-14)19-22-12(2)23-28-19/h3-7,13,25H,8-10H2,1-2H3,(H2,20,21) WRNCEWZJPITBMV-UHFFFAOYSA-N 295152 (S)-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.39 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 410 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295152&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469823 381618244 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563401 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-8-13(9-24)10-25)6-16(11)14-5-17(18(20)21-7-14)19-22-12(2)23-28-19/h3-7,13,25H,8-10H2,1-2H3,(H2,20,21) WRNCEWZJPITBMV-UHFFFAOYSA-N 295152 (S)-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.39 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295152&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469823 381618244 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563402 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N1CC(CO)C1 InChI=1S/C19H21N5O4S/c1-11-3-4-15(29(26,27)24-8-13(9-24)10-25)6-16(11)14-5-17(18(20)21-7-14)19-22-12(2)23-28-19/h3-7,13,25H,8-10H2,1-2H3,(H2,20,21) WRNCEWZJPITBMV-UHFFFAOYSA-N 295152 (S)-((3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 37.39 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295152&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469823 381618244 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563403 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295153 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 38 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 320 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295153&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470596 381618245 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563404 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295153 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 38 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295153&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470596 381618245 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563405 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295153 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 38 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295153&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470596 381618245 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563406 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295153 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 38 Phosphatidylinositol 4-kinase beta Human 3100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295153&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470596 381618245 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563407 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295153 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 38 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 38.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295153&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470596 381618245 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563408 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C21H24N4O4S/c1-13-3-4-17(30(26,27)24-10-15-5-6-28-12-15)9-18(13)16-8-19(21(22)23-11-16)20-7-14(2)25-29-20/h3-4,7-9,11,15,24H,5-6,10,12H2,1-2H3,(H2,22,23) HJBUXSYRSZQEGF-UHFFFAOYSA-N 295153 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 38 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 70.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295153&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470596 381618245 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563409 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)24-9-18(19,20)21)7-14(10)12-6-15(17(22)23-8-12)16-5-11(2)25-28-16/h3-8,24H,9H2,1-2H3,(H2,22,23) LYOOOZASPUBWMK-UHFFFAOYSA-N 295154 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2,2,2-trifluoroethyl)benzenesulfonamide::US10112926, Example 39 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 450 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295154&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470151 381618246 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563410 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)24-9-18(19,20)21)7-14(10)12-6-15(17(22)23-8-12)16-5-11(2)25-28-16/h3-8,24H,9H2,1-2H3,(H2,22,23) LYOOOZASPUBWMK-UHFFFAOYSA-N 295154 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2,2,2-trifluoroethyl)benzenesulfonamide::US10112926, Example 39 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295154&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470151 381618246 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563411 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)24-9-18(19,20)21)7-14(10)12-6-15(17(22)23-8-12)16-5-11(2)25-28-16/h3-8,24H,9H2,1-2H3,(H2,22,23) LYOOOZASPUBWMK-UHFFFAOYSA-N 295154 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2,2,2-trifluoroethyl)benzenesulfonamide::US10112926, Example 39 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295154&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470151 381618246 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563412 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)24-9-18(19,20)21)7-14(10)12-6-15(17(22)23-8-12)16-5-11(2)25-28-16/h3-8,24H,9H2,1-2H3,(H2,22,23) LYOOOZASPUBWMK-UHFFFAOYSA-N 295154 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2,2,2-trifluoroethyl)benzenesulfonamide::US10112926, Example 39 Phosphatidylinositol 4-kinase beta Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295154&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470151 381618246 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563413 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)24-9-18(19,20)21)7-14(10)12-6-15(17(22)23-8-12)16-5-11(2)25-28-16/h3-8,24H,9H2,1-2H3,(H2,22,23) LYOOOZASPUBWMK-UHFFFAOYSA-N 295154 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2,2,2-trifluoroethyl)benzenesulfonamide::US10112926, Example 39 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 96.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295154&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470151 381618246 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563414 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)24-9-18(19,20)21)7-14(10)12-6-15(17(22)23-8-12)16-5-11(2)25-28-16/h3-8,24H,9H2,1-2H3,(H2,22,23) LYOOOZASPUBWMK-UHFFFAOYSA-N 295154 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-(2,2,2-trifluoroethyl)benzenesulfonamide::US10112926, Example 39 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 290 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295154&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470151 381618246 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563415 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCO1 |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(26,27)24-12-16-4-3-7-28-16)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)25-29-20/h5-6,8-11,16,24H,3-4,7,12H2,1-2H3,(H2,22,23) MHVYUFNZKSQYMS-UHFFFAOYSA-N 295155 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 40 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 440 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295155&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470182 381618247 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563416 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCO1 |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(26,27)24-12-16-4-3-7-28-16)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)25-29-20/h5-6,8-11,16,24H,3-4,7,12H2,1-2H3,(H2,22,23) MHVYUFNZKSQYMS-UHFFFAOYSA-N 295155 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 40 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295155&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470182 381618247 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563417 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCO1 |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(26,27)24-12-16-4-3-7-28-16)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)25-29-20/h5-6,8-11,16,24H,3-4,7,12H2,1-2H3,(H2,22,23) MHVYUFNZKSQYMS-UHFFFAOYSA-N 295155 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 40 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295155&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470182 381618247 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563418 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCO1 |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(26,27)24-12-16-4-3-7-28-16)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)25-29-20/h5-6,8-11,16,24H,3-4,7,12H2,1-2H3,(H2,22,23) MHVYUFNZKSQYMS-UHFFFAOYSA-N 295155 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 40 Phosphatidylinositol 4-kinase beta Human 3200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295155&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470182 381618247 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563419 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCCO1 |r| InChI=1S/C21H24N4O4S/c1-13-5-6-17(30(26,27)24-12-16-4-3-7-28-16)10-18(13)15-9-19(21(22)23-11-15)20-8-14(2)25-29-20/h5-6,8-11,16,24H,3-4,7,12H2,1-2H3,(H2,22,23) MHVYUFNZKSQYMS-UHFFFAOYSA-N 295155 (S)-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 40 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 380 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295155&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470182 381618247 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563420 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CO)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-4-5-15(30(27,28)23-11-20(2,3)26)8-16(12)13-6-17(19(21)22-9-13)18-7-14(10-25)24-29-18/h4-9,23,25-26H,10-11H2,1-3H3,(H2,21,22) RXUICGPCVJHIGZ-UHFFFAOYSA-N 295156 3-(6-Amino-5-(3-(hydroxymethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 41 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 760 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295156&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470097 381618248 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563421 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CO)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-4-5-15(30(27,28)23-11-20(2,3)26)8-16(12)13-6-17(19(21)22-9-13)18-7-14(10-25)24-29-18/h4-9,23,25-26H,10-11H2,1-3H3,(H2,21,22) RXUICGPCVJHIGZ-UHFFFAOYSA-N 295156 3-(6-Amino-5-(3-(hydroxymethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 41 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 630 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295156&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470097 381618248 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563422 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CO)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-4-5-15(30(27,28)23-11-20(2,3)26)8-16(12)13-6-17(19(21)22-9-13)18-7-14(10-25)24-29-18/h4-9,23,25-26H,10-11H2,1-3H3,(H2,21,22) RXUICGPCVJHIGZ-UHFFFAOYSA-N 295156 3-(6-Amino-5-(3-(hydroxymethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 41 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295156&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470097 381618248 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563423 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CO)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-4-5-15(30(27,28)23-11-20(2,3)26)8-16(12)13-6-17(19(21)22-9-13)18-7-14(10-25)24-29-18/h4-9,23,25-26H,10-11H2,1-3H3,(H2,21,22) RXUICGPCVJHIGZ-UHFFFAOYSA-N 295156 3-(6-Amino-5-(3-(hydroxymethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 41 Phosphatidylinositol 4-kinase beta Human 2000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295156&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470097 381618248 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563424 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CO)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-4-5-15(30(27,28)23-11-20(2,3)26)8-16(12)13-6-17(19(21)22-9-13)18-7-14(10-25)24-29-18/h4-9,23,25-26H,10-11H2,1-3H3,(H2,21,22) RXUICGPCVJHIGZ-UHFFFAOYSA-N 295156 3-(6-Amino-5-(3-(hydroxymethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 41 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 28.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295156&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470097 381618248 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563425 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(CO)no1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-4-5-15(30(27,28)23-11-20(2,3)26)8-16(12)13-6-17(19(21)22-9-13)18-7-14(10-25)24-29-18/h4-9,23,25-26H,10-11H2,1-3H3,(H2,21,22) RXUICGPCVJHIGZ-UHFFFAOYSA-N 295156 3-(6-Amino-5-(3-(hydroxymethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 41 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 550 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295156&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470097 381618248 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563426 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(=O)N1CCOCC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C24H29N5O6S/c1-15-4-5-17(36(32,33)27-14-24(2,3)31)11-18(15)16-10-19(22(25)26-13-16)21-12-20(28-35-21)23(30)29-6-8-34-9-7-29/h4-5,10-13,27,31H,6-9,14H2,1-3H3,(H2,25,26) QYYODQPTAHMUEZ-UHFFFAOYSA-N 295157 3-(6-Amino-5-(3-(morpholine-4-carbonyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 42 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 890 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295157&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470014 381618249 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563427 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(=O)N1CCOCC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C24H29N5O6S/c1-15-4-5-17(36(32,33)27-14-24(2,3)31)11-18(15)16-10-19(22(25)26-13-16)21-12-20(28-35-21)23(30)29-6-8-34-9-7-29/h4-5,10-13,27,31H,6-9,14H2,1-3H3,(H2,25,26) QYYODQPTAHMUEZ-UHFFFAOYSA-N 295157 3-(6-Amino-5-(3-(morpholine-4-carbonyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 42 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295157&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470014 381618249 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563428 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(=O)N1CCOCC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C24H29N5O6S/c1-15-4-5-17(36(32,33)27-14-24(2,3)31)11-18(15)16-10-19(22(25)26-13-16)21-12-20(28-35-21)23(30)29-6-8-34-9-7-29/h4-5,10-13,27,31H,6-9,14H2,1-3H3,(H2,25,26) QYYODQPTAHMUEZ-UHFFFAOYSA-N 295157 3-(6-Amino-5-(3-(morpholine-4-carbonyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 42 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295157&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470014 381618249 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563429 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(=O)N1CCOCC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C24H29N5O6S/c1-15-4-5-17(36(32,33)27-14-24(2,3)31)11-18(15)16-10-19(22(25)26-13-16)21-12-20(28-35-21)23(30)29-6-8-34-9-7-29/h4-5,10-13,27,31H,6-9,14H2,1-3H3,(H2,25,26) QYYODQPTAHMUEZ-UHFFFAOYSA-N 295157 3-(6-Amino-5-(3-(morpholine-4-carbonyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 42 Phosphatidylinositol 4-kinase beta Human 2900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295157&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470014 381618249 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563430 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(=O)N1CCOCC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C24H29N5O6S/c1-15-4-5-17(36(32,33)27-14-24(2,3)31)11-18(15)16-10-19(22(25)26-13-16)21-12-20(28-35-21)23(30)29-6-8-34-9-7-29/h4-5,10-13,27,31H,6-9,14H2,1-3H3,(H2,25,26) QYYODQPTAHMUEZ-UHFFFAOYSA-N 295157 3-(6-Amino-5-(3-(morpholine-4-carbonyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 42 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 56.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295157&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470014 381618249 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563431 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(=O)N1CCOCC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C24H29N5O6S/c1-15-4-5-17(36(32,33)27-14-24(2,3)31)11-18(15)16-10-19(22(25)26-13-16)21-12-20(28-35-21)23(30)29-6-8-34-9-7-29/h4-5,10-13,27,31H,6-9,14H2,1-3H3,(H2,25,26) QYYODQPTAHMUEZ-UHFFFAOYSA-N 295157 3-(6-Amino-5-(3-(morpholine-4-carbonyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 42 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295157&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470014 381618249 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563432 CN(C)C(=O)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H27N5O5S/c1-13-6-7-15(33(30,31)25-12-22(2,3)29)9-16(13)14-8-17(20(23)24-11-14)19-10-18(26-32-19)21(28)27(4)5/h6-11,25,29H,12H2,1-5H3,(H2,23,24) GDGMXRJGSVWGND-UHFFFAOYSA-N 295158 5-(2-Amino-5-(5-(N-(2-hydroxy-2-methylpropyl)sulfamoyl)-2-methylphenyl)pyridin-3-yl)-N,N-dimethylisoxazole-3-carboxamide::US10112926, Example 43 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 2600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295158&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470009 381618250 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563433 CN(C)C(=O)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H27N5O5S/c1-13-6-7-15(33(30,31)25-12-22(2,3)29)9-16(13)14-8-17(20(23)24-11-14)19-10-18(26-32-19)21(28)27(4)5/h6-11,25,29H,12H2,1-5H3,(H2,23,24) GDGMXRJGSVWGND-UHFFFAOYSA-N 295158 5-(2-Amino-5-(5-(N-(2-hydroxy-2-methylpropyl)sulfamoyl)-2-methylphenyl)pyridin-3-yl)-N,N-dimethylisoxazole-3-carboxamide::US10112926, Example 43 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295158&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470009 381618250 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563434 CN(C)C(=O)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H27N5O5S/c1-13-6-7-15(33(30,31)25-12-22(2,3)29)9-16(13)14-8-17(20(23)24-11-14)19-10-18(26-32-19)21(28)27(4)5/h6-11,25,29H,12H2,1-5H3,(H2,23,24) GDGMXRJGSVWGND-UHFFFAOYSA-N 295158 5-(2-Amino-5-(5-(N-(2-hydroxy-2-methylpropyl)sulfamoyl)-2-methylphenyl)pyridin-3-yl)-N,N-dimethylisoxazole-3-carboxamide::US10112926, Example 43 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295158&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470009 381618250 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563435 CN(C)C(=O)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H27N5O5S/c1-13-6-7-15(33(30,31)25-12-22(2,3)29)9-16(13)14-8-17(20(23)24-11-14)19-10-18(26-32-19)21(28)27(4)5/h6-11,25,29H,12H2,1-5H3,(H2,23,24) GDGMXRJGSVWGND-UHFFFAOYSA-N 295158 5-(2-Amino-5-(5-(N-(2-hydroxy-2-methylpropyl)sulfamoyl)-2-methylphenyl)pyridin-3-yl)-N,N-dimethylisoxazole-3-carboxamide::US10112926, Example 43 Phosphatidylinositol 4-kinase beta Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295158&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470009 381618250 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563436 CN(C)C(=O)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H27N5O5S/c1-13-6-7-15(33(30,31)25-12-22(2,3)29)9-16(13)14-8-17(20(23)24-11-14)19-10-18(26-32-19)21(28)27(4)5/h6-11,25,29H,12H2,1-5H3,(H2,23,24) GDGMXRJGSVWGND-UHFFFAOYSA-N 295158 5-(2-Amino-5-(5-(N-(2-hydroxy-2-methylpropyl)sulfamoyl)-2-methylphenyl)pyridin-3-yl)-N,N-dimethylisoxazole-3-carboxamide::US10112926, Example 43 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 66.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295158&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470009 381618250 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563437 CN(C)C(=O)c1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H27N5O5S/c1-13-6-7-15(33(30,31)25-12-22(2,3)29)9-16(13)14-8-17(20(23)24-11-14)19-10-18(26-32-19)21(28)27(4)5/h6-11,25,29H,12H2,1-5H3,(H2,23,24) GDGMXRJGSVWGND-UHFFFAOYSA-N 295158 5-(2-Amino-5-(5-(N-(2-hydroxy-2-methylpropyl)sulfamoyl)-2-methylphenyl)pyridin-3-yl)-N,N-dimethylisoxazole-3-carboxamide::US10112926, Example 43 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1900 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295158&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470009 381618250 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563438 CCCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-4-7-26-23-28(24,25)14-6-5-11(2)15(9-14)13-8-16(17(19)20-10-13)18-21-12(3)22-27-18/h5-6,8-10,23H,4,7H2,1-3H3,(H2,19,20) WJGUPWANJQCMJY-UHFFFAOYSA-N 295159 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-propoxybenzenesulfonamide::US10112926, Example 44 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 50.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295159&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470100 381618251 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563439 CCCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-4-7-26-23-28(24,25)14-6-5-11(2)15(9-14)13-8-16(17(19)20-10-13)18-21-12(3)22-27-18/h5-6,8-10,23H,4,7H2,1-3H3,(H2,19,20) WJGUPWANJQCMJY-UHFFFAOYSA-N 295159 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-propoxybenzenesulfonamide::US10112926, Example 44 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295159&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470100 381618251 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563440 CCCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-4-7-26-23-28(24,25)14-6-5-11(2)15(9-14)13-8-16(17(19)20-10-13)18-21-12(3)22-27-18/h5-6,8-10,23H,4,7H2,1-3H3,(H2,19,20) WJGUPWANJQCMJY-UHFFFAOYSA-N 295159 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-propoxybenzenesulfonamide::US10112926, Example 44 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295159&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470100 381618251 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563441 CCCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-4-7-26-23-28(24,25)14-6-5-11(2)15(9-14)13-8-16(17(19)20-10-13)18-21-12(3)22-27-18/h5-6,8-10,23H,4,7H2,1-3H3,(H2,19,20) WJGUPWANJQCMJY-UHFFFAOYSA-N 295159 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-propoxybenzenesulfonamide::US10112926, Example 44 Phosphatidylinositol 4-kinase beta Human 3550 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295159&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470100 381618251 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563442 CCCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-4-7-26-23-28(24,25)14-6-5-11(2)15(9-14)13-8-16(17(19)20-10-13)18-21-12(3)22-27-18/h5-6,8-10,23H,4,7H2,1-3H3,(H2,19,20) WJGUPWANJQCMJY-UHFFFAOYSA-N 295159 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-propoxybenzenesulfonamide::US10112926, Example 44 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 29.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295159&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470100 381618251 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563443 CCCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-4-7-26-23-28(24,25)14-6-5-11(2)15(9-14)13-8-16(17(19)20-10-13)18-21-12(3)22-27-18/h5-6,8-10,23H,4,7H2,1-3H3,(H2,19,20) WJGUPWANJQCMJY-UHFFFAOYSA-N 295159 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-propoxybenzenesulfonamide::US10112926, Example 44 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 70.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295159&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470100 381618251 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563444 CCCONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-4-7-26-23-28(24,25)14-6-5-11(2)15(9-14)13-8-16(17(19)20-10-13)18-21-12(3)22-27-18/h5-6,8-10,23H,4,7H2,1-3H3,(H2,19,20) WJGUPWANJQCMJY-UHFFFAOYSA-N 295159 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-propoxybenzenesulfonamide::US10112926, Example 44 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295159&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470100 381618251 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563445 CC(C)ONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10(2)26-23-28(24,25)14-6-5-11(3)15(8-14)13-7-16(17(19)20-9-13)18-21-12(4)22-27-18/h5-10,23H,1-4H3,(H2,19,20) HSWPXKIYDSDFCQ-UHFFFAOYSA-N 295160 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-isopropoxy-4-methylbenzenesulfonamide::US10112926, Example 45 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 230 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295160&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470392 381618252 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563446 CC(C)ONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10(2)26-23-28(24,25)14-6-5-11(3)15(8-14)13-7-16(17(19)20-9-13)18-21-12(4)22-27-18/h5-10,23H,1-4H3,(H2,19,20) HSWPXKIYDSDFCQ-UHFFFAOYSA-N 295160 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-isopropoxy-4-methylbenzenesulfonamide::US10112926, Example 45 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295160&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470392 381618252 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563447 CC(C)ONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10(2)26-23-28(24,25)14-6-5-11(3)15(8-14)13-7-16(17(19)20-9-13)18-21-12(4)22-27-18/h5-10,23H,1-4H3,(H2,19,20) HSWPXKIYDSDFCQ-UHFFFAOYSA-N 295160 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-isopropoxy-4-methylbenzenesulfonamide::US10112926, Example 45 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295160&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470392 381618252 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563448 CC(C)ONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10(2)26-23-28(24,25)14-6-5-11(3)15(8-14)13-7-16(17(19)20-9-13)18-21-12(4)22-27-18/h5-10,23H,1-4H3,(H2,19,20) HSWPXKIYDSDFCQ-UHFFFAOYSA-N 295160 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-isopropoxy-4-methylbenzenesulfonamide::US10112926, Example 45 Phosphatidylinositol 4-kinase beta Human 7400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295160&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470392 381618252 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563449 CC(C)ONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10(2)26-23-28(24,25)14-6-5-11(3)15(8-14)13-7-16(17(19)20-9-13)18-21-12(4)22-27-18/h5-10,23H,1-4H3,(H2,19,20) HSWPXKIYDSDFCQ-UHFFFAOYSA-N 295160 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-isopropoxy-4-methylbenzenesulfonamide::US10112926, Example 45 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 110 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295160&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470392 381618252 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563450 CC(C)ONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10(2)26-23-28(24,25)14-6-5-11(3)15(8-14)13-7-16(17(19)20-9-13)18-21-12(4)22-27-18/h5-10,23H,1-4H3,(H2,19,20) HSWPXKIYDSDFCQ-UHFFFAOYSA-N 295160 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-isopropoxy-4-methylbenzenesulfonamide::US10112926, Example 45 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 60.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295160&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470392 381618252 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563451 CC(C)ONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10(2)26-23-28(24,25)14-6-5-11(3)15(8-14)13-7-16(17(19)20-9-13)18-21-12(4)22-27-18/h5-10,23H,1-4H3,(H2,19,20) HSWPXKIYDSDFCQ-UHFFFAOYSA-N 295160 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-isopropoxy-4-methylbenzenesulfonamide::US10112926, Example 45 Serine/threonine-protein kinase mTOR Human 9100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295160&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470392 381618252 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563452 CONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C16H17N5O4S/c1-9-4-5-12(26(22,23)21-24-3)7-13(9)11-6-14(15(17)18-8-11)16-19-10(2)20-25-16/h4-8,21H,1-3H3,(H2,17,18) KDGYKWAGHXCLDN-UHFFFAOYSA-N 295161 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-methoxy-4-methylbenzenesulfonamide::US10112926, Example 46 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 390 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295161&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470099 381618253 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563453 CONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C16H17N5O4S/c1-9-4-5-12(26(22,23)21-24-3)7-13(9)11-6-14(15(17)18-8-11)16-19-10(2)20-25-16/h4-8,21H,1-3H3,(H2,17,18) KDGYKWAGHXCLDN-UHFFFAOYSA-N 295161 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-methoxy-4-methylbenzenesulfonamide::US10112926, Example 46 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295161&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470099 381618253 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563454 CONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C16H17N5O4S/c1-9-4-5-12(26(22,23)21-24-3)7-13(9)11-6-14(15(17)18-8-11)16-19-10(2)20-25-16/h4-8,21H,1-3H3,(H2,17,18) KDGYKWAGHXCLDN-UHFFFAOYSA-N 295161 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-methoxy-4-methylbenzenesulfonamide::US10112926, Example 46 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295161&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470099 381618253 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563455 CONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C16H17N5O4S/c1-9-4-5-12(26(22,23)21-24-3)7-13(9)11-6-14(15(17)18-8-11)16-19-10(2)20-25-16/h4-8,21H,1-3H3,(H2,17,18) KDGYKWAGHXCLDN-UHFFFAOYSA-N 295161 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-methoxy-4-methylbenzenesulfonamide::US10112926, Example 46 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295161&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470099 381618253 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563456 CONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C16H17N5O4S/c1-9-4-5-12(26(22,23)21-24-3)7-13(9)11-6-14(15(17)18-8-11)16-19-10(2)20-25-16/h4-8,21H,1-3H3,(H2,17,18) KDGYKWAGHXCLDN-UHFFFAOYSA-N 295161 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-methoxy-4-methylbenzenesulfonamide::US10112926, Example 46 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 67.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295161&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470099 381618253 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563457 CONS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C16H17N5O4S/c1-9-4-5-12(26(22,23)21-24-3)7-13(9)11-6-14(15(17)18-8-11)16-19-10(2)20-25-16/h4-8,21H,1-3H3,(H2,17,18) KDGYKWAGHXCLDN-UHFFFAOYSA-N 295161 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-methoxy-4-methylbenzenesulfonamide::US10112926, Example 46 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 180 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295161&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470099 381618253 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563458 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOC(C)(C)C InChI=1S/C19H23N5O4S/c1-11-6-7-14(29(25,26)24-28-19(3,4)5)9-15(11)13-8-16(17(20)21-10-13)18-22-12(2)23-27-18/h6-10,24H,1-5H3,(H2,20,21) WGPBHPOXJOWHCY-UHFFFAOYSA-N 295162 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(tert-butoxy)-4-methylbenzenesulfonamide::US10112926, Example 47 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 100.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295162&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470386 381618254 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563459 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOC(C)(C)C InChI=1S/C19H23N5O4S/c1-11-6-7-14(29(25,26)24-28-19(3,4)5)9-15(11)13-8-16(17(20)21-10-13)18-22-12(2)23-27-18/h6-10,24H,1-5H3,(H2,20,21) WGPBHPOXJOWHCY-UHFFFAOYSA-N 295162 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(tert-butoxy)-4-methylbenzenesulfonamide::US10112926, Example 47 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 890 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295162&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470386 381618254 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563460 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOC(C)(C)C InChI=1S/C19H23N5O4S/c1-11-6-7-14(29(25,26)24-28-19(3,4)5)9-15(11)13-8-16(17(20)21-10-13)18-22-12(2)23-27-18/h6-10,24H,1-5H3,(H2,20,21) WGPBHPOXJOWHCY-UHFFFAOYSA-N 295162 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(tert-butoxy)-4-methylbenzenesulfonamide::US10112926, Example 47 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295162&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470386 381618254 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563461 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOC(C)(C)C InChI=1S/C19H23N5O4S/c1-11-6-7-14(29(25,26)24-28-19(3,4)5)9-15(11)13-8-16(17(20)21-10-13)18-22-12(2)23-27-18/h6-10,24H,1-5H3,(H2,20,21) WGPBHPOXJOWHCY-UHFFFAOYSA-N 295162 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(tert-butoxy)-4-methylbenzenesulfonamide::US10112926, Example 47 Phosphatidylinositol 4-kinase beta Human 4400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295162&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470386 381618254 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563462 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOC(C)(C)C InChI=1S/C19H23N5O4S/c1-11-6-7-14(29(25,26)24-28-19(3,4)5)9-15(11)13-8-16(17(20)21-10-13)18-22-12(2)23-27-18/h6-10,24H,1-5H3,(H2,20,21) WGPBHPOXJOWHCY-UHFFFAOYSA-N 295162 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(tert-butoxy)-4-methylbenzenesulfonamide::US10112926, Example 47 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 94.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295162&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470386 381618254 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563463 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOC(C)(C)C InChI=1S/C19H23N5O4S/c1-11-6-7-14(29(25,26)24-28-19(3,4)5)9-15(11)13-8-16(17(20)21-10-13)18-22-12(2)23-27-18/h6-10,24H,1-5H3,(H2,20,21) WGPBHPOXJOWHCY-UHFFFAOYSA-N 295162 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(tert-butoxy)-4-methylbenzenesulfonamide::US10112926, Example 47 Serine/threonine-protein kinase mTOR Human 4000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295162&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470386 381618254 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563464 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-3-4-13(30(27,28)24-6-5-18(19,20)21)8-14(10)12-7-15(16(22)23-9-12)17-25-11(2)26-29-17/h3-4,7-9,24H,5-6H2,1-2H3,(H2,22,23) YMHFHEFMQSMIQU-UHFFFAOYSA-N 295163 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 48 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295163&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470020 381618255 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563465 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-3-4-13(30(27,28)24-6-5-18(19,20)21)8-14(10)12-7-15(16(22)23-9-12)17-25-11(2)26-29-17/h3-4,7-9,24H,5-6H2,1-2H3,(H2,22,23) YMHFHEFMQSMIQU-UHFFFAOYSA-N 295163 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 48 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295163&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470020 381618255 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563466 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-3-4-13(30(27,28)24-6-5-18(19,20)21)8-14(10)12-7-15(16(22)23-9-12)17-25-11(2)26-29-17/h3-4,7-9,24H,5-6H2,1-2H3,(H2,22,23) YMHFHEFMQSMIQU-UHFFFAOYSA-N 295163 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 48 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295163&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470020 381618255 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563467 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-3-4-13(30(27,28)24-6-5-18(19,20)21)8-14(10)12-7-15(16(22)23-9-12)17-25-11(2)26-29-17/h3-4,7-9,24H,5-6H2,1-2H3,(H2,22,23) YMHFHEFMQSMIQU-UHFFFAOYSA-N 295163 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 48 Phosphatidylinositol 4-kinase beta Human 6000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295163&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470020 381618255 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563468 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-3-4-13(30(27,28)24-6-5-18(19,20)21)8-14(10)12-7-15(16(22)23-9-12)17-25-11(2)26-29-17/h3-4,7-9,24H,5-6H2,1-2H3,(H2,22,23) YMHFHEFMQSMIQU-UHFFFAOYSA-N 295163 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 48 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 73.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295163&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470020 381618255 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563469 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-3-4-13(30(27,28)24-6-5-18(19,20)21)8-14(10)12-7-15(16(22)23-9-12)17-25-11(2)26-29-17/h3-4,7-9,24H,5-6H2,1-2H3,(H2,22,23) YMHFHEFMQSMIQU-UHFFFAOYSA-N 295163 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 48 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 110 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295163&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470020 381618255 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563470 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-3-4-13(30(27,28)24-6-5-18(19,20)21)8-14(10)12-7-15(16(22)23-9-12)17-25-11(2)26-29-17/h3-4,7-9,24H,5-6H2,1-2H3,(H2,22,23) YMHFHEFMQSMIQU-UHFFFAOYSA-N 295163 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(3,3,3-trifluoropropyl)benzenesulfonamide::US10112926, Example 48 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295163&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470020 381618255 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563471 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)25-15-5-7-28-8-6-15)10-17(12)14-9-18(19(21)22-11-14)20-23-13(2)24-29-20/h3-4,9-11,15,25H,5-8H2,1-2H3,(H2,21,22) CLSUEJLINCVYNH-UHFFFAOYSA-N 295164 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 49 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 270 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295164&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470040 381618256 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563472 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)25-15-5-7-28-8-6-15)10-17(12)14-9-18(19(21)22-11-14)20-23-13(2)24-29-20/h3-4,9-11,15,25H,5-8H2,1-2H3,(H2,21,22) CLSUEJLINCVYNH-UHFFFAOYSA-N 295164 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 49 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295164&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470040 381618256 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563473 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)25-15-5-7-28-8-6-15)10-17(12)14-9-18(19(21)22-11-14)20-23-13(2)24-29-20/h3-4,9-11,15,25H,5-8H2,1-2H3,(H2,21,22) CLSUEJLINCVYNH-UHFFFAOYSA-N 295164 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 49 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295164&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470040 381618256 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563474 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)25-15-5-7-28-8-6-15)10-17(12)14-9-18(19(21)22-11-14)20-23-13(2)24-29-20/h3-4,9-11,15,25H,5-8H2,1-2H3,(H2,21,22) CLSUEJLINCVYNH-UHFFFAOYSA-N 295164 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 49 Phosphatidylinositol 4-kinase beta Human 6800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295164&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470040 381618256 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563475 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)25-15-5-7-28-8-6-15)10-17(12)14-9-18(19(21)22-11-14)20-23-13(2)24-29-20/h3-4,9-11,15,25H,5-8H2,1-2H3,(H2,21,22) CLSUEJLINCVYNH-UHFFFAOYSA-N 295164 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 49 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 89.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295164&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470040 381618256 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563476 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)25-15-5-7-28-8-6-15)10-17(12)14-9-18(19(21)22-11-14)20-23-13(2)24-29-20/h3-4,9-11,15,25H,5-8H2,1-2H3,(H2,21,22) CLSUEJLINCVYNH-UHFFFAOYSA-N 295164 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 49 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 140 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295164&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470040 381618256 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563477 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCOCC1 InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)25-15-5-7-28-8-6-15)10-17(12)14-9-18(19(21)22-11-14)20-23-13(2)24-29-20/h3-4,9-11,15,25H,5-8H2,1-2H3,(H2,21,22) CLSUEJLINCVYNH-UHFFFAOYSA-N 295164 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(tetrahydro-2H-pyran-4-yl)benzenesulfonamide::US10112926, Example 49 Serine/threonine-protein kinase mTOR Human 8100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295164&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470040 381618256 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563478 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)24-9-21(10-26)11-29-12-21)7-17(13)15-6-18(20(22)23-8-15)19-5-14(2)25-30-19/h3-8,24,26H,9-12H2,1-2H3,(H2,22,23) UIAOVNUDKCZSHU-UHFFFAOYSA-N 295165 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 50 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295165&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470565 381618257 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563479 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)24-9-21(10-26)11-29-12-21)7-17(13)15-6-18(20(22)23-8-15)19-5-14(2)25-30-19/h3-8,24,26H,9-12H2,1-2H3,(H2,22,23) UIAOVNUDKCZSHU-UHFFFAOYSA-N 295165 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 50 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295165&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470565 381618257 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563480 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)24-9-21(10-26)11-29-12-21)7-17(13)15-6-18(20(22)23-8-15)19-5-14(2)25-30-19/h3-8,24,26H,9-12H2,1-2H3,(H2,22,23) UIAOVNUDKCZSHU-UHFFFAOYSA-N 295165 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 50 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295165&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470565 381618257 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563481 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)24-9-21(10-26)11-29-12-21)7-17(13)15-6-18(20(22)23-8-15)19-5-14(2)25-30-19/h3-8,24,26H,9-12H2,1-2H3,(H2,22,23) UIAOVNUDKCZSHU-UHFFFAOYSA-N 295165 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 50 Phosphatidylinositol 4-kinase beta Human 4700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295165&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470565 381618257 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563482 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)24-9-21(10-26)11-29-12-21)7-17(13)15-6-18(20(22)23-8-15)19-5-14(2)25-30-19/h3-8,24,26H,9-12H2,1-2H3,(H2,22,23) UIAOVNUDKCZSHU-UHFFFAOYSA-N 295165 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 50 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 45.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295165&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470565 381618257 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563483 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)24-9-21(10-26)11-29-12-21)7-17(13)15-6-18(20(22)23-8-15)19-5-14(2)25-30-19/h3-8,24,26H,9-12H2,1-2H3,(H2,22,23) UIAOVNUDKCZSHU-UHFFFAOYSA-N 295165 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 50 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 480 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295165&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470565 381618257 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563484 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C21H25N5O5S/c1-13-3-4-16(32(28,29)24-12-21(27)5-7-30-8-6-21)10-17(13)15-9-18(19(22)23-11-15)20-25-14(2)26-31-20/h3-4,9-11,24,27H,5-8,12H2,1-2H3,(H2,22,23) KHWRTKCIJJCJIB-UHFFFAOYSA-N 295166 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 51 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 420 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295166&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470223 381618258 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563485 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C21H25N5O5S/c1-13-3-4-16(32(28,29)24-12-21(27)5-7-30-8-6-21)10-17(13)15-9-18(19(22)23-11-15)20-25-14(2)26-31-20/h3-4,9-11,24,27H,5-8,12H2,1-2H3,(H2,22,23) KHWRTKCIJJCJIB-UHFFFAOYSA-N 295166 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 51 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295166&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470223 381618258 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563486 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C21H25N5O5S/c1-13-3-4-16(32(28,29)24-12-21(27)5-7-30-8-6-21)10-17(13)15-9-18(19(22)23-11-15)20-25-14(2)26-31-20/h3-4,9-11,24,27H,5-8,12H2,1-2H3,(H2,22,23) KHWRTKCIJJCJIB-UHFFFAOYSA-N 295166 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 51 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295166&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470223 381618258 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563487 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C21H25N5O5S/c1-13-3-4-16(32(28,29)24-12-21(27)5-7-30-8-6-21)10-17(13)15-9-18(19(22)23-11-15)20-25-14(2)26-31-20/h3-4,9-11,24,27H,5-8,12H2,1-2H3,(H2,22,23) KHWRTKCIJJCJIB-UHFFFAOYSA-N 295166 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 51 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295166&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470223 381618258 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563488 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C21H25N5O5S/c1-13-3-4-16(32(28,29)24-12-21(27)5-7-30-8-6-21)10-17(13)15-9-18(19(22)23-11-15)20-25-14(2)26-31-20/h3-4,9-11,24,27H,5-8,12H2,1-2H3,(H2,22,23) KHWRTKCIJJCJIB-UHFFFAOYSA-N 295166 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 51 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 61.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295166&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470223 381618258 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563489 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C21H25N5O5S/c1-13-3-4-16(32(28,29)24-12-21(27)5-7-30-8-6-21)10-17(13)15-9-18(19(22)23-11-15)20-25-14(2)26-31-20/h3-4,9-11,24,27H,5-8,12H2,1-2H3,(H2,22,23) KHWRTKCIJJCJIB-UHFFFAOYSA-N 295166 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 51 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295166&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470223 381618258 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563490 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C20H23N5O5S/c1-12-3-4-15(31(27,28)23-8-20(9-26)10-29-11-20)6-16(12)14-5-17(18(21)22-7-14)19-24-13(2)25-30-19/h3-7,23,26H,8-11H2,1-2H3,(H2,21,22) MGOVDHPUAAHQDN-UHFFFAOYSA-N 295167 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 52 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295167&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470380 381618259 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563491 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C20H23N5O5S/c1-12-3-4-15(31(27,28)23-8-20(9-26)10-29-11-20)6-16(12)14-5-17(18(21)22-7-14)19-24-13(2)25-30-19/h3-7,23,26H,8-11H2,1-2H3,(H2,21,22) MGOVDHPUAAHQDN-UHFFFAOYSA-N 295167 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 52 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295167&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470380 381618259 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563492 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C20H23N5O5S/c1-12-3-4-15(31(27,28)23-8-20(9-26)10-29-11-20)6-16(12)14-5-17(18(21)22-7-14)19-24-13(2)25-30-19/h3-7,23,26H,8-11H2,1-2H3,(H2,21,22) MGOVDHPUAAHQDN-UHFFFAOYSA-N 295167 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 52 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295167&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470380 381618259 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563493 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C20H23N5O5S/c1-12-3-4-15(31(27,28)23-8-20(9-26)10-29-11-20)6-16(12)14-5-17(18(21)22-7-14)19-24-13(2)25-30-19/h3-7,23,26H,8-11H2,1-2H3,(H2,21,22) MGOVDHPUAAHQDN-UHFFFAOYSA-N 295167 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 52 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295167&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470380 381618259 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563494 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C20H23N5O5S/c1-12-3-4-15(31(27,28)23-8-20(9-26)10-29-11-20)6-16(12)14-5-17(18(21)22-7-14)19-24-13(2)25-30-19/h3-7,23,26H,8-11H2,1-2H3,(H2,21,22) MGOVDHPUAAHQDN-UHFFFAOYSA-N 295167 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 52 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 86.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295167&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470380 381618259 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563495 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C20H23N5O5S/c1-12-3-4-15(31(27,28)23-8-20(9-26)10-29-11-20)6-16(12)14-5-17(18(21)22-7-14)19-24-13(2)25-30-19/h3-7,23,26H,8-11H2,1-2H3,(H2,21,22) MGOVDHPUAAHQDN-UHFFFAOYSA-N 295167 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 52 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295167&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470380 381618259 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563496 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCC1 InChI=1S/C22H26N4O4S/c1-14-5-6-17(31(28,29)25-13-22(27)7-3-4-8-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-30-20/h5-6,9-12,25,27H,3-4,7-8,13H2,1-2H3,(H2,23,24) IWSFDMXAZTXLKH-UHFFFAOYSA-N 295168 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 53 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 680 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295168&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512137 381618260 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563497 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCC1 InChI=1S/C22H26N4O4S/c1-14-5-6-17(31(28,29)25-13-22(27)7-3-4-8-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-30-20/h5-6,9-12,25,27H,3-4,7-8,13H2,1-2H3,(H2,23,24) IWSFDMXAZTXLKH-UHFFFAOYSA-N 295168 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 53 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295168&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512137 381618260 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563498 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCC1 InChI=1S/C22H26N4O4S/c1-14-5-6-17(31(28,29)25-13-22(27)7-3-4-8-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-30-20/h5-6,9-12,25,27H,3-4,7-8,13H2,1-2H3,(H2,23,24) IWSFDMXAZTXLKH-UHFFFAOYSA-N 295168 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 53 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295168&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512137 381618260 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563499 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCC1 InChI=1S/C22H26N4O4S/c1-14-5-6-17(31(28,29)25-13-22(27)7-3-4-8-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-30-20/h5-6,9-12,25,27H,3-4,7-8,13H2,1-2H3,(H2,23,24) IWSFDMXAZTXLKH-UHFFFAOYSA-N 295168 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 53 Phosphatidylinositol 4-kinase beta Human 2300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295168&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512137 381618260 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563500 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCC1 InChI=1S/C22H26N4O4S/c1-14-5-6-17(31(28,29)25-13-22(27)7-3-4-8-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-30-20/h5-6,9-12,25,27H,3-4,7-8,13H2,1-2H3,(H2,23,24) IWSFDMXAZTXLKH-UHFFFAOYSA-N 295168 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 53 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 93.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295168&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512137 381618260 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563501 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCCC1 InChI=1S/C22H26N4O4S/c1-14-5-6-17(31(28,29)25-13-22(27)7-3-4-8-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-30-20/h5-6,9-12,25,27H,3-4,7-8,13H2,1-2H3,(H2,23,24) IWSFDMXAZTXLKH-UHFFFAOYSA-N 295168 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1-hydroxycyclopentyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 53 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 90.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295168&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512137 381618260 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563502 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)25-13-22(27)5-7-30-8-6-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-31-20/h3-4,9-12,25,27H,5-8,13H2,1-2H3,(H2,23,24) GBPOCZURIQUBGV-UHFFFAOYSA-N 295169 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 54 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 790 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295169&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469990 381618261 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563503 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)25-13-22(27)5-7-30-8-6-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-31-20/h3-4,9-12,25,27H,5-8,13H2,1-2H3,(H2,23,24) GBPOCZURIQUBGV-UHFFFAOYSA-N 295169 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 54 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295169&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469990 381618261 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563504 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)25-13-22(27)5-7-30-8-6-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-31-20/h3-4,9-12,25,27H,5-8,13H2,1-2H3,(H2,23,24) GBPOCZURIQUBGV-UHFFFAOYSA-N 295169 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 54 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295169&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469990 381618261 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563505 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)25-13-22(27)5-7-30-8-6-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-31-20/h3-4,9-12,25,27H,5-8,13H2,1-2H3,(H2,23,24) GBPOCZURIQUBGV-UHFFFAOYSA-N 295169 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 54 Phosphatidylinositol 4-kinase beta Human 5200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295169&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469990 381618261 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563506 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)25-13-22(27)5-7-30-8-6-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-31-20/h3-4,9-12,25,27H,5-8,13H2,1-2H3,(H2,23,24) GBPOCZURIQUBGV-UHFFFAOYSA-N 295169 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 54 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 100.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295169&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469990 381618261 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563507 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)25-13-22(27)5-7-30-8-6-22)11-18(14)16-10-19(21(23)24-12-16)20-9-15(2)26-31-20/h3-4,9-12,25,27H,5-8,13H2,1-2H3,(H2,23,24) GBPOCZURIQUBGV-UHFFFAOYSA-N 295169 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 54 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295169&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469990 381618261 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563508 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;7.81,1.31,;6.91,2.56,;5.45,2.08,;5.45,.54,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C19H21N5O5S/c1-10-3-4-15(30(26,27)24-28-14-6-13(25)7-14)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-29-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) OZKKRHXRCMWNID-UHFFFAOYSA-N 295170 trans-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 55 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 90.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295170&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472766 381618262 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563509 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;7.81,1.31,;6.91,2.56,;5.45,2.08,;5.45,.54,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C19H21N5O5S/c1-10-3-4-15(30(26,27)24-28-14-6-13(25)7-14)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-29-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) OZKKRHXRCMWNID-UHFFFAOYSA-N 295170 trans-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 55 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295170&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472766 381618262 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563510 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;7.81,1.31,;6.91,2.56,;5.45,2.08,;5.45,.54,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C19H21N5O5S/c1-10-3-4-15(30(26,27)24-28-14-6-13(25)7-14)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-29-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) OZKKRHXRCMWNID-UHFFFAOYSA-N 295170 trans-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 55 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295170&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472766 381618262 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563511 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;7.81,1.31,;6.91,2.56,;5.45,2.08,;5.45,.54,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C19H21N5O5S/c1-10-3-4-15(30(26,27)24-28-14-6-13(25)7-14)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-29-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) OZKKRHXRCMWNID-UHFFFAOYSA-N 295170 trans-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 55 Phosphatidylinositol 4-kinase beta Human 4700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295170&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472766 381618262 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563512 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;7.81,1.31,;6.91,2.56,;5.45,2.08,;5.45,.54,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C19H21N5O5S/c1-10-3-4-15(30(26,27)24-28-14-6-13(25)7-14)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-29-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) OZKKRHXRCMWNID-UHFFFAOYSA-N 295170 trans-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 55 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 8.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295170&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472766 381618262 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563513 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;7.81,1.31,;6.91,2.56,;5.45,2.08,;5.45,.54,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C19H21N5O5S/c1-10-3-4-15(30(26,27)24-28-14-6-13(25)7-14)8-16(10)12-5-17(18(20)21-9-12)19-22-11(2)23-29-19/h3-5,8-9,13-14,24-25H,6-7H2,1-2H3,(H2,20,21) OZKKRHXRCMWNID-UHFFFAOYSA-N 295170 trans-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 55 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 20.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295170&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472766 381618262 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563514 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C19H21N5O5S/c1-11-3-4-14(30(26,27)22-8-19(25)9-28-10-19)6-15(11)13-5-16(17(20)21-7-13)18-23-12(2)24-29-18/h3-7,22,25H,8-10H2,1-2H3,(H2,20,21) SEDBZSHXAYCNDU-UHFFFAOYSA-N 295171 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 56 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295171&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470049 381618263 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563515 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C19H21N5O5S/c1-11-3-4-14(30(26,27)22-8-19(25)9-28-10-19)6-15(11)13-5-16(17(20)21-7-13)18-23-12(2)24-29-18/h3-7,22,25H,8-10H2,1-2H3,(H2,20,21) SEDBZSHXAYCNDU-UHFFFAOYSA-N 295171 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 56 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295171&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470049 381618263 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563516 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C19H21N5O5S/c1-11-3-4-14(30(26,27)22-8-19(25)9-28-10-19)6-15(11)13-5-16(17(20)21-7-13)18-23-12(2)24-29-18/h3-7,22,25H,8-10H2,1-2H3,(H2,20,21) SEDBZSHXAYCNDU-UHFFFAOYSA-N 295171 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 56 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295171&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470049 381618263 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563517 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C19H21N5O5S/c1-11-3-4-14(30(26,27)22-8-19(25)9-28-10-19)6-15(11)13-5-16(17(20)21-7-13)18-23-12(2)24-29-18/h3-7,22,25H,8-10H2,1-2H3,(H2,20,21) SEDBZSHXAYCNDU-UHFFFAOYSA-N 295171 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 56 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295171&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470049 381618263 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563518 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C19H21N5O5S/c1-11-3-4-14(30(26,27)22-8-19(25)9-28-10-19)6-15(11)13-5-16(17(20)21-7-13)18-23-12(2)24-29-18/h3-7,22,25H,8-10H2,1-2H3,(H2,20,21) SEDBZSHXAYCNDU-UHFFFAOYSA-N 295171 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 56 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 80.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295171&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470049 381618263 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563519 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C19H21N5O5S/c1-11-3-4-14(30(26,27)22-8-19(25)9-28-10-19)6-15(11)13-5-16(17(20)21-7-13)18-23-12(2)24-29-18/h3-7,22,25H,8-10H2,1-2H3,(H2,20,21) SEDBZSHXAYCNDU-UHFFFAOYSA-N 295171 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 56 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295171&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470049 381618263 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563520 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCO1 InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295172 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 57 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295172&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469820 381618264 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563521 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCO1 InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295172 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 57 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295172&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469820 381618264 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563522 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCO1 InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295172 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 57 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295172&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469820 381618264 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563523 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCO1 InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295172 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 57 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295172&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469820 381618264 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563524 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCO1 InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295172 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 57 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 190 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295172&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469820 381618264 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563525 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCO1 InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295172 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 57 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 980 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295172&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469820 381618264 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563526 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCO1 InChI=1S/C20H23N5O4S/c1-12-5-6-16(30(26,27)23-11-15-4-3-7-28-15)9-17(12)14-8-18(19(21)22-10-14)20-24-13(2)25-29-20/h5-6,8-10,15,23H,3-4,7,11H2,1-2H3,(H2,21,22) WAOBNLUKXUNDIU-UHFFFAOYSA-N 295172 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-2-yl)methyl)benzenesulfonamide::US10112926, Example 57 Serine/threonine-protein kinase mTOR Human 2400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295172&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469820 381618264 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563527 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O3S/c1-14-5-6-17(29(27,28)24-13-21(2,3)26)10-18(14)16-9-19(20(22)23-11-16)15-7-8-25(4)12-15/h5-12,24,26H,13H2,1-4H3,(H2,22,23) KMNXBZNWONRMLO-UHFFFAOYSA-N 295173 3-(6-Amino-5-(1-methyl-1H-pyrrol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 58 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295173&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470025 381618265 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563528 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O3S/c1-14-5-6-17(29(27,28)24-13-21(2,3)26)10-18(14)16-9-19(20(22)23-11-16)15-7-8-25(4)12-15/h5-12,24,26H,13H2,1-4H3,(H2,22,23) KMNXBZNWONRMLO-UHFFFAOYSA-N 295173 3-(6-Amino-5-(1-methyl-1H-pyrrol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 58 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295173&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470025 381618265 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563529 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O3S/c1-14-5-6-17(29(27,28)24-13-21(2,3)26)10-18(14)16-9-19(20(22)23-11-16)15-7-8-25(4)12-15/h5-12,24,26H,13H2,1-4H3,(H2,22,23) KMNXBZNWONRMLO-UHFFFAOYSA-N 295173 3-(6-Amino-5-(1-methyl-1H-pyrrol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 58 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295173&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470025 381618265 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563530 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O3S/c1-14-5-6-17(29(27,28)24-13-21(2,3)26)10-18(14)16-9-19(20(22)23-11-16)15-7-8-25(4)12-15/h5-12,24,26H,13H2,1-4H3,(H2,22,23) KMNXBZNWONRMLO-UHFFFAOYSA-N 295173 3-(6-Amino-5-(1-methyl-1H-pyrrol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 58 Phosphatidylinositol 4-kinase beta Human 3200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295173&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470025 381618265 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563531 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O3S/c1-14-5-6-17(29(27,28)24-13-21(2,3)26)10-18(14)16-9-19(20(22)23-11-16)15-7-8-25(4)12-15/h5-12,24,26H,13H2,1-4H3,(H2,22,23) KMNXBZNWONRMLO-UHFFFAOYSA-N 295173 3-(6-Amino-5-(1-methyl-1H-pyrrol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 58 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 120 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295173&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470025 381618265 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563532 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H26N4O3S/c1-14-5-6-17(29(27,28)24-13-21(2,3)26)10-18(14)16-9-19(20(22)23-11-16)15-7-8-25(4)12-15/h5-12,24,26H,13H2,1-4H3,(H2,22,23) KMNXBZNWONRMLO-UHFFFAOYSA-N 295173 3-(6-Amino-5-(1-methyl-1H-pyrrol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 58 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 720 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295173&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470025 381618265 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563533 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-28-13(2)24-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) UCAPYWQNLZVGFX-UHFFFAOYSA-N 295174 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 59 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 830 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295174&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470156 381618266 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563534 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-28-13(2)24-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) UCAPYWQNLZVGFX-UHFFFAOYSA-N 295174 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 59 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 9200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295174&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470156 381618266 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563535 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-28-13(2)24-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) UCAPYWQNLZVGFX-UHFFFAOYSA-N 295174 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 59 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295174&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470156 381618266 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563536 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-28-13(2)24-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) UCAPYWQNLZVGFX-UHFFFAOYSA-N 295174 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 59 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295174&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470156 381618266 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563537 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-28-13(2)24-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) UCAPYWQNLZVGFX-UHFFFAOYSA-N 295174 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 59 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 280 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295174&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470156 381618266 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563538 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)23-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-28-13(2)24-18/h5-10,23,25H,11H2,1-4H3,(H2,21,22) UCAPYWQNLZVGFX-UHFFFAOYSA-N 295174 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 59 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 710 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295174&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470156 381618266 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563539 Cc1cnn(c1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-9-23-25(11-13)18-7-15(10-22-19(18)21)17-8-16(6-5-14(17)2)29(27,28)24-12-20(3,4)26/h5-11,24,26H,12H2,1-4H3,(H2,21,22) BKNUWOQIJVIGMO-UHFFFAOYSA-N 295175 3-(6-Amino-5-(4-methyl-1H-pyrazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 60 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 9400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295175&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470060 381618267 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563540 Cc1cnn(c1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-9-23-25(11-13)18-7-15(10-22-19(18)21)17-8-16(6-5-14(17)2)29(27,28)24-12-20(3,4)26/h5-11,24,26H,12H2,1-4H3,(H2,21,22) BKNUWOQIJVIGMO-UHFFFAOYSA-N 295175 3-(6-Amino-5-(4-methyl-1H-pyrazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 60 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295175&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470060 381618267 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563541 Cc1cnn(c1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-9-23-25(11-13)18-7-15(10-22-19(18)21)17-8-16(6-5-14(17)2)29(27,28)24-12-20(3,4)26/h5-11,24,26H,12H2,1-4H3,(H2,21,22) BKNUWOQIJVIGMO-UHFFFAOYSA-N 295175 3-(6-Amino-5-(4-methyl-1H-pyrazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 60 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295175&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470060 381618267 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563542 Cc1cnn(c1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-9-23-25(11-13)18-7-15(10-22-19(18)21)17-8-16(6-5-14(17)2)29(27,28)24-12-20(3,4)26/h5-11,24,26H,12H2,1-4H3,(H2,21,22) BKNUWOQIJVIGMO-UHFFFAOYSA-N 295175 3-(6-Amino-5-(4-methyl-1H-pyrazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 60 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295175&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470060 381618267 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563543 Cc1cnn(c1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-9-23-25(11-13)18-7-15(10-22-19(18)21)17-8-16(6-5-14(17)2)29(27,28)24-12-20(3,4)26/h5-11,24,26H,12H2,1-4H3,(H2,21,22) BKNUWOQIJVIGMO-UHFFFAOYSA-N 295175 3-(6-Amino-5-(4-methyl-1H-pyrazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 60 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 880 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295175&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470060 381618267 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563544 Cc1cnn(c1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-9-23-25(11-13)18-7-15(10-22-19(18)21)17-8-16(6-5-14(17)2)29(27,28)24-12-20(3,4)26/h5-11,24,26H,12H2,1-4H3,(H2,21,22) BKNUWOQIJVIGMO-UHFFFAOYSA-N 295175 3-(6-Amino-5-(4-methyl-1H-pyrazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 60 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295175&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470060 381618267 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563545 Cc1cnn(c1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-9-23-25(11-13)18-7-15(10-22-19(18)21)17-8-16(6-5-14(17)2)29(27,28)24-12-20(3,4)26/h5-11,24,26H,12H2,1-4H3,(H2,21,22) BKNUWOQIJVIGMO-UHFFFAOYSA-N 295175 3-(6-Amino-5-(4-methyl-1H-pyrazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 60 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295175&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470060 381618267 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563546 Cc1c(cnn1C)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O3S/c1-13-6-7-16(30(28,29)25-12-21(3,4)27)9-17(13)15-8-18(20(22)23-10-15)19-11-24-26(5)14(19)2/h6-11,25,27H,12H2,1-5H3,(H2,22,23) HCUAPUXZDWBUPG-UHFFFAOYSA-N 295176 3-(6-Amino-5-(1,5-dimethyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 61 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295176&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470391 381618268 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563547 Cc1c(cnn1C)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O3S/c1-13-6-7-16(30(28,29)25-12-21(3,4)27)9-17(13)15-8-18(20(22)23-10-15)19-11-24-26(5)14(19)2/h6-11,25,27H,12H2,1-5H3,(H2,22,23) HCUAPUXZDWBUPG-UHFFFAOYSA-N 295176 3-(6-Amino-5-(1,5-dimethyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 61 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295176&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470391 381618268 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563548 Cc1c(cnn1C)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O3S/c1-13-6-7-16(30(28,29)25-12-21(3,4)27)9-17(13)15-8-18(20(22)23-10-15)19-11-24-26(5)14(19)2/h6-11,25,27H,12H2,1-5H3,(H2,22,23) HCUAPUXZDWBUPG-UHFFFAOYSA-N 295176 3-(6-Amino-5-(1,5-dimethyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 61 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295176&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470391 381618268 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563549 Cc1c(cnn1C)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O3S/c1-13-6-7-16(30(28,29)25-12-21(3,4)27)9-17(13)15-8-18(20(22)23-10-15)19-11-24-26(5)14(19)2/h6-11,25,27H,12H2,1-5H3,(H2,22,23) HCUAPUXZDWBUPG-UHFFFAOYSA-N 295176 3-(6-Amino-5-(1,5-dimethyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 61 Phosphatidylinositol 4-kinase beta Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295176&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470391 381618268 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563550 Cc1c(cnn1C)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O3S/c1-13-6-7-16(30(28,29)25-12-21(3,4)27)9-17(13)15-8-18(20(22)23-10-15)19-11-24-26(5)14(19)2/h6-11,25,27H,12H2,1-5H3,(H2,22,23) HCUAPUXZDWBUPG-UHFFFAOYSA-N 295176 3-(6-Amino-5-(1,5-dimethyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 61 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 1700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295176&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470391 381618268 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563551 Cc1c(cnn1C)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O3S/c1-13-6-7-16(30(28,29)25-12-21(3,4)27)9-17(13)15-8-18(20(22)23-10-15)19-11-24-26(5)14(19)2/h6-11,25,27H,12H2,1-5H3,(H2,22,23) HCUAPUXZDWBUPG-UHFFFAOYSA-N 295176 3-(6-Amino-5-(1,5-dimethyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 61 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 5800 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295176&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470391 381618268 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563552 Cc1c(cnn1C)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H27N5O3S/c1-13-6-7-16(30(28,29)25-12-21(3,4)27)9-17(13)15-8-18(20(22)23-10-15)19-11-24-26(5)14(19)2/h6-11,25,27H,12H2,1-5H3,(H2,22,23) HCUAPUXZDWBUPG-UHFFFAOYSA-N 295176 3-(6-Amino-5-(1,5-dimethyl-1H-pyrazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 61 Serine/threonine-protein kinase mTOR Human 6700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295176&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470391 381618268 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563553 Cc1oncc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-23-28-13(18)2/h5-10,24-25H,11H2,1-4H3,(H2,21,22) HVCOKXCYSQTABY-UHFFFAOYSA-N 295177 3-(6-Amino-5-(5-methylisoxazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 62 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295177&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470497 381618269 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563554 Cc1oncc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-23-28-13(18)2/h5-10,24-25H,11H2,1-4H3,(H2,21,22) HVCOKXCYSQTABY-UHFFFAOYSA-N 295177 3-(6-Amino-5-(5-methylisoxazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 62 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295177&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470497 381618269 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563555 Cc1oncc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-23-28-13(18)2/h5-10,24-25H,11H2,1-4H3,(H2,21,22) HVCOKXCYSQTABY-UHFFFAOYSA-N 295177 3-(6-Amino-5-(5-methylisoxazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 62 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295177&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470497 381618269 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563556 Cc1oncc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-23-28-13(18)2/h5-10,24-25H,11H2,1-4H3,(H2,21,22) HVCOKXCYSQTABY-UHFFFAOYSA-N 295177 3-(6-Amino-5-(5-methylisoxazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 62 Phosphatidylinositol 4-kinase beta Human 6600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295177&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470497 381618269 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563557 Cc1oncc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-23-28-13(18)2/h5-10,24-25H,11H2,1-4H3,(H2,21,22) HVCOKXCYSQTABY-UHFFFAOYSA-N 295177 3-(6-Amino-5-(5-methylisoxazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 62 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 2600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295177&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470497 381618269 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563558 Cc1oncc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-23-28-13(18)2/h5-10,24-25H,11H2,1-4H3,(H2,21,22) HVCOKXCYSQTABY-UHFFFAOYSA-N 295177 3-(6-Amino-5-(5-methylisoxazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 62 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 5000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295177&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470497 381618269 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563559 Cc1oncc1-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O4S/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(19(21)22-9-14)18-10-23-28-13(18)2/h5-10,24-25H,11H2,1-4H3,(H2,21,22) HVCOKXCYSQTABY-UHFFFAOYSA-N 295177 3-(6-Amino-5-(5-methylisoxazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 62 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295177&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470497 381618269 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563560 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cn(C)nn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)22-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-25(4)24-23-17/h5-10,22,26H,11H2,1-4H3,(H2,20,21) OEMPKVVMYSHASG-UHFFFAOYSA-N 295178 3-(6-Amino-5-(1-methyl-1H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 63 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295178&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470356 381618270 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563561 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cn(C)nn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)22-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-25(4)24-23-17/h5-10,22,26H,11H2,1-4H3,(H2,20,21) OEMPKVVMYSHASG-UHFFFAOYSA-N 295178 3-(6-Amino-5-(1-methyl-1H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 63 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295178&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470356 381618270 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563562 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cn(C)nn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)22-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-25(4)24-23-17/h5-10,22,26H,11H2,1-4H3,(H2,20,21) OEMPKVVMYSHASG-UHFFFAOYSA-N 295178 3-(6-Amino-5-(1-methyl-1H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 63 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295178&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470356 381618270 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563563 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cn(C)nn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)22-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-25(4)24-23-17/h5-10,22,26H,11H2,1-4H3,(H2,20,21) OEMPKVVMYSHASG-UHFFFAOYSA-N 295178 3-(6-Amino-5-(1-methyl-1H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 63 Phosphatidylinositol 4-kinase beta Human 9600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295178&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470356 381618270 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563564 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cn(C)nn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)22-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-25(4)24-23-17/h5-10,22,26H,11H2,1-4H3,(H2,20,21) OEMPKVVMYSHASG-UHFFFAOYSA-N 295178 3-(6-Amino-5-(1-methyl-1H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 63 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 355 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295178&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470356 381618270 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563565 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cn(C)nn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)22-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-25(4)24-23-17/h5-10,22,26H,11H2,1-4H3,(H2,20,21) OEMPKVVMYSHASG-UHFFFAOYSA-N 295178 3-(6-Amino-5-(1-methyl-1H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 63 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 540 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295178&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470356 381618270 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563566 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cn(C)nn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H24N6O3S/c1-12-5-6-14(29(27,28)22-11-19(2,3)26)8-15(12)13-7-16(18(20)21-9-13)17-10-25(4)24-23-17/h5-10,22,26H,11H2,1-4H3,(H2,20,21) OEMPKVVMYSHASG-UHFFFAOYSA-N 295178 3-(6-Amino-5-(1-methyl-1H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 63 Serine/threonine-protein kinase mTOR Human 5300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295178&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470356 381618270 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563567 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccno1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(18(20)21-10-13)17-6-7-22-27-17/h4-10,23-24H,11H2,1-3H3,(H2,20,21) FBFHUGMVRQBPIQ-UHFFFAOYSA-N 295179 3-(6-Amino-5-(isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 64 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 340 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295179&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470468 381618271 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563568 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccno1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(18(20)21-10-13)17-6-7-22-27-17/h4-10,23-24H,11H2,1-3H3,(H2,20,21) FBFHUGMVRQBPIQ-UHFFFAOYSA-N 295179 3-(6-Amino-5-(isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 64 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 950 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295179&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470468 381618271 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563569 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccno1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(18(20)21-10-13)17-6-7-22-27-17/h4-10,23-24H,11H2,1-3H3,(H2,20,21) FBFHUGMVRQBPIQ-UHFFFAOYSA-N 295179 3-(6-Amino-5-(isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 64 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295179&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470468 381618271 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563570 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccno1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(18(20)21-10-13)17-6-7-22-27-17/h4-10,23-24H,11H2,1-3H3,(H2,20,21) FBFHUGMVRQBPIQ-UHFFFAOYSA-N 295179 3-(6-Amino-5-(isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 64 Phosphatidylinositol 4-kinase beta Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295179&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470468 381618271 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563571 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccno1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(18(20)21-10-13)17-6-7-22-27-17/h4-10,23-24H,11H2,1-3H3,(H2,20,21) FBFHUGMVRQBPIQ-UHFFFAOYSA-N 295179 3-(6-Amino-5-(isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 64 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 49.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295179&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470468 381618271 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563572 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccno1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(18(20)21-10-13)17-6-7-22-27-17/h4-10,23-24H,11H2,1-3H3,(H2,20,21) FBFHUGMVRQBPIQ-UHFFFAOYSA-N 295179 3-(6-Amino-5-(isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 64 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 650 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295179&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470468 381618271 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563573 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(F)(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H21F3N4O4S/c1-11-4-5-13(32(29,30)26-10-19(2,3)28)7-14(11)12-6-15(18(24)25-9-12)16-8-17(27-31-16)20(21,22)23/h4-9,26,28H,10H2,1-3H3,(H2,24,25) FJWYPPVOAUXKBU-UHFFFAOYSA-N 295180 3-(6-Amino-5-(3-(trifluoromethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 65 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 2300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295180&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469816 381618272 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563574 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(F)(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H21F3N4O4S/c1-11-4-5-13(32(29,30)26-10-19(2,3)28)7-14(11)12-6-15(18(24)25-9-12)16-8-17(27-31-16)20(21,22)23/h4-9,26,28H,10H2,1-3H3,(H2,24,25) FJWYPPVOAUXKBU-UHFFFAOYSA-N 295180 3-(6-Amino-5-(3-(trifluoromethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 65 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 9500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295180&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469816 381618272 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563575 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(F)(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H21F3N4O4S/c1-11-4-5-13(32(29,30)26-10-19(2,3)28)7-14(11)12-6-15(18(24)25-9-12)16-8-17(27-31-16)20(21,22)23/h4-9,26,28H,10H2,1-3H3,(H2,24,25) FJWYPPVOAUXKBU-UHFFFAOYSA-N 295180 3-(6-Amino-5-(3-(trifluoromethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 65 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295180&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469816 381618272 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563576 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(F)(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H21F3N4O4S/c1-11-4-5-13(32(29,30)26-10-19(2,3)28)7-14(11)12-6-15(18(24)25-9-12)16-8-17(27-31-16)20(21,22)23/h4-9,26,28H,10H2,1-3H3,(H2,24,25) FJWYPPVOAUXKBU-UHFFFAOYSA-N 295180 3-(6-Amino-5-(3-(trifluoromethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 65 Phosphatidylinositol 4-kinase beta Human 5200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295180&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469816 381618272 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563577 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(F)(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H21F3N4O4S/c1-11-4-5-13(32(29,30)26-10-19(2,3)28)7-14(11)12-6-15(18(24)25-9-12)16-8-17(27-31-16)20(21,22)23/h4-9,26,28H,10H2,1-3H3,(H2,24,25) FJWYPPVOAUXKBU-UHFFFAOYSA-N 295180 3-(6-Amino-5-(3-(trifluoromethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 65 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 215 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295180&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469816 381618272 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563578 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(F)(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H21F3N4O4S/c1-11-4-5-13(32(29,30)26-10-19(2,3)28)7-14(11)12-6-15(18(24)25-9-12)16-8-17(27-31-16)20(21,22)23/h4-9,26,28H,10H2,1-3H3,(H2,24,25) FJWYPPVOAUXKBU-UHFFFAOYSA-N 295180 3-(6-Amino-5-(3-(trifluoromethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 65 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 590 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295180&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469816 381618272 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563579 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cc(no1)C(F)(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H21F3N4O4S/c1-11-4-5-13(32(29,30)26-10-19(2,3)28)7-14(11)12-6-15(18(24)25-9-12)16-8-17(27-31-16)20(21,22)23/h4-9,26,28H,10H2,1-3H3,(H2,24,25) FJWYPPVOAUXKBU-UHFFFAOYSA-N 295180 3-(6-Amino-5-(3-(trifluoromethyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 65 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295180&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469816 381618272 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563580 CN(C)Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H29N5O4S/c1-14-6-7-17(32(29,30)25-13-22(2,3)28)10-18(14)15-8-19(21(23)24-11-15)20-9-16(26-31-20)12-27(4)5/h6-11,25,28H,12-13H2,1-5H3,(H2,23,24) OJXUIKFHEPWBTB-UHFFFAOYSA-N 295181 3-(6-Amino-5-(3-((dimethylamino)methyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 66 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295181&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470125 381618273 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563581 CN(C)Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H29N5O4S/c1-14-6-7-17(32(29,30)25-13-22(2,3)28)10-18(14)15-8-19(21(23)24-11-15)20-9-16(26-31-20)12-27(4)5/h6-11,25,28H,12-13H2,1-5H3,(H2,23,24) OJXUIKFHEPWBTB-UHFFFAOYSA-N 295181 3-(6-Amino-5-(3-((dimethylamino)methyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 66 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295181&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470125 381618273 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563582 CN(C)Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H29N5O4S/c1-14-6-7-17(32(29,30)25-13-22(2,3)28)10-18(14)15-8-19(21(23)24-11-15)20-9-16(26-31-20)12-27(4)5/h6-11,25,28H,12-13H2,1-5H3,(H2,23,24) OJXUIKFHEPWBTB-UHFFFAOYSA-N 295181 3-(6-Amino-5-(3-((dimethylamino)methyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 66 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295181&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470125 381618273 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563583 CN(C)Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H29N5O4S/c1-14-6-7-17(32(29,30)25-13-22(2,3)28)10-18(14)15-8-19(21(23)24-11-15)20-9-16(26-31-20)12-27(4)5/h6-11,25,28H,12-13H2,1-5H3,(H2,23,24) OJXUIKFHEPWBTB-UHFFFAOYSA-N 295181 3-(6-Amino-5-(3-((dimethylamino)methyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 66 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295181&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470125 381618273 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563584 CN(C)Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H29N5O4S/c1-14-6-7-17(32(29,30)25-13-22(2,3)28)10-18(14)15-8-19(21(23)24-11-15)20-9-16(26-31-20)12-27(4)5/h6-11,25,28H,12-13H2,1-5H3,(H2,23,24) OJXUIKFHEPWBTB-UHFFFAOYSA-N 295181 3-(6-Amino-5-(3-((dimethylamino)methyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 66 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 140 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295181&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470125 381618273 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563585 CN(C)Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H29N5O4S/c1-14-6-7-17(32(29,30)25-13-22(2,3)28)10-18(14)15-8-19(21(23)24-11-15)20-9-16(26-31-20)12-27(4)5/h6-11,25,28H,12-13H2,1-5H3,(H2,23,24) OJXUIKFHEPWBTB-UHFFFAOYSA-N 295181 3-(6-Amino-5-(3-((dimethylamino)methyl)isoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 66 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295181&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470125 381618273 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563586 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) GLYYQEJQPGRHPJ-UHFFFAOYSA-N 295182 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 67 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 220 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295182&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469942 381618274 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563587 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) GLYYQEJQPGRHPJ-UHFFFAOYSA-N 295182 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 67 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295182&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469942 381618274 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563588 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) GLYYQEJQPGRHPJ-UHFFFAOYSA-N 295182 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 67 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 9500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295182&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469942 381618274 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563589 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) GLYYQEJQPGRHPJ-UHFFFAOYSA-N 295182 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 67 Phosphatidylinositol 4-kinase beta Human 2300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295182&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469942 381618274 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563590 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) GLYYQEJQPGRHPJ-UHFFFAOYSA-N 295182 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 67 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 9.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295182&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469942 381618274 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563591 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O5S/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) GLYYQEJQPGRHPJ-UHFFFAOYSA-N 295182 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 67 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295182&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469942 381618274 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563592 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O4S2/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) JTAQBMNOEJZXPF-UHFFFAOYSA-N 295183 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 68 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295183&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469965 381618275 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563593 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O4S2/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) JTAQBMNOEJZXPF-UHFFFAOYSA-N 295183 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 68 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295183&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469965 381618275 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563594 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O4S2/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) JTAQBMNOEJZXPF-UHFFFAOYSA-N 295183 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 68 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 8400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295183&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469965 381618275 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563595 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O4S2/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) JTAQBMNOEJZXPF-UHFFFAOYSA-N 295183 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 68 Phosphatidylinositol 4-kinase beta Human 2500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295183&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469965 381618275 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563596 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O4S2/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) JTAQBMNOEJZXPF-UHFFFAOYSA-N 295183 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 68 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 23.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295183&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469965 381618275 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563597 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)COC1 InChI=1S/C21H24N4O4S2/c1-13-3-4-16(31(27,28)25-9-21(10-26)11-29-12-21)6-17(13)15-5-18(20(22)24-7-15)19-8-23-14(2)30-19/h3-8,25-26H,9-12H2,1-2H3,(H2,22,24) JTAQBMNOEJZXPF-UHFFFAOYSA-N 295183 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-(hydroxymethyl)oxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 68 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295183&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469965 381618275 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563598 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)25-10-21(3)11-28-12-21)7-17(13)15-6-18(20(22)24-8-15)19-9-23-14(2)29-19/h4-9,25H,10-12H2,1-3H3,(H2,22,24) MZVFITYKDVDNGL-UHFFFAOYSA-N 295184 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methyl-N-((3-methyloxetan-3-yl)methyl)benzenesulfonamide::US10112926, Example 69 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 320 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295184&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470098 381618276 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563599 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)25-10-21(3)11-28-12-21)7-17(13)15-6-18(20(22)24-8-15)19-9-23-14(2)29-19/h4-9,25H,10-12H2,1-3H3,(H2,22,24) MZVFITYKDVDNGL-UHFFFAOYSA-N 295184 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methyl-N-((3-methyloxetan-3-yl)methyl)benzenesulfonamide::US10112926, Example 69 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295184&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470098 381618276 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563600 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)25-10-21(3)11-28-12-21)7-17(13)15-6-18(20(22)24-8-15)19-9-23-14(2)29-19/h4-9,25H,10-12H2,1-3H3,(H2,22,24) MZVFITYKDVDNGL-UHFFFAOYSA-N 295184 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methyl-N-((3-methyloxetan-3-yl)methyl)benzenesulfonamide::US10112926, Example 69 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 4400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295184&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470098 381618276 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563601 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)25-10-21(3)11-28-12-21)7-17(13)15-6-18(20(22)24-8-15)19-9-23-14(2)29-19/h4-9,25H,10-12H2,1-3H3,(H2,22,24) MZVFITYKDVDNGL-UHFFFAOYSA-N 295184 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methyl-N-((3-methyloxetan-3-yl)methyl)benzenesulfonamide::US10112926, Example 69 Phosphatidylinositol 4-kinase beta Human 2400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295184&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470098 381618276 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563602 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)25-10-21(3)11-28-12-21)7-17(13)15-6-18(20(22)24-8-15)19-9-23-14(2)29-19/h4-9,25H,10-12H2,1-3H3,(H2,22,24) MZVFITYKDVDNGL-UHFFFAOYSA-N 295184 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methyl-N-((3-methyloxetan-3-yl)methyl)benzenesulfonamide::US10112926, Example 69 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 34.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295184&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470098 381618276 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563603 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(C)COC1 InChI=1S/C21H24N4O4S/c1-13-4-5-16(30(26,27)25-10-21(3)11-28-12-21)7-17(13)15-6-18(20(22)24-8-15)19-9-23-14(2)29-19/h4-9,25H,10-12H2,1-3H3,(H2,22,24) MZVFITYKDVDNGL-UHFFFAOYSA-N 295184 3-(6-Amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-4-methyl-N-((3-methyloxetan-3-yl)methyl)benzenesulfonamide::US10112926, Example 69 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 740 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295184&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470098 381618276 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563604 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:26.28,wD:29.32,(-2.34,5,;-2.34,3.46,;-3.68,2.69,;-3.68,1.15,;-2.34,.38,;-1.01,1.15,;-1.01,2.69,;.33,3.47,;.33,5,;1.66,5.77,;2.99,5,;4.33,5.78,;2.99,3.47,;1.66,2.7,;4.33,2.69,;4.33,1.15,;5.79,.68,;6.7,1.92,;5.79,3.17,;6.19,-.81,;5.1,-1.9,;7.68,-1.21,;-2.34,-1.16,;-3.88,-1.16,;-.8,-1.16,;-2.34,-2.7,;-3.68,-3.47,;-3.68,-5.01,;-5.01,-5.78,;-6.34,-5.01,;-7.68,-5.78,;-6.34,-3.47,;-5.01,-2.69,)| InChI=1S/C21H23F2N5O4S/c1-11-2-7-15(33(30,31)28-13-3-5-14(29)6-4-13)9-16(11)12-8-17(19(24)25-10-12)21-26-20(18(22)23)27-32-21/h2,7-10,13-14,18,28-29H,3-6H2,1H3,(H2,24,25) KHDSNMCNVGLJEF-UHFFFAOYSA-N 295185 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 70 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 580 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295185&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470390 381618277 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563605 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:26.28,wD:29.32,(-2.34,5,;-2.34,3.46,;-3.68,2.69,;-3.68,1.15,;-2.34,.38,;-1.01,1.15,;-1.01,2.69,;.33,3.47,;.33,5,;1.66,5.77,;2.99,5,;4.33,5.78,;2.99,3.47,;1.66,2.7,;4.33,2.69,;4.33,1.15,;5.79,.68,;6.7,1.92,;5.79,3.17,;6.19,-.81,;5.1,-1.9,;7.68,-1.21,;-2.34,-1.16,;-3.88,-1.16,;-.8,-1.16,;-2.34,-2.7,;-3.68,-3.47,;-3.68,-5.01,;-5.01,-5.78,;-6.34,-5.01,;-7.68,-5.78,;-6.34,-3.47,;-5.01,-2.69,)| InChI=1S/C21H23F2N5O4S/c1-11-2-7-15(33(30,31)28-13-3-5-14(29)6-4-13)9-16(11)12-8-17(19(24)25-10-12)21-26-20(18(22)23)27-32-21/h2,7-10,13-14,18,28-29H,3-6H2,1H3,(H2,24,25) KHDSNMCNVGLJEF-UHFFFAOYSA-N 295185 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 70 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295185&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470390 381618277 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563606 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:26.28,wD:29.32,(-2.34,5,;-2.34,3.46,;-3.68,2.69,;-3.68,1.15,;-2.34,.38,;-1.01,1.15,;-1.01,2.69,;.33,3.47,;.33,5,;1.66,5.77,;2.99,5,;4.33,5.78,;2.99,3.47,;1.66,2.7,;4.33,2.69,;4.33,1.15,;5.79,.68,;6.7,1.92,;5.79,3.17,;6.19,-.81,;5.1,-1.9,;7.68,-1.21,;-2.34,-1.16,;-3.88,-1.16,;-.8,-1.16,;-2.34,-2.7,;-3.68,-3.47,;-3.68,-5.01,;-5.01,-5.78,;-6.34,-5.01,;-7.68,-5.78,;-6.34,-3.47,;-5.01,-2.69,)| InChI=1S/C21H23F2N5O4S/c1-11-2-7-15(33(30,31)28-13-3-5-14(29)6-4-13)9-16(11)12-8-17(19(24)25-10-12)21-26-20(18(22)23)27-32-21/h2,7-10,13-14,18,28-29H,3-6H2,1H3,(H2,24,25) KHDSNMCNVGLJEF-UHFFFAOYSA-N 295185 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 70 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295185&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470390 381618277 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563607 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:26.28,wD:29.32,(-2.34,5,;-2.34,3.46,;-3.68,2.69,;-3.68,1.15,;-2.34,.38,;-1.01,1.15,;-1.01,2.69,;.33,3.47,;.33,5,;1.66,5.77,;2.99,5,;4.33,5.78,;2.99,3.47,;1.66,2.7,;4.33,2.69,;4.33,1.15,;5.79,.68,;6.7,1.92,;5.79,3.17,;6.19,-.81,;5.1,-1.9,;7.68,-1.21,;-2.34,-1.16,;-3.88,-1.16,;-.8,-1.16,;-2.34,-2.7,;-3.68,-3.47,;-3.68,-5.01,;-5.01,-5.78,;-6.34,-5.01,;-7.68,-5.78,;-6.34,-3.47,;-5.01,-2.69,)| InChI=1S/C21H23F2N5O4S/c1-11-2-7-15(33(30,31)28-13-3-5-14(29)6-4-13)9-16(11)12-8-17(19(24)25-10-12)21-26-20(18(22)23)27-32-21/h2,7-10,13-14,18,28-29H,3-6H2,1H3,(H2,24,25) KHDSNMCNVGLJEF-UHFFFAOYSA-N 295185 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 70 Phosphatidylinositol 4-kinase beta Human 8200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295185&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470390 381618277 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563608 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:26.28,wD:29.32,(-2.34,5,;-2.34,3.46,;-3.68,2.69,;-3.68,1.15,;-2.34,.38,;-1.01,1.15,;-1.01,2.69,;.33,3.47,;.33,5,;1.66,5.77,;2.99,5,;4.33,5.78,;2.99,3.47,;1.66,2.7,;4.33,2.69,;4.33,1.15,;5.79,.68,;6.7,1.92,;5.79,3.17,;6.19,-.81,;5.1,-1.9,;7.68,-1.21,;-2.34,-1.16,;-3.88,-1.16,;-.8,-1.16,;-2.34,-2.7,;-3.68,-3.47,;-3.68,-5.01,;-5.01,-5.78,;-6.34,-5.01,;-7.68,-5.78,;-6.34,-3.47,;-5.01,-2.69,)| InChI=1S/C21H23F2N5O4S/c1-11-2-7-15(33(30,31)28-13-3-5-14(29)6-4-13)9-16(11)12-8-17(19(24)25-10-12)21-26-20(18(22)23)27-32-21/h2,7-10,13-14,18,28-29H,3-6H2,1H3,(H2,24,25) KHDSNMCNVGLJEF-UHFFFAOYSA-N 295185 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 70 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 47.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295185&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470390 381618277 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563609 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:26.28,wD:29.32,(-2.34,5,;-2.34,3.46,;-3.68,2.69,;-3.68,1.15,;-2.34,.38,;-1.01,1.15,;-1.01,2.69,;.33,3.47,;.33,5,;1.66,5.77,;2.99,5,;4.33,5.78,;2.99,3.47,;1.66,2.7,;4.33,2.69,;4.33,1.15,;5.79,.68,;6.7,1.92,;5.79,3.17,;6.19,-.81,;5.1,-1.9,;7.68,-1.21,;-2.34,-1.16,;-3.88,-1.16,;-.8,-1.16,;-2.34,-2.7,;-3.68,-3.47,;-3.68,-5.01,;-5.01,-5.78,;-6.34,-5.01,;-7.68,-5.78,;-6.34,-3.47,;-5.01,-2.69,)| InChI=1S/C21H23F2N5O4S/c1-11-2-7-15(33(30,31)28-13-3-5-14(29)6-4-13)9-16(11)12-8-17(19(24)25-10-12)21-26-20(18(22)23)27-32-21/h2,7-10,13-14,18,28-29H,3-6H2,1H3,(H2,24,25) KHDSNMCNVGLJEF-UHFFFAOYSA-N 295185 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 70 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1100 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295185&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470390 381618277 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563610 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:26.28,wD:29.32,(-2.34,5,;-2.34,3.46,;-3.68,2.69,;-3.68,1.15,;-2.34,.38,;-1.01,1.15,;-1.01,2.69,;.33,3.47,;.33,5,;1.66,5.77,;2.99,5,;4.33,5.78,;2.99,3.47,;1.66,2.7,;4.33,2.69,;4.33,1.15,;5.79,.68,;6.7,1.92,;5.79,3.17,;6.19,-.81,;5.1,-1.9,;7.68,-1.21,;-2.34,-1.16,;-3.88,-1.16,;-.8,-1.16,;-2.34,-2.7,;-3.68,-3.47,;-3.68,-5.01,;-5.01,-5.78,;-6.34,-5.01,;-7.68,-5.78,;-6.34,-3.47,;-5.01,-2.69,)| InChI=1S/C21H23F2N5O4S/c1-11-2-7-15(33(30,31)28-13-3-5-14(29)6-4-13)9-16(11)12-8-17(19(24)25-10-12)21-26-20(18(22)23)27-32-21/h2,7-10,13-14,18,28-29H,3-6H2,1H3,(H2,24,25) KHDSNMCNVGLJEF-UHFFFAOYSA-N 295185 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 70 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295185&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470390 381618277 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563611 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H21F2N5O4S/c1-10-4-5-12(31(28,29)24-9-19(2,3)27)7-13(10)11-6-14(16(22)23-8-11)18-25-17(15(20)21)26-30-18/h4-8,15,24,27H,9H2,1-3H3,(H2,22,23) PXSPUJOREZRZKR-UHFFFAOYSA-N 295186 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 71 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 2600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295186&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470699 381618278 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563612 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H21F2N5O4S/c1-10-4-5-12(31(28,29)24-9-19(2,3)27)7-13(10)11-6-14(16(22)23-8-11)18-25-17(15(20)21)26-30-18/h4-8,15,24,27H,9H2,1-3H3,(H2,22,23) PXSPUJOREZRZKR-UHFFFAOYSA-N 295186 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 71 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295186&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470699 381618278 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563613 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H21F2N5O4S/c1-10-4-5-12(31(28,29)24-9-19(2,3)27)7-13(10)11-6-14(16(22)23-8-11)18-25-17(15(20)21)26-30-18/h4-8,15,24,27H,9H2,1-3H3,(H2,22,23) PXSPUJOREZRZKR-UHFFFAOYSA-N 295186 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 71 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295186&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470699 381618278 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563614 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H21F2N5O4S/c1-10-4-5-12(31(28,29)24-9-19(2,3)27)7-13(10)11-6-14(16(22)23-8-11)18-25-17(15(20)21)26-30-18/h4-8,15,24,27H,9H2,1-3H3,(H2,22,23) PXSPUJOREZRZKR-UHFFFAOYSA-N 295186 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 71 Phosphatidylinositol 4-kinase beta Human 10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295186&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470699 381618278 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563615 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H21F2N5O4S/c1-10-4-5-12(31(28,29)24-9-19(2,3)27)7-13(10)11-6-14(16(22)23-8-11)18-25-17(15(20)21)26-30-18/h4-8,15,24,27H,9H2,1-3H3,(H2,22,23) PXSPUJOREZRZKR-UHFFFAOYSA-N 295186 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 71 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 47.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295186&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470699 381618278 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563616 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H21F2N5O4S/c1-10-4-5-12(31(28,29)24-9-19(2,3)27)7-13(10)11-6-14(16(22)23-8-11)18-25-17(15(20)21)26-30-18/h4-8,15,24,27H,9H2,1-3H3,(H2,22,23) PXSPUJOREZRZKR-UHFFFAOYSA-N 295186 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 71 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 5900 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295186&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470699 381618278 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563617 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C(F)F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H21F2N5O4S/c1-10-4-5-12(31(28,29)24-9-19(2,3)27)7-13(10)11-6-14(16(22)23-8-11)18-25-17(15(20)21)26-30-18/h4-8,15,24,27H,9H2,1-3H3,(H2,22,23) PXSPUJOREZRZKR-UHFFFAOYSA-N 295186 3-(6-Amino-5-(3-(difluoromethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 71 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295186&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470699 381618278 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563618 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)Nc1cccc(C)n1 InChI=1S/C21H20N6O3S/c1-12-7-8-16(31(28,29)27-19-6-4-5-13(2)24-19)10-17(12)15-9-18(20(22)23-11-15)21-25-14(3)26-30-21/h4-11H,1-3H3,(H2,22,23)(H,24,27) PDLCAVUHYFSFFJ-UHFFFAOYSA-N 295187 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 72 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295187&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472699 381618279 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563619 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)Nc1cccc(C)n1 InChI=1S/C21H20N6O3S/c1-12-7-8-16(31(28,29)27-19-6-4-5-13(2)24-19)10-17(12)15-9-18(20(22)23-11-15)21-25-14(3)26-30-21/h4-11H,1-3H3,(H2,22,23)(H,24,27) PDLCAVUHYFSFFJ-UHFFFAOYSA-N 295187 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 72 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295187&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472699 381618279 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563620 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)Nc1cccc(C)n1 InChI=1S/C21H20N6O3S/c1-12-7-8-16(31(28,29)27-19-6-4-5-13(2)24-19)10-17(12)15-9-18(20(22)23-11-15)21-25-14(3)26-30-21/h4-11H,1-3H3,(H2,22,23)(H,24,27) PDLCAVUHYFSFFJ-UHFFFAOYSA-N 295187 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 72 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295187&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472699 381618279 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563621 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)Nc1cccc(C)n1 InChI=1S/C21H20N6O3S/c1-12-7-8-16(31(28,29)27-19-6-4-5-13(2)24-19)10-17(12)15-9-18(20(22)23-11-15)21-25-14(3)26-30-21/h4-11H,1-3H3,(H2,22,23)(H,24,27) PDLCAVUHYFSFFJ-UHFFFAOYSA-N 295187 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 72 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295187&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472699 381618279 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563622 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)Nc1cccc(C)n1 InChI=1S/C21H20N6O3S/c1-12-7-8-16(31(28,29)27-19-6-4-5-13(2)24-19)10-17(12)15-9-18(20(22)23-11-15)21-25-14(3)26-30-21/h4-11H,1-3H3,(H2,22,23)(H,24,27) PDLCAVUHYFSFFJ-UHFFFAOYSA-N 295187 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 72 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 62.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295187&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472699 381618279 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563623 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)Nc1cccc(C)n1 InChI=1S/C21H20N6O3S/c1-12-7-8-16(31(28,29)27-19-6-4-5-13(2)24-19)10-17(12)15-9-18(20(22)23-11-15)21-25-14(3)26-30-21/h4-11H,1-3H3,(H2,22,23)(H,24,27) PDLCAVUHYFSFFJ-UHFFFAOYSA-N 295187 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 72 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295187&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472699 381618279 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563624 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)Nc1cccc(C)n1 InChI=1S/C21H20N6O3S/c1-12-7-8-16(31(28,29)27-19-6-4-5-13(2)24-19)10-17(12)15-9-18(20(22)23-11-15)21-25-14(3)26-30-21/h4-11H,1-3H3,(H2,22,23)(H,24,27) PDLCAVUHYFSFFJ-UHFFFAOYSA-N 295187 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-(6-methylpyridin-2-yl)benzenesulfonamide::US10112926, Example 72 Serine/threonine-protein kinase mTOR Human 370 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295187&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118472699 381618279 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563625 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)21-5-6-23)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)22-26-17/h3-4,7-10,21,23H,5-6H2,1-2H3,(H2,19,20) MFBREKOQHXGTEB-UHFFFAOYSA-N 295188 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 73 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 240 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295188&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470189 381618280 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563626 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)21-5-6-23)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)22-26-17/h3-4,7-10,21,23H,5-6H2,1-2H3,(H2,19,20) MFBREKOQHXGTEB-UHFFFAOYSA-N 295188 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 73 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295188&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470189 381618280 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563627 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)21-5-6-23)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)22-26-17/h3-4,7-10,21,23H,5-6H2,1-2H3,(H2,19,20) MFBREKOQHXGTEB-UHFFFAOYSA-N 295188 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 73 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295188&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470189 381618280 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563628 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)21-5-6-23)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)22-26-17/h3-4,7-10,21,23H,5-6H2,1-2H3,(H2,19,20) MFBREKOQHXGTEB-UHFFFAOYSA-N 295188 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 73 Phosphatidylinositol 4-kinase beta Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295188&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470189 381618280 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563629 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)21-5-6-23)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)22-26-17/h3-4,7-10,21,23H,5-6H2,1-2H3,(H2,19,20) MFBREKOQHXGTEB-UHFFFAOYSA-N 295188 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 73 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 520 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295188&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470189 381618280 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563630 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)21-5-6-23)9-15(11)13-8-16(18(19)20-10-13)17-7-12(2)22-26-17/h3-4,7-10,21,23H,5-6H2,1-2H3,(H2,19,20) MFBREKOQHXGTEB-UHFFFAOYSA-N 295188 3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 73 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295188&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470189 381618280 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563631 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O2S2/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) GONAZVJVEUPAPN-UHFFFAOYSA-N 295189 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 74 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 520 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295189&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469967 381618281 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563632 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O2S2/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) GONAZVJVEUPAPN-UHFFFAOYSA-N 295189 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 74 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295189&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469967 381618281 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563633 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O2S2/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) GONAZVJVEUPAPN-UHFFFAOYSA-N 295189 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 74 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295189&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469967 381618281 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563634 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O2S2/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) GONAZVJVEUPAPN-UHFFFAOYSA-N 295189 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 74 Phosphatidylinositol 4-kinase beta Human 5000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295189&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469967 381618281 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563635 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O2S2/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) GONAZVJVEUPAPN-UHFFFAOYSA-N 295189 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 74 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 60.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295189&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469967 381618281 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563636 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C16H16N4O2S2/c1-9-3-4-12(24(18,21)22)6-13(9)11-5-14(16(17)20-7-11)15-8-19-10(2)23-15/h3-8H,1-2H3,(H2,17,20)(H2,18,21,22) GONAZVJVEUPAPN-UHFFFAOYSA-N 295189 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 74 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295189&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469967 381618281 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563637 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C15H15N5O3S/c1-8-3-4-11(24(17,21)22)6-12(8)10-5-13(14(16)18-7-10)15-19-9(2)20-23-15/h3-7H,1-2H3,(H2,16,18)(H2,17,21,22) SMKWNHCBJWLZQT-UHFFFAOYSA-N 295190 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 75 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 660 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295190&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469951 381618282 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563638 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C15H15N5O3S/c1-8-3-4-11(24(17,21)22)6-12(8)10-5-13(14(16)18-7-10)15-19-9(2)20-23-15/h3-7H,1-2H3,(H2,16,18)(H2,17,21,22) SMKWNHCBJWLZQT-UHFFFAOYSA-N 295190 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 75 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295190&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469951 381618282 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563639 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C15H15N5O3S/c1-8-3-4-11(24(17,21)22)6-12(8)10-5-13(14(16)18-7-10)15-19-9(2)20-23-15/h3-7H,1-2H3,(H2,16,18)(H2,17,21,22) SMKWNHCBJWLZQT-UHFFFAOYSA-N 295190 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 75 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295190&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469951 381618282 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563640 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C15H15N5O3S/c1-8-3-4-11(24(17,21)22)6-12(8)10-5-13(14(16)18-7-10)15-19-9(2)20-23-15/h3-7H,1-2H3,(H2,16,18)(H2,17,21,22) SMKWNHCBJWLZQT-UHFFFAOYSA-N 295190 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 75 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295190&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469951 381618282 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563641 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C15H15N5O3S/c1-8-3-4-11(24(17,21)22)6-12(8)10-5-13(14(16)18-7-10)15-19-9(2)20-23-15/h3-7H,1-2H3,(H2,16,18)(H2,17,21,22) SMKWNHCBJWLZQT-UHFFFAOYSA-N 295190 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 75 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 75.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295190&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469951 381618282 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563642 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C15H15N5O3S/c1-8-3-4-11(24(17,21)22)6-12(8)10-5-13(14(16)18-7-10)15-19-9(2)20-23-15/h3-7H,1-2H3,(H2,16,18)(H2,17,21,22) SMKWNHCBJWLZQT-UHFFFAOYSA-N 295190 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 75 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295190&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469951 381618282 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563643 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(N)(=O)=O InChI=1S/C15H15N5O3S/c1-8-3-4-11(24(17,21)22)6-12(8)10-5-13(14(16)18-7-10)15-19-9(2)20-23-15/h3-7H,1-2H3,(H2,16,18)(H2,17,21,22) SMKWNHCBJWLZQT-UHFFFAOYSA-N 295190 3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methylbenzenesulfonamide::US10112926, Example 75 Serine/threonine-protein kinase mTOR Human 8200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295190&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118469951 381618282 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563644 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](CO)C1 |r,wU:24.26,26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-2.94,-11.69,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-1.86,-9.81,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295191 US10112926, Example 76a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 350 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295191&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618283 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563645 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](CO)C1 |r,wU:24.26,26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-2.94,-11.69,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-1.86,-9.81,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295191 US10112926, Example 76a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3850 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295191&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618283 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563646 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](CO)C1 |r,wU:24.26,26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-2.94,-11.69,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-1.86,-9.81,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295191 US10112926, Example 76a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295191&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618283 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563647 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](CO)C1 |r,wU:24.26,26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-2.94,-11.69,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-1.86,-9.81,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295191 US10112926, Example 76a Phosphatidylinositol 4-kinase beta Human 7000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295191&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618283 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563648 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](CO)C1 |r,wU:24.26,26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-2.94,-11.69,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-1.86,-9.81,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295191 US10112926, Example 76a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 69.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295191&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618283 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563649 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](CO)C1 |r,wU:24.26,26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-2.94,-11.69,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-1.86,-9.81,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295191 US10112926, Example 76a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 530 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295191&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618283 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563650 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](CO)C1 |r,wU:24.26,wD:26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-1.86,-9.81,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-2.94,-11.69,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295192 US10112926, Example 76b Phosphatidylinositol 3-kinase regulatory subunit alpha Human 210 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295192&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618284 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563651 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](CO)C1 |r,wU:24.26,wD:26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-1.86,-9.81,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-2.94,-11.69,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295192 US10112926, Example 76b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295192&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618284 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563652 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](CO)C1 |r,wU:24.26,wD:26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-1.86,-9.81,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-2.94,-11.69,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295192 US10112926, Example 76b Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295192&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618284 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563653 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](CO)C1 |r,wU:24.26,wD:26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-1.86,-9.81,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-2.94,-11.69,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295192 US10112926, Example 76b Phosphatidylinositol 4-kinase beta Human 6800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295192&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618284 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563654 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](CO)C1 |r,wU:24.26,wD:26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-1.86,-9.81,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-2.94,-11.69,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295192 US10112926, Example 76b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 38.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295192&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618284 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563655 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](CO)C1 |r,wU:24.26,wD:26.29,(4.78,-6.84,;4.01,-5.51,;4.48,-4.05,;3.24,-3.14,;1.99,-4.05,;2.47,-5.51,;.66,-3.28,;-.68,-4.05,;-2.01,-3.28,;-2.01,-1.74,;-.68,-.97,;.66,-1.74,;1.99,-.97,;-3.34,-4.05,;-3.34,-5.59,;-4.68,-6.36,;-6.01,-5.59,;-6.01,-4.05,;-4.68,-3.28,;-4.68,-1.74,;-4.68,-7.9,;-6.22,-7.9,;-3.14,-7.9,;-4.68,-9.44,;-3.34,-10.21,;-1.86,-9.81,;-1.46,-11.29,;-.12,-12.06,;1.21,-11.29,;-2.94,-11.69,)| InChI=1S/C20H23N5O4S/c1-11-3-4-16(30(27,28)25-15-5-13(6-15)10-26)8-17(11)14-7-18(19(21)22-9-14)20-23-12(2)24-29-20/h3-4,7-9,13,15,25-26H,5-6,10H2,1-2H3,(H2,21,22) RTTVESHNTCUEOK-UHFFFAOYSA-N 295192 US10112926, Example 76b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295192&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472593 381618284 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563656 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:25.27,wD:28.31,(8.67,3.46,;7.34,2.69,;6,3.47,;4.67,2.69,;4.67,1.16,;6,.38,;7.34,1.16,;3.33,3.47,;2,2.7,;.67,3.47,;.67,5,;2,5.77,;3.33,5,;4.67,5.78,;-.67,2.69,;-.67,1.15,;-2,.38,;-3.33,1.15,;-3.33,2.69,;-2,3.46,;-2,5,;-2,-1.16,;-3.54,-1.16,;-.46,-1.16,;-2,-2.7,;-3.33,-3.47,;-3.33,-5.01,;-4.67,-5.78,;-6,-5.01,;-7.34,-5.78,;-8.67,-5.01,;-6,-3.47,;-4.67,-2.69,)| InChI=1S/C25H30N4O3S/c1-16-3-8-22(33(31,32)29-21-6-4-18(15-30)5-7-21)13-23(16)20-12-24(25(26)28-14-20)19-9-10-27-17(2)11-19/h3,8-14,18,21,29-30H,4-7,15H2,1-2H3,(H2,26,28) XOMIVKVWJYDNPK-UHFFFAOYSA-N 295193 trans-3-(2-Amino-2′-methyl-[3,4′-bipyridin]-5-yl)-N-(−4-(hydroxymethyl)cyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 77 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 30.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295193&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470270 381618285 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563657 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:25.27,wD:28.31,(8.67,3.46,;7.34,2.69,;6,3.47,;4.67,2.69,;4.67,1.16,;6,.38,;7.34,1.16,;3.33,3.47,;2,2.7,;.67,3.47,;.67,5,;2,5.77,;3.33,5,;4.67,5.78,;-.67,2.69,;-.67,1.15,;-2,.38,;-3.33,1.15,;-3.33,2.69,;-2,3.46,;-2,5,;-2,-1.16,;-3.54,-1.16,;-.46,-1.16,;-2,-2.7,;-3.33,-3.47,;-3.33,-5.01,;-4.67,-5.78,;-6,-5.01,;-7.34,-5.78,;-8.67,-5.01,;-6,-3.47,;-4.67,-2.69,)| InChI=1S/C25H30N4O3S/c1-16-3-8-22(33(31,32)29-21-6-4-18(15-30)5-7-21)13-23(16)20-12-24(25(26)28-14-20)19-9-10-27-17(2)11-19/h3,8-14,18,21,29-30H,4-7,15H2,1-2H3,(H2,26,28) XOMIVKVWJYDNPK-UHFFFAOYSA-N 295193 trans-3-(2-Amino-2′-methyl-[3,4′-bipyridin]-5-yl)-N-(−4-(hydroxymethyl)cyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 77 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295193&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470270 381618285 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563658 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:25.27,wD:28.31,(8.67,3.46,;7.34,2.69,;6,3.47,;4.67,2.69,;4.67,1.16,;6,.38,;7.34,1.16,;3.33,3.47,;2,2.7,;.67,3.47,;.67,5,;2,5.77,;3.33,5,;4.67,5.78,;-.67,2.69,;-.67,1.15,;-2,.38,;-3.33,1.15,;-3.33,2.69,;-2,3.46,;-2,5,;-2,-1.16,;-3.54,-1.16,;-.46,-1.16,;-2,-2.7,;-3.33,-3.47,;-3.33,-5.01,;-4.67,-5.78,;-6,-5.01,;-7.34,-5.78,;-8.67,-5.01,;-6,-3.47,;-4.67,-2.69,)| InChI=1S/C25H30N4O3S/c1-16-3-8-22(33(31,32)29-21-6-4-18(15-30)5-7-21)13-23(16)20-12-24(25(26)28-14-20)19-9-10-27-17(2)11-19/h3,8-14,18,21,29-30H,4-7,15H2,1-2H3,(H2,26,28) XOMIVKVWJYDNPK-UHFFFAOYSA-N 295193 trans-3-(2-Amino-2′-methyl-[3,4′-bipyridin]-5-yl)-N-(−4-(hydroxymethyl)cyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 77 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295193&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470270 381618285 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563659 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:25.27,wD:28.31,(8.67,3.46,;7.34,2.69,;6,3.47,;4.67,2.69,;4.67,1.16,;6,.38,;7.34,1.16,;3.33,3.47,;2,2.7,;.67,3.47,;.67,5,;2,5.77,;3.33,5,;4.67,5.78,;-.67,2.69,;-.67,1.15,;-2,.38,;-3.33,1.15,;-3.33,2.69,;-2,3.46,;-2,5,;-2,-1.16,;-3.54,-1.16,;-.46,-1.16,;-2,-2.7,;-3.33,-3.47,;-3.33,-5.01,;-4.67,-5.78,;-6,-5.01,;-7.34,-5.78,;-8.67,-5.01,;-6,-3.47,;-4.67,-2.69,)| InChI=1S/C25H30N4O3S/c1-16-3-8-22(33(31,32)29-21-6-4-18(15-30)5-7-21)13-23(16)20-12-24(25(26)28-14-20)19-9-10-27-17(2)11-19/h3,8-14,18,21,29-30H,4-7,15H2,1-2H3,(H2,26,28) XOMIVKVWJYDNPK-UHFFFAOYSA-N 295193 trans-3-(2-Amino-2′-methyl-[3,4′-bipyridin]-5-yl)-N-(−4-(hydroxymethyl)cyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 77 Phosphatidylinositol 4-kinase beta Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295193&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470270 381618285 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563660 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:25.27,wD:28.31,(8.67,3.46,;7.34,2.69,;6,3.47,;4.67,2.69,;4.67,1.16,;6,.38,;7.34,1.16,;3.33,3.47,;2,2.7,;.67,3.47,;.67,5,;2,5.77,;3.33,5,;4.67,5.78,;-.67,2.69,;-.67,1.15,;-2,.38,;-3.33,1.15,;-3.33,2.69,;-2,3.46,;-2,5,;-2,-1.16,;-3.54,-1.16,;-.46,-1.16,;-2,-2.7,;-3.33,-3.47,;-3.33,-5.01,;-4.67,-5.78,;-6,-5.01,;-7.34,-5.78,;-8.67,-5.01,;-6,-3.47,;-4.67,-2.69,)| InChI=1S/C25H30N4O3S/c1-16-3-8-22(33(31,32)29-21-6-4-18(15-30)5-7-21)13-23(16)20-12-24(25(26)28-14-20)19-9-10-27-17(2)11-19/h3,8-14,18,21,29-30H,4-7,15H2,1-2H3,(H2,26,28) XOMIVKVWJYDNPK-UHFFFAOYSA-N 295193 trans-3-(2-Amino-2′-methyl-[3,4′-bipyridin]-5-yl)-N-(−4-(hydroxymethyl)cyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 77 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 31.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295193&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470270 381618285 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563661 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:25.27,wD:28.31,(8.67,3.46,;7.34,2.69,;6,3.47,;4.67,2.69,;4.67,1.16,;6,.38,;7.34,1.16,;3.33,3.47,;2,2.7,;.67,3.47,;.67,5,;2,5.77,;3.33,5,;4.67,5.78,;-.67,2.69,;-.67,1.15,;-2,.38,;-3.33,1.15,;-3.33,2.69,;-2,3.46,;-2,5,;-2,-1.16,;-3.54,-1.16,;-.46,-1.16,;-2,-2.7,;-3.33,-3.47,;-3.33,-5.01,;-4.67,-5.78,;-6,-5.01,;-7.34,-5.78,;-8.67,-5.01,;-6,-3.47,;-4.67,-2.69,)| InChI=1S/C25H30N4O3S/c1-16-3-8-22(33(31,32)29-21-6-4-18(15-30)5-7-21)13-23(16)20-12-24(25(26)28-14-20)19-9-10-27-17(2)11-19/h3,8-14,18,21,29-30H,4-7,15H2,1-2H3,(H2,26,28) XOMIVKVWJYDNPK-UHFFFAOYSA-N 295193 trans-3-(2-Amino-2′-methyl-[3,4′-bipyridin]-5-yl)-N-(−4-(hydroxymethyl)cyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 77 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295193&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470270 381618285 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563662 Cc1cc(ccn1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:25.27,wD:28.31,(8.67,3.46,;7.34,2.69,;6,3.47,;4.67,2.69,;4.67,1.16,;6,.38,;7.34,1.16,;3.33,3.47,;2,2.7,;.67,3.47,;.67,5,;2,5.77,;3.33,5,;4.67,5.78,;-.67,2.69,;-.67,1.15,;-2,.38,;-3.33,1.15,;-3.33,2.69,;-2,3.46,;-2,5,;-2,-1.16,;-3.54,-1.16,;-.46,-1.16,;-2,-2.7,;-3.33,-3.47,;-3.33,-5.01,;-4.67,-5.78,;-6,-5.01,;-7.34,-5.78,;-8.67,-5.01,;-6,-3.47,;-4.67,-2.69,)| InChI=1S/C25H30N4O3S/c1-16-3-8-22(33(31,32)29-21-6-4-18(15-30)5-7-21)13-23(16)20-12-24(25(26)28-14-20)19-9-10-27-17(2)11-19/h3,8-14,18,21,29-30H,4-7,15H2,1-2H3,(H2,26,28) XOMIVKVWJYDNPK-UHFFFAOYSA-N 295193 trans-3-(2-Amino-2′-methyl-[3,4′-bipyridin]-5-yl)-N-(−4-(hydroxymethyl)cyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 77 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295193&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470270 381618285 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563663 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-2.94,5,;-2.94,3.47,;-4.27,2.69,;-4.27,1.15,;-2.94,.38,;-1.61,1.15,;-1.61,2.69,;-.27,3.47,;-.27,5,;1.06,5.78,;2.4,5,;3.73,5.78,;2.4,3.47,;1.06,2.69,;3.73,2.69,;3.73,1.15,;5.19,.68,;5.96,-.65,;7.5,-.65,;8.27,-1.99,;8.27,.68,;6.73,.68,;6.1,1.93,;5.19,3.17,;-2.94,-1.15,;-1.4,-1.15,;-4.48,-1.15,;-2.94,-2.69,;-4.27,-3.47,;-4.27,-5,;-5.61,-5.78,;-6.94,-5,;-8.27,-5.78,;-6.94,-3.47,;-5.61,-2.69,)| InChI=1S/C22H24F3N5O4S/c1-12-2-7-16(35(32,33)30-14-3-5-15(31)6-4-14)9-17(12)13-8-18(20(26)27-11-13)21-28-19(29-34-21)10-22(23,24)25/h2,7-9,11,14-15,30-31H,3-6,10H2,1H3,(H2,26,27) NSWURHBWYFQRSK-UHFFFAOYSA-N 295194 trans-3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 78 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 90.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295194&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470161 381618286 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563664 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-2.94,5,;-2.94,3.47,;-4.27,2.69,;-4.27,1.15,;-2.94,.38,;-1.61,1.15,;-1.61,2.69,;-.27,3.47,;-.27,5,;1.06,5.78,;2.4,5,;3.73,5.78,;2.4,3.47,;1.06,2.69,;3.73,2.69,;3.73,1.15,;5.19,.68,;5.96,-.65,;7.5,-.65,;8.27,-1.99,;8.27,.68,;6.73,.68,;6.1,1.93,;5.19,3.17,;-2.94,-1.15,;-1.4,-1.15,;-4.48,-1.15,;-2.94,-2.69,;-4.27,-3.47,;-4.27,-5,;-5.61,-5.78,;-6.94,-5,;-8.27,-5.78,;-6.94,-3.47,;-5.61,-2.69,)| InChI=1S/C22H24F3N5O4S/c1-12-2-7-16(35(32,33)30-14-3-5-15(31)6-4-14)9-17(12)13-8-18(20(26)27-11-13)21-28-19(29-34-21)10-22(23,24)25/h2,7-9,11,14-15,30-31H,3-6,10H2,1H3,(H2,26,27) NSWURHBWYFQRSK-UHFFFAOYSA-N 295194 trans-3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 78 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295194&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470161 381618286 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563665 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-2.94,5,;-2.94,3.47,;-4.27,2.69,;-4.27,1.15,;-2.94,.38,;-1.61,1.15,;-1.61,2.69,;-.27,3.47,;-.27,5,;1.06,5.78,;2.4,5,;3.73,5.78,;2.4,3.47,;1.06,2.69,;3.73,2.69,;3.73,1.15,;5.19,.68,;5.96,-.65,;7.5,-.65,;8.27,-1.99,;8.27,.68,;6.73,.68,;6.1,1.93,;5.19,3.17,;-2.94,-1.15,;-1.4,-1.15,;-4.48,-1.15,;-2.94,-2.69,;-4.27,-3.47,;-4.27,-5,;-5.61,-5.78,;-6.94,-5,;-8.27,-5.78,;-6.94,-3.47,;-5.61,-2.69,)| InChI=1S/C22H24F3N5O4S/c1-12-2-7-16(35(32,33)30-14-3-5-15(31)6-4-14)9-17(12)13-8-18(20(26)27-11-13)21-28-19(29-34-21)10-22(23,24)25/h2,7-9,11,14-15,30-31H,3-6,10H2,1H3,(H2,26,27) NSWURHBWYFQRSK-UHFFFAOYSA-N 295194 trans-3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 78 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295194&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470161 381618286 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563666 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-2.94,5,;-2.94,3.47,;-4.27,2.69,;-4.27,1.15,;-2.94,.38,;-1.61,1.15,;-1.61,2.69,;-.27,3.47,;-.27,5,;1.06,5.78,;2.4,5,;3.73,5.78,;2.4,3.47,;1.06,2.69,;3.73,2.69,;3.73,1.15,;5.19,.68,;5.96,-.65,;7.5,-.65,;8.27,-1.99,;8.27,.68,;6.73,.68,;6.1,1.93,;5.19,3.17,;-2.94,-1.15,;-1.4,-1.15,;-4.48,-1.15,;-2.94,-2.69,;-4.27,-3.47,;-4.27,-5,;-5.61,-5.78,;-6.94,-5,;-8.27,-5.78,;-6.94,-3.47,;-5.61,-2.69,)| InChI=1S/C22H24F3N5O4S/c1-12-2-7-16(35(32,33)30-14-3-5-15(31)6-4-14)9-17(12)13-8-18(20(26)27-11-13)21-28-19(29-34-21)10-22(23,24)25/h2,7-9,11,14-15,30-31H,3-6,10H2,1H3,(H2,26,27) NSWURHBWYFQRSK-UHFFFAOYSA-N 295194 trans-3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 78 Phosphatidylinositol 4-kinase beta Human 490 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295194&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470161 381618286 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563667 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-2.94,5,;-2.94,3.47,;-4.27,2.69,;-4.27,1.15,;-2.94,.38,;-1.61,1.15,;-1.61,2.69,;-.27,3.47,;-.27,5,;1.06,5.78,;2.4,5,;3.73,5.78,;2.4,3.47,;1.06,2.69,;3.73,2.69,;3.73,1.15,;5.19,.68,;5.96,-.65,;7.5,-.65,;8.27,-1.99,;8.27,.68,;6.73,.68,;6.1,1.93,;5.19,3.17,;-2.94,-1.15,;-1.4,-1.15,;-4.48,-1.15,;-2.94,-2.69,;-4.27,-3.47,;-4.27,-5,;-5.61,-5.78,;-6.94,-5,;-8.27,-5.78,;-6.94,-3.47,;-5.61,-2.69,)| InChI=1S/C22H24F3N5O4S/c1-12-2-7-16(35(32,33)30-14-3-5-15(31)6-4-14)9-17(12)13-8-18(20(26)27-11-13)21-28-19(29-34-21)10-22(23,24)25/h2,7-9,11,14-15,30-31H,3-6,10H2,1H3,(H2,26,27) NSWURHBWYFQRSK-UHFFFAOYSA-N 295194 trans-3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 78 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 18.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295194&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470161 381618286 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563668 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:28.30,wD:31.34,(-2.94,5,;-2.94,3.47,;-4.27,2.69,;-4.27,1.15,;-2.94,.38,;-1.61,1.15,;-1.61,2.69,;-.27,3.47,;-.27,5,;1.06,5.78,;2.4,5,;3.73,5.78,;2.4,3.47,;1.06,2.69,;3.73,2.69,;3.73,1.15,;5.19,.68,;5.96,-.65,;7.5,-.65,;8.27,-1.99,;8.27,.68,;6.73,.68,;6.1,1.93,;5.19,3.17,;-2.94,-1.15,;-1.4,-1.15,;-4.48,-1.15,;-2.94,-2.69,;-4.27,-3.47,;-4.27,-5,;-5.61,-5.78,;-6.94,-5,;-8.27,-5.78,;-6.94,-3.47,;-5.61,-2.69,)| InChI=1S/C22H24F3N5O4S/c1-12-2-7-16(35(32,33)30-14-3-5-15(31)6-4-14)9-17(12)13-8-18(20(26)27-11-13)21-28-19(29-34-21)10-22(23,24)25/h2,7-9,11,14-15,30-31H,3-6,10H2,1H3,(H2,26,27) NSWURHBWYFQRSK-UHFFFAOYSA-N 295194 trans-3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 78 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 100.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295194&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470161 381618286 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563669 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-12-4-5-14(34(31,32)27-7-6-20(2,3)30)9-15(12)13-8-16(18(25)26-11-13)19-28-17(29-33-19)10-21(22,23)24/h4-5,8-9,11,27,30H,6-7,10H2,1-3H3,(H2,25,26) FJZPGNVKNOFELP-UHFFFAOYSA-N 295195 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 79 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 130 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295195&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472702 381618287 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563670 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-12-4-5-14(34(31,32)27-7-6-20(2,3)30)9-15(12)13-8-16(18(25)26-11-13)19-28-17(29-33-19)10-21(22,23)24/h4-5,8-9,11,27,30H,6-7,10H2,1-3H3,(H2,25,26) FJZPGNVKNOFELP-UHFFFAOYSA-N 295195 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 79 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295195&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472702 381618287 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563671 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-12-4-5-14(34(31,32)27-7-6-20(2,3)30)9-15(12)13-8-16(18(25)26-11-13)19-28-17(29-33-19)10-21(22,23)24/h4-5,8-9,11,27,30H,6-7,10H2,1-3H3,(H2,25,26) FJZPGNVKNOFELP-UHFFFAOYSA-N 295195 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 79 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295195&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472702 381618287 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563672 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-12-4-5-14(34(31,32)27-7-6-20(2,3)30)9-15(12)13-8-16(18(25)26-11-13)19-28-17(29-33-19)10-21(22,23)24/h4-5,8-9,11,27,30H,6-7,10H2,1-3H3,(H2,25,26) FJZPGNVKNOFELP-UHFFFAOYSA-N 295195 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 79 Phosphatidylinositol 4-kinase beta Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295195&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472702 381618287 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563673 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-12-4-5-14(34(31,32)27-7-6-20(2,3)30)9-15(12)13-8-16(18(25)26-11-13)19-28-17(29-33-19)10-21(22,23)24/h4-5,8-9,11,27,30H,6-7,10H2,1-3H3,(H2,25,26) FJZPGNVKNOFELP-UHFFFAOYSA-N 295195 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 79 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 34.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295195&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472702 381618287 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563674 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(CC(F)(F)F)no1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H24F3N5O4S/c1-12-4-5-14(34(31,32)27-7-6-20(2,3)30)9-15(12)13-8-16(18(25)26-11-13)19-28-17(29-33-19)10-21(22,23)24/h4-5,8-9,11,27,30H,6-7,10H2,1-3H3,(H2,25,26) FJZPGNVKNOFELP-UHFFFAOYSA-N 295195 3-(6-Amino-5-(3-(2,2,2-trifluoroethyl)-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 79 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 120 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295195&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472702 381618287 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563675 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H25N5O4S/c1-12-4-7-15(31(28,29)24-11-21(2,3)27)9-16(12)14-8-17(18(22)23-10-14)20-25-19(26-30-20)13-5-6-13/h4,7-10,13,24,27H,5-6,11H2,1-3H3,(H2,22,23) IFRFDGPZNZGMAT-UHFFFAOYSA-N 295196 3-(6-Amino-5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 80 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295196&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470071 381618288 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563676 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H25N5O4S/c1-12-4-7-15(31(28,29)24-11-21(2,3)27)9-16(12)14-8-17(18(22)23-10-14)20-25-19(26-30-20)13-5-6-13/h4,7-10,13,24,27H,5-6,11H2,1-3H3,(H2,22,23) IFRFDGPZNZGMAT-UHFFFAOYSA-N 295196 3-(6-Amino-5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 80 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4650 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295196&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470071 381618288 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563677 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H25N5O4S/c1-12-4-7-15(31(28,29)24-11-21(2,3)27)9-16(12)14-8-17(18(22)23-10-14)20-25-19(26-30-20)13-5-6-13/h4,7-10,13,24,27H,5-6,11H2,1-3H3,(H2,22,23) IFRFDGPZNZGMAT-UHFFFAOYSA-N 295196 3-(6-Amino-5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 80 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295196&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470071 381618288 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563678 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H25N5O4S/c1-12-4-7-15(31(28,29)24-11-21(2,3)27)9-16(12)14-8-17(18(22)23-10-14)20-25-19(26-30-20)13-5-6-13/h4,7-10,13,24,27H,5-6,11H2,1-3H3,(H2,22,23) IFRFDGPZNZGMAT-UHFFFAOYSA-N 295196 3-(6-Amino-5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 80 Phosphatidylinositol 4-kinase beta Human 3550 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295196&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470071 381618288 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563679 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H25N5O4S/c1-12-4-7-15(31(28,29)24-11-21(2,3)27)9-16(12)14-8-17(18(22)23-10-14)20-25-19(26-30-20)13-5-6-13/h4,7-10,13,24,27H,5-6,11H2,1-3H3,(H2,22,23) IFRFDGPZNZGMAT-UHFFFAOYSA-N 295196 3-(6-Amino-5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 80 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295196&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470071 381618288 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563680 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H25N5O4S/c1-12-4-7-15(31(28,29)24-11-21(2,3)27)9-16(12)14-8-17(18(22)23-10-14)20-25-19(26-30-20)13-5-6-13/h4,7-10,13,24,27H,5-6,11H2,1-3H3,(H2,22,23) IFRFDGPZNZGMAT-UHFFFAOYSA-N 295196 3-(6-Amino-5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 80 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1150 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295196&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470071 381618288 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563681 Cc1ccc(cc1-c1cnc(N)c(c1)-c1nc(no1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C21H25N5O4S/c1-12-4-7-15(31(28,29)24-11-21(2,3)27)9-16(12)14-8-17(18(22)23-10-14)20-25-19(26-30-20)13-5-6-13/h4,7-10,13,24,27H,5-6,11H2,1-3H3,(H2,22,23) IFRFDGPZNZGMAT-UHFFFAOYSA-N 295196 3-(6-Amino-5-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 80 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295196&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470071 381618288 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563682 Cc1ccc(cc1-c1cnc(N)c(c1)-n1cncn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C18H22N6O3S/c1-12-4-5-14(28(26,27)23-9-18(2,3)25)7-15(12)13-6-16(17(19)21-8-13)24-11-20-10-22-24/h4-8,10-11,23,25H,9H2,1-3H3,(H2,19,21) YBMKGRHRGCAQDY-UHFFFAOYSA-N 295197 3-(6-Amino-5-(1H-1,2,4-triazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 81 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 7500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295197&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470134 381618289 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563683 Cc1ccc(cc1-c1cnc(N)c(c1)-n1cncn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C18H22N6O3S/c1-12-4-5-14(28(26,27)23-9-18(2,3)25)7-15(12)13-6-16(17(19)21-8-13)24-11-20-10-22-24/h4-8,10-11,23,25H,9H2,1-3H3,(H2,19,21) YBMKGRHRGCAQDY-UHFFFAOYSA-N 295197 3-(6-Amino-5-(1H-1,2,4-triazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 81 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295197&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470134 381618289 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563684 Cc1ccc(cc1-c1cnc(N)c(c1)-n1cncn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C18H22N6O3S/c1-12-4-5-14(28(26,27)23-9-18(2,3)25)7-15(12)13-6-16(17(19)21-8-13)24-11-20-10-22-24/h4-8,10-11,23,25H,9H2,1-3H3,(H2,19,21) YBMKGRHRGCAQDY-UHFFFAOYSA-N 295197 3-(6-Amino-5-(1H-1,2,4-triazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 81 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >9800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295197&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470134 381618289 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563685 Cc1ccc(cc1-c1cnc(N)c(c1)-n1cncn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C18H22N6O3S/c1-12-4-5-14(28(26,27)23-9-18(2,3)25)7-15(12)13-6-16(17(19)21-8-13)24-11-20-10-22-24/h4-8,10-11,23,25H,9H2,1-3H3,(H2,19,21) YBMKGRHRGCAQDY-UHFFFAOYSA-N 295197 3-(6-Amino-5-(1H-1,2,4-triazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 81 Phosphatidylinositol 4-kinase beta Human >9775 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295197&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470134 381618289 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563686 Cc1ccc(cc1-c1cnc(N)c(c1)-n1cncn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C18H22N6O3S/c1-12-4-5-14(28(26,27)23-9-18(2,3)25)7-15(12)13-6-16(17(19)21-8-13)24-11-20-10-22-24/h4-8,10-11,23,25H,9H2,1-3H3,(H2,19,21) YBMKGRHRGCAQDY-UHFFFAOYSA-N 295197 3-(6-Amino-5-(1H-1,2,4-triazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 81 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 1800 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295197&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470134 381618289 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563687 Cc1ccc(cc1-c1cnc(N)c(c1)-n1cncn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C18H22N6O3S/c1-12-4-5-14(28(26,27)23-9-18(2,3)25)7-15(12)13-6-16(17(19)21-8-13)24-11-20-10-22-24/h4-8,10-11,23,25H,9H2,1-3H3,(H2,19,21) YBMKGRHRGCAQDY-UHFFFAOYSA-N 295197 3-(6-Amino-5-(1H-1,2,4-triazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 81 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 6180 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295197&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470134 381618289 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563688 Cc1ccc(cc1-c1cnc(N)c(c1)-n1cncn1)S(=O)(=O)NCC(C)(C)O InChI=1S/C18H22N6O3S/c1-12-4-5-14(28(26,27)23-9-18(2,3)25)7-15(12)13-6-16(17(19)21-8-13)24-11-20-10-22-24/h4-8,10-11,23,25H,9H2,1-3H3,(H2,19,21) YBMKGRHRGCAQDY-UHFFFAOYSA-N 295197 3-(6-Amino-5-(1H-1,2,4-triazol-1-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 81 Serine/threonine-protein kinase mTOR Human 6600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295197&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470134 381618289 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563689 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-2.79,2.6,;-1.3,3,;.03,2.23,;-1.7,4.48,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295198 US10112926, Example 82a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 140 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295198&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618290 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563690 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-2.79,2.6,;-1.3,3,;.03,2.23,;-1.7,4.48,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295198 US10112926, Example 82a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1030 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295198&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618290 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563691 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-2.79,2.6,;-1.3,3,;.03,2.23,;-1.7,4.48,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295198 US10112926, Example 82a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 3850 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295198&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618290 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563692 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-2.79,2.6,;-1.3,3,;.03,2.23,;-1.7,4.48,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295198 US10112926, Example 82a Phosphatidylinositol 4-kinase beta Human 1350 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295198&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618290 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563693 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-2.79,2.6,;-1.3,3,;.03,2.23,;-1.7,4.48,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295198 US10112926, Example 82a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 41.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295198&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618290 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563694 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H]1C[C@H](O)C1 |r,wU:24.26,26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-2.79,2.6,;-1.3,3,;.03,2.23,;-1.7,4.48,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295198 US10112926, Example 82a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 190 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295198&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618290 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563695 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-1.7,4.48,;-1.3,3,;.03,2.23,;-2.79,2.6,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295199 US10112926, Example 82b Phosphatidylinositol 3-kinase regulatory subunit alpha Human 230 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295199&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618291 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563696 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-1.7,4.48,;-1.3,3,;.03,2.23,;-2.79,2.6,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295199 US10112926, Example 82b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295199&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618291 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563697 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-1.7,4.48,;-1.3,3,;.03,2.23,;-2.79,2.6,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295199 US10112926, Example 82b Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 2500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295199&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618291 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563698 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-1.7,4.48,;-1.3,3,;.03,2.23,;-2.79,2.6,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295199 US10112926, Example 82b Phosphatidylinositol 4-kinase beta Human 1500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295199&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618291 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563699 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-1.7,4.48,;-1.3,3,;.03,2.23,;-2.79,2.6,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295199 US10112926, Example 82b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 38.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295199&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618291 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563700 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1C[C@H](O)C1 |r,wU:24.26,wD:26.29,(6.06,9.48,;4.52,9.48,;3.61,8.23,;2.15,8.71,;2.15,10.25,;3.61,10.72,;.82,11.02,;-.52,10.25,;-1.85,11.02,;-1.85,12.56,;-.52,13.33,;.82,12.56,;2.15,13.33,;-3.19,10.25,;-3.19,8.71,;-4.52,7.94,;-5.85,8.71,;-5.85,10.25,;-4.52,11.02,;-4.52,12.56,;-4.52,6.4,;-2.98,6.4,;-6.06,6.4,;-4.52,4.86,;-3.19,4.09,;-1.7,4.48,;-1.3,3,;.03,2.23,;-2.79,2.6,)| InChI=1S/C20H22N4O4S/c1-11-3-4-16(29(26,27)24-14-6-15(25)7-14)8-17(11)13-5-18(20(21)23-9-13)19-10-22-12(2)28-19/h3-5,8-10,14-15,24-25H,6-7H2,1-2H3,(H2,21,23) YJIUXGKGVIYTOQ-UHFFFAOYSA-N 295199 US10112926, Example 82b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 210 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295199&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470061 381618291 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563701 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(CO)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-2.98,.32,;-6.06,.32,;-4.52,-1.22,;-4.52,-2.76,;-5.61,-3.85,;-4.52,-4.94,;-4.52,-6.48,;-3.19,-7.25,;-3.43,-3.85,)| InChI=1S/C21H24N4O3S2/c1-12-3-4-17(30(27,28)25-16-5-14(6-16)11-26)8-18(12)15-7-19(21(22)24-9-15)20-10-23-13(2)29-20/h3-4,7-10,14,16,25-26H,5-6,11H2,1-2H3,(H2,22,24) FZAIFTKROVUFIQ-UHFFFAOYSA-N 295200 (1-((3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 83.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295200&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126550882 381618292 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563702 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(CO)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-2.98,.32,;-6.06,.32,;-4.52,-1.22,;-4.52,-2.76,;-5.61,-3.85,;-4.52,-4.94,;-4.52,-6.48,;-3.19,-7.25,;-3.43,-3.85,)| InChI=1S/C21H24N4O3S2/c1-12-3-4-17(30(27,28)25-16-5-14(6-16)11-26)8-18(12)15-7-19(21(22)24-9-15)20-10-23-13(2)29-20/h3-4,7-10,14,16,25-26H,5-6,11H2,1-2H3,(H2,22,24) FZAIFTKROVUFIQ-UHFFFAOYSA-N 295200 (1-((3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 83.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295200&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550882 381618292 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563703 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(CO)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-2.98,.32,;-6.06,.32,;-4.52,-1.22,;-4.52,-2.76,;-5.61,-3.85,;-4.52,-4.94,;-4.52,-6.48,;-3.19,-7.25,;-3.43,-3.85,)| InChI=1S/C21H24N4O3S2/c1-12-3-4-17(30(27,28)25-16-5-14(6-16)11-26)8-18(12)15-7-19(21(22)24-9-15)20-10-23-13(2)29-20/h3-4,7-10,14,16,25-26H,5-6,11H2,1-2H3,(H2,22,24) FZAIFTKROVUFIQ-UHFFFAOYSA-N 295200 (1-((3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 83.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 4600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295200&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126550882 381618292 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563704 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(CO)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-2.98,.32,;-6.06,.32,;-4.52,-1.22,;-4.52,-2.76,;-5.61,-3.85,;-4.52,-4.94,;-4.52,-6.48,;-3.19,-7.25,;-3.43,-3.85,)| InChI=1S/C21H24N4O3S2/c1-12-3-4-17(30(27,28)25-16-5-14(6-16)11-26)8-18(12)15-7-19(21(22)24-9-15)20-10-23-13(2)29-20/h3-4,7-10,14,16,25-26H,5-6,11H2,1-2H3,(H2,22,24) FZAIFTKROVUFIQ-UHFFFAOYSA-N 295200 (1-((3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 83.1 Phosphatidylinositol 4-kinase beta Human 2500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295200&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126550882 381618292 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563705 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(CO)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-2.98,.32,;-6.06,.32,;-4.52,-1.22,;-4.52,-2.76,;-5.61,-3.85,;-4.52,-4.94,;-4.52,-6.48,;-3.19,-7.25,;-3.43,-3.85,)| InChI=1S/C21H24N4O3S2/c1-12-3-4-17(30(27,28)25-16-5-14(6-16)11-26)8-18(12)15-7-19(21(22)24-9-15)20-10-23-13(2)29-20/h3-4,7-10,14,16,25-26H,5-6,11H2,1-2H3,(H2,22,24) FZAIFTKROVUFIQ-UHFFFAOYSA-N 295200 (1-((3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 83.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 170 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295200&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550882 381618292 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563706 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC(CO)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-2.98,.32,;-6.06,.32,;-4.52,-1.22,;-4.52,-2.76,;-5.61,-3.85,;-4.52,-4.94,;-4.52,-6.48,;-3.19,-7.25,;-3.43,-3.85,)| InChI=1S/C21H24N4O3S2/c1-12-3-4-17(30(27,28)25-16-5-14(6-16)11-26)8-18(12)15-7-19(21(22)24-9-15)20-10-23-13(2)29-20/h3-4,7-10,14,16,25-26H,5-6,11H2,1-2H3,(H2,22,24) FZAIFTKROVUFIQ-UHFFFAOYSA-N 295200 (1-((3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)azetidin-3-yl)methanol::US10112926, Example 83.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295200&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550882 381618292 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563707 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O3S2/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) DZTLWKBUHSDUNK-UHFFFAOYSA-N 295201 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 83.2 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295201&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470129 381618293 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563708 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O3S2/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) DZTLWKBUHSDUNK-UHFFFAOYSA-N 295201 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 83.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 6200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295201&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470129 381618293 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563709 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O3S2/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) DZTLWKBUHSDUNK-UHFFFAOYSA-N 295201 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 83.2 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 6200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295201&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470129 381618293 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563710 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O3S2/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) DZTLWKBUHSDUNK-UHFFFAOYSA-N 295201 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 83.2 Phosphatidylinositol 4-kinase beta Human 2400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295201&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470129 381618293 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563711 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O3S2/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) DZTLWKBUHSDUNK-UHFFFAOYSA-N 295201 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 83.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 39.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295201&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470129 381618293 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563712 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O3S2/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) DZTLWKBUHSDUNK-UHFFFAOYSA-N 295201 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-4-methyl-N-(oxetan-3-ylmethyl)benzenesulfonamide::US10112926, Example 83.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 660 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295201&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470129 381618293 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563713 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O4S2/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) GSUIRMQANCJZQD-UHFFFAOYSA-N 295202 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 83.3 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 570 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295202&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470459 381618294 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563714 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O4S2/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) GSUIRMQANCJZQD-UHFFFAOYSA-N 295202 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 83.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295202&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470459 381618294 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563715 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O4S2/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) GSUIRMQANCJZQD-UHFFFAOYSA-N 295202 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 83.3 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 9700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295202&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470459 381618294 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563716 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O4S2/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) GSUIRMQANCJZQD-UHFFFAOYSA-N 295202 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 83.3 Phosphatidylinositol 4-kinase beta Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295202&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470459 381618294 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563717 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O4S2/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) GSUIRMQANCJZQD-UHFFFAOYSA-N 295202 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((3-hydroxyoxetan-3-yl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 83.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 900 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295202&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470459 381618294 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563718 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) ZMLQYUGCULYVRF-UHFFFAOYSA-N 295203 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 83.4 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 350 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295203&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470587 381618295 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563719 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) ZMLQYUGCULYVRF-UHFFFAOYSA-N 295203 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 83.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295203&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470587 381618295 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563720 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) ZMLQYUGCULYVRF-UHFFFAOYSA-N 295203 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 83.4 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295203&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470587 381618295 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563721 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) ZMLQYUGCULYVRF-UHFFFAOYSA-N 295203 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 83.4 Phosphatidylinositol 4-kinase beta Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295203&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470587 381618295 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563722 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) ZMLQYUGCULYVRF-UHFFFAOYSA-N 295203 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 83.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 38.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295203&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470587 381618295 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563723 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) ZMLQYUGCULYVRF-UHFFFAOYSA-N 295203 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(3-hydroxy-2,2-dimethylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 83.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 640 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295203&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470587 381618295 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563724 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O3S2/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HAQJXVVQKLYBFG-UHFFFAOYSA-N 295204 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 83.5 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 430 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295204&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470022 381618296 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563725 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O3S2/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HAQJXVVQKLYBFG-UHFFFAOYSA-N 295204 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 83.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 3400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295204&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470022 381618296 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563726 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O3S2/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HAQJXVVQKLYBFG-UHFFFAOYSA-N 295204 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 83.5 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 5200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295204&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470022 381618296 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563727 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O3S2/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HAQJXVVQKLYBFG-UHFFFAOYSA-N 295204 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 83.5 Phosphatidylinositol 4-kinase beta Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295204&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470022 381618296 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563728 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O3S2/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HAQJXVVQKLYBFG-UHFFFAOYSA-N 295204 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 83.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 86.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295204&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470022 381618296 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563729 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O3S2/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HAQJXVVQKLYBFG-UHFFFAOYSA-N 295204 3-(6-Amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide::US10112926, Example 83.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295204&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470022 381618296 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563730 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1C[C@H](O)C1 |r,wU:25.27,27.30,(5.15,.82,;4.38,2.15,;2.92,2.63,;2.92,4.17,;4.38,4.64,;5.29,3.4,;1.59,4.94,;.25,4.17,;-1.08,4.94,;-1.08,6.48,;.25,7.25,;1.59,6.48,;2.92,7.25,;-2.42,4.17,;-2.42,2.63,;-3.75,1.86,;-5.08,2.63,;-5.08,4.17,;-3.75,4.94,;-3.75,6.48,;-3.75,.32,;-2.21,.32,;-5.29,.32,;-3.75,-1.22,;-2.42,-1.99,;-2.42,-3.53,;-3.5,-4.62,;-2.42,-5.71,;-2.42,-7.25,;-1.33,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)24-10-14-6-16(26)7-14)9-18(12)15-8-19(21(22)23-11-15)20-5-13(2)25-29-20/h3-5,8-9,11,14,16,24,26H,6-7,10H2,1-2H3,(H2,22,23) NGGCUTXLGFVQRS-UHFFFAOYSA-N 295205 cis-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(((1s,3s)-3-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 84 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 270 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295205&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470121 381618297 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563731 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1C[C@H](O)C1 |r,wU:25.27,27.30,(5.15,.82,;4.38,2.15,;2.92,2.63,;2.92,4.17,;4.38,4.64,;5.29,3.4,;1.59,4.94,;.25,4.17,;-1.08,4.94,;-1.08,6.48,;.25,7.25,;1.59,6.48,;2.92,7.25,;-2.42,4.17,;-2.42,2.63,;-3.75,1.86,;-5.08,2.63,;-5.08,4.17,;-3.75,4.94,;-3.75,6.48,;-3.75,.32,;-2.21,.32,;-5.29,.32,;-3.75,-1.22,;-2.42,-1.99,;-2.42,-3.53,;-3.5,-4.62,;-2.42,-5.71,;-2.42,-7.25,;-1.33,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)24-10-14-6-16(26)7-14)9-18(12)15-8-19(21(22)23-11-15)20-5-13(2)25-29-20/h3-5,8-9,11,14,16,24,26H,6-7,10H2,1-2H3,(H2,22,23) NGGCUTXLGFVQRS-UHFFFAOYSA-N 295205 cis-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(((1s,3s)-3-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 84 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4450 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295205&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470121 381618297 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563732 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1C[C@H](O)C1 |r,wU:25.27,27.30,(5.15,.82,;4.38,2.15,;2.92,2.63,;2.92,4.17,;4.38,4.64,;5.29,3.4,;1.59,4.94,;.25,4.17,;-1.08,4.94,;-1.08,6.48,;.25,7.25,;1.59,6.48,;2.92,7.25,;-2.42,4.17,;-2.42,2.63,;-3.75,1.86,;-5.08,2.63,;-5.08,4.17,;-3.75,4.94,;-3.75,6.48,;-3.75,.32,;-2.21,.32,;-5.29,.32,;-3.75,-1.22,;-2.42,-1.99,;-2.42,-3.53,;-3.5,-4.62,;-2.42,-5.71,;-2.42,-7.25,;-1.33,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)24-10-14-6-16(26)7-14)9-18(12)15-8-19(21(22)23-11-15)20-5-13(2)25-29-20/h3-5,8-9,11,14,16,24,26H,6-7,10H2,1-2H3,(H2,22,23) NGGCUTXLGFVQRS-UHFFFAOYSA-N 295205 cis-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(((1s,3s)-3-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 84 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295205&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470121 381618297 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563733 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1C[C@H](O)C1 |r,wU:25.27,27.30,(5.15,.82,;4.38,2.15,;2.92,2.63,;2.92,4.17,;4.38,4.64,;5.29,3.4,;1.59,4.94,;.25,4.17,;-1.08,4.94,;-1.08,6.48,;.25,7.25,;1.59,6.48,;2.92,7.25,;-2.42,4.17,;-2.42,2.63,;-3.75,1.86,;-5.08,2.63,;-5.08,4.17,;-3.75,4.94,;-3.75,6.48,;-3.75,.32,;-2.21,.32,;-5.29,.32,;-3.75,-1.22,;-2.42,-1.99,;-2.42,-3.53,;-3.5,-4.62,;-2.42,-5.71,;-2.42,-7.25,;-1.33,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)24-10-14-6-16(26)7-14)9-18(12)15-8-19(21(22)23-11-15)20-5-13(2)25-29-20/h3-5,8-9,11,14,16,24,26H,6-7,10H2,1-2H3,(H2,22,23) NGGCUTXLGFVQRS-UHFFFAOYSA-N 295205 cis-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(((1s,3s)-3-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 84 Phosphatidylinositol 4-kinase beta Human 2650 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295205&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470121 381618297 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563734 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1C[C@H](O)C1 |r,wU:25.27,27.30,(5.15,.82,;4.38,2.15,;2.92,2.63,;2.92,4.17,;4.38,4.64,;5.29,3.4,;1.59,4.94,;.25,4.17,;-1.08,4.94,;-1.08,6.48,;.25,7.25,;1.59,6.48,;2.92,7.25,;-2.42,4.17,;-2.42,2.63,;-3.75,1.86,;-5.08,2.63,;-5.08,4.17,;-3.75,4.94,;-3.75,6.48,;-3.75,.32,;-2.21,.32,;-5.29,.32,;-3.75,-1.22,;-2.42,-1.99,;-2.42,-3.53,;-3.5,-4.62,;-2.42,-5.71,;-2.42,-7.25,;-1.33,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)24-10-14-6-16(26)7-14)9-18(12)15-8-19(21(22)23-11-15)20-5-13(2)25-29-20/h3-5,8-9,11,14,16,24,26H,6-7,10H2,1-2H3,(H2,22,23) NGGCUTXLGFVQRS-UHFFFAOYSA-N 295205 cis-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(((1s,3s)-3-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 84 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 8.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295205&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470121 381618297 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563735 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1C[C@H](O)C1 |r,wU:25.27,27.30,(5.15,.82,;4.38,2.15,;2.92,2.63,;2.92,4.17,;4.38,4.64,;5.29,3.4,;1.59,4.94,;.25,4.17,;-1.08,4.94,;-1.08,6.48,;.25,7.25,;1.59,6.48,;2.92,7.25,;-2.42,4.17,;-2.42,2.63,;-3.75,1.86,;-5.08,2.63,;-5.08,4.17,;-3.75,4.94,;-3.75,6.48,;-3.75,.32,;-2.21,.32,;-5.29,.32,;-3.75,-1.22,;-2.42,-1.99,;-2.42,-3.53,;-3.5,-4.62,;-2.42,-5.71,;-2.42,-7.25,;-1.33,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)24-10-14-6-16(26)7-14)9-18(12)15-8-19(21(22)23-11-15)20-5-13(2)25-29-20/h3-5,8-9,11,14,16,24,26H,6-7,10H2,1-2H3,(H2,22,23) NGGCUTXLGFVQRS-UHFFFAOYSA-N 295205 cis-3-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(((1s,3s)-3-hydroxycyclobutyl)methyl)-4-methylbenzenesulfonamide::US10112926, Example 84 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 150 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295205&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470121 381618297 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563736 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) HXQFBOHIYKLZRJ-UHFFFAOYSA-N 295206 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 85 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295206&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470184 381618298 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563737 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) HXQFBOHIYKLZRJ-UHFFFAOYSA-N 295206 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 85 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295206&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470184 381618298 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563738 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) HXQFBOHIYKLZRJ-UHFFFAOYSA-N 295206 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 85 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295206&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470184 381618298 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563739 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) HXQFBOHIYKLZRJ-UHFFFAOYSA-N 295206 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 85 Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295206&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470184 381618298 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563740 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) HXQFBOHIYKLZRJ-UHFFFAOYSA-N 295206 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 85 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 20.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295206&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470184 381618298 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563741 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) HXQFBOHIYKLZRJ-UHFFFAOYSA-N 295206 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 85 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 650 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295206&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470184 381618298 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563742 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295207 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 86 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 220 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295207&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470135 381618299 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563743 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295207 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 86 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295207&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470135 381618299 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563744 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295207 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 86 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295207&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470135 381618299 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563745 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295207 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 86 Phosphatidylinositol 4-kinase beta Human 6300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295207&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470135 381618299 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563746 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295207 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 86 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 65.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295207&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470135 381618299 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563747 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295207 (R)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 86 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 290 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295207&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470135 381618299 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563748 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295208 (S)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 87 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 290 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295208&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470346 381618300 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563749 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295208 (S)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 87 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295208&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470346 381618300 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563750 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295208 (S)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 87 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295208&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470346 381618300 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563751 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295208 (S)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 87 Phosphatidylinositol 4-kinase beta Human 6100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295208&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470346 381618300 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563752 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295208 (S)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 87 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 140 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295208&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470346 381618300 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563753 Cc1noc(n1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC[C@@H]1CCOC1 |r| InChI=1S/C20H23N5O4S/c1-12-3-4-16(30(26,27)23-9-14-5-6-28-11-14)8-17(12)15-7-18(19(21)22-10-15)20-24-13(2)25-29-20/h3-4,7-8,10,14,23H,5-6,9,11H2,1-2H3,(H2,21,22) GNQPFHFGZVJSCD-UHFFFAOYSA-N 295208 (S)-3-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-methyl-N-((tetrahydrofuran-3-yl)methyl)benzenesulfonamide::US10112926, Example 87 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 140 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295208&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470346 381618300 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563754 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23ClN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) MSEBGSRJRAODPC-UHFFFAOYSA-N 295209 5-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 88 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 60.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295209&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470361 381618301 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563755 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23ClN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) MSEBGSRJRAODPC-UHFFFAOYSA-N 295209 5-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 88 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 270 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295209&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470361 381618301 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563756 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23ClN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) MSEBGSRJRAODPC-UHFFFAOYSA-N 295209 5-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 88 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295209&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470361 381618301 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563757 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23ClN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) MSEBGSRJRAODPC-UHFFFAOYSA-N 295209 5-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 88 Phosphatidylinositol 4-kinase beta Human 310 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295209&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470361 381618301 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563758 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23ClN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) MSEBGSRJRAODPC-UHFFFAOYSA-N 295209 5-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 88 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 13.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295209&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470361 381618301 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563759 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23ClN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) MSEBGSRJRAODPC-UHFFFAOYSA-N 295209 5-(6-Amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 88 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 70.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295209&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470361 381618301 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563760 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22ClN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DGRSCXKIGGIRPN-UHFFFAOYSA-N 295210 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 89 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 100.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295210&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470096 381618302 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563761 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22ClN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DGRSCXKIGGIRPN-UHFFFAOYSA-N 295210 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 89 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 230 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295210&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470096 381618302 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563762 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22ClN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DGRSCXKIGGIRPN-UHFFFAOYSA-N 295210 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 89 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295210&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470096 381618302 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563763 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22ClN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DGRSCXKIGGIRPN-UHFFFAOYSA-N 295210 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 89 Phosphatidylinositol 4-kinase beta Human 1500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295210&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470096 381618302 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563764 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22ClN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DGRSCXKIGGIRPN-UHFFFAOYSA-N 295210 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 89 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 15.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295210&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470096 381618302 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563765 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(Cl)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22ClN5O4S/c1-10-5-15(20)16(30(27,28)23-9-19(3,4)26)7-13(10)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DGRSCXKIGGIRPN-UHFFFAOYSA-N 295210 5-(6-Amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-2-chloro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 89 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 130 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295210&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470096 381618302 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563766 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(18(21)22-10-14)19-23-9-13(2)28-19/h5-10,24-25H,11H2,1-4H3,(H2,21,22) CICFFAJMTOTWDF-UHFFFAOYSA-N 295211 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 90 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 160 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295211&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469936 381618303 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563767 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(18(21)22-10-14)19-23-9-13(2)28-19/h5-10,24-25H,11H2,1-4H3,(H2,21,22) CICFFAJMTOTWDF-UHFFFAOYSA-N 295211 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 90 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 880 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295211&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469936 381618303 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563768 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(18(21)22-10-14)19-23-9-13(2)28-19/h5-10,24-25H,11H2,1-4H3,(H2,21,22) CICFFAJMTOTWDF-UHFFFAOYSA-N 295211 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 90 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295211&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469936 381618303 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563769 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(18(21)22-10-14)19-23-9-13(2)28-19/h5-10,24-25H,11H2,1-4H3,(H2,21,22) CICFFAJMTOTWDF-UHFFFAOYSA-N 295211 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 90 Phosphatidylinositol 4-kinase beta Human 750 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295211&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469936 381618303 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563770 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(18(21)22-10-14)19-23-9-13(2)28-19/h5-10,24-25H,11H2,1-4H3,(H2,21,22) CICFFAJMTOTWDF-UHFFFAOYSA-N 295211 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 90 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 12.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295211&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469936 381618303 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563771 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H24N4O3S2/c1-12-5-6-15(29(26,27)24-11-20(3,4)25)8-16(12)14-7-17(18(21)22-10-14)19-23-9-13(2)28-19/h5-10,24-25H,11H2,1-4H3,(H2,21,22) CICFFAJMTOTWDF-UHFFFAOYSA-N 295211 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 90 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 320 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295211&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469936 381618303 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563772 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(19(22)23-12-15)20-24-11-14(2)29-20/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,23) MYJVZDXYKKUBQF-UHFFFAOYSA-N 295212 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 91 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 160 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295212&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470336 381618304 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563773 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(19(22)23-12-15)20-24-11-14(2)29-20/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,23) MYJVZDXYKKUBQF-UHFFFAOYSA-N 295212 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 91 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 220 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295212&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470336 381618304 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563774 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(19(22)23-12-15)20-24-11-14(2)29-20/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,23) MYJVZDXYKKUBQF-UHFFFAOYSA-N 295212 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 91 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295212&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470336 381618304 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563775 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(19(22)23-12-15)20-24-11-14(2)29-20/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,23) MYJVZDXYKKUBQF-UHFFFAOYSA-N 295212 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 91 Phosphatidylinositol 4-kinase beta Human 790 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295212&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470336 381618304 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563776 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(19(22)23-12-15)20-24-11-14(2)29-20/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,23) MYJVZDXYKKUBQF-UHFFFAOYSA-N 295212 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 91 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 16.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295212&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470336 381618304 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563777 Cc1cnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)25-8-7-21(3,4)26)10-17(13)15-9-18(19(22)23-12-15)20-24-11-14(2)29-20/h5-6,9-12,25-26H,7-8H2,1-4H3,(H2,22,23) MYJVZDXYKKUBQF-UHFFFAOYSA-N 295212 3-(6-Amino-5-(5-methylthiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 91 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 80.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295212&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470336 381618304 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563778 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(6.06,2.56,;4.52,2.56,;3.61,3.81,;2.15,3.33,;2.15,1.79,;3.61,1.32,;.82,4.1,;-.52,3.33,;-1.85,4.1,;-1.85,5.64,;-.52,6.41,;.82,5.64,;2.15,6.41,;-3.19,3.33,;-3.19,1.79,;-4.52,1.02,;-5.85,1.79,;-5.85,3.33,;-4.52,4.1,;-4.52,5.64,;-4.52,-.52,;-2.98,-.52,;-6.06,-.52,;-4.52,-2.06,;-3.43,-3.15,;-3.83,-4.63,;-2.74,-5.72,;-1.25,-5.32,;-.16,-6.41,;-.85,-3.84,;-1.94,-2.75,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)24-11-15)21-12-30-14(2)25-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) DQZLROXWLDKQMA-UHFFFAOYSA-N 295213 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 92 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295213&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470465 381618305 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563779 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(6.06,2.56,;4.52,2.56,;3.61,3.81,;2.15,3.33,;2.15,1.79,;3.61,1.32,;.82,4.1,;-.52,3.33,;-1.85,4.1,;-1.85,5.64,;-.52,6.41,;.82,5.64,;2.15,6.41,;-3.19,3.33,;-3.19,1.79,;-4.52,1.02,;-5.85,1.79,;-5.85,3.33,;-4.52,4.1,;-4.52,5.64,;-4.52,-.52,;-2.98,-.52,;-6.06,-.52,;-4.52,-2.06,;-3.43,-3.15,;-3.83,-4.63,;-2.74,-5.72,;-1.25,-5.32,;-.16,-6.41,;-.85,-3.84,;-1.94,-2.75,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)24-11-15)21-12-30-14(2)25-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) DQZLROXWLDKQMA-UHFFFAOYSA-N 295213 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 92 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295213&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470465 381618305 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563780 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(6.06,2.56,;4.52,2.56,;3.61,3.81,;2.15,3.33,;2.15,1.79,;3.61,1.32,;.82,4.1,;-.52,3.33,;-1.85,4.1,;-1.85,5.64,;-.52,6.41,;.82,5.64,;2.15,6.41,;-3.19,3.33,;-3.19,1.79,;-4.52,1.02,;-5.85,1.79,;-5.85,3.33,;-4.52,4.1,;-4.52,5.64,;-4.52,-.52,;-2.98,-.52,;-6.06,-.52,;-4.52,-2.06,;-3.43,-3.15,;-3.83,-4.63,;-2.74,-5.72,;-1.25,-5.32,;-.16,-6.41,;-.85,-3.84,;-1.94,-2.75,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)24-11-15)21-12-30-14(2)25-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) DQZLROXWLDKQMA-UHFFFAOYSA-N 295213 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 92 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295213&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470465 381618305 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563781 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(6.06,2.56,;4.52,2.56,;3.61,3.81,;2.15,3.33,;2.15,1.79,;3.61,1.32,;.82,4.1,;-.52,3.33,;-1.85,4.1,;-1.85,5.64,;-.52,6.41,;.82,5.64,;2.15,6.41,;-3.19,3.33,;-3.19,1.79,;-4.52,1.02,;-5.85,1.79,;-5.85,3.33,;-4.52,4.1,;-4.52,5.64,;-4.52,-.52,;-2.98,-.52,;-6.06,-.52,;-4.52,-2.06,;-3.43,-3.15,;-3.83,-4.63,;-2.74,-5.72,;-1.25,-5.32,;-.16,-6.41,;-.85,-3.84,;-1.94,-2.75,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)24-11-15)21-12-30-14(2)25-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) DQZLROXWLDKQMA-UHFFFAOYSA-N 295213 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 92 Phosphatidylinositol 4-kinase beta Human 5100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295213&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470465 381618305 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563782 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(6.06,2.56,;4.52,2.56,;3.61,3.81,;2.15,3.33,;2.15,1.79,;3.61,1.32,;.82,4.1,;-.52,3.33,;-1.85,4.1,;-1.85,5.64,;-.52,6.41,;.82,5.64,;2.15,6.41,;-3.19,3.33,;-3.19,1.79,;-4.52,1.02,;-5.85,1.79,;-5.85,3.33,;-4.52,4.1,;-4.52,5.64,;-4.52,-.52,;-2.98,-.52,;-6.06,-.52,;-4.52,-2.06,;-3.43,-3.15,;-3.83,-4.63,;-2.74,-5.72,;-1.25,-5.32,;-.16,-6.41,;-.85,-3.84,;-1.94,-2.75,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)24-11-15)21-12-30-14(2)25-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) DQZLROXWLDKQMA-UHFFFAOYSA-N 295213 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 92 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 13.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295213&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470465 381618305 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563783 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(6.06,2.56,;4.52,2.56,;3.61,3.81,;2.15,3.33,;2.15,1.79,;3.61,1.32,;.82,4.1,;-.52,3.33,;-1.85,4.1,;-1.85,5.64,;-.52,6.41,;.82,5.64,;2.15,6.41,;-3.19,3.33,;-3.19,1.79,;-4.52,1.02,;-5.85,1.79,;-5.85,3.33,;-4.52,4.1,;-4.52,5.64,;-4.52,-.52,;-2.98,-.52,;-6.06,-.52,;-4.52,-2.06,;-3.43,-3.15,;-3.83,-4.63,;-2.74,-5.72,;-1.25,-5.32,;-.16,-6.41,;-.85,-3.84,;-1.94,-2.75,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)24-11-15)21-12-30-14(2)25-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,24) DQZLROXWLDKQMA-UHFFFAOYSA-N 295213 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 92 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 270 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295213&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470465 381618305 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563784 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)10-17(13)15-9-18(20(22)23-11-15)19-12-29-14(2)25-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) YNMYVNBIKCDIFI-UHFFFAOYSA-N 295214 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 93 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 880 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295214&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469998 381618306 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563785 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)10-17(13)15-9-18(20(22)23-11-15)19-12-29-14(2)25-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) YNMYVNBIKCDIFI-UHFFFAOYSA-N 295214 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 93 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295214&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469998 381618306 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563786 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)10-17(13)15-9-18(20(22)23-11-15)19-12-29-14(2)25-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) YNMYVNBIKCDIFI-UHFFFAOYSA-N 295214 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 93 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295214&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469998 381618306 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563787 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)10-17(13)15-9-18(20(22)23-11-15)19-12-29-14(2)25-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) YNMYVNBIKCDIFI-UHFFFAOYSA-N 295214 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 93 Phosphatidylinositol 4-kinase beta Human 7500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295214&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469998 381618306 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563788 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)10-17(13)15-9-18(20(22)23-11-15)19-12-29-14(2)25-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) YNMYVNBIKCDIFI-UHFFFAOYSA-N 295214 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 93 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 57.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295214&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469998 381618306 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563789 Cc1nc(cs1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C21H26N4O3S2/c1-13-5-6-16(30(27,28)24-8-7-21(3,4)26)10-17(13)15-9-18(20(22)23-11-15)19-12-29-14(2)25-19/h5-6,9-12,24,26H,7-8H2,1-4H3,(H2,22,23) YNMYVNBIKCDIFI-UHFFFAOYSA-N 295214 3-(6-Amino-5-(2-methylthiazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide::US10112926, Example 93 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 450 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295214&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469998 381618306 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563790 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-10-19(2,3)24)7-15(12)13-6-16(18(20)22-8-13)17-9-21-11-27-17/h4-9,11,23-24H,10H2,1-3H3,(H2,20,22) PPGFFMTXKQEFFH-UHFFFAOYSA-N 295215 3-(6-amino-5-(oxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 810 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295215&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470592 381618307 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563791 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-10-19(2,3)24)7-15(12)13-6-16(18(20)22-8-13)17-9-21-11-27-17/h4-9,11,23-24H,10H2,1-3H3,(H2,20,22) PPGFFMTXKQEFFH-UHFFFAOYSA-N 295215 3-(6-amino-5-(oxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295215&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470592 381618307 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563792 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-10-19(2,3)24)7-15(12)13-6-16(18(20)22-8-13)17-9-21-11-27-17/h4-9,11,23-24H,10H2,1-3H3,(H2,20,22) PPGFFMTXKQEFFH-UHFFFAOYSA-N 295215 3-(6-amino-5-(oxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295215&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470592 381618307 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563793 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-10-19(2,3)24)7-15(12)13-6-16(18(20)22-8-13)17-9-21-11-27-17/h4-9,11,23-24H,10H2,1-3H3,(H2,20,22) PPGFFMTXKQEFFH-UHFFFAOYSA-N 295215 3-(6-amino-5-(oxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94a Phosphatidylinositol 4-kinase beta Human 3800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295215&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470592 381618307 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563794 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-10-19(2,3)24)7-15(12)13-6-16(18(20)22-8-13)17-9-21-11-27-17/h4-9,11,23-24H,10H2,1-3H3,(H2,20,22) PPGFFMTXKQEFFH-UHFFFAOYSA-N 295215 3-(6-amino-5-(oxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 180 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295215&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470592 381618307 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563795 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-10-19(2,3)24)7-15(12)13-6-16(18(20)22-8-13)17-9-21-11-27-17/h4-9,11,23-24H,10H2,1-3H3,(H2,20,22) PPGFFMTXKQEFFH-UHFFFAOYSA-N 295215 3-(6-amino-5-(oxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2800 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295215&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470592 381618307 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563796 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-10-19(2,3)24)7-15(12)13-6-16(18(20)22-8-13)17-9-21-11-27-17/h4-9,11,23-24H,10H2,1-3H3,(H2,20,22) PPGFFMTXKQEFFH-UHFFFAOYSA-N 295215 3-(6-amino-5-(oxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94a Serine/threonine-protein kinase mTOR Human 3300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295215&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470592 381618307 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563797 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ncco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(17(20)22-10-13)18-21-6-7-27-18/h4-10,23-24H,11H2,1-3H3,(H2,20,22) QIOZOVYBDJVYEY-UHFFFAOYSA-N 295216 3-(6-amino-5-(oxazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94b Phosphatidylinositol 3-kinase regulatory subunit alpha Human 750 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295216&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470358 381618308 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563798 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ncco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(17(20)22-10-13)18-21-6-7-27-18/h4-10,23-24H,11H2,1-3H3,(H2,20,22) QIOZOVYBDJVYEY-UHFFFAOYSA-N 295216 3-(6-amino-5-(oxazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94b Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295216&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470358 381618308 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563799 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ncco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(17(20)22-10-13)18-21-6-7-27-18/h4-10,23-24H,11H2,1-3H3,(H2,20,22) QIOZOVYBDJVYEY-UHFFFAOYSA-N 295216 3-(6-amino-5-(oxazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94b Phosphatidylinositol 4-kinase beta Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295216&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470358 381618308 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563800 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ncco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(17(20)22-10-13)18-21-6-7-27-18/h4-10,23-24H,11H2,1-3H3,(H2,20,22) QIOZOVYBDJVYEY-UHFFFAOYSA-N 295216 3-(6-amino-5-(oxazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 76.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295216&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470358 381618308 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563801 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ncco1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-4-5-14(28(25,26)23-11-19(2,3)24)9-15(12)13-8-16(17(20)22-10-13)18-21-6-7-27-18/h4-10,23-24H,11H2,1-3H3,(H2,20,22) QIOZOVYBDJVYEY-UHFFFAOYSA-N 295216 3-(6-amino-5-(oxazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 94b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 730 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295216&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470358 381618308 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563802 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;5.45,.54,;5.45,2.08,;6.91,2.56,;7.81,1.31,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C20H22N4O5S/c1-11-3-4-16(30(26,27)24-28-15-7-14(25)8-15)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-29-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) IICBFVCHOUCXJI-UHFFFAOYSA-N 295217 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 95 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 100.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295217&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470514 381618309 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563803 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;5.45,.54,;5.45,2.08,;6.91,2.56,;7.81,1.31,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C20H22N4O5S/c1-11-3-4-16(30(26,27)24-28-15-7-14(25)8-15)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-29-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) IICBFVCHOUCXJI-UHFFFAOYSA-N 295217 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 95 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 690 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295217&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470514 381618309 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563804 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;5.45,.54,;5.45,2.08,;6.91,2.56,;7.81,1.31,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C20H22N4O5S/c1-11-3-4-16(30(26,27)24-28-15-7-14(25)8-15)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-29-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) IICBFVCHOUCXJI-UHFFFAOYSA-N 295217 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 95 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295217&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470514 381618309 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563805 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;5.45,.54,;5.45,2.08,;6.91,2.56,;7.81,1.31,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C20H22N4O5S/c1-11-3-4-16(30(26,27)24-28-15-7-14(25)8-15)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-29-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) IICBFVCHOUCXJI-UHFFFAOYSA-N 295217 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 95 Phosphatidylinositol 4-kinase beta Human 860 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295217&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470514 381618309 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563806 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;5.45,.54,;5.45,2.08,;6.91,2.56,;7.81,1.31,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C20H22N4O5S/c1-11-3-4-16(30(26,27)24-28-15-7-14(25)8-15)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-29-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) IICBFVCHOUCXJI-UHFFFAOYSA-N 295217 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 95 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 14.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295217&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470514 381618309 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563807 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;5.45,.54,;5.45,2.08,;6.91,2.56,;7.81,1.31,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C20H22N4O5S/c1-11-3-4-16(30(26,27)24-28-15-7-14(25)8-15)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-29-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) IICBFVCHOUCXJI-UHFFFAOYSA-N 295217 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 95 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 90.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295217&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470514 381618309 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563808 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NO[C@H]1C[C@H](O)C1 |r,wU:27.30,wD:25.27,(7.68,-1.27,;6.91,.07,;5.45,.54,;5.45,2.08,;6.91,2.56,;7.81,1.31,;4.11,2.85,;2.78,2.08,;1.44,2.85,;1.44,4.39,;2.78,5.16,;4.11,4.39,;5.45,5.16,;.11,2.08,;.11,.54,;-1.22,-.23,;-2.56,.54,;-2.56,2.08,;-1.22,2.85,;-1.22,4.39,;-1.22,-1.77,;.32,-1.77,;-2.76,-1.77,;-1.22,-3.31,;-2.56,-4.08,;-4.1,-4.08,;-5.19,-2.99,;-6.27,-4.08,;-7.81,-4.08,;-5.19,-5.16,)| InChI=1S/C20H22N4O5S/c1-11-3-4-16(30(26,27)24-28-15-7-14(25)8-15)9-17(11)13-6-18(20(21)22-10-13)19-5-12(2)23-29-19/h3-6,9-10,14-15,24-25H,7-8H2,1-2H3,(H2,21,22) IICBFVCHOUCXJI-UHFFFAOYSA-N 295217 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((1r,3r)-3-hydroxycyclobutoxy)-4-methylbenzenesulfonamide::US10112926, Example 95 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295217&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470514 381618309 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563809 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC[C@@H](O)C1 |r| InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)9-15)10-18(12)14-8-19(21(22)23-11-14)20-7-13(2)24-29-20/h3,6-8,10-11,15-16,25-26H,4-5,9H2,1-2H3,(H2,22,23) GUEKBZDTFPBEIB-UHFFFAOYSA-N 295218 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 96 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295218&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126550883 381618310 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563810 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC[C@@H](O)C1 |r| InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)9-15)10-18(12)14-8-19(21(22)23-11-14)20-7-13(2)24-29-20/h3,6-8,10-11,15-16,25-26H,4-5,9H2,1-2H3,(H2,22,23) GUEKBZDTFPBEIB-UHFFFAOYSA-N 295218 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 96 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1380 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295218&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550883 381618310 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563811 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC[C@@H](O)C1 |r| InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)9-15)10-18(12)14-8-19(21(22)23-11-14)20-7-13(2)24-29-20/h3,6-8,10-11,15-16,25-26H,4-5,9H2,1-2H3,(H2,22,23) GUEKBZDTFPBEIB-UHFFFAOYSA-N 295218 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 96 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295218&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126550883 381618310 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563812 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC[C@@H](O)C1 |r| InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)9-15)10-18(12)14-8-19(21(22)23-11-14)20-7-13(2)24-29-20/h3,6-8,10-11,15-16,25-26H,4-5,9H2,1-2H3,(H2,22,23) GUEKBZDTFPBEIB-UHFFFAOYSA-N 295218 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 96 Phosphatidylinositol 4-kinase beta Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295218&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126550883 381618310 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563813 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC[C@@H](O)C1 |r| InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)9-15)10-18(12)14-8-19(21(22)23-11-14)20-7-13(2)24-29-20/h3,6-8,10-11,15-16,25-26H,4-5,9H2,1-2H3,(H2,22,23) GUEKBZDTFPBEIB-UHFFFAOYSA-N 295218 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 96 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 9.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295218&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550883 381618310 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563814 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC[C@@H](O)C1 |r| InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)9-15)10-18(12)14-8-19(21(22)23-11-14)20-7-13(2)24-29-20/h3,6-8,10-11,15-16,25-26H,4-5,9H2,1-2H3,(H2,22,23) GUEKBZDTFPBEIB-UHFFFAOYSA-N 295218 trans-3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(3-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 96 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 630 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295218&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550883 381618310 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563815 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(10.26,-1.16,;8.72,-1.16,;7.82,-2.4,;6.35,-1.92,;6.35,-.39,;7.82,.09,;5.02,.39,;3.69,-.39,;2.35,.39,;2.35,1.92,;3.69,2.69,;5.02,1.92,;6.35,2.69,;1.02,-.39,;-.31,.39,;-1.65,-.39,;-1.65,-1.92,;-.31,-2.69,;1.02,-1.92,;2.35,-2.69,;-2.98,.39,;-2.21,1.72,;-3.75,-.95,;-4.31,1.16,;-5.8,.76,;-6.89,1.85,;-8.38,1.45,;-8.78,-.04,;-10.26,-.44,;-7.69,-1.13,;-6.2,-.73,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) FFRDFQZNAIEKKG-UHFFFAOYSA-N 295219 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 97 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 160 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295219&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470222 381618311 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563816 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(10.26,-1.16,;8.72,-1.16,;7.82,-2.4,;6.35,-1.92,;6.35,-.39,;7.82,.09,;5.02,.39,;3.69,-.39,;2.35,.39,;2.35,1.92,;3.69,2.69,;5.02,1.92,;6.35,2.69,;1.02,-.39,;-.31,.39,;-1.65,-.39,;-1.65,-1.92,;-.31,-2.69,;1.02,-1.92,;2.35,-2.69,;-2.98,.39,;-2.21,1.72,;-3.75,-.95,;-4.31,1.16,;-5.8,.76,;-6.89,1.85,;-8.38,1.45,;-8.78,-.04,;-10.26,-.44,;-7.69,-1.13,;-6.2,-.73,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) FFRDFQZNAIEKKG-UHFFFAOYSA-N 295219 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 97 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295219&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470222 381618311 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563817 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(10.26,-1.16,;8.72,-1.16,;7.82,-2.4,;6.35,-1.92,;6.35,-.39,;7.82,.09,;5.02,.39,;3.69,-.39,;2.35,.39,;2.35,1.92,;3.69,2.69,;5.02,1.92,;6.35,2.69,;1.02,-.39,;-.31,.39,;-1.65,-.39,;-1.65,-1.92,;-.31,-2.69,;1.02,-1.92,;2.35,-2.69,;-2.98,.39,;-2.21,1.72,;-3.75,-.95,;-4.31,1.16,;-5.8,.76,;-6.89,1.85,;-8.38,1.45,;-8.78,-.04,;-10.26,-.44,;-7.69,-1.13,;-6.2,-.73,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) FFRDFQZNAIEKKG-UHFFFAOYSA-N 295219 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 97 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 3800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295219&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470222 381618311 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563818 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(10.26,-1.16,;8.72,-1.16,;7.82,-2.4,;6.35,-1.92,;6.35,-.39,;7.82,.09,;5.02,.39,;3.69,-.39,;2.35,.39,;2.35,1.92,;3.69,2.69,;5.02,1.92,;6.35,2.69,;1.02,-.39,;-.31,.39,;-1.65,-.39,;-1.65,-1.92,;-.31,-2.69,;1.02,-1.92,;2.35,-2.69,;-2.98,.39,;-2.21,1.72,;-3.75,-.95,;-4.31,1.16,;-5.8,.76,;-6.89,1.85,;-8.38,1.45,;-8.78,-.04,;-10.26,-.44,;-7.69,-1.13,;-6.2,-.73,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) FFRDFQZNAIEKKG-UHFFFAOYSA-N 295219 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 97 Phosphatidylinositol 4-kinase beta Human 1340 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295219&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470222 381618311 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563819 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(10.26,-1.16,;8.72,-1.16,;7.82,-2.4,;6.35,-1.92,;6.35,-.39,;7.82,.09,;5.02,.39,;3.69,-.39,;2.35,.39,;2.35,1.92,;3.69,2.69,;5.02,1.92,;6.35,2.69,;1.02,-.39,;-.31,.39,;-1.65,-.39,;-1.65,-1.92,;-.31,-2.69,;1.02,-1.92,;2.35,-2.69,;-2.98,.39,;-2.21,1.72,;-3.75,-.95,;-4.31,1.16,;-5.8,.76,;-6.89,1.85,;-8.38,1.45,;-8.78,-.04,;-10.26,-.44,;-7.69,-1.13,;-6.2,-.73,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) FFRDFQZNAIEKKG-UHFFFAOYSA-N 295219 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 97 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 12.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295219&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470222 381618311 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563820 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(10.26,-1.16,;8.72,-1.16,;7.82,-2.4,;6.35,-1.92,;6.35,-.39,;7.82,.09,;5.02,.39,;3.69,-.39,;2.35,.39,;2.35,1.92,;3.69,2.69,;5.02,1.92,;6.35,2.69,;1.02,-.39,;-.31,.39,;-1.65,-.39,;-1.65,-1.92,;-.31,-2.69,;1.02,-1.92,;2.35,-2.69,;-2.98,.39,;-2.21,1.72,;-3.75,-.95,;-4.31,1.16,;-5.8,.76,;-6.89,1.85,;-8.38,1.45,;-8.78,-.04,;-10.26,-.44,;-7.69,-1.13,;-6.2,-.73,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) FFRDFQZNAIEKKG-UHFFFAOYSA-N 295219 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 97 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 520 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295219&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470222 381618311 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563821 Cc1ncc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:27.30,wD:24.26,(10.26,-1.16,;8.72,-1.16,;7.82,-2.4,;6.35,-1.92,;6.35,-.39,;7.82,.09,;5.02,.39,;3.69,-.39,;2.35,.39,;2.35,1.92,;3.69,2.69,;5.02,1.92,;6.35,2.69,;1.02,-.39,;-.31,.39,;-1.65,-.39,;-1.65,-1.92,;-.31,-2.69,;1.02,-1.92,;2.35,-2.69,;-2.98,.39,;-2.21,1.72,;-3.75,-.95,;-4.31,1.16,;-5.8,.76,;-6.89,1.85,;-8.38,1.45,;-8.78,-.04,;-10.26,-.44,;-7.69,-1.13,;-6.2,-.73,)| InChI=1S/C22H26N4O3S2/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) FFRDFQZNAIEKKG-UHFFFAOYSA-N 295219 3-(6-amino-5-(2-methylthiazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide::US10112926, Example 97 Serine/threonine-protein kinase mTOR Human 6500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295219&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470222 381618311 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563822 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.92,;6.42,1.92,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.7,;.05,3.47,;.05,5.01,;1.38,5.77,;2.71,5.01,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.46,;-2.62,5,;-2.62,-1.16,;-1.08,-1.16,;-4.16,-1.16,;-2.62,-2.7,;-3.96,-3.47,;-3.96,-5.01,;-5.29,-5.77,;-6.62,-5.01,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.7,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) CWWCJCDUPKPEJG-UHFFFAOYSA-N 295220 3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 98 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 210 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295220&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470233 381618312 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563823 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.92,;6.42,1.92,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.7,;.05,3.47,;.05,5.01,;1.38,5.77,;2.71,5.01,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.46,;-2.62,5,;-2.62,-1.16,;-1.08,-1.16,;-4.16,-1.16,;-2.62,-2.7,;-3.96,-3.47,;-3.96,-5.01,;-5.29,-5.77,;-6.62,-5.01,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.7,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) CWWCJCDUPKPEJG-UHFFFAOYSA-N 295220 3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 98 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295220&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470233 381618312 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563824 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.92,;6.42,1.92,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.7,;.05,3.47,;.05,5.01,;1.38,5.77,;2.71,5.01,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.46,;-2.62,5,;-2.62,-1.16,;-1.08,-1.16,;-4.16,-1.16,;-2.62,-2.7,;-3.96,-3.47,;-3.96,-5.01,;-5.29,-5.77,;-6.62,-5.01,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.7,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) CWWCJCDUPKPEJG-UHFFFAOYSA-N 295220 3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 98 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 2500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295220&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470233 381618312 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563825 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.92,;6.42,1.92,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.7,;.05,3.47,;.05,5.01,;1.38,5.77,;2.71,5.01,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.46,;-2.62,5,;-2.62,-1.16,;-1.08,-1.16,;-4.16,-1.16,;-2.62,-2.7,;-3.96,-3.47,;-3.96,-5.01,;-5.29,-5.77,;-6.62,-5.01,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.7,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) CWWCJCDUPKPEJG-UHFFFAOYSA-N 295220 3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 98 Phosphatidylinositol 4-kinase beta Human 830 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295220&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470233 381618312 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563826 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.92,;6.42,1.92,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.7,;.05,3.47,;.05,5.01,;1.38,5.77,;2.71,5.01,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.46,;-2.62,5,;-2.62,-1.16,;-1.08,-1.16,;-4.16,-1.16,;-2.62,-2.7,;-3.96,-3.47,;-3.96,-5.01,;-5.29,-5.77,;-6.62,-5.01,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.7,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) CWWCJCDUPKPEJG-UHFFFAOYSA-N 295220 3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 98 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 15.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295220&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470233 381618312 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563827 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.92,;6.42,1.92,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.7,;.05,3.47,;.05,5.01,;1.38,5.77,;2.71,5.01,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.46,;-2.62,5,;-2.62,-1.16,;-1.08,-1.16,;-4.16,-1.16,;-2.62,-2.7,;-3.96,-3.47,;-3.96,-5.01,;-5.29,-5.77,;-6.62,-5.01,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.7,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) CWWCJCDUPKPEJG-UHFFFAOYSA-N 295220 3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 98 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 210 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295220&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470233 381618312 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563828 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](O)CC1 |r,wU:24.26,wD:27.30,(7.96,1.92,;6.42,1.92,;5.51,.68,;4.05,1.15,;4.05,2.69,;5.51,3.17,;2.71,3.47,;1.38,2.7,;.05,3.47,;.05,5.01,;1.38,5.77,;2.71,5.01,;4.05,5.78,;-1.29,2.69,;-1.29,1.15,;-2.62,.38,;-3.96,1.15,;-3.96,2.69,;-2.62,3.46,;-2.62,5,;-2.62,-1.16,;-1.08,-1.16,;-4.16,-1.16,;-2.62,-2.7,;-3.96,-3.47,;-3.96,-5.01,;-5.29,-5.77,;-6.62,-5.01,;-7.96,-5.78,;-6.62,-3.47,;-5.29,-2.7,)| InChI=1S/C22H26N4O4S/c1-13-3-8-18(31(28,29)26-16-4-6-17(27)7-5-16)10-19(13)15-9-20(22(23)25-11-15)21-12-24-14(2)30-21/h3,8-12,16-17,26-27H,4-7H2,1-2H3,(H2,23,25) CWWCJCDUPKPEJG-UHFFFAOYSA-N 295220 3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1r,4r)-4-hydroxycyclohexyl)-4-methylbenzenesulfonamide hydrochloride::US10112926, Example 98 Serine/threonine-protein kinase mTOR Human 7900 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295220&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470233 381618312 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563829 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H23FN4O5S/c1-11-5-16(21)18(31(27,28)25-29-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)24-30-17/h5-9,25-26H,10H2,1-4H3,(H2,22,23) SEMFARBMXOASOD-UHFFFAOYSA-N 295221 5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide::US10112926, Example 99 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 180 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295221 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295221&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470397 381618313 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563830 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H23FN4O5S/c1-11-5-16(21)18(31(27,28)25-29-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)24-30-17/h5-9,25-26H,10H2,1-4H3,(H2,22,23) SEMFARBMXOASOD-UHFFFAOYSA-N 295221 5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide::US10112926, Example 99 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295221 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295221&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470397 381618313 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563831 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H23FN4O5S/c1-11-5-16(21)18(31(27,28)25-29-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)24-30-17/h5-9,25-26H,10H2,1-4H3,(H2,22,23) SEMFARBMXOASOD-UHFFFAOYSA-N 295221 5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide::US10112926, Example 99 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295221 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295221&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470397 381618313 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563832 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H23FN4O5S/c1-11-5-16(21)18(31(27,28)25-29-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)24-30-17/h5-9,25-26H,10H2,1-4H3,(H2,22,23) SEMFARBMXOASOD-UHFFFAOYSA-N 295221 5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide::US10112926, Example 99 Phosphatidylinositol 4-kinase beta Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295221 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295221&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470397 381618313 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563833 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H23FN4O5S/c1-11-5-16(21)18(31(27,28)25-29-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)24-30-17/h5-9,25-26H,10H2,1-4H3,(H2,22,23) SEMFARBMXOASOD-UHFFFAOYSA-N 295221 5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide::US10112926, Example 99 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 22.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295221 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295221&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470397 381618313 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563834 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H23FN4O5S/c1-11-5-16(21)18(31(27,28)25-29-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)24-30-17/h5-9,25-26H,10H2,1-4H3,(H2,22,23) SEMFARBMXOASOD-UHFFFAOYSA-N 295221 5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide::US10112926, Example 99 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 410 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295221 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295221&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470397 381618313 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563835 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-11-6-12(2)17(30(27,28)23-10-20(4,5)26)8-15(11)14-7-16(18(21)22-9-14)19-24-13(3)25-29-19/h6-9,23,26H,10H2,1-5H3,(H2,21,22) LYSPEQLEBUPCJX-UHFFFAOYSA-N 295222 5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-2,4-dimethylbenzenesulfonamide::US10112926, Example 100 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 260 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295222&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469977 381618314 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563836 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-11-6-12(2)17(30(27,28)23-10-20(4,5)26)8-15(11)14-7-16(18(21)22-9-14)19-24-13(3)25-29-19/h6-9,23,26H,10H2,1-5H3,(H2,21,22) LYSPEQLEBUPCJX-UHFFFAOYSA-N 295222 5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-2,4-dimethylbenzenesulfonamide::US10112926, Example 100 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2250 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295222&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469977 381618314 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563837 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-11-6-12(2)17(30(27,28)23-10-20(4,5)26)8-15(11)14-7-16(18(21)22-9-14)19-24-13(3)25-29-19/h6-9,23,26H,10H2,1-5H3,(H2,21,22) LYSPEQLEBUPCJX-UHFFFAOYSA-N 295222 5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-2,4-dimethylbenzenesulfonamide::US10112926, Example 100 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295222&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469977 381618314 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563838 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-11-6-12(2)17(30(27,28)23-10-20(4,5)26)8-15(11)14-7-16(18(21)22-9-14)19-24-13(3)25-29-19/h6-9,23,26H,10H2,1-5H3,(H2,21,22) LYSPEQLEBUPCJX-UHFFFAOYSA-N 295222 5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-2,4-dimethylbenzenesulfonamide::US10112926, Example 100 Phosphatidylinositol 4-kinase beta Human 4250 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295222&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469977 381618314 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563839 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-11-6-12(2)17(30(27,28)23-10-20(4,5)26)8-15(11)14-7-16(18(21)22-9-14)19-24-13(3)25-29-19/h6-9,23,26H,10H2,1-5H3,(H2,21,22) LYSPEQLEBUPCJX-UHFFFAOYSA-N 295222 5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-2,4-dimethylbenzenesulfonamide::US10112926, Example 100 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 24.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295222&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469977 381618314 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563840 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O4S/c1-11-6-12(2)17(30(27,28)23-10-20(4,5)26)8-15(11)14-7-16(18(21)22-9-14)19-24-13(3)25-29-19/h6-9,23,26H,10H2,1-5H3,(H2,21,22) LYSPEQLEBUPCJX-UHFFFAOYSA-N 295222 5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-2,4-dimethylbenzenesulfonamide::US10112926, Example 100 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295222&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469977 381618314 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563841 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1COC[C@H]1O |r| InChI=1S/C20H22N4O5S/c1-11-3-4-14(30(26,27)24-17-9-28-10-18(17)25)7-15(11)13-6-16(20(21)22-8-13)19-5-12(2)23-29-19/h3-8,17-18,24-25H,9-10H2,1-2H3,(H2,21,22) UVSDWWSWVGVLAM-UHFFFAOYSA-N 295223 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(trans-4-hydroxytetrahydrofuran-3-yl)-4-methylbenzenesulfonamide:trifluoroacetic acid 1:1::US10112926, Example 101.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 520 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295223&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126550885 381618315 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563842 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1COC[C@H]1O |r| InChI=1S/C20H22N4O5S/c1-11-3-4-14(30(26,27)24-17-9-28-10-18(17)25)7-15(11)13-6-16(20(21)22-8-13)19-5-12(2)23-29-19/h3-8,17-18,24-25H,9-10H2,1-2H3,(H2,21,22) UVSDWWSWVGVLAM-UHFFFAOYSA-N 295223 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(trans-4-hydroxytetrahydrofuran-3-yl)-4-methylbenzenesulfonamide:trifluoroacetic acid 1:1::US10112926, Example 101.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 4700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295223&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550885 381618315 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563843 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1COC[C@H]1O |r| InChI=1S/C20H22N4O5S/c1-11-3-4-14(30(26,27)24-17-9-28-10-18(17)25)7-15(11)13-6-16(20(21)22-8-13)19-5-12(2)23-29-19/h3-8,17-18,24-25H,9-10H2,1-2H3,(H2,21,22) UVSDWWSWVGVLAM-UHFFFAOYSA-N 295223 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(trans-4-hydroxytetrahydrofuran-3-yl)-4-methylbenzenesulfonamide:trifluoroacetic acid 1:1::US10112926, Example 101.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295223&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126550885 381618315 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563844 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1COC[C@H]1O |r| InChI=1S/C20H22N4O5S/c1-11-3-4-14(30(26,27)24-17-9-28-10-18(17)25)7-15(11)13-6-16(20(21)22-8-13)19-5-12(2)23-29-19/h3-8,17-18,24-25H,9-10H2,1-2H3,(H2,21,22) UVSDWWSWVGVLAM-UHFFFAOYSA-N 295223 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(trans-4-hydroxytetrahydrofuran-3-yl)-4-methylbenzenesulfonamide:trifluoroacetic acid 1:1::US10112926, Example 101.1 Phosphatidylinositol 4-kinase beta Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295223&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126550885 381618315 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563845 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1COC[C@H]1O |r| InChI=1S/C20H22N4O5S/c1-11-3-4-14(30(26,27)24-17-9-28-10-18(17)25)7-15(11)13-6-16(20(21)22-8-13)19-5-12(2)23-29-19/h3-8,17-18,24-25H,9-10H2,1-2H3,(H2,21,22) UVSDWWSWVGVLAM-UHFFFAOYSA-N 295223 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(trans-4-hydroxytetrahydrofuran-3-yl)-4-methylbenzenesulfonamide:trifluoroacetic acid 1:1::US10112926, Example 101.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 40.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295223&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550885 381618315 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563846 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1COC[C@H]1O |r| InChI=1S/C20H22N4O5S/c1-11-3-4-14(30(26,27)24-17-9-28-10-18(17)25)7-15(11)13-6-16(20(21)22-8-13)19-5-12(2)23-29-19/h3-8,17-18,24-25H,9-10H2,1-2H3,(H2,21,22) UVSDWWSWVGVLAM-UHFFFAOYSA-N 295223 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(trans-4-hydroxytetrahydrofuran-3-yl)-4-methylbenzenesulfonamide:trifluoroacetic acid 1:1::US10112926, Example 101.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 970 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295223&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550885 381618315 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563847 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1COC[C@H]1O |r| InChI=1S/C20H22N4O5S/c1-11-3-4-14(30(26,27)24-17-9-28-10-18(17)25)7-15(11)13-6-16(20(21)22-8-13)19-5-12(2)23-29-19/h3-8,17-18,24-25H,9-10H2,1-2H3,(H2,21,22) UVSDWWSWVGVLAM-UHFFFAOYSA-N 295223 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(trans-4-hydroxytetrahydrofuran-3-yl)-4-methylbenzenesulfonamide:trifluoroacetic acid 1:1::US10112926, Example 101.1 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295223&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 126550885 381618315 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563848 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC[C@H]1O |r| InChI=1S/C21H24N4O4S/c1-12-6-7-15(30(27,28)25-18-4-3-5-19(18)26)10-16(12)14-9-17(21(22)23-11-14)20-8-13(2)24-29-20/h6-11,18-19,25-26H,3-5H2,1-2H3,(H2,22,23) WNFRNSMPYGJUNB-UHFFFAOYSA-N 295224 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((trans)-2-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 101.2 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 440 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295224&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126550886 381618316 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563849 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC[C@H]1O |r| InChI=1S/C21H24N4O4S/c1-12-6-7-15(30(27,28)25-18-4-3-5-19(18)26)10-16(12)14-9-17(21(22)23-11-14)20-8-13(2)24-29-20/h6-11,18-19,25-26H,3-5H2,1-2H3,(H2,22,23) WNFRNSMPYGJUNB-UHFFFAOYSA-N 295224 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((trans)-2-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 101.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295224&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550886 381618316 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563850 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC[C@H]1O |r| InChI=1S/C21H24N4O4S/c1-12-6-7-15(30(27,28)25-18-4-3-5-19(18)26)10-16(12)14-9-17(21(22)23-11-14)20-8-13(2)24-29-20/h6-11,18-19,25-26H,3-5H2,1-2H3,(H2,22,23) WNFRNSMPYGJUNB-UHFFFAOYSA-N 295224 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((trans)-2-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 101.2 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295224&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126550886 381618316 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563851 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC[C@H]1O |r| InChI=1S/C21H24N4O4S/c1-12-6-7-15(30(27,28)25-18-4-3-5-19(18)26)10-16(12)14-9-17(21(22)23-11-14)20-8-13(2)24-29-20/h6-11,18-19,25-26H,3-5H2,1-2H3,(H2,22,23) WNFRNSMPYGJUNB-UHFFFAOYSA-N 295224 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((trans)-2-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 101.2 Phosphatidylinositol 4-kinase beta Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295224&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126550886 381618316 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563852 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC[C@H]1O |r| InChI=1S/C21H24N4O4S/c1-12-6-7-15(30(27,28)25-18-4-3-5-19(18)26)10-16(12)14-9-17(21(22)23-11-14)20-8-13(2)24-29-20/h6-11,18-19,25-26H,3-5H2,1-2H3,(H2,22,23) WNFRNSMPYGJUNB-UHFFFAOYSA-N 295224 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((trans)-2-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 101.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 40.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295224&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550886 381618316 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563853 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC[C@H]1O |r| InChI=1S/C21H24N4O4S/c1-12-6-7-15(30(27,28)25-18-4-3-5-19(18)26)10-16(12)14-9-17(21(22)23-11-14)20-8-13(2)24-29-20/h6-11,18-19,25-26H,3-5H2,1-2H3,(H2,22,23) WNFRNSMPYGJUNB-UHFFFAOYSA-N 295224 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((trans)-2-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 101.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 360 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295224&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126550886 381618316 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563854 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC[C@H]1O |r| InChI=1S/C21H24N4O4S/c1-12-6-7-15(30(27,28)25-18-4-3-5-19(18)26)10-16(12)14-9-17(21(22)23-11-14)20-8-13(2)24-29-20/h6-11,18-19,25-26H,3-5H2,1-2H3,(H2,22,23) WNFRNSMPYGJUNB-UHFFFAOYSA-N 295224 3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-((trans)-2-hydroxycyclopentyl)-4-methylbenzenesulfonamide::US10112926, Example 101.2 Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295224&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 126550886 381618316 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563855 C[C@H]1CN(C[C@@H]1O)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-12-4-5-16(30(27,28)25-10-13(2)19(26)11-25)8-17(12)15-7-18(21(22)23-9-15)20-6-14(3)24-29-20/h4-9,13,19,26H,10-11H2,1-3H3,(H2,22,23) YOGSAMRCKNNUJK-UHFFFAOYSA-N 295225 trans-1-((3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-4-methylpyrrolidin-3-ol::US10112926, Example 101.3 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295225&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472265 381618317 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563856 C[C@H]1CN(C[C@@H]1O)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-12-4-5-16(30(27,28)25-10-13(2)19(26)11-25)8-17(12)15-7-18(21(22)23-9-15)20-6-14(3)24-29-20/h4-9,13,19,26H,10-11H2,1-3H3,(H2,22,23) YOGSAMRCKNNUJK-UHFFFAOYSA-N 295225 trans-1-((3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-4-methylpyrrolidin-3-ol::US10112926, Example 101.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295225&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472265 381618317 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563857 C[C@H]1CN(C[C@@H]1O)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-12-4-5-16(30(27,28)25-10-13(2)19(26)11-25)8-17(12)15-7-18(21(22)23-9-15)20-6-14(3)24-29-20/h4-9,13,19,26H,10-11H2,1-3H3,(H2,22,23) YOGSAMRCKNNUJK-UHFFFAOYSA-N 295225 trans-1-((3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-4-methylpyrrolidin-3-ol::US10112926, Example 101.3 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295225&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472265 381618317 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563858 C[C@H]1CN(C[C@@H]1O)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-12-4-5-16(30(27,28)25-10-13(2)19(26)11-25)8-17(12)15-7-18(21(22)23-9-15)20-6-14(3)24-29-20/h4-9,13,19,26H,10-11H2,1-3H3,(H2,22,23) YOGSAMRCKNNUJK-UHFFFAOYSA-N 295225 trans-1-((3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-4-methylpyrrolidin-3-ol::US10112926, Example 101.3 Phosphatidylinositol 4-kinase beta Human 3600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295225&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472265 381618317 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563859 C[C@H]1CN(C[C@@H]1O)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-12-4-5-16(30(27,28)25-10-13(2)19(26)11-25)8-17(12)15-7-18(21(22)23-9-15)20-6-14(3)24-29-20/h4-9,13,19,26H,10-11H2,1-3H3,(H2,22,23) YOGSAMRCKNNUJK-UHFFFAOYSA-N 295225 trans-1-((3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-4-methylpyrrolidin-3-ol::US10112926, Example 101.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 130 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295225&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472265 381618317 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563860 C[C@H]1CN(C[C@@H]1O)S(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cc(C)no1 |r| InChI=1S/C21H24N4O4S/c1-12-4-5-16(30(27,28)25-10-13(2)19(26)11-25)8-17(12)15-7-18(21(22)23-9-15)20-6-14(3)24-29-20/h4-9,13,19,26H,10-11H2,1-3H3,(H2,22,23) YOGSAMRCKNNUJK-UHFFFAOYSA-N 295225 trans-1-((3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-4-methylphenyl)sulfonyl)-4-methylpyrrolidin-3-ol::US10112926, Example 101.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 790 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295225&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472265 381618317 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563861 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O3S2/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-24-23-12(2)28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) OVCMBXRXDHSOSA-UHFFFAOYSA-N 295226 3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 102 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 3100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295226&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469999 381618318 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563862 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O3S2/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-24-23-12(2)28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) OVCMBXRXDHSOSA-UHFFFAOYSA-N 295226 3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 102 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1750 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295226&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469999 381618318 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563863 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O3S2/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-24-23-12(2)28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) OVCMBXRXDHSOSA-UHFFFAOYSA-N 295226 3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 102 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295226&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469999 381618318 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563864 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O3S2/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-24-23-12(2)28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) OVCMBXRXDHSOSA-UHFFFAOYSA-N 295226 3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 102 Phosphatidylinositol 4-kinase beta Human 8600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295226&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469999 381618318 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563865 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O3S2/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-24-23-12(2)28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) OVCMBXRXDHSOSA-UHFFFAOYSA-N 295226 3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 102 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 55.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295226&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469999 381618318 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563866 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H23N5O3S2/c1-11-5-6-14(29(26,27)22-10-19(3,4)25)8-15(11)13-7-16(17(20)21-9-13)18-24-23-12(2)28-18/h5-9,22,25H,10H2,1-4H3,(H2,20,21) OVCMBXRXDHSOSA-UHFFFAOYSA-N 295226 3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide::US10112926, Example 102 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295226&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469999 381618318 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563867 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295227 US10112926, Example 103a Phosphatidylinositol 3-kinase regulatory subunit alpha Human 620 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295227&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472762 381618319 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563868 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295227 US10112926, Example 103a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 5000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295227&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472762 381618319 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563869 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295227 US10112926, Example 103a Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295227&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472762 381618319 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563870 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295227 US10112926, Example 103a Phosphatidylinositol 4-kinase beta Human 770 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295227&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472762 381618319 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563871 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295227 US10112926, Example 103a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 45.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295227&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472762 381618319 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563872 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295227 US10112926, Example 103a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295227&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472762 381618319 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563873 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295228 US10112926, Example 103b Phosphatidylinositol 3-kinase regulatory subunit alpha Human 500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295228&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472663 381618320 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563874 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295228 US10112926, Example 103b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295228&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472663 381618320 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563875 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295228 US10112926, Example 103b Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295228&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472663 381618320 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563876 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295228 US10112926, Example 103b Phosphatidylinositol 4-kinase beta Human 2000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295228&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472663 381618320 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563877 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295228 US10112926, Example 103b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 72.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295228&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472663 381618320 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563878 Cc1cc(on1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@@H](CO)C(F)(F)F |r| InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)7-14(10)12-6-15(18(23)24-8-12)16-5-11(2)25-30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,24) SVSSPHFLEURYPE-UHFFFAOYSA-N 295228 US10112926, Example 103b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 720 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295228&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472663 381618320 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563879 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC(O)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-6.06,.32,;-2.98,.32,;-4.52,-1.22,;-3.19,-1.99,;-3.19,-3.53,;-4.27,-4.62,;-3.19,-5.71,;-3.19,-7.25,;-2.1,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)25-9-14-5-16(26)6-14)8-18(12)15-7-19(21(22)24-10-15)20-11-23-13(2)29-20/h3-4,7-8,10-11,14,16,25-26H,5-6,9H2,1-2H3,(H2,22,24) LLTMEMCACRUIGZ-UHFFFAOYSA-N 295229 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxycyclobutyl) methyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.1 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 180 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295229&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470269 381618321 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563880 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC(O)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-6.06,.32,;-2.98,.32,;-4.52,-1.22,;-3.19,-1.99,;-3.19,-3.53,;-4.27,-4.62,;-3.19,-5.71,;-3.19,-7.25,;-2.1,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)25-9-14-5-16(26)6-14)8-18(12)15-7-19(21(22)24-10-15)20-11-23-13(2)29-20/h3-4,7-8,10-11,14,16,25-26H,5-6,9H2,1-2H3,(H2,22,24) LLTMEMCACRUIGZ-UHFFFAOYSA-N 295229 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxycyclobutyl) methyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295229&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470269 381618321 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563881 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC(O)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-6.06,.32,;-2.98,.32,;-4.52,-1.22,;-3.19,-1.99,;-3.19,-3.53,;-4.27,-4.62,;-3.19,-5.71,;-3.19,-7.25,;-2.1,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)25-9-14-5-16(26)6-14)8-18(12)15-7-19(21(22)24-10-15)20-11-23-13(2)29-20/h3-4,7-8,10-11,14,16,25-26H,5-6,9H2,1-2H3,(H2,22,24) LLTMEMCACRUIGZ-UHFFFAOYSA-N 295229 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxycyclobutyl) methyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.1 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295229&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470269 381618321 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563882 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC(O)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-6.06,.32,;-2.98,.32,;-4.52,-1.22,;-3.19,-1.99,;-3.19,-3.53,;-4.27,-4.62,;-3.19,-5.71,;-3.19,-7.25,;-2.1,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)25-9-14-5-16(26)6-14)8-18(12)15-7-19(21(22)24-10-15)20-11-23-13(2)29-20/h3-4,7-8,10-11,14,16,25-26H,5-6,9H2,1-2H3,(H2,22,24) LLTMEMCACRUIGZ-UHFFFAOYSA-N 295229 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxycyclobutyl) methyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.1 Phosphatidylinositol 4-kinase beta Human 2400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295229&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470269 381618321 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563883 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC(O)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-6.06,.32,;-2.98,.32,;-4.52,-1.22,;-3.19,-1.99,;-3.19,-3.53,;-4.27,-4.62,;-3.19,-5.71,;-3.19,-7.25,;-2.1,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)25-9-14-5-16(26)6-14)8-18(12)15-7-19(21(22)24-10-15)20-11-23-13(2)29-20/h3-4,7-8,10-11,14,16,25-26H,5-6,9H2,1-2H3,(H2,22,24) LLTMEMCACRUIGZ-UHFFFAOYSA-N 295229 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxycyclobutyl) methyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 120 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295229&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470269 381618321 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563884 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC(O)C1 |(6.06,3.4,;4.52,3.4,;3.61,2.15,;2.15,2.63,;2.15,4.17,;3.61,4.64,;.82,4.94,;-.52,4.17,;-1.85,4.94,;-1.85,6.48,;-.52,7.25,;.82,6.48,;2.15,7.25,;-3.19,4.17,;-3.19,2.63,;-4.52,1.86,;-5.85,2.63,;-5.85,4.17,;-4.52,4.94,;-4.52,6.48,;-4.52,.32,;-6.06,.32,;-2.98,.32,;-4.52,-1.22,;-3.19,-1.99,;-3.19,-3.53,;-4.27,-4.62,;-3.19,-5.71,;-3.19,-7.25,;-2.1,-4.62,)| InChI=1S/C21H24N4O4S/c1-12-3-4-17(30(27,28)25-9-14-5-16(26)6-14)8-18(12)15-7-19(21(22)24-10-15)20-11-23-13(2)29-20/h3-4,7-8,10-11,14,16,25-26H,5-6,9H2,1-2H3,(H2,22,24) LLTMEMCACRUIGZ-UHFFFAOYSA-N 295229 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxycyclobutyl) methyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295229&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470269 381618321 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563885 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) CMECVPSSXLFMPW-UHFFFAOYSA-N 295230 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-2,2- dimethylpropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.2 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 310 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295230&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470190 381618322 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563886 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) CMECVPSSXLFMPW-UHFFFAOYSA-N 295230 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-2,2- dimethylpropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295230&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470190 381618322 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563887 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) CMECVPSSXLFMPW-UHFFFAOYSA-N 295230 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-2,2- dimethylpropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.2 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 3300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295230&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470190 381618322 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563888 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) CMECVPSSXLFMPW-UHFFFAOYSA-N 295230 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-2,2- dimethylpropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.2 Phosphatidylinositol 4-kinase beta Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295230&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470190 381618322 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563889 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) CMECVPSSXLFMPW-UHFFFAOYSA-N 295230 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-2,2- dimethylpropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 280 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295230&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470190 381618322 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563890 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(C)(C)CO InChI=1S/C21H26N4O4S/c1-13-5-6-16(30(27,28)25-11-21(3,4)12-26)8-17(13)15-7-18(20(22)24-9-15)19-10-23-14(2)29-19/h5-10,25-26H,11-12H2,1-4H3,(H2,22,24) CMECVPSSXLFMPW-UHFFFAOYSA-N 295230 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-2,2- dimethylpropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 8900 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295230&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470190 381618322 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563891 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) URDZEXSJWWSUNW-UHFFFAOYSA-N 295231 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(oxetan-3- ylmethyl)benzenesulfon- amide::US10112926, Example 104.3 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 580 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295231&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470197 381618323 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563892 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) URDZEXSJWWSUNW-UHFFFAOYSA-N 295231 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(oxetan-3- ylmethyl)benzenesulfon- amide::US10112926, Example 104.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295231&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470197 381618323 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563893 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) URDZEXSJWWSUNW-UHFFFAOYSA-N 295231 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(oxetan-3- ylmethyl)benzenesulfon- amide::US10112926, Example 104.3 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 4700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295231&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470197 381618323 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563894 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) URDZEXSJWWSUNW-UHFFFAOYSA-N 295231 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(oxetan-3- ylmethyl)benzenesulfon- amide::US10112926, Example 104.3 Phosphatidylinositol 4-kinase beta Human 4600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295231&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470197 381618323 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563895 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) URDZEXSJWWSUNW-UHFFFAOYSA-N 295231 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(oxetan-3- ylmethyl)benzenesulfon- amide::US10112926, Example 104.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 87.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295231&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470197 381618323 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563896 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1COC1 InChI=1S/C20H22N4O4S/c1-12-3-4-16(29(25,26)24-7-14-10-27-11-14)6-17(12)15-5-18(20(21)23-8-15)19-9-22-13(2)28-19/h3-6,8-9,14,24H,7,10-11H2,1-2H3,(H2,21,23) URDZEXSJWWSUNW-UHFFFAOYSA-N 295231 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(oxetan-3- ylmethyl)benzenesulfon- amide::US10112926, Example 104.3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295231&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470197 381618323 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563897 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 190 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563898 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563899 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 4000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563900 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 4-kinase beta Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563901 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 62.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563902 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563903 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HEWXADMEINETGQ-UHFFFAOYSA-N 295233 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxyethyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.5 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 350 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295233&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470398 381618325 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563904 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HEWXADMEINETGQ-UHFFFAOYSA-N 295233 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxyethyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295233&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470398 381618325 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563905 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HEWXADMEINETGQ-UHFFFAOYSA-N 295233 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxyethyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.5 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 2000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295233&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470398 381618325 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563906 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HEWXADMEINETGQ-UHFFFAOYSA-N 295233 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxyethyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.5 Phosphatidylinositol 4-kinase beta Human 3100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295233&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470398 381618325 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563907 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HEWXADMEINETGQ-UHFFFAOYSA-N 295233 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxyethyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 230 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295233&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470398 381618325 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563908 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCO InChI=1S/C18H20N4O4S/c1-11-3-4-14(27(24,25)22-5-6-23)8-15(11)13-7-16(18(19)21-9-13)17-10-20-12(2)26-17/h3-4,7-10,22-23H,5-6H2,1-2H3,(H2,19,21) HEWXADMEINETGQ-UHFFFAOYSA-N 295233 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxyethyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295233&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470398 381618325 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563909 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O4S/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) VZGXFTQRANZCFW-UHFFFAOYSA-N 295234 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxypropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.6 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 220 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295234&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470087 381618326 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563910 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O4S/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) VZGXFTQRANZCFW-UHFFFAOYSA-N 295234 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxypropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295234&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470087 381618326 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563911 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O4S/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) VZGXFTQRANZCFW-UHFFFAOYSA-N 295234 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxypropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.6 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295234&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470087 381618326 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563912 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O4S/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) VZGXFTQRANZCFW-UHFFFAOYSA-N 295234 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxypropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.6 Phosphatidylinositol 4-kinase beta Human 2200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295234&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470087 381618326 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563913 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O4S/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) VZGXFTQRANZCFW-UHFFFAOYSA-N 295234 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxypropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 92.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295234&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470087 381618326 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563914 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCCO InChI=1S/C19H22N4O4S/c1-12-4-5-15(28(25,26)23-6-3-7-24)9-16(12)14-8-17(19(20)22-10-14)18-11-21-13(2)27-18/h4-5,8-11,23-24H,3,6-7H2,1-2H3,(H2,20,22) VZGXFTQRANZCFW-UHFFFAOYSA-N 295234 3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxypropyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295234&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470087 381618326 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563915 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O5S/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) LROPHDOTMYDOGU-UHFFFAOYSA-N 295235 US10112926, Example 104.7::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxyoxetan-3- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 310 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295235&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470442 381618327 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563916 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O5S/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) LROPHDOTMYDOGU-UHFFFAOYSA-N 295235 US10112926, Example 104.7::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxyoxetan-3- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295235&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470442 381618327 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563917 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O5S/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) LROPHDOTMYDOGU-UHFFFAOYSA-N 295235 US10112926, Example 104.7::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxyoxetan-3- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 3200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295235&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470442 381618327 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563918 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O5S/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) LROPHDOTMYDOGU-UHFFFAOYSA-N 295235 US10112926, Example 104.7::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxyoxetan-3- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 1800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295235&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470442 381618327 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563919 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O5S/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) LROPHDOTMYDOGU-UHFFFAOYSA-N 295235 US10112926, Example 104.7::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxyoxetan-3- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 13.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295235&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470442 381618327 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563920 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)COC1 InChI=1S/C20H22N4O5S/c1-12-3-4-15(30(26,27)24-9-20(25)10-28-11-20)6-16(12)14-5-17(19(21)23-7-14)18-8-22-13(2)29-18/h3-8,24-25H,9-11H2,1-2H3,(H2,21,23) LROPHDOTMYDOGU-UHFFFAOYSA-N 295235 US10112926, Example 104.7::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((3- hydroxyoxetan-3- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295235&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470442 381618327 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563921 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCOC1 InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)26-10-16-4-3-7-29-13-16)9-19(14)17-8-20(22(23)25-11-17)21-12-24-15(2)30-21/h5-6,8-9,11-12,16,26H,3-4,7,10,13H2,1-2H3,(H2,23,25) YUOWESWMDNFZDM-UHFFFAOYSA-N 295236 US10112926, Example 104.8::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-((tetrahydro- 2H-pyran-3- yl)methyl)benzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 150 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295236&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470117 381618328 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563922 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCOC1 InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)26-10-16-4-3-7-29-13-16)9-19(14)17-8-20(22(23)25-11-17)21-12-24-15(2)30-21/h5-6,8-9,11-12,16,26H,3-4,7,10,13H2,1-2H3,(H2,23,25) YUOWESWMDNFZDM-UHFFFAOYSA-N 295236 US10112926, Example 104.8::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-((tetrahydro- 2H-pyran-3- yl)methyl)benzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295236&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470117 381618328 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563923 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCOC1 InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)26-10-16-4-3-7-29-13-16)9-19(14)17-8-20(22(23)25-11-17)21-12-24-15(2)30-21/h5-6,8-9,11-12,16,26H,3-4,7,10,13H2,1-2H3,(H2,23,25) YUOWESWMDNFZDM-UHFFFAOYSA-N 295236 US10112926, Example 104.8::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-((tetrahydro- 2H-pyran-3- yl)methyl)benzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 4800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295236&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470117 381618328 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563924 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCOC1 InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)26-10-16-4-3-7-29-13-16)9-19(14)17-8-20(22(23)25-11-17)21-12-24-15(2)30-21/h5-6,8-9,11-12,16,26H,3-4,7,10,13H2,1-2H3,(H2,23,25) YUOWESWMDNFZDM-UHFFFAOYSA-N 295236 US10112926, Example 104.8::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-((tetrahydro- 2H-pyran-3- yl)methyl)benzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 2000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295236&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470117 381618328 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563925 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCOC1 InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)26-10-16-4-3-7-29-13-16)9-19(14)17-8-20(22(23)25-11-17)21-12-24-15(2)30-21/h5-6,8-9,11-12,16,26H,3-4,7,10,13H2,1-2H3,(H2,23,25) YUOWESWMDNFZDM-UHFFFAOYSA-N 295236 US10112926, Example 104.8::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-((tetrahydro- 2H-pyran-3- yl)methyl)benzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 56.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295236&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470117 381618328 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563926 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CCCOC1 InChI=1S/C22H26N4O4S/c1-14-5-6-18(31(27,28)26-10-16-4-3-7-29-13-16)9-19(14)17-8-20(22(23)25-11-17)21-12-24-15(2)30-21/h5-6,8-9,11-12,16,26H,3-4,7,10,13H2,1-2H3,(H2,23,25) YUOWESWMDNFZDM-UHFFFAOYSA-N 295236 US10112926, Example 104.8::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-((tetrahydro- 2H-pyran-3- yl)methyl)benzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 590 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295236&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470117 381618328 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563927 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)25-9-18(19,20)21)6-14(10)12-5-15(17(22)24-7-12)16-8-23-11(2)28-16/h3-8,25H,9H2,1-2H3,(H2,22,24) BKBKVFZENFTPMI-UHFFFAOYSA-N 295237 US10112926, Example 104.9::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(2,2,2- trifluoroethyl)benzene- sulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 220 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295237&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470104 381618329 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563928 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)25-9-18(19,20)21)6-14(10)12-5-15(17(22)24-7-12)16-8-23-11(2)28-16/h3-8,25H,9H2,1-2H3,(H2,22,24) BKBKVFZENFTPMI-UHFFFAOYSA-N 295237 US10112926, Example 104.9::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(2,2,2- trifluoroethyl)benzene- sulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295237&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470104 381618329 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563929 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)25-9-18(19,20)21)6-14(10)12-5-15(17(22)24-7-12)16-8-23-11(2)28-16/h3-8,25H,9H2,1-2H3,(H2,22,24) BKBKVFZENFTPMI-UHFFFAOYSA-N 295237 US10112926, Example 104.9::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(2,2,2- trifluoroethyl)benzene- sulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295237&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470104 381618329 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563930 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)25-9-18(19,20)21)6-14(10)12-5-15(17(22)24-7-12)16-8-23-11(2)28-16/h3-8,25H,9H2,1-2H3,(H2,22,24) BKBKVFZENFTPMI-UHFFFAOYSA-N 295237 US10112926, Example 104.9::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(2,2,2- trifluoroethyl)benzene- sulfonamide Phosphatidylinositol 4-kinase beta Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295237&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470104 381618329 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563931 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)25-9-18(19,20)21)6-14(10)12-5-15(17(22)24-7-12)16-8-23-11(2)28-16/h3-8,25H,9H2,1-2H3,(H2,22,24) BKBKVFZENFTPMI-UHFFFAOYSA-N 295237 US10112926, Example 104.9::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(2,2,2- trifluoroethyl)benzene- sulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 91.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295237&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470104 381618329 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563932 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)(F)F InChI=1S/C18H17F3N4O3S/c1-10-3-4-13(29(26,27)25-9-18(19,20)21)6-14(10)12-5-15(17(22)24-7-12)16-8-23-11(2)28-16/h3-8,25H,9H2,1-2H3,(H2,22,24) BKBKVFZENFTPMI-UHFFFAOYSA-N 295237 US10112926, Example 104.9::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(2,2,2- trifluoroethyl)benzene- sulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295237&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470104 381618329 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563933 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)24-9-17(19)20)6-14(10)12-5-15(18(21)23-7-12)16-8-22-11(2)27-16/h3-8,17,24H,9H2,1-2H3,(H2,21,23) LUEFAVVZVXRANQ-UHFFFAOYSA-N 295238 US10112926, Example 104.10::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2,2- difluoroethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 270 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295238&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470132 381618330 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563934 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)24-9-17(19)20)6-14(10)12-5-15(18(21)23-7-12)16-8-22-11(2)27-16/h3-8,17,24H,9H2,1-2H3,(H2,21,23) LUEFAVVZVXRANQ-UHFFFAOYSA-N 295238 US10112926, Example 104.10::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2,2- difluoroethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295238&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470132 381618330 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563935 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)24-9-17(19)20)6-14(10)12-5-15(18(21)23-7-12)16-8-22-11(2)27-16/h3-8,17,24H,9H2,1-2H3,(H2,21,23) LUEFAVVZVXRANQ-UHFFFAOYSA-N 295238 US10112926, Example 104.10::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2,2- difluoroethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295238&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470132 381618330 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563936 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)24-9-17(19)20)6-14(10)12-5-15(18(21)23-7-12)16-8-22-11(2)27-16/h3-8,17,24H,9H2,1-2H3,(H2,21,23) LUEFAVVZVXRANQ-UHFFFAOYSA-N 295238 US10112926, Example 104.10::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2,2- difluoroethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295238&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470132 381618330 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563937 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)24-9-17(19)20)6-14(10)12-5-15(18(21)23-7-12)16-8-22-11(2)27-16/h3-8,17,24H,9H2,1-2H3,(H2,21,23) LUEFAVVZVXRANQ-UHFFFAOYSA-N 295238 US10112926, Example 104.10::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2,2- difluoroethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 48.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295238&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470132 381618330 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563938 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC(F)F InChI=1S/C18H18F2N4O3S/c1-10-3-4-13(28(25,26)24-9-17(19)20)6-14(10)12-5-15(18(21)23-7-12)16-8-22-11(2)27-16/h3-8,17,24H,9H2,1-2H3,(H2,21,23) LUEFAVVZVXRANQ-UHFFFAOYSA-N 295238 US10112926, Example 104.10::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2,2- difluoroethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295238&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470132 381618330 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563939 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:27.30,wD:24.26,(6.06,1.93,;4.52,1.93,;3.61,.68,;2.15,1.15,;2.15,2.69,;3.61,3.17,;.82,3.47,;-.52,2.69,;-1.85,3.47,;-1.85,5,;-.52,5.78,;.82,5,;2.15,5.78,;-3.19,2.69,;-3.19,1.15,;-4.52,.38,;-5.85,1.15,;-5.85,2.69,;-4.52,3.47,;-4.52,5,;-4.52,-1.15,;-6.06,-1.15,;-2.98,-1.15,;-4.52,-2.69,;-3.19,-3.47,;-3.19,-5,;-1.85,-5.78,;-.52,-5,;.82,-5.78,;2.15,-5,;-.52,-3.47,;-1.85,-2.69,)| InChI=1S/C23H28N4O4S/c1-14-3-8-19(32(29,30)27-18-6-4-16(13-28)5-7-18)10-20(14)17-9-21(23(24)26-11-17)22-12-25-15(2)31-22/h3,8-12,16,18,27-28H,4-7,13H2,1-2H3,(H2,24,26) AZRMEFUCNQGJLU-UHFFFAOYSA-N 295239 US10112926, Example 104.11::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- ((1r,4r)-4- (hydroxymethyl)cyclo- hexyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 30.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295239&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470195 381618331 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563940 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:27.30,wD:24.26,(6.06,1.93,;4.52,1.93,;3.61,.68,;2.15,1.15,;2.15,2.69,;3.61,3.17,;.82,3.47,;-.52,2.69,;-1.85,3.47,;-1.85,5,;-.52,5.78,;.82,5,;2.15,5.78,;-3.19,2.69,;-3.19,1.15,;-4.52,.38,;-5.85,1.15,;-5.85,2.69,;-4.52,3.47,;-4.52,5,;-4.52,-1.15,;-6.06,-1.15,;-2.98,-1.15,;-4.52,-2.69,;-3.19,-3.47,;-3.19,-5,;-1.85,-5.78,;-.52,-5,;.82,-5.78,;2.15,-5,;-.52,-3.47,;-1.85,-2.69,)| InChI=1S/C23H28N4O4S/c1-14-3-8-19(32(29,30)27-18-6-4-16(13-28)5-7-18)10-20(14)17-9-21(23(24)26-11-17)22-12-25-15(2)31-22/h3,8-12,16,18,27-28H,4-7,13H2,1-2H3,(H2,24,26) AZRMEFUCNQGJLU-UHFFFAOYSA-N 295239 US10112926, Example 104.11::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- ((1r,4r)-4- (hydroxymethyl)cyclo- hexyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295239&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470195 381618331 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563941 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:27.30,wD:24.26,(6.06,1.93,;4.52,1.93,;3.61,.68,;2.15,1.15,;2.15,2.69,;3.61,3.17,;.82,3.47,;-.52,2.69,;-1.85,3.47,;-1.85,5,;-.52,5.78,;.82,5,;2.15,5.78,;-3.19,2.69,;-3.19,1.15,;-4.52,.38,;-5.85,1.15,;-5.85,2.69,;-4.52,3.47,;-4.52,5,;-4.52,-1.15,;-6.06,-1.15,;-2.98,-1.15,;-4.52,-2.69,;-3.19,-3.47,;-3.19,-5,;-1.85,-5.78,;-.52,-5,;.82,-5.78,;2.15,-5,;-.52,-3.47,;-1.85,-2.69,)| InChI=1S/C23H28N4O4S/c1-14-3-8-19(32(29,30)27-18-6-4-16(13-28)5-7-18)10-20(14)17-9-21(23(24)26-11-17)22-12-25-15(2)31-22/h3,8-12,16,18,27-28H,4-7,13H2,1-2H3,(H2,24,26) AZRMEFUCNQGJLU-UHFFFAOYSA-N 295239 US10112926, Example 104.11::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- ((1r,4r)-4- (hydroxymethyl)cyclo- hexyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295239&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470195 381618331 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563942 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:27.30,wD:24.26,(6.06,1.93,;4.52,1.93,;3.61,.68,;2.15,1.15,;2.15,2.69,;3.61,3.17,;.82,3.47,;-.52,2.69,;-1.85,3.47,;-1.85,5,;-.52,5.78,;.82,5,;2.15,5.78,;-3.19,2.69,;-3.19,1.15,;-4.52,.38,;-5.85,1.15,;-5.85,2.69,;-4.52,3.47,;-4.52,5,;-4.52,-1.15,;-6.06,-1.15,;-2.98,-1.15,;-4.52,-2.69,;-3.19,-3.47,;-3.19,-5,;-1.85,-5.78,;-.52,-5,;.82,-5.78,;2.15,-5,;-.52,-3.47,;-1.85,-2.69,)| InChI=1S/C23H28N4O4S/c1-14-3-8-19(32(29,30)27-18-6-4-16(13-28)5-7-18)10-20(14)17-9-21(23(24)26-11-17)22-12-25-15(2)31-22/h3,8-12,16,18,27-28H,4-7,13H2,1-2H3,(H2,24,26) AZRMEFUCNQGJLU-UHFFFAOYSA-N 295239 US10112926, Example 104.11::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- ((1r,4r)-4- (hydroxymethyl)cyclo- hexyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 7.00 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295239&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470195 381618331 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563943 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CC[C@H](CO)CC1 |r,wU:27.30,wD:24.26,(6.06,1.93,;4.52,1.93,;3.61,.68,;2.15,1.15,;2.15,2.69,;3.61,3.17,;.82,3.47,;-.52,2.69,;-1.85,3.47,;-1.85,5,;-.52,5.78,;.82,5,;2.15,5.78,;-3.19,2.69,;-3.19,1.15,;-4.52,.38,;-5.85,1.15,;-5.85,2.69,;-4.52,3.47,;-4.52,5,;-4.52,-1.15,;-6.06,-1.15,;-2.98,-1.15,;-4.52,-2.69,;-3.19,-3.47,;-3.19,-5,;-1.85,-5.78,;-.52,-5,;.82,-5.78,;2.15,-5,;-.52,-3.47,;-1.85,-2.69,)| InChI=1S/C23H28N4O4S/c1-14-3-8-19(32(29,30)27-18-6-4-16(13-28)5-7-18)10-20(14)17-9-21(23(24)26-11-17)22-12-25-15(2)31-22/h3,8-12,16,18,27-28H,4-7,13H2,1-2H3,(H2,24,26) AZRMEFUCNQGJLU-UHFFFAOYSA-N 295239 US10112926, Example 104.11::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- ((1r,4r)-4- (hydroxymethyl)cyclo- hexyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 610 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295239&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470195 381618331 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563944 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC1 InChI=1S/C20H22N4O3S/c1-12-3-6-16(28(25,26)24-9-14-4-5-14)8-17(12)15-7-18(20(21)23-10-15)19-11-22-13(2)27-19/h3,6-8,10-11,14,24H,4-5,9H2,1-2H3,(H2,21,23) MBESWNUKFQWNPY-UHFFFAOYSA-N 295240 US10112926, Example 104.12::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- (cyclopropylmethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 130 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295240&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470280 381618332 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563945 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC1 InChI=1S/C20H22N4O3S/c1-12-3-6-16(28(25,26)24-9-14-4-5-14)8-17(12)15-7-18(20(21)23-10-15)19-11-22-13(2)27-19/h3,6-8,10-11,14,24H,4-5,9H2,1-2H3,(H2,21,23) MBESWNUKFQWNPY-UHFFFAOYSA-N 295240 US10112926, Example 104.12::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- (cyclopropylmethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 950 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295240&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470280 381618332 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563946 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC1 InChI=1S/C20H22N4O3S/c1-12-3-6-16(28(25,26)24-9-14-4-5-14)8-17(12)15-7-18(20(21)23-10-15)19-11-22-13(2)27-19/h3,6-8,10-11,14,24H,4-5,9H2,1-2H3,(H2,21,23) MBESWNUKFQWNPY-UHFFFAOYSA-N 295240 US10112926, Example 104.12::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- (cyclopropylmethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295240&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470280 381618332 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563947 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC1 InChI=1S/C20H22N4O3S/c1-12-3-6-16(28(25,26)24-9-14-4-5-14)8-17(12)15-7-18(20(21)23-10-15)19-11-22-13(2)27-19/h3,6-8,10-11,14,24H,4-5,9H2,1-2H3,(H2,21,23) MBESWNUKFQWNPY-UHFFFAOYSA-N 295240 US10112926, Example 104.12::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- (cyclopropylmethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 2100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295240&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470280 381618332 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563948 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC1 InChI=1S/C20H22N4O3S/c1-12-3-6-16(28(25,26)24-9-14-4-5-14)8-17(12)15-7-18(20(21)23-10-15)19-11-22-13(2)27-19/h3,6-8,10-11,14,24H,4-5,9H2,1-2H3,(H2,21,23) MBESWNUKFQWNPY-UHFFFAOYSA-N 295240 US10112926, Example 104.12::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- (cyclopropylmethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 70.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295240&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470280 381618332 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563949 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1CC1 InChI=1S/C20H22N4O3S/c1-12-3-6-16(28(25,26)24-9-14-4-5-14)8-17(12)15-7-18(20(21)23-10-15)19-11-22-13(2)27-19/h3,6-8,10-11,14,24H,4-5,9H2,1-2H3,(H2,21,23) MBESWNUKFQWNPY-UHFFFAOYSA-N 295240 US10112926, Example 104.12::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- (cyclopropylmethyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1500 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295240&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470280 381618332 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563950 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)27-13-23(14-28)5-7-31-8-6-23)10-19(15)17-9-20(22(24)26-11-17)21-12-25-16(2)32-21/h3-4,9-12,27-28H,5-8,13-14H2,1-2H3,(H2,24,26) KHCAURPGZPNTRJ-UHFFFAOYSA-N 295241 US10112926, Example 104.13::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- (hydroxymethyl)tetra- hydro-2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 240 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295241&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470507 381618333 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563951 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)27-13-23(14-28)5-7-31-8-6-23)10-19(15)17-9-20(22(24)26-11-17)21-12-25-16(2)32-21/h3-4,9-12,27-28H,5-8,13-14H2,1-2H3,(H2,24,26) KHCAURPGZPNTRJ-UHFFFAOYSA-N 295241 US10112926, Example 104.13::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- (hydroxymethyl)tetra- hydro-2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295241&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470507 381618333 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563952 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)27-13-23(14-28)5-7-31-8-6-23)10-19(15)17-9-20(22(24)26-11-17)21-12-25-16(2)32-21/h3-4,9-12,27-28H,5-8,13-14H2,1-2H3,(H2,24,26) KHCAURPGZPNTRJ-UHFFFAOYSA-N 295241 US10112926, Example 104.13::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- (hydroxymethyl)tetra- hydro-2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295241&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470507 381618333 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563953 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)27-13-23(14-28)5-7-31-8-6-23)10-19(15)17-9-20(22(24)26-11-17)21-12-25-16(2)32-21/h3-4,9-12,27-28H,5-8,13-14H2,1-2H3,(H2,24,26) KHCAURPGZPNTRJ-UHFFFAOYSA-N 295241 US10112926, Example 104.13::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- (hydroxymethyl)tetra- hydro-2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 3400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295241&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470507 381618333 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563954 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)27-13-23(14-28)5-7-31-8-6-23)10-19(15)17-9-20(22(24)26-11-17)21-12-25-16(2)32-21/h3-4,9-12,27-28H,5-8,13-14H2,1-2H3,(H2,24,26) KHCAURPGZPNTRJ-UHFFFAOYSA-N 295241 US10112926, Example 104.13::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- (hydroxymethyl)tetra- hydro-2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 110 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295241&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470507 381618333 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563955 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(CO)CCOCC1 InChI=1S/C23H28N4O5S/c1-15-3-4-18(33(29,30)27-13-23(14-28)5-7-31-8-6-23)10-19(15)17-9-20(22(24)26-11-17)21-12-25-16(2)32-21/h3-4,9-12,27-28H,5-8,13-14H2,1-2H3,(H2,24,26) KHCAURPGZPNTRJ-UHFFFAOYSA-N 295241 US10112926, Example 104.13::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- (hydroxymethyl)tetra- hydro-2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295241&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470507 381618333 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563956 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)8-16(11)13-7-17(19(20)22-9-13)18-10-21-12(2)26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,22) LYXSLPTXTJXYGM-UHFFFAOYSA-N 295242 US10112926, Example 104.14::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- cyclopropyl-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 210 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295242&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470338 381618334 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563957 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)8-16(11)13-7-17(19(20)22-9-13)18-10-21-12(2)26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,22) LYXSLPTXTJXYGM-UHFFFAOYSA-N 295242 US10112926, Example 104.14::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- cyclopropyl-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295242&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470338 381618334 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563958 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)8-16(11)13-7-17(19(20)22-9-13)18-10-21-12(2)26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,22) LYXSLPTXTJXYGM-UHFFFAOYSA-N 295242 US10112926, Example 104.14::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- cyclopropyl-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295242&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470338 381618334 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563959 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)8-16(11)13-7-17(19(20)22-9-13)18-10-21-12(2)26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,22) LYXSLPTXTJXYGM-UHFFFAOYSA-N 295242 US10112926, Example 104.14::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- cyclopropyl-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295242&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470338 381618334 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563960 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)8-16(11)13-7-17(19(20)22-9-13)18-10-21-12(2)26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,22) LYXSLPTXTJXYGM-UHFFFAOYSA-N 295242 US10112926, Example 104.14::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- cyclopropyl-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 72.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295242&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470338 381618334 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563961 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CC1 InChI=1S/C19H20N4O3S/c1-11-3-6-15(27(24,25)23-14-4-5-14)8-16(11)13-7-17(19(20)22-9-13)18-10-21-12(2)26-18/h3,6-10,14,23H,4-5H2,1-2H3,(H2,20,22) LYXSLPTXTJXYGM-UHFFFAOYSA-N 295242 US10112926, Example 104.14::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N- cyclopropyl-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295242&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470338 381618334 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563962 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cnc(C)o1 InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)23-8-12(2)24)7-16(11)14-6-17(19(20)22-9-14)18-10-21-13(3)27-18/h4-7,9-10,12,23-24H,8H2,1-3H3,(H2,20,22) BHUCXTFJLHAUGW-UHFFFAOYSA-N 295243 US10112926, Example 104.15::rac-3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxypropyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 190 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295243&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470089 381618335 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563963 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cnc(C)o1 InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)23-8-12(2)24)7-16(11)14-6-17(19(20)22-9-14)18-10-21-13(3)27-18/h4-7,9-10,12,23-24H,8H2,1-3H3,(H2,20,22) BHUCXTFJLHAUGW-UHFFFAOYSA-N 295243 US10112926, Example 104.15::rac-3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxypropyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295243&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470089 381618335 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563964 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cnc(C)o1 InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)23-8-12(2)24)7-16(11)14-6-17(19(20)22-9-14)18-10-21-13(3)27-18/h4-7,9-10,12,23-24H,8H2,1-3H3,(H2,20,22) BHUCXTFJLHAUGW-UHFFFAOYSA-N 295243 US10112926, Example 104.15::rac-3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxypropyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295243&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470089 381618335 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563965 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cnc(C)o1 InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)23-8-12(2)24)7-16(11)14-6-17(19(20)22-9-14)18-10-21-13(3)27-18/h4-7,9-10,12,23-24H,8H2,1-3H3,(H2,20,22) BHUCXTFJLHAUGW-UHFFFAOYSA-N 295243 US10112926, Example 104.15::rac-3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxypropyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 1900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295243&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470089 381618335 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563966 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cnc(C)o1 InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)23-8-12(2)24)7-16(11)14-6-17(19(20)22-9-14)18-10-21-13(3)27-18/h4-7,9-10,12,23-24H,8H2,1-3H3,(H2,20,22) BHUCXTFJLHAUGW-UHFFFAOYSA-N 295243 US10112926, Example 104.15::rac-3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxypropyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 30.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295243&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470089 381618335 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563967 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1cnc(C)o1 InChI=1S/C19H22N4O4S/c1-11-4-5-15(28(25,26)23-8-12(2)24)7-16(11)14-6-17(19(20)22-9-14)18-10-21-13(3)27-18/h4-7,9-10,12,23-24H,8H2,1-3H3,(H2,20,22) BHUCXTFJLHAUGW-UHFFFAOYSA-N 295243 US10112926, Example 104.15::rac-3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(2- hydroxypropyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 5000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295243&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470089 381618335 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563968 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 3-kinase regulatory subunit alpha Human 140 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563969 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563970 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563971 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 4-kinase beta Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563972 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 47.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563973 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)C1 InChI=1S/C21H24N4O4S/c1-12-3-6-17(30(27,28)25-15-4-5-16(26)8-15)9-18(12)14-7-19(21(22)24-10-14)20-11-23-13(2)29-20/h3,6-7,9-11,15-16,25-26H,4-5,8H2,1-2H3,(H2,22,24) PSVUWFQVQAHYRE-UHFFFAOYSA-N 295232 US10112926, Example 104.16::(+/-)trans-3-(6-amino- 5-(2-methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxycyclopentyl)-4- methylbenzenesulfon- amide::US10112926, Example 104.4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 3400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295232&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470055 381618324 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563974 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O3S2/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) WVPLMQRDKYAYCC-UHFFFAOYSA-N 295245 US10112926, Example 105::3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295245&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470303 381618336 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563975 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O3S2/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) WVPLMQRDKYAYCC-UHFFFAOYSA-N 295245 US10112926, Example 105::3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 7600 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295245&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470303 381618336 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563976 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O3S2/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) WVPLMQRDKYAYCC-UHFFFAOYSA-N 295245 US10112926, Example 105::3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295245&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470303 381618336 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563977 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O3S2/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) WVPLMQRDKYAYCC-UHFFFAOYSA-N 295245 US10112926, Example 105::3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human 2900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295245&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470303 381618336 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563978 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O3S2/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) WVPLMQRDKYAYCC-UHFFFAOYSA-N 295245 US10112926, Example 105::3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 9.40 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295245&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470303 381618336 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563979 Cc1nnc(s1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H25N5O3S2/c1-12-5-6-15(30(27,28)23-8-7-20(3,4)26)10-16(12)14-9-17(18(21)22-11-14)19-25-24-13(2)29-19/h5-6,9-11,23,26H,7-8H2,1-4H3,(H2,21,22) WVPLMQRDKYAYCC-UHFFFAOYSA-N 295245 US10112926, Example 105::3-(6-amino-5-(5-methyl-1,3,4-thiadiazol-2-yl)pyridin-3-yl)-N-(3-hydroxy-3-methyl butyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 680 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295245&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470303 381618336 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563980 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H26N6O3S/c1-13-5-6-15(30(28,29)24-8-7-20(2,3)27)10-16(13)14-9-17(19(21)22-11-14)18-12-23-26(4)25-18/h5-6,9-12,24,27H,7-8H2,1-4H3,(H2,21,22) FRHKVIMTLRQAGG-UHFFFAOYSA-N 295246 US10112926, Example 106::3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 330 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295246&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470016 381618337 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563981 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H26N6O3S/c1-13-5-6-15(30(28,29)24-8-7-20(2,3)27)10-16(13)14-9-17(19(21)22-11-14)18-12-23-26(4)25-18/h5-6,9-12,24,27H,7-8H2,1-4H3,(H2,21,22) FRHKVIMTLRQAGG-UHFFFAOYSA-N 295246 US10112926, Example 106::3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295246&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470016 381618337 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563982 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H26N6O3S/c1-13-5-6-15(30(28,29)24-8-7-20(2,3)27)10-16(13)14-9-17(19(21)22-11-14)18-12-23-26(4)25-18/h5-6,9-12,24,27H,7-8H2,1-4H3,(H2,21,22) FRHKVIMTLRQAGG-UHFFFAOYSA-N 295246 US10112926, Example 106::3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295246&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470016 381618337 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563983 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H26N6O3S/c1-13-5-6-15(30(28,29)24-8-7-20(2,3)27)10-16(13)14-9-17(19(21)22-11-14)18-12-23-26(4)25-18/h5-6,9-12,24,27H,7-8H2,1-4H3,(H2,21,22) FRHKVIMTLRQAGG-UHFFFAOYSA-N 295246 US10112926, Example 106::3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human 6400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295246&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470016 381618337 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563984 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H26N6O3S/c1-13-5-6-15(30(28,29)24-8-7-20(2,3)27)10-16(13)14-9-17(19(21)22-11-14)18-12-23-26(4)25-18/h5-6,9-12,24,27H,7-8H2,1-4H3,(H2,21,22) FRHKVIMTLRQAGG-UHFFFAOYSA-N 295246 US10112926, Example 106::3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 13.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295246&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470016 381618337 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563985 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H26N6O3S/c1-13-5-6-15(30(28,29)24-8-7-20(2,3)27)10-16(13)14-9-17(19(21)22-11-14)18-12-23-26(4)25-18/h5-6,9-12,24,27H,7-8H2,1-4H3,(H2,21,22) FRHKVIMTLRQAGG-UHFFFAOYSA-N 295246 US10112926, Example 106::3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 720 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295246&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470016 381618337 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563986 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnn(C)n1)S(=O)(=O)NCCC(C)(C)O InChI=1S/C20H26N6O3S/c1-13-5-6-15(30(28,29)24-8-7-20(2,3)27)10-16(13)14-9-17(19(21)22-11-14)18-12-23-26(4)25-18/h5-6,9-12,24,27H,7-8H2,1-4H3,(H2,21,22) FRHKVIMTLRQAGG-UHFFFAOYSA-N 295246 US10112926, Example 106::3-(6-amino-5-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-3-yl)-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide Serine/threonine-protein kinase mTOR Human 7600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295246&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118470016 381618337 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 563987 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) IVWMPAOBMMXESU-UHFFFAOYSA-N 295247 US10112926, Example 107::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride Phosphatidylinositol 3-kinase regulatory subunit alpha Human 50.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295247&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470547 381618338 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563988 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) IVWMPAOBMMXESU-UHFFFAOYSA-N 295247 US10112926, Example 107::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 460 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295247&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470547 381618338 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563989 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) IVWMPAOBMMXESU-UHFFFAOYSA-N 295247 US10112926, Example 107::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295247&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470547 381618338 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563990 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) IVWMPAOBMMXESU-UHFFFAOYSA-N 295247 US10112926, Example 107::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride Phosphatidylinositol 4-kinase beta Human 660 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295247&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470547 381618338 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563991 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) IVWMPAOBMMXESU-UHFFFAOYSA-N 295247 US10112926, Example 107::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 24.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295247&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470547 381618338 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563992 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NOCC(C)(C)O InChI=1S/C20H24N4O5S/c1-12-5-6-15(30(26,27)24-28-11-20(3,4)25)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)29-18/h5-10,24-25H,11H2,1-4H3,(H2,21,23) IVWMPAOBMMXESU-UHFFFAOYSA-N 295247 US10112926, Example 107::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropoxy)-4-methylbenzenesulfonamide hydrochloride Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 32.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295247&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470547 381618338 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563993 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10-4-5-14(28(25,26)21-8-11(2)24)7-15(10)13-6-16(17(19)20-9-13)18-22-12(3)23-27-18/h4-7,9,11,21,24H,8H2,1-3H3,(H2,19,20) OXKACKLTXZOHOG-UHFFFAOYSA-N 295248 US10112926, Example 108::Rac-3-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 640 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295248&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118472316 381618339 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 563994 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10-4-5-14(28(25,26)21-8-11(2)24)7-15(10)13-6-16(17(19)20-9-13)18-22-12(3)23-27-18/h4-7,9,11,21,24H,8H2,1-3H3,(H2,19,20) OXKACKLTXZOHOG-UHFFFAOYSA-N 295248 US10112926, Example 108::Rac-3-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 7300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295248&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472316 381618339 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 563995 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10-4-5-14(28(25,26)21-8-11(2)24)7-15(10)13-6-16(17(19)20-9-13)18-22-12(3)23-27-18/h4-7,9,11,21,24H,8H2,1-3H3,(H2,19,20) OXKACKLTXZOHOG-UHFFFAOYSA-N 295248 US10112926, Example 108::Rac-3-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295248&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118472316 381618339 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 563996 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10-4-5-14(28(25,26)21-8-11(2)24)7-15(10)13-6-16(17(19)20-9-13)18-22-12(3)23-27-18/h4-7,9,11,21,24H,8H2,1-3H3,(H2,19,20) OXKACKLTXZOHOG-UHFFFAOYSA-N 295248 US10112926, Example 108::Rac-3-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human 5900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295248&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118472316 381618339 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 563997 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10-4-5-14(28(25,26)21-8-11(2)24)7-15(10)13-6-16(17(19)20-9-13)18-22-12(3)23-27-18/h4-7,9,11,21,24H,8H2,1-3H3,(H2,19,20) OXKACKLTXZOHOG-UHFFFAOYSA-N 295248 US10112926, Example 108::Rac-3-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 41.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295248&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472316 381618339 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 563998 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10-4-5-14(28(25,26)21-8-11(2)24)7-15(10)13-6-16(17(19)20-9-13)18-22-12(3)23-27-18/h4-7,9,11,21,24H,8H2,1-3H3,(H2,19,20) OXKACKLTXZOHOG-UHFFFAOYSA-N 295248 US10112926, Example 108::Rac-3-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 140 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295248&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118472316 381618339 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 563999 CC(O)CNS(=O)(=O)c1ccc(C)c(c1)-c1cnc(N)c(c1)-c1nc(C)no1 InChI=1S/C18H21N5O4S/c1-10-4-5-14(28(25,26)21-8-11(2)24)7-15(10)13-6-16(17(19)20-9-13)18-22-12(3)23-27-18/h4-7,9,11,21,24H,8H2,1-3H3,(H2,19,20) OXKACKLTXZOHOG-UHFFFAOYSA-N 295248 US10112926, Example 108::Rac-3-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-N-(2-hydroxypropyl)-4-methylbenzenesulfonamide Serine/threonine-protein kinase mTOR Human >10000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795957 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295248&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 118472316 381618339 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 7TZO,9F45,9F44,9ED8,9ED7,9ED4,8RCN,8RCK,8RCH,8ERA,7UXH,7UXC,6ZWO,6ZWM,5ZCS,5H64,7PE9,7PE8,7PE7,5WBY,5WBU,4JT6,4JT5,4JSX,4JSV,4JSP,4JSN,5FLC,3JBZ,2GAQ,1AUE,5WBH,9NGT,1FAP,4FAP,3FAP,2RSE,2FAP,1NSG,8ER7,8ER6,9DBO,8PPZ,4DRJ,4DRI,4DRH,7EPD Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 564000 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23FN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) XUWNECGLJFPCFS-UHFFFAOYSA-N 295249 US10112926, Example 109::5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 790 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295249&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470062 381618340 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564001 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23FN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) XUWNECGLJFPCFS-UHFFFAOYSA-N 295249 US10112926, Example 109::5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295249&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470062 381618340 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564002 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23FN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) XUWNECGLJFPCFS-UHFFFAOYSA-N 295249 US10112926, Example 109::5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295249&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470062 381618340 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564003 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23FN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) XUWNECGLJFPCFS-UHFFFAOYSA-N 295249 US10112926, Example 109::5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human 5000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295249&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470062 381618340 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564004 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23FN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) XUWNECGLJFPCFS-UHFFFAOYSA-N 295249 US10112926, Example 109::5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 45.5 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295249&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470062 381618340 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564005 Cc1cc(on1)-c1cc(cnc1N)-c1cc(c(F)cc1C)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H23FN4O4S/c1-11-5-16(21)18(30(27,28)24-10-20(3,4)26)8-14(11)13-7-15(19(22)23-9-13)17-6-12(2)25-29-17/h5-9,24,26H,10H2,1-4H3,(H2,22,23) XUWNECGLJFPCFS-UHFFFAOYSA-N 295249 US10112926, Example 109::5-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-2-fluoro-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2000 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295249&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470062 381618340 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 564006 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-5-6-15(29(27,28)23-12-20(2,3)26)10-16(13)14-9-17(19(21)22-11-14)18-7-8-25(4)24-18/h5-11,23,26H,12H2,1-4H3,(H2,21,22) VNMSHPLTTQXABF-UHFFFAOYSA-N 295250 US10112926, Example 110::3-(6-amino-5-(1-methyl-1H-pyrazol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 2750 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295250&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470122 381618341 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564007 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-5-6-15(29(27,28)23-12-20(2,3)26)10-16(13)14-9-17(19(21)22-11-14)18-7-8-25(4)24-18/h5-11,23,26H,12H2,1-4H3,(H2,21,22) VNMSHPLTTQXABF-UHFFFAOYSA-N 295250 US10112926, Example 110::3-(6-amino-5-(1-methyl-1H-pyrazol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 9500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295250&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470122 381618341 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564008 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-5-6-15(29(27,28)23-12-20(2,3)26)10-16(13)14-9-17(19(21)22-11-14)18-7-8-25(4)24-18/h5-11,23,26H,12H2,1-4H3,(H2,21,22) VNMSHPLTTQXABF-UHFFFAOYSA-N 295250 US10112926, Example 110::3-(6-amino-5-(1-methyl-1H-pyrazol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295250&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470122 381618341 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564009 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-5-6-15(29(27,28)23-12-20(2,3)26)10-16(13)14-9-17(19(21)22-11-14)18-7-8-25(4)24-18/h5-11,23,26H,12H2,1-4H3,(H2,21,22) VNMSHPLTTQXABF-UHFFFAOYSA-N 295250 US10112926, Example 110::3-(6-amino-5-(1-methyl-1H-pyrazol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295250&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470122 381618341 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564010 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-5-6-15(29(27,28)23-12-20(2,3)26)10-16(13)14-9-17(19(21)22-11-14)18-7-8-25(4)24-18/h5-11,23,26H,12H2,1-4H3,(H2,21,22) VNMSHPLTTQXABF-UHFFFAOYSA-N 295250 US10112926, Example 110::3-(6-amino-5-(1-methyl-1H-pyrazol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 150 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295250&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470122 381618341 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564011 Cc1ccc(cc1-c1cnc(N)c(c1)-c1ccn(C)n1)S(=O)(=O)NCC(C)(C)O InChI=1S/C20H25N5O3S/c1-13-5-6-15(29(27,28)23-12-20(2,3)26)10-16(13)14-9-17(19(21)22-11-14)18-7-8-25(4)24-18/h5-11,23,26H,12H2,1-4H3,(H2,21,22) VNMSHPLTTQXABF-UHFFFAOYSA-N 295250 US10112926, Example 110::3-(6-amino-5-(1-methyl-1H-pyrazol-3-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1280 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295250&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470122 381618341 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 564012 Cc1cc(on1)-c1cc(cnc1N)-c1cccc(c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-7-17(27-23-12)16-9-14(10-21-18(16)20)13-5-4-6-15(8-13)28(25,26)22-11-19(2,3)24/h4-10,22,24H,11H2,1-3H3,(H2,20,21) PZDXBEADTGGIOD-UHFFFAOYSA-N 295251 US10112926, Example 111::3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)benzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 580 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295251&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470149 381618342 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564013 Cc1cc(on1)-c1cc(cnc1N)-c1cccc(c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-7-17(27-23-12)16-9-14(10-21-18(16)20)13-5-4-6-15(8-13)28(25,26)22-11-19(2,3)24/h4-10,22,24H,11H2,1-3H3,(H2,20,21) PZDXBEADTGGIOD-UHFFFAOYSA-N 295251 US10112926, Example 111::3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)benzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295251&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470149 381618342 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564014 Cc1cc(on1)-c1cc(cnc1N)-c1cccc(c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-7-17(27-23-12)16-9-14(10-21-18(16)20)13-5-4-6-15(8-13)28(25,26)22-11-19(2,3)24/h4-10,22,24H,11H2,1-3H3,(H2,20,21) PZDXBEADTGGIOD-UHFFFAOYSA-N 295251 US10112926, Example 111::3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)benzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 2900 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295251&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470149 381618342 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564015 Cc1cc(on1)-c1cc(cnc1N)-c1cccc(c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-7-17(27-23-12)16-9-14(10-21-18(16)20)13-5-4-6-15(8-13)28(25,26)22-11-19(2,3)24/h4-10,22,24H,11H2,1-3H3,(H2,20,21) PZDXBEADTGGIOD-UHFFFAOYSA-N 295251 US10112926, Example 111::3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)benzenesulfonamide Phosphatidylinositol 4-kinase beta Human 1700 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295251&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470149 381618342 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564016 Cc1cc(on1)-c1cc(cnc1N)-c1cccc(c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-7-17(27-23-12)16-9-14(10-21-18(16)20)13-5-4-6-15(8-13)28(25,26)22-11-19(2,3)24/h4-10,22,24H,11H2,1-3H3,(H2,20,21) PZDXBEADTGGIOD-UHFFFAOYSA-N 295251 US10112926, Example 111::3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)benzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 1400 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295251&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470149 381618342 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564017 Cc1cc(on1)-c1cc(cnc1N)-c1cccc(c1)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22N4O4S/c1-12-7-17(27-23-12)16-9-14(10-21-18(16)20)13-5-4-6-15(8-13)28(25,26)22-11-19(2,3)24/h4-10,22,24H,11H2,1-3H3,(H2,20,21) PZDXBEADTGGIOD-UHFFFAOYSA-N 295251 US10112926, Example 111::3-(6-amino-5-(3-methylisoxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)benzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295251&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470149 381618342 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 564018 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)9-16)10-19(13)15-8-20(22(23)25-11-15)21-12-24-14(2)30-21/h6-8,10-12,16-17,26-27H,3-5,9H2,1-2H3,(H2,23,25) YVBUTAWXLPEFFD-UHFFFAOYSA-N 295252 US10112926, Example 112::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1S,3S)-3-hydroxycyclohexyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 140 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295252&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118469997 381618343 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564019 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)9-16)10-19(13)15-8-20(22(23)25-11-15)21-12-24-14(2)30-21/h6-8,10-12,16-17,26-27H,3-5,9H2,1-2H3,(H2,23,25) YVBUTAWXLPEFFD-UHFFFAOYSA-N 295252 US10112926, Example 112::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1S,3S)-3-hydroxycyclohexyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 660 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295252&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469997 381618343 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564020 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)9-16)10-19(13)15-8-20(22(23)25-11-15)21-12-24-14(2)30-21/h6-8,10-12,16-17,26-27H,3-5,9H2,1-2H3,(H2,23,25) YVBUTAWXLPEFFD-UHFFFAOYSA-N 295252 US10112926, Example 112::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1S,3S)-3-hydroxycyclohexyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 3500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295252&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118469997 381618343 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564021 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)9-16)10-19(13)15-8-20(22(23)25-11-15)21-12-24-14(2)30-21/h6-8,10-12,16-17,26-27H,3-5,9H2,1-2H3,(H2,23,25) YVBUTAWXLPEFFD-UHFFFAOYSA-N 295252 US10112926, Example 112::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1S,3S)-3-hydroxycyclohexyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human 730 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295252&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118469997 381618343 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564022 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)9-16)10-19(13)15-8-20(22(23)25-11-15)21-12-24-14(2)30-21/h6-8,10-12,16-17,26-27H,3-5,9H2,1-2H3,(H2,23,25) YVBUTAWXLPEFFD-UHFFFAOYSA-N 295252 US10112926, Example 112::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1S,3S)-3-hydroxycyclohexyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 38.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295252&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469997 381618343 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564023 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)N[C@H]1CCC[C@H](O)C1 |r| InChI=1S/C22H26N4O4S/c1-13-6-7-18(31(28,29)26-16-4-3-5-17(27)9-16)10-19(13)15-8-20(22(23)25-11-15)21-12-24-14(2)30-21/h6-8,10-12,16-17,26-27H,3-5,9H2,1-2H3,(H2,23,25) YVBUTAWXLPEFFD-UHFFFAOYSA-N 295252 US10112926, Example 112::3-(6-amino-5-(2-methyloxazol-5-yl)pyridin-3-yl)-N-((1S,3S)-3-hydroxycyclohexyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 410 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295252&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118469997 381618343 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 564024 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)13(7-16(10)30(27,28)23-9-19(3,4)26)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DJVHYZVMRNHCLP-UHFFFAOYSA-N 295253 US10112926, Example 113::5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-fluoro-N-(2-hydroxy-2-methylpropyl)-2-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 1150 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295253&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470115 381618344 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564025 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)13(7-16(10)30(27,28)23-9-19(3,4)26)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DJVHYZVMRNHCLP-UHFFFAOYSA-N 295253 US10112926, Example 113::5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-fluoro-N-(2-hydroxy-2-methylpropyl)-2-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 8850 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295253&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470115 381618344 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564026 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)13(7-16(10)30(27,28)23-9-19(3,4)26)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DJVHYZVMRNHCLP-UHFFFAOYSA-N 295253 US10112926, Example 113::5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-fluoro-N-(2-hydroxy-2-methylpropyl)-2-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295253&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470115 381618344 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564027 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)13(7-16(10)30(27,28)23-9-19(3,4)26)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DJVHYZVMRNHCLP-UHFFFAOYSA-N 295253 US10112926, Example 113::5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-fluoro-N-(2-hydroxy-2-methylpropyl)-2-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human 2450 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295253&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470115 381618344 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564028 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)13(7-16(10)30(27,28)23-9-19(3,4)26)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DJVHYZVMRNHCLP-UHFFFAOYSA-N 295253 US10112926, Example 113::5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-fluoro-N-(2-hydroxy-2-methylpropyl)-2-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 305 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295253&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470115 381618344 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564029 Cc1noc(n1)-c1cc(cnc1N)-c1cc(c(C)cc1F)S(=O)(=O)NCC(C)(C)O InChI=1S/C19H22FN5O4S/c1-10-5-15(20)13(7-16(10)30(27,28)23-9-19(3,4)26)12-6-14(17(21)22-8-12)18-24-11(2)25-29-18/h5-8,23,26H,9H2,1-4H3,(H2,21,22) DJVHYZVMRNHCLP-UHFFFAOYSA-N 295253 US10112926, Example 113::5-(6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-3-yl)-4-fluoro-N-(2-hydroxy-2-methylpropyl)-2-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 2600 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295253&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470115 381618344 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 564030 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)24-11-20(25)5-6-20)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h3-4,7-10,24-25H,5-6,11H2,1-2H3,(H2,21,23) CFXFNGXSAGVSFT-UHFFFAOYSA-N 295254 US10112926, Example 114.1::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 250 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295254&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470537 381618345 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564031 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)24-11-20(25)5-6-20)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h3-4,7-10,24-25H,5-6,11H2,1-2H3,(H2,21,23) CFXFNGXSAGVSFT-UHFFFAOYSA-N 295254 US10112926, Example 114.1::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295254&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470537 381618345 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564032 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)24-11-20(25)5-6-20)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h3-4,7-10,24-25H,5-6,11H2,1-2H3,(H2,21,23) CFXFNGXSAGVSFT-UHFFFAOYSA-N 295254 US10112926, Example 114.1::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 3400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295254&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470537 381618345 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564033 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)24-11-20(25)5-6-20)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h3-4,7-10,24-25H,5-6,11H2,1-2H3,(H2,21,23) CFXFNGXSAGVSFT-UHFFFAOYSA-N 295254 US10112926, Example 114.1::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 4500 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295254&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470537 381618345 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564034 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)24-11-20(25)5-6-20)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h3-4,7-10,24-25H,5-6,11H2,1-2H3,(H2,21,23) CFXFNGXSAGVSFT-UHFFFAOYSA-N 295254 US10112926, Example 114.1::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 77.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295254&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470537 381618345 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564035 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CC1 InChI=1S/C20H22N4O4S/c1-12-3-4-15(29(26,27)24-11-20(25)5-6-20)8-16(12)14-7-17(19(21)23-9-14)18-10-22-13(2)28-18/h3-4,7-10,24-25H,5-6,11H2,1-2H3,(H2,21,23) CFXFNGXSAGVSFT-UHFFFAOYSA-N 295254 US10112926, Example 114.1::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((1- hydroxycyclopropyl) methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1200 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295254&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470537 381618345 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 564036 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C(F)(F)F InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)6-14(10)12-5-15(18(23)25-7-12)16-8-24-11(2)30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,25) PKROJKUFSWAOPD-UHFFFAOYSA-N 295255 US10112926, Example 114.2::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(1,1,1- trifluoro-3- hydroxypropan-2- yl)benzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 410 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295255&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512398 381618346 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564037 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C(F)(F)F InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)6-14(10)12-5-15(18(23)25-7-12)16-8-24-11(2)30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,25) PKROJKUFSWAOPD-UHFFFAOYSA-N 295255 US10112926, Example 114.2::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(1,1,1- trifluoro-3- hydroxypropan-2- yl)benzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 2800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295255&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512398 381618346 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564038 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C(F)(F)F InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)6-14(10)12-5-15(18(23)25-7-12)16-8-24-11(2)30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,25) PKROJKUFSWAOPD-UHFFFAOYSA-N 295255 US10112926, Example 114.2::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(1,1,1- trifluoro-3- hydroxypropan-2- yl)benzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 4400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295255&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512398 381618346 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564039 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C(F)(F)F InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)6-14(10)12-5-15(18(23)25-7-12)16-8-24-11(2)30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,25) PKROJKUFSWAOPD-UHFFFAOYSA-N 295255 US10112926, Example 114.2::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(1,1,1- trifluoro-3- hydroxypropan-2- yl)benzenesulfonamide Phosphatidylinositol 4-kinase beta Human 2300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295255&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512398 381618346 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564040 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C(F)(F)F InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)6-14(10)12-5-15(18(23)25-7-12)16-8-24-11(2)30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,25) PKROJKUFSWAOPD-UHFFFAOYSA-N 295255 US10112926, Example 114.2::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(1,1,1- trifluoro-3- hydroxypropan-2- yl)benzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 120 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295255&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512398 381618346 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564041 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC(CO)C(F)(F)F InChI=1S/C19H19F3N4O4S/c1-10-3-4-13(31(28,29)26-17(9-27)19(20,21)22)6-14(10)12-5-15(18(23)25-7-12)16-8-24-11(2)30-16/h3-8,17,26-27H,9H2,1-2H3,(H2,23,25) PKROJKUFSWAOPD-UHFFFAOYSA-N 295255 US10112926, Example 114.2::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-4- methyl-N-(1,1,1- trifluoro-3- hydroxypropan-2- yl)benzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1300 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295255&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512398 381618346 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 564042 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)26-13-22(27)5-7-30-8-6-22)10-18(14)16-9-19(21(23)25-11-16)20-12-24-15(2)31-20/h3-4,9-12,26-27H,5-8,13H2,1-2H3,(H2,23,25) YYPWGZLHIYHJDM-UHFFFAOYSA-N 295256 US10112926, Example 114.3::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- hydroxytetrahydro- 2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 590 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295256&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512204 381618347 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564043 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)26-13-22(27)5-7-30-8-6-22)10-18(14)16-9-19(21(23)25-11-16)20-12-24-15(2)31-20/h3-4,9-12,26-27H,5-8,13H2,1-2H3,(H2,23,25) YYPWGZLHIYHJDM-UHFFFAOYSA-N 295256 US10112926, Example 114.3::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- hydroxytetrahydro- 2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 8400 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295256&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512204 381618347 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564044 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)26-13-22(27)5-7-30-8-6-22)10-18(14)16-9-19(21(23)25-11-16)20-12-24-15(2)31-20/h3-4,9-12,26-27H,5-8,13H2,1-2H3,(H2,23,25) YYPWGZLHIYHJDM-UHFFFAOYSA-N 295256 US10112926, Example 114.3::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- hydroxytetrahydro- 2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human >10000 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295256&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512204 381618347 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564045 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)26-13-22(27)5-7-30-8-6-22)10-18(14)16-9-19(21(23)25-11-16)20-12-24-15(2)31-20/h3-4,9-12,26-27H,5-8,13H2,1-2H3,(H2,23,25) YYPWGZLHIYHJDM-UHFFFAOYSA-N 295256 US10112926, Example 114.3::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- hydroxytetrahydro- 2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 8100 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295256&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512204 381618347 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564046 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)26-13-22(27)5-7-30-8-6-22)10-18(14)16-9-19(21(23)25-11-16)20-12-24-15(2)31-20/h3-4,9-12,26-27H,5-8,13H2,1-2H3,(H2,23,25) YYPWGZLHIYHJDM-UHFFFAOYSA-N 295256 US10112926, Example 114.3::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- hydroxytetrahydro- 2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 120 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295256&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512204 381618347 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564047 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NCC1(O)CCOCC1 InChI=1S/C22H26N4O5S/c1-14-3-4-17(32(28,29)26-13-22(27)5-7-30-8-6-22)10-18(14)16-9-19(21(23)25-11-16)20-12-24-15(2)31-20/h3-4,9-12,26-27H,5-8,13H2,1-2H3,(H2,23,25) YYPWGZLHIYHJDM-UHFFFAOYSA-N 295256 US10112926, Example 114.3::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-((4- hydroxytetrahydro- 2H-pyran-4- yl)methyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 1700 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295256&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512204 381618347 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 564048 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)(C1)C(F)(F)F InChI=1S/C22H23F3N4O4S/c1-12-3-4-16(34(31,32)29-15-5-6-21(30,9-15)22(23,24)25)8-17(12)14-7-18(20(26)28-10-14)19-11-27-13(2)33-19/h3-4,7-8,10-11,15,29-30H,5-6,9H2,1-2H3,(H2,26,28) LEWJWUJNURRNQY-UHFFFAOYSA-N 295257 US10112926, Example 114.4::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-3- (trifluoromethyl)cyclo- pentyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 80.0 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295257&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 126512379 381618348 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564049 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)(C1)C(F)(F)F InChI=1S/C22H23F3N4O4S/c1-12-3-4-16(34(31,32)29-15-5-6-21(30,9-15)22(23,24)25)8-17(12)14-7-18(20(26)28-10-14)19-11-27-13(2)33-19/h3-4,7-8,10-11,15,29-30H,5-6,9H2,1-2H3,(H2,26,28) LEWJWUJNURRNQY-UHFFFAOYSA-N 295257 US10112926, Example 114.4::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-3- (trifluoromethyl)cyclo- pentyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295257&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512379 381618348 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564050 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)(C1)C(F)(F)F InChI=1S/C22H23F3N4O4S/c1-12-3-4-16(34(31,32)29-15-5-6-21(30,9-15)22(23,24)25)8-17(12)14-7-18(20(26)28-10-14)19-11-27-13(2)33-19/h3-4,7-8,10-11,15,29-30H,5-6,9H2,1-2H3,(H2,26,28) LEWJWUJNURRNQY-UHFFFAOYSA-N 295257 US10112926, Example 114.4::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-3- (trifluoromethyl)cyclo- pentyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 1200 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295257&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 126512379 381618348 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564051 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)(C1)C(F)(F)F InChI=1S/C22H23F3N4O4S/c1-12-3-4-16(34(31,32)29-15-5-6-21(30,9-15)22(23,24)25)8-17(12)14-7-18(20(26)28-10-14)19-11-27-13(2)33-19/h3-4,7-8,10-11,15,29-30H,5-6,9H2,1-2H3,(H2,26,28) LEWJWUJNURRNQY-UHFFFAOYSA-N 295257 US10112926, Example 114.4::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-3- (trifluoromethyl)cyclo- pentyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4-kinase beta Human 630 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295257&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 126512379 381618348 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564052 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)(C1)C(F)(F)F InChI=1S/C22H23F3N4O4S/c1-12-3-4-16(34(31,32)29-15-5-6-21(30,9-15)22(23,24)25)8-17(12)14-7-18(20(26)28-10-14)19-11-27-13(2)33-19/h3-4,7-8,10-11,15,29-30H,5-6,9H2,1-2H3,(H2,26,28) LEWJWUJNURRNQY-UHFFFAOYSA-N 295257 US10112926, Example 114.4::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-3- (trifluoromethyl)cyclo- pentyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 49.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295257&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512379 381618348 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564053 Cc1ncc(o1)-c1cc(cnc1N)-c1cc(ccc1C)S(=O)(=O)NC1CCC(O)(C1)C(F)(F)F InChI=1S/C22H23F3N4O4S/c1-12-3-4-16(34(31,32)29-15-5-6-21(30,9-15)22(23,24)25)8-17(12)14-7-18(20(26)28-10-14)19-11-27-13(2)33-19/h3-4,7-8,10-11,15,29-30H,5-6,9H2,1-2H3,(H2,26,28) LEWJWUJNURRNQY-UHFFFAOYSA-N 295257 US10112926, Example 114.4::3-(6-amino-5-(2- methyloxazol-5- yl)pyridin-3-yl)-N-(3- hydroxy-3- (trifluoromethyl)cyclo- pentyl)-4- methylbenzenesulfon- amide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 190 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295257&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 126512379 381618348 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49 564054 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnc(o1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)26-12-22(2,3)27)9-17(13)15-8-18(20(23)24-10-15)19-11-25-21(30-19)14-5-6-14/h4,7-11,14,26-27H,5-6,12H2,1-3H3,(H2,23,24) QATDLTPQGNUUQD-UHFFFAOYSA-N 295258 US10112926, Example 115::3-(6-Amino-5-(2-cyclopropyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase regulatory subunit alpha Human 280 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=375&target=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295258&enzyme=Phosphatidylinositol+3-kinase+regulatory+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 118470084 381618349 1 MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR 8W9A,8TU6,8H37,8H36,9LWS,9LWR,9LWQ,8ILV,8ILS,8ILR,8GUB,8DD8,8DD4,8DCX,8DCP,7MYO,7MYN,5ITD,5FI4,4WAF,8TSD,8TSC,8TSB,8TSA,8TS9,8TS8,8TS7,4YKN,8SBJ,8SBC,7PG6,7PG5,5UL1,5UKJ,5UK8,4JPS,8TGD,8TDU,8AM0,7TZ7,4ZOP,8W9B,8V8V,8V8U,8V8J,8V8I,8V8H,6NCT,5SXK,5SXJ,5SXI,5SXF,5SXE,5SXD,5SXC,5SXB,5SXA,5SX9,5SX8,5SWT,5SWR,5SWP,5SWO,5SWG,5SW8,4OVV,4OVU,4A55,2RD0,5XGJ,5XGI,5XGH,1PBW,7RNS,1BFJ,1BFI,1QAD,5AUL,7RNU,1PHT,3I5S,3I5R,1PKT,1PKS Phosphatidylinositol 3-kinase regulatory subunit alpha P85A_HUMAN P27986 B3KT19 D3DWA0 E7EX19 Q15747 Q4VBZ7 Q53EM6 Q8IXA2 Q8N1C5 564055 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnc(o1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)26-12-22(2,3)27)9-17(13)15-8-18(20(23)24-10-15)19-11-25-21(30-19)14-5-6-14/h4,7-11,14,26-27H,5-6,12H2,1-3H3,(H2,23,24) QATDLTPQGNUUQD-UHFFFAOYSA-N 295258 US10112926, Example 115::3-(6-Amino-5-(2-cyclopropyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human 1300 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2107&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295258&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+beta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470084 381618349 1 MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform PK3CB_HUMAN P42338 D3DNF0 Q24JU2 564056 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnc(o1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)26-12-22(2,3)27)9-17(13)15-8-18(20(23)24-10-15)19-11-25-21(30-19)14-5-6-14/h4,7-11,14,26-27H,5-6,12H2,1-3H3,(H2,23,24) QATDLTPQGNUUQD-UHFFFAOYSA-N 295258 US10112926, Example 115::3-(6-Amino-5-(2-cyclopropyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 3-kinase catalytic subunit type 3 Human 6800 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2763&target=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295258&enzyme=Phosphatidylinositol+3-kinase+catalytic+subunit+type+3&column=ki&startPg=0&Increment=50&submit=Search 118470084 381618349 1 MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK 9MHH,9MHG,9MHF,9C82,8SOR,7BL1,3LS8,5ANL,4UWL,4UWK,4UWH,4UWG,4UWF,4OYS,8RXR,3IHY,5ENN,4PH4 Phosphatidylinositol 3-kinase catalytic subunit type 3 PK3C3_HUMAN Q8NEB9 Q15134 564057 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnc(o1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)26-12-22(2,3)27)9-17(13)15-8-18(20(23)24-10-15)19-11-25-21(30-19)14-5-6-14/h4,7-11,14,26-27H,5-6,12H2,1-3H3,(H2,23,24) QATDLTPQGNUUQD-UHFFFAOYSA-N 295258 US10112926, Example 115::3-(6-Amino-5-(2-cyclopropyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4-kinase beta Human 620 7.5000 25.00 C US Patent 10.7270/Q22R3TQ9 aid1795955 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7798&target=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295258&enzyme=Phosphatidylinositol+4-kinase+beta&column=ki&startPg=0&Increment=50&submit=Search 118470084 381618349 1 MGDTVVEPAPLKPTSEPTSGPPGNNGGSLLSVITEGVGELSVIDPEVAQKACQEVLEKVKLLHGGVAVSSRGTPLELVNGDGVDSEIRCLDDPPAQIREEEDEMGAAVASGTAKGARRRRQNNSAKQSWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSVENLPECGITHEQRAGSFSTVPNYDNDDEAWSVDDIGELQVELPEVHTNSCDNISQFSVDSITSQESKEPVFIAAGDIRRRLSEQLAHTPTAFKRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRSITTKLYDGFQYLTNGIM 8Q6H,8Q6G,8Q6F,5FBW,5FBV,5FBR,5FBQ,5FBL,4WAG,4WAE,6GL3,2N73 Phosphatidylinositol 4-kinase beta PI4KB_HUMAN Q9UBF8 B4DGI2 O15096 P78405 Q5VWB9 Q5VWC0 Q5VWC1 Q9BWR6 564058 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnc(o1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)26-12-22(2,3)27)9-17(13)15-8-18(20(23)24-10-15)19-11-25-21(30-19)14-5-6-14/h4,7-11,14,26-27H,5-6,12H2,1-3H3,(H2,23,24) QATDLTPQGNUUQD-UHFFFAOYSA-N 295258 US10112926, Example 115::3-(6-Amino-5-(2-cyclopropyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human 13.0 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2113&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295258&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+gamma+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470084 381618349 1 MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA 8DP0,7MEZ,5KAE,5EDS,4WWP,4WWO,4WWN,4DK5,5JHB,5JHA,4FLH,4FJZ,4FJY,4FHK,4FHJ,4F1S,4AOF,3S2A,3QK0,3QJZ,3QAR,3QAQ,3L13,3DBS,8SC8,7Z61,7KKE,7JX0,7JWZ,7JWE,6T3C,6T3B,6GQ7,6FH5,6C1S,5T23,4URK,4J6I,4HLE,4GB9,4G11,4FAD,4FA6,3ZW3,3ZVV,3TL5,3T8M,3R7R,3R7Q,3PS6,3PRZ,3PRE,3OAW,3L17,3L16,3L08,3CST,3CSF,3APF,3APD,3APC,9GG9,5G2N,4ANW,4ANU,6XRN,6XRM,6XRL,3NZU,3NZS,1E90,1E8X,1E8W,1E7V Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform PK3CG_HUMAN P48736 A4D0Q6 Q8IV23 Q9BZC8 564059 Cc1ccc(cc1-c1cnc(N)c(c1)-c1cnc(o1)C1CC1)S(=O)(=O)NCC(C)(C)O InChI=1S/C22H26N4O4S/c1-13-4-7-16(31(28,29)26-12-22(2,3)27)9-17(13)15-8-18(20(23)24-10-15)19-11-25-21(30-19)14-5-6-14/h4,7-11,14,26-27H,5-6,12H2,1-3H3,(H2,23,24) QATDLTPQGNUUQD-UHFFFAOYSA-N 295258 US10112926, Example 115::3-(6-Amino-5-(2-cyclopropyloxazol-5-yl)pyridin-3-yl)-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human 380 7.5000 US Patent 10.7270/Q22R3TQ9 aid1795956 US10112926 Bellenie, BR; Bloomfield, GC; Bruce, I; Culshaw, AJ; Hall, EC; Hollingworth, GJ; Neef, J; Spendiff, M; Watson, SJ 10/30/2018 3/2/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=295258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2109&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=295258&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+delta+isoform&column=ki&startPg=0&Increment=50&submit=Search 118470084 381618349 1 MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ 9L3R,9GDI,9GCF,7LQ1,6OCU,5DXU,6G6W,7LM2,8S3R,8BCY,7JIS,6PYU,6PYR,6OCO,5T8F,5VLR,5UBT,5M6U Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform PK3CD_HUMAN O00329 A6NCG0 G1FFP1 O15445 Q5SR49